
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Moderna Inc: 2 directors</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Moderna Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Moderna Inc (MRNA) - Financial Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">384</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Moderna: Analyst Q&A feedback: shingles back on the radar?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Niall Alexander / Manos Mastorakis / Mr. Rajan Sharma</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US0021202025 / US52187K1016 / US7599161095 / US1920051067 / US68403P2039 / US29251M1062 / US29428V1044 / US31189P1021 / US5560991094 / US83587F2020 / US00771V1089 / US78667J1088 / US67576A1007 / CA98420N1050 / US2681582019 / US7207951036 / US68235C1071 / US45826J1051 / US4834971032 / US0327241065 / CA98985W1023 / US98887Q1040 / US6085501095 / US59045L1061 / US03969F1093 / US53635D2027 / US9842411095 / US29772L1089 / US60770K1079 / US15117B2025 / US21900C3088 / US90041T1088 / US46583P1021 / US68236P1075 / US3596161097 / US75382E1091 / US00166B1052 / US0843101017 / US45720L1070 / US82024L1035 / US3441741077 / US89422G1076</td><td class="leftalignment">aTyr Pharma Inc / Leap Therapeutics Inc / Repligen Corp / Codexis Inc / Oramed Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Sorrento Therapeutics Inc / Aerie Pharmaceuticals Inc / SAGE Therapeutics Inc / Ocular Therapeutix Inc / Xenon Pharmaceuticals Inc / Dynavax Technologies Corp / Pieris Pharmaceuticals Inc / OncoCyte Corp / Intellia Therapeutics Inc / Kalvista Pharmaceuticals Inc / AnaptysBio Inc / Zymeworks Inc / Zai Lab Ltd / Molecular Templates Inc / Mersana Therapeutics Inc / Arcus Biosciences Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Eton Pharmaceuticals Inc / Moderna Inc / Celldex Therapeutics Inc / CorMedix Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Oncternal Therapeutics Inc / Fulcrum Therapeutics Inc / Rapt Therapeutics Inc / ALX Oncology Holdings Inc / Berkeley Lights Inc / Inhibrx Inc / Shattuck Labs Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Major healthcare conference in Jan-2022-Day 1 takeaways</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CHRS.OQ / NVAX.OQ / MRNA.OQ / CTLT.N / 2269.HK / ZLAB.OQ</td><td class="leftalignment">Coherus BioSciences Inc / Novavax Inc / Moderna Inc / Catalent Inc / WuXi Biologics (Cayman) Inc / Zai Lab Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Moderna: Brief takes on today’s updates</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Niall Alexander / Manos Mastorakis / Mr. Rajan Sharma</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">COVID Vaccine Revenues of $17.5B in 2021 and Guided to $18.5-22B in 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : Live from the J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">FY2021 Sales Come In Above Consensus; 2022 APAs Increase 9% To $18.5B</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: ALNY/NVS Liver Collab; SGMO Regains SCD Rights</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ALNY.OQ / SGMO.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Sangamo Therapeutics Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology: 2022 Outlook: Sentiment & Valuations Have Been Reset, but Underlying Themes driving Digitization in HC Remain Intact</td><td class="leftalignment">English</td><td class="rightalignment">159</td><td class="leftalignment">AMWL.N / GDRX.OQ / BBY.N / WMT.N / ORCL.N / PFIZ.NS / CERN.OQ / MSFT.OQ / AMZN.OQ / MDRX.OQ / NUAN.OQ / OSH.N / EHTH.OQ / MRNA.OQ / CHNG.OQ / VCRA.N / PINC.OQ / CSLT.N / GOOGL.OQ / HQY.OQ / EVH.N / TDOC.N / TRHC.OQ / TVTY.OQ / FB.PS / NXGN.OQ / LYFT.OQ / ZM.OQ / ONEM.OQ / ACCD.OQ / SLQT.N / GOCO.OQ / MPLN.N / TLMD.OQ / HIMS.N / PRVA.OQ / CANO.N / DH.OQ</td><td class="leftalignment">American Well Corp / Goodrx Holdings Inc / Best Buy Co Inc / Walmart Inc / Oracle Corp / Pfizer Ltd / Cerner Corp / Microsoft Corp / Amazon.com Inc / Allscripts Healthcare Solutions Inc / Nuance Communications Inc / Oak Street Health Inc / eHealth Inc / Moderna Inc / Change Healthcare Inc / Vocera Communications Inc / Premier Inc / Castlight Health Inc / Alphabet Inc / Healthequity Inc / Evolent Health Inc / Teladoc Health Inc / Tabula Rasa HealthCare Inc / Tivity Health Inc / San Miguel Food and Beverage Inc / NextGen Healthcare Inc / Lyft Inc / Zoom Video Communications Inc / 1Life Healthcare Inc / Accolade Inc / SelectQuote Inc / Gohealth Inc / Multiplan Corp / Soc Telemed Inc / Hims & Hers Health Inc / Privia Health Group Inc / Cano Health Inc / Definitive Healthcare Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">India / Philippines / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Carlos Consuegra / Jialin (Jay) Jin</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: Biotech funding growth does not appear to be a good indicator of CXO revenue growth</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LONN.S / CRL.N / ICLR.OQ / MRNA.OQ / EDIT.OQ / 2269.HK</td><td class="leftalignment">Lonza Group AG / Charles River Laboratories International Inc / ICON PLC / Moderna Inc / Editas Medicine Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, MRNA</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / BA.N / BBY.N / CAH.N / CCK.N / CE.N / EOG.N / F.N / HIG.N / HLT.N / KEY.N / MRK.N / OXY.N / PFE.N / RHI.N / TMX.N / TOL.N / UAL.N / USB.N / VNT.N / ZEN.N / DIS.N / WLK.N / GD.N / CR.N / AFG.N / SPOT.N / AMG.N / RCL.N / IFF.N / DV.N / LH.N / FNF.N / DVN.N / OLN.N / TGT.N / RKT.N / SNV.N / AMP.N / HXL.N / AZO.N / FDS.N / EQT.N / ATO.N / HWM.N / BYD.N / DNB.N / HRL.N / SAM.N / ABC.N / JNPR.N / GME.N / TDY.N / COP.N / INTC.OQ / ORI.N / ADPT.OQ / AGL.N / CRUS.OQ / FAF.N / FISV.OQ / HOLX.OQ / KLAC.OQ / MKL.N / RJF.N / RGEN.OQ / SEIC.OQ / SF.N / FL.N / QCOM.OQ / NKTR.OQ / TPR.N / SRCL.OQ / MRCY.OQ / MRVL.OQ / ILMN.OQ / WOOF.OQ / WYNN.OQ / PA1436583006 / MNST.OQ / MOH.N / EXP.N / OSH.N / LVS.N / OC.N / FRPT.OQ / BX.N / NVR.N / WRB.N / MRNA.OQ / CLH.N / AI.N / AVGO.OQ / NXPI.OQ / BAH.N / CZR.OQ / TRGP.N / MSP.N / HII.N / Z.OQ / TRIP.OQ / ALSN.N / FB.OQ / BERY.N / FANG.OQ / WEX.N / RNG.N / NCLH.N / FIVN.OQ / SYF.N / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / COUP.OQ / UAA.N / OKTA.OQ / CVNA.N / ROKU.OQ / KDP.N / PLAN.N / NFE.OQ / LYFT.O / BYND.OQ / UBER.N / CRWD.OQ / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / JAMF.OQ / BEPC.N / DCT.OQ / PLTR.N / SHC.OQ / SKLZ.N / CLVT.N / SGFY.N / VMEO.OQ / FIGS.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Boeing Co / Best Buy Co Inc / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / KeyCorp / Merck & Co Inc / Occidental Petroleum Corp / Pfizer Inc / Robert Half International Inc / Terminix Global Holdings Inc / Toll Brothers Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Walt Disney Co / Westlake Chemical Corp / General Dynamics Corp / Crane Co / American Financial Group Inc / Spotify Technology SA / Affiliated Managers Group Inc / Royal Caribbean Cruises Ltd / International Flavors & Fragrances Inc / DoubleVerify Holdings Inc / Laboratory Corporation of America Holdings / Fidelity National Financial Inc / Devon Energy Corp / Olin Corp / Target Corp / Rocket Companies Inc / Synovus Financial Corp / Ameriprise Financial Inc / Hexcel Corp / Autozone Inc / Factset Research Systems Inc / EQT Corp / Atmos Energy Corp / Howmet Aerospace Inc / Boyd Gaming Corp / Dun & Bradstreet Holdings Inc / Hormel Foods Corp / Boston Beer Company Inc / Amerisourcebergen Corp / Juniper Networks Inc / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / agilon health Inc / Cirrus Logic Inc / First American Financial Corp / Fiserv Inc / Hologic Inc / KLA Corp / Markel Corp / Raymond James Financial Inc / Repligen Corp / SEI Investments Co / Stifel Financial Corp / Foot Locker Inc / Qualcomm Inc / Nektar Therapeutics / Tapestry Inc / Stericycle Inc / Mercury Systems Inc / Marvell Technology Inc / Illumina Inc / Petco Health and Wellness Company Inc / Wynn Resorts Ltd / Carnival Corp / Monster Beverage Corp / Molina Healthcare Inc / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Owens Corning / Freshpet Inc / Blackstone Inc / NVR Inc / W R Berkley Corp / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / NXP Semiconductors NV / Booz Allen Hamilton Holding Corp / Caesars Entertainment Inc / Targa Resources Corp / Datto Holding Corp / Huntington Ingalls Industries Inc / Zillow Group Inc / Tripadvisor Inc / Allison Transmission Holdings Inc / Meta Platforms Inc / Berry Global Group Inc / Diamondback Energy Inc / WEX Inc / RingCentral Inc / Norwegian Cruise Line Holdings Ltd / Five9 Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Coupa Software Inc / Under Armour Inc / Okta Inc / Carvana Co / Roku Inc / Keurig Dr Pepper Inc / Anaplan Inc / New Fortress Energy Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Jamf Holding Corp / Brookfield Renewable Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / Skillz Inc / CLARIVATE PLC / Signify Health Inc / Vimeo Inc / Figs Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Liberia / Luxembourg / Netherlands / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">First Patient Dosed in Phase I Eclipse Study of Epstein-Barr Virus Vaccine</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Moderna, Inc. (MRNA) - Moderna could face lawsuit over COVID vaccine</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - Feedback from sell-side vaccines meeting</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">SASY.PA / PFE.N / AZN.L / GSK.L / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Sanofi SA / Pfizer Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Jan. 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / BA.N / BAC.N / C.N / CCL.N / CF.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / JPM.N / LLY.N / LUV.N / MDT.N / PFE.N / RHI.N / T.N / TMO.N / WFC.N / DRE.N / SPG.N / PG.N / NUE.N / DIS.N / UNH.N / TFX.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / IT.N / GWW.N / VZ.N / V.N / ACN.N / PLD.N / TWTR.N / MAA.N / HPQ.N / COP.N / AOS.N / AAPL.OQ / AMAT.OQ / CERN.OQ / CSCO.OQ / FISV.OQ / ATVI.OQ / MSFT.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / COST.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / CZR.OQ / AMD.OQ / FANG.OQ / ABBV.N / LEGN.DE / NCLH.N / GOOGL.OQ / PAYC.N / ANET.N / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Abbott Laboratories / Boeing Co / Bank of America Corp / Citigroup Inc / Carnival Corp / CF Industries Holdings Inc / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / JPMorgan Chase & Co / Eli Lilly and Co / Southwest Airlines Co / Medtronic PLC / Pfizer Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Duke Realty Corp / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / Visa Inc / Accenture PLC / Prologis Inc / Twitter Inc / Mid-America Apartment Communities Inc / HP Inc / Conocophillips / A O Smith Corp / Apple Inc / Applied Materials Inc / Cerner Corp / Cisco Systems Inc / Fiserv Inc / Activision Blizzard Inc / Microsoft Corp / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Costco Wholesale Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Caesars Entertainment Inc / Advanced Micro Devices Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Germany / Ireland / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Jan 2022</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / AMGN.OQ / NVAX.OQ / 006280.KS / TEVA.N / MRNA.OQ / 068270.KS / 086900.KQ / 207940.KS / 091990.KQ / 302440.KS</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Amgen Inc / Novavax Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Moderna Inc / Celltrion Inc / Medy Tox Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Indonesia Market Strategy: CS Monthly Insight: Virus mutation, higher rates, and economic recovery</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">7203.T / ASII.JK / CTRA.JK / JNJ.N / PFE.N / SMRA.JK / BMRI.JK / MRNA.OQ / TCSQ.L / ARTO.JK / BUKA.JK</td><td class="leftalignment">Toyota Motor Corp / Astra International Tbk PT / Ciputra Development Tbk PT / Johnson & Johnson / Pfizer Inc / Summarecon Agung Tbk PT / Bank Mandiri (Persero) Tbk PT / Moderna Inc / TCS Group Holding PLC / Bank Jago Tbk PT / Bukalapak.com Tbk PT</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cyprus / Indonesia / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">ECONOMIC REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ungfru Hanel T. Topada / Mr. Gregorius Gary</td></tr>
<tr class="odd"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">1H22 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">375558103 / 031162100 / 766559603 / 09062X103 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G50871105 / 03835T200 / 78667J108 / 03209R103 / 16383L106 / 868459108 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 68404V100 / 98401F105 / 23284F105 / 03168L105 / 80706P103 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 87808K106 / 483347100 / 37890U108 / 29668H708 / 68906L105 / 04016X101 / 87184Q107 / 481116101 / 59935V107 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 05454B105 / 729139105 / 00972D105 / 760273102 / 00973J101 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 80810D103 / 92243A200 / 74366E102 / 00166B105 / 45790W108 / 04335A105 / 23257D103 / 76029N106 / 4525EP101 / 46565G104 / 52490G102 / 75382E109 / 38341P102 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 92556V106 / 03890D108 / 03835L207 / 413197104 / 002120202 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 00288U106 / 38406L103 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 75974E103 / 09077A106 / 75082Q105 / 23954D109 / 15673T100 / 61225M102 / 730541109 / 670703107 / 68217N105 / 87978U108 / 00032Q104</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Jazz Pharmaceuticals PLC / Aptose Biosciences Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Supernus Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Scholar Rock Holding Corp / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / ESSA Pharma Inc / Otonomy Inc / argenx SE / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Milestone Pharmaceuticals Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Axcella Health Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / Akouos Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Schrodinger Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Replimune Group Inc / Immunic Inc / Iteos Therapeutics Inc / Legend Biotech Corp / Rapt Therapeutics Inc / Gossamer Bio Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Viatris Inc / Aravive Inc / Aptevo Therapeutics Inc / Harmony Biosciences Holdings Inc / aTyr Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Abcellera Biologics Inc / Gracell Biotechnologies Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Reneo Pharmaceuticals Inc / Biomea Fusion Inc / Rain Therapeutics Inc / Day One Biopharmaceuticals Inc / Century Therapeutics Inc / Monte Rosa Therapeutics Inc / POINT Biopharma Global Inc / Nuvalent Inc / Omega Therapeutics Inc / Tempest Therapeutics Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Allison M. Bratzel, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Top Picks & Focus Names for 2022: LEGN, KYMR, XNCR, MRNA, ALNY, CRSP, ARWR, FATE</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.OQ / ALNY.OQ / ARWR.OQ / CRSP.BN / FATE.OQ / KYMR.OQ / LEGN.OQ / XNCR.OQ / 02043Q107 / 16383L106 / 31189P102 / 04280A100 / 81750R102 / 98401F105 / H17182108 / 481116101 / 60770K107 / 65343E108 / 359616109 / 04335A105 / 52490G102 / 501575104 / 73730P108 / 26818M108 / 15673T100 / 61225M102 / 68217N105</td><td class="leftalignment">Moderna Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / CRISPR Therapeutics AG / Fate Therapeutics Inc / Kymera Therapeutics Inc / Legend Biotech Corp / Xencor Inc / Alnylam Pharmaceuticals Inc / ChemoCentryx Inc / Fate Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Seres Therapeutics Inc / Xencor Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Moderna Inc / NextCure Inc / Fulcrum Therapeutics Inc / Arvinas Inc / Legend Biotech Corp / Kymera Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Century Therapeutics Inc / Monte Rosa Therapeutics Inc / Omega Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Two-bagger Moderna soars 143% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna slumps 26% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">COVID-19 Vaccine/Therapeutics Names: Expect Volatile 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / REGN.O / VRTX.O / MRNA.O / SRPT.O / INO.O</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / Inovio Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: NVS Nets Gyroscope to GT Nest; PFE DMD Hold</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">BB Banco de Investimento S.A.</td><td class="leftalignment">Monitor Diário BDRX-12/23/2021</td><td class="leftalignment">Portuguese</td><td class="rightalignment">9</td><td class="leftalignment">MELI34 / BABA34 / TSLA34 / FBOK34 / GOGL34 / M1RN34 / MSFT34 / AAPL34 / NVDC34 / PFIZ34</td><td class="leftalignment">Mercadolibre Inc / Alibaba Group Holding Ltd / Tesla Inc / Meta Platforms Inc / Alphabet Inc / Moderna Inc / Microsoft Corp / Apple Inc / NVIDIA Corp / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Renato Od / Jose Roberto dos Anjos</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">LOGC (Buy): PT to $16 as LOGC Hits Snooze on SUNRISE Interim Data</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">54142F102 / 02043Q107 / 339 / 800677106 / MRNA.O / 75901B107 / ADVM.O / 45826J105 / 28106W103 / MGTX.O / H17182108 / 501147102 / FIXX.O / 77313F106 / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">LogicBio Therapeutics Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Sangamo Therapeutics Inc / Moderna Inc / Regenxbio Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Rocket Pharmaceuticals Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SKAN.S: SKAN - Global market leader for high-end aseptic process solutions</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">SKAN.S / 4502.T / BAX.N / EKTAB.ST / PFE.N / PHG.AS / AZN.L / SASY.PA / ROG.S / DHR.N / GEBN.S / NOVN.S / LONN.S / SATG.DE / PKI.N / BANB.S / GSK.L / 6869.T / HOLX.OQ / GILD.OQ / NVAX.OQ / TECN.S / LOGN.S / BEAN.S / IFCN.S / STMN.S / LEHN.S / SCHP.S / BCHN.S / SIKA.S / SOON.S / DIAS.MI / MRNA.OQ / BRG.AX / ABBV.N / CLLS.OQ / EDIT.OQ / VACN.S / CRSP.OQ / COTNE.S / SENSI.S / SIGNC.S / AVTR.N</td><td class="leftalignment">SKAN Group AG / Takeda Pharmaceutical Co Ltd / Baxter International Inc / Elekta AB (publ) / Pfizer Inc / Koninklijke Philips NV / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Geberit AG / Novartis AG / Lonza Group AG / Sartorius AG / PerkinElmer Inc / Bachem Holding AG / GlaxoSmithKline PLC / Sysmex Corp / Hologic Inc / Gilead Sciences Inc / Novavax Inc / Tecan Group AG / Logitech International SA / Belimo Holding AG / Inficon Holding AG / Straumann Holding AG / Lem Holding SA / Schindler Holding AG / Burckhardt Compression Holding AG / Sika AG / Sonova Holding AG / DiaSorin SpA / Moderna Inc / Breville Group Ltd / Abbvie Inc / Cellectis SA / Editas Medicine Inc / VAT Group AG / CRISPR Therapeutics AG / Comet Holding AG / Sensirion Holding AG / SIG Combibloc Group AG / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / United Kingdom / Italy / Japan / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Herr Patrick Laager / Herr. Christoph Gretler</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : Time To Change the Definition of 'Fully Vaccinated'?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Omicron Data Affirms Status Quo Though Commercial Questions Remain</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">60770K10</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cautiously Optimistic That 1273 Efficacy Could Be Similar For Omicron vs. Delta</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / SONN.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Sonnet Biotherapeutics Holdings Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">mRNA-1273 Booster Increases Neutralizing Antibodies Against Omicron Variant</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">1273 Boosters Show Omicron Neutralizing Activity; Tough To Compare To PFE/BNTX</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CABA Cap'd at Low Doses? GBIO Monkeying Around</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">CABA.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Cabaletta Bio Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, Dec. 20, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Dec. 20, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Moderna Inc (MRNA) - Financial Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">396</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ACA / ALLO / ATRC / GBT / INCY / INSP / MBIO / NBIX / RAD / SAGE / WMT / GILD.O / EW / ONEM.O / RMD / FMTX / ISRG / ALPN / SGEN / REGN.O / VRTX.O / SSNC.O / NKTR / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / LHCG.O / INFI.O / TMDI / TNDM.O / ENSG.O / 483548103 / MRNA.O / BLRX / ADUS.O / AGIO / FATE.O / 02005N100 / RXDX.O / VBLT.O / APTO.O / EVH / 100063846 / IONS.O / 04280A100 / EDIT / VRAY / CRSP / SRRA / ATNX.O / APLS.O / 720795103 / ELOX.OQ / ARVN / XFOR.O / TMDX / KRTX / PSNL.O / 50127T109 / 87164F105 / PNTG.O / GMDA / ZNTL.O / ORIC.O / SPRB.OQ / TARS.O / VOR.O / NKTX.O / BMEA.O / CLNN.O / RZLT.O / CRBU.O / MDNA.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / AtriCure Inc / Global Blood Therapeutics Inc / Incyte Corp / Inspire Medical Systems Inc / Mustang Bio Inc / Neurocrine Biosciences Inc / Rite Aid Corp / SAGE Therapeutics Inc / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Resmed Inc / Forma Therapeutics Holdings Inc / Intuitive Surgical Inc / Alpine Immune Sciences Inc / Seagen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Nektar Therapeutics / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Titan Medical Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / BioLine RX Ltd / Addus Homecare Corp / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Ally Financial Inc / Prometheus Biosciences Inc / Vascular Biogenics Ltd / Aptose Biosciences Inc / Evolent Health Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Editas Medicine Inc / ViewRay Inc / CRISPR Therapeutics AG / Sierra Oncology Inc / Athenex Inc / Apellis Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Personalis Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / Pennant Group Inc / Gamida Cell Ltd / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Spruce Biosciences Inc / Tarsus Pharmaceuticals Inc / Vor Biopharma Inc / Nkarta Inc / Biomea Fusion Inc / Clene Inc. / Rezolute Inc / Caribou Biosciences Inc / Medicenna Therapeutics Corp / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AAPL / AMT / APP / APPS / BBY / CCI / CHTR / CME / DISH / DLR / EA / FDX / GLW / GS / HRL / ICE / INTC.O / IS / MBIO / MCD / MS / MSFT / NBIX / NET / NKE / ORCL / QCOM.O / QUIK / RNG / RXT / SAP / SONY / SPOT / T / TTWO / U / UPS / WH / WMT / AMZN.O / CMCSA.O / NICE / CSCO.O / ATVI.O / NVDA.O / ADBE.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / CSGS.O / SBAC.O / VG / AMD.O / EQIX / VZ / NFLX / CEVA / CRNT.O / LUMN / ALPN / DOX.O / VRTX.O / MRVL.O / VRNT / AVGO.O / NDAQ / NDSN.O / 478160104 / GOOG.O / 36467W109 / CCOI / COIN / MRNA.O / TSLA.O / ZNGA / FB.O / WDAY / TMUS / FDEV.L / WIX.O / FIVN.O / 82655M107 / 02005N100 / CXDO / IONS.O / 04280A100 / TTD.O / SRRA / OKTA.O / ROKU.O / MDB.O / EGHT.K / BILI.O / ELOX.OQ / CBOE.K / LOVE / ZM.O / FSLY / PSNL.O / 50127T109 / 87164F105 / CMBM / DKNG / FUBO / SPRB.OQ / TEUM.PK / ONDS.OQ / DOCN / HUYA.K / BMEA.O / MNDY.O / NN.O</td><td class="leftalignment">Apple Inc / American Tower Corp / Applovin Corp / Digital Turbine Inc / Best Buy Co Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / DISH Network Corp / Digital Realty Trust Inc / Electronic Arts Inc / FedEx Corp / Corning Inc / Goldman Sachs Group Inc / Hormel Foods Corp / Intercontinental Exchange Inc / Intel Corp / Ironsource Ltd / Mustang Bio Inc / McDonald's Corp / Morgan Stanley / Microsoft Corp / Neurocrine Biosciences Inc / Cloudflare Inc / Nike Inc / Oracle Corp / Qualcomm Inc / QuickLogic Corp / RingCentral Inc / Rackspace Technology Inc / SAP SE / Sony Group Corp / Spotify Technology SA / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / United Parcel Service Inc / Wyndham Hotels & Resorts Inc / Walmart Inc / Amazon.com Inc / Comcast Corp / Nice Ltd / Cisco Systems Inc / Activision Blizzard Inc / NVIDIA Corp / Adobe Inc / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / CSG Systems International Inc / SBA Communications Corp / Vonage Holdings Corp / Advanced Micro Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / CEVA Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Alpine Immune Sciences Inc / Amdocs Ltd / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Verint Systems Inc / Broadcom Inc / Nasdaq Inc / Nordson Corp / Johnson & Johnson / Alphabet Inc / GameStop Corp / Cogent Communications Holdings Inc / Coinbase Global Inc / Moderna Inc / Tesla Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Wix.Com Ltd / Five9 Inc / Sify Technologies Ltd / Ally Financial Inc / Crexendo Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Trade Desk Inc / Sierra Oncology Inc / Okta Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Bilibili Inc / Eloxx Pharmaceuticals Inc / Cboe Global Markets Inc / Lovesac Co / Zoom Video Communications Inc / Fastly Inc / Personalis Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / Cambium Networks Corp / DraftKings Inc / Fubotv Inc / Spruce Biosciences Inc / Pareteum Corp / Ondas Holdings Inc / DigitalOcean Holdings Inc / HUYA Inc / Biomea Fusion Inc / Monday.Com Ltd / NextNav Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / India / Israel / Japan / Luxembourg / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Don't Blink, Ribosome-Targeting Company in Your Rearview Mirror; Initiate at Outperform (PT $4)</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ELOX.OQ / VRTX.O / MRNA.O / IONS.O / 04280A100</td><td class="leftalignment">Eloxx Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moderna Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.33): First dose rate 79%, 78% have had two doses</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.33）：ワクチン接種率は1回目が79%、2回目は78%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Biopharmaceuticals: SAN/GSK: Brief takes on first P3 recombinant COVID vaccine datapoint</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GSK.L / AZN.L / SASY.PA / MRNA.OQ / BNTX.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / AstraZeneca PLC / Sanofi SA / Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Shorting the CNBC Next Gen 50 Index</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">TSLA.OQ / CCO.TO / FSR.N / W.N / GME.N / AAPL.OQ / PENN.OQ / AMZN.OQ / PLUG.OQ / MTCH.OQ / NFLX.OQ / CMG.N / CROX.OQ / COIN.OQ / LULU.OQ / MRNA.OQ / ENPH.OQ / WIX.OQ / GOOGL.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / SQ.N / WEED.TO / PANW.OQ / SFIX.OQ / DOCU.OQ / LYFT.OQ / UBER.N / ZM.OQ / CHWY.N / CRWD.OQ / SPCE.N / DKNG.OQ / LMND.N / GDRX.OQ / PLTR.N / RBLX.N / DASH.N / UPST.OQ / BMBL.OQ / CHPT.N / TLRY.TO / ME.OQ / LCID.OQ / BROS.N</td><td class="leftalignment">Tesla Inc / Cameco Corp / Fisker Inc / Wayfair Inc / GameStop Corp / Apple Inc / Penn National Gaming Inc / Amazon.com Inc / Plug Power Inc / Match Group Inc / Netflix Inc / Chipotle Mexican Grill Inc / Crocs Inc / Coinbase Global Inc / Lululemon Athletica Inc / Moderna Inc / Enphase Energy Inc / Wix.Com Ltd / Alphabet Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Block Inc / Canopy Growth Corp / Palo Alto Networks Inc / Stitch Fix Inc / DocuSign Inc / Lyft Inc / Uber Technologies Inc / Zoom Video Communications Inc / Chewy Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / DraftKings Inc / Lemonade Inc / Goodrx Holdings Inc / Palantir Technologies Inc / Roblox Corp / DoorDash Inc / Upstart Holdings Inc / Bumble Inc / ChargePoint Holdings Inc / Tilray Brands Inc / 23andMe Holding Co. / Lucid Group Inc / Dutch Bros Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 9.6% Y/Y Including COVID-19 Vaccine Volume Benefit (1.6% Without)</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra / Jialin (Jay) Jin</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Moderna Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US3596161097 / US0021202025 / US7599161095 / US29089Q1058 / US1920051067 / US68403P2039 / US29251M1062 / US16934W1062 / US29428V1044 / US5560991094 / US00771V1089 / US4277461020 / US78667J1088 / US67576A1007 / CA98420N1050 / US2681582019 / US7207951036 / US45826J1051 / US0327241065 / US52187K1016 / US3621LQ1099 / US98887Q1040 / US6085501095 / US59045L1061 / US53635D2027 / US9842411095 / US29772L1089 / US60770K1079 / US15117B2025 / US98420X1037 / US21900C3088 / US90041T1088 / US46583P1021 / US68236P1075 / US75382E1091 / US52490G1022 / US37186H1005 / US0843101017 / US45720L1070 / US82024L1035 / US89422G1076 / US04635X1028</td><td class="leftalignment">Fulcrum Therapeutics Inc / aTyr Pharma Inc / Repligen Corp / Emergent BioSolutions Inc / Codexis Inc / Oramed Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Chimerix Inc / Epizyme Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / SAGE Therapeutics Inc / Ocular Therapeutix Inc / Xenon Pharmaceuticals Inc / Dynavax Technologies Corp / Pieris Pharmaceuticals Inc / Intellia Therapeutics Inc / AnaptysBio Inc / Leap Therapeutics Inc / G1 Therapeutics Inc / Zai Lab Ltd / Molecular Templates Inc / Mersana Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Eton Pharmaceuticals Inc / Moderna Inc / Celldex Therapeutics Inc / X4 Pharmaceuticals Inc / CorMedix Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Oncternal Therapeutics Inc / Rapt Therapeutics Inc / Legend Biotech Corp / Genetron Holdings Ltd / Berkeley Lights Inc / Inhibrx Inc / Shattuck Labs Inc / Travere Therapeutics Inc / Astria Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Moderna in bottom 3% performers of NASDAQ-100 Index in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) AAV GT Data for MGTX (RIX) & QURE (HemB)</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">MGTX.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 199800 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">MeiraGTx Holdings PLC / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / ToolGen Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAPL / ACN / AGCO / ATRC / BJ / CMG / CSII / CSL / DE / DLTR / EEFT.O / ELF / FOCS / HRB / INSP / INTC.O / ITT / MPAA / MSFT / NOW / ORCL / PZZA / RNG / ROK / RXN / SAGE / SAP / SBUX / TRMB / TUP / U / USM / AMZN.O / CHKP.O / EW / MSCI / ASTE.O / ADBE.O / EGAN / HEAR / RMD / CRVL.O / AMBA / MPWR.O / NVMI / VECO.O / ISRG / NFLX / BRZE.O / PLUG.O / SMTC.O / ADSK.O / FRPT / UTHR.O / ARRY.O / IRT.N / FCEL.O / EXTR.O / BLK.N / OSUR.O / AMSC.O / MRVL.O / FRSH.OQ / TMP.A / WIRE.OQ / VRTS.OQ / POOL.OQ / CALM.OQ / QDEL.O / INTA.O / DIOD.O / ITRI.O / NATI.O / PCTY.O / LPSN.O / CARG / 459200101 / PEB.NZ / DPZ / GOOG.O / LHCG.O / 192446102 / CLMT.O / SPWR.O / IOSP.OQ / XPO / ATNI.O / EHTH / CSIQ.O / FSLR.O / MASI.O / TMDI / MRNA.O / DECK.N / WPRT.O / MYRG.O / TWIN.O / BLRX / BCPC.O / MUSA.N / TSLA.O / SWAV / PCYO.O / AMRS.O / WWD.O / HZNP.OQ / ENPH.O / CG.O / SRPT.O / WDAY / CNHI / WIX.O / FIVN.O / TBK.O / CUBI.K / WING.O / BWXT.K / SEDG.O / RUN.O / MIME.OQ / WKHS.O / AQMS.O / TTD.O / COUP.O / BL.O / EVBG.O / AQB / HLNE.O / YEXT.K / ROKU.O / MDB.O / EGHT.K / DOCU.O / 875372203 / SG.N / ARVN / LOVE / XFOR.O / ZM.O / TMDX / KERN.O / 114944851 / ZI.OQ / 02081G201 / NOVA.K / VLDR.O / AAIC.K / SHLS.O / XM.O / APPH / TSP.O / 975657107 / EVCM.O / ENVX.O / CWAN.N / LILM.O / USER.K</td><td class="leftalignment">Apple Inc / Accenture PLC / AGCO Corp / AtriCure Inc / BJ's Wholesale Club Holdings Inc / Chipotle Mexican Grill Inc / Cardiovascular Systems Inc / Carlisle Companies Inc / Deere & Co / Dollar Tree Inc / Euronet Worldwide Inc / elf Beauty Inc / Focus Financial Partners Inc / H & R Block Inc / Inspire Medical Systems Inc / Intel Corp / ITT Inc / Motorcar Parts of America Inc / Microsoft Corp / ServiceNow Inc / Oracle Corp / Papa John's International Inc / RingCentral Inc / Rockwell Automation Inc / Zurn Water Solutions Corp / SAGE Therapeutics Inc / SAP SE / Starbucks Corp / Trimble Inc / Tupperware Brands Corp / Unity Software Inc / United States Cellular Corp / Amazon.com Inc / Check Point Software Technologies Ltd / Edwards Lifesciences Corp / MSCI Inc / Astec Industries Inc / Adobe Inc / eGain Corp / Turtle Beach Corp / Resmed Inc / CorVel Corp / Ambarella Inc / Monolithic Power Systems Inc / Nova Ltd / Veeco Instruments Inc / Intuitive Surgical Inc / Netflix Inc / Braze Inc / Plug Power Inc / Semtech Corp / Autodesk Inc / Freshpet Inc / United Therapeutics Corp / Array Technologies Inc / Independence Realty Trust Inc / Fuelcell Energy Inc / Extreme Networks Inc / BlackRock Inc / OraSure Technologies Inc / American Superconductor Corp / Marvell Technology Inc / Freshworks Inc / Tompkins Financial Corp / Encore Wire Corp / Virtus Investment Partners Inc / Pool Corp / Cal-Maine Foods Inc / Quidel Corp / Intapp Inc / Diodes Inc / Itron Inc / National Instruments Corp / Paylocity Holding Corp / LivePerson Inc / CarGurus Inc / International Business Machines Corp / Pacific Edge Ltd / Domino's Pizza Inc / Alphabet Inc / LHC Group Inc / Cognizant Technology Solutions Corp / Calumet Specialty Products Partners LP / SunPower Corp / Innospec Inc / XPO Logistics Inc / ATN International Inc / eHealth Inc / Canadian Solar Inc / First Solar Inc / Masimo Corp / Titan Medical Inc / Moderna Inc / Deckers Outdoor Corp / Westport Fuel Systems Inc / MYR Group Inc / Twin Disc Inc / BioLine RX Ltd / Balchem Corp / Murphy Usa Inc / Tesla Inc / Shockwave Medical Inc / Pure Cycle Corp / Amyris Inc / Woodward Inc / Horizon Therapeutics PLC / Enphase Energy Inc / Carlyle Group Inc / Sarepta Therapeutics Inc / Workday Inc / CNH Industrial NV / Wix.Com Ltd / Five9 Inc / Triumph Bancorp Inc / Customers Bancorp Inc / Wingstop Inc / BWX Technologies Inc / Solaredge Technologies Inc / Sunrun Inc / Mimecast Ltd / Workhorse Group Inc / Aqua Metals Inc / Trade Desk Inc / Coupa Software Inc / Blackline Inc / Everbridge Inc / AquaBounty Technologies Inc / Hamilton Lane Inc / Yext Inc / Roku Inc / MongoDB Inc / 8x8 Inc / DocuSign Inc / Tandem Diabetes Care Inc / Sweetgreen Inc / Arvinas Inc / Lovesac Co / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Transmedics Group Inc / Akerna Corp / Crescent Capital BDC Inc / ZoomInfo Technologies Inc / Alphatec Holdings Inc / Sunnova Energy International Inc / Velodyne Lidar Inc / Arlington Asset Investment Corp / Shoals Technologies Group Inc / Qualtrics International Inc / AppHarvest Inc / TuSimple Holdings Inc / Winston Pharmaceuticals Inc / EverCommerce Inc / Enovix Corp / Clearwater Analytics Holdings Inc / Lilium NV / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Ireland / Israel / Netherlands / New Zealand / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">mRNA-1010 Flu Phase 1 Data a Good First Step</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Pharmaceuticals: MRNA flu takes/SAN x-reads: Chickens can’t catch a break…?</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRNA.OQ / SASY.PA / BNTX.OQ</td><td class="leftalignment">Moderna Inc / Sanofi SA / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : Who Knew Phase 1 Flu Vaccine Data Could be so Controversial?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRNA - MRNA: They just said what?! Takeaways from the interim flu readout</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Andrew Galler / Dr. Tim M. Anderson, MD</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">mRNA-1010 Flu Immunogenicity Similar W/ Market Leader; Competitive Profile TBD</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Onerous AE's, No Dose Response, Unclear Differentiation — '1010 Remains 0/10</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">60770K10 / 80105N10 / G3910J11</td><td class="leftalignment">Moderna Inc / Sanofi SA / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Geoffrey Porges, MBBS / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D. / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">ACA / BAX / DNLI / EBS / ICPT / INMD / NBIX / OM / PRGO / RAD / SAGE / SVA / WMT / GILD.O / EW / ONEM.O / ALKS.O / OPNT.O / REGN.O / SSNC.O / MRNS / NKTR / NOVN.O / CCRN.O / BCRX.O / AMED.O / EXAS.O / ANGN.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / CMMB / FREQ / ACAD.O / ALNY.O / DXCM.O / LHCG.O / MBRX.O / CBAY / CYCC.O / INFI.O / HUMA / 02043Q107 / TNDM.O / ENSG.O / 483548103 / MRNA.O / VERO / 771195104 / ADUS.O / GLAXOSM.LG / SPRO.O / 695127100 / SRPT.O / AERI.O / MDWD.O / 02005N100 / RXDX.O / INO.O / VBLT.O / NVRO / AUPH.O / GLPG.O / EVH / NVCR.O / 100063846 / IONS.O / CLRB.O / VRAY / NTLA / FLGT.O / IOVA / MTEM.O / ATNX.O / PTGX.O / 720795103 / ORTX.O / BNGO.O / IMUX.O / ZM.O / TMDX / IDYA.O / PSNL.O / DMTK.O / XAIR / PNTG.O / BCYC / NMTR.O / ORIC.O / PHGE.K / PLRX.O / NNOX / HGEN.O / TSHA.O / FSTX.O / PRTG.O / SNSE.O / IMCR.O / PHVS.O / 03823M100 / 390320109 / EVAX.O / RZLT.O / SERA.OQ / CGTX.OQ / ATXS.O</td><td class="leftalignment">Arcosa Inc / Baxter International Inc / Denali Therapeutics Inc / Emergent BioSolutions Inc / Intercept Pharmaceuticals Inc / Inmode Ltd / Neurocrine Biosciences Inc / Outset Medical Inc / Perrigo Company PLC / Rite Aid Corp / SAGE Therapeutics Inc / Sinovac Biotech Ltd / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Alkermes Plc / Opiant Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Marinus Pharmaceuticals Inc / Nektar Therapeutics / Novan Inc / Cross Country Healthcare Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Exact Sciences Corp / Angion Biomedica Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Cymabay Therapeutics Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Humacyte Inc / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Venus Concept Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Spero Therapeutics Inc / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / Ally Financial Inc / Prometheus Biosciences Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Aurinia Pharmaceuticals Inc / Galapagos NV / Evolent Health Inc / Novocure Ltd / Truist Financial Corp / Ionis Pharmaceuticals Inc / Cellectar Biosciences Inc / ViewRay Inc / Intellia Therapeutics Inc / Fulgent Genetics Inc / Iovance Biotherapeutics Inc / Molecular Templates Inc / Athenex Inc / Protagonist Therapeutics Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Immunic Inc / Zoom Video Communications Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / Personalis Inc / DermTech Inc / Beyond Air Inc / Pennant Group Inc / Bicycle Therapeutics PLC / 9 Meters Biopharma Inc / Oric Pharmaceuticals Inc / Biomx Inc / Pliant Therapeutics Inc / Nano-X Imaging Ltd / Humanigen Inc / Taysha Gene Therapies Inc / F-Star Therapeutics Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Pharvaris NV / Applied Minerals Inc / Great Elm Capital Corp / Evaxion Biotech A/S / Rezolute Inc / Sera Prognostics Inc / Cognition Therapeutics Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Belgium / Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Nigeria / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Quadrivalent Flu Vaccine mRNA-1010 Safe & Active; Advanced Candidates Coming</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, Dec. 10, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Dec. 10, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Kiwoom Securities</td><td class="leftalignment">kiwoom 미 국 주 식 가 이드 weekly (2021.12.2~12.9)-12/09/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">27</td><td class="leftalignment">DAL / DOCU / MRVL / GNRC / MRNA / LULU / NCLH / OKTA</td><td class="leftalignment">Delta Air Lines Inc / DocuSign Inc / Marvell Technology Inc / Generac Holdings Inc / Moderna Inc / Lululemon Athletica Inc / Norwegian Cruise Line Holdings Ltd / Okta Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Won Ju Lee / Seong Jin Ji</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Fighting Failing Omicron Immunity with Boosters Is Short-Term Strategy</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Dilip Joseph / Na Sun / Greco Song, Ph.D. / Daniel Tarjan, Ph.D. / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US3596161097 / US0021202025 / US7599161095 / US29089Q1058 / US1920051067 / US68403P2039 / US29251M1062 / US16934W1062 / US29428V1044 / US5560991094 / US00771V1089 / US4277461020 / US78667J1088 / US67576A1007 / CA98420N1050 / US2681582019 / US7207951036 / US45826J1051 / US87184Q1076 / US0327241065 / US52187K1016 / US3621LQ1099 / US6085501095 / US59045L1061 / US53635D2027 / US9842411095 / US29772L1089 / US60770K1079 / US15117B2025 / US98420X1037 / US21900C3088 / US90041T1088 / US46583P1021 / US68236P1075 / US75382E1091 / US74017N1054 / US52490G1022 / US37186H1005 / US0843101017 / US45720L1070 / US82024L1035</td><td class="leftalignment">Fulcrum Therapeutics Inc / aTyr Pharma Inc / Repligen Corp / Emergent BioSolutions Inc / Codexis Inc / Oramed Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Chimerix Inc / Epizyme Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / SAGE Therapeutics Inc / Ocular Therapeutix Inc / Xenon Pharmaceuticals Inc / Dynavax Technologies Corp / Pieris Pharmaceuticals Inc / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / AnaptysBio Inc / Leap Therapeutics Inc / G1 Therapeutics Inc / Molecular Templates Inc / Mersana Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Eton Pharmaceuticals Inc / Moderna Inc / Celldex Therapeutics Inc / X4 Pharmaceuticals Inc / CorMedix Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Oncternal Therapeutics Inc / Rapt Therapeutics Inc / Precigen Inc / Legend Biotech Corp / Genetron Holdings Ltd / Berkeley Lights Inc / Inhibrx Inc / Shattuck Labs Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: COVID: Sigal omicron paper, GSK (Medicago, Sotro) and BAVA/Shio data</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GSK.L / AZN.L / MRNA.OQ / BNTX.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / AstraZeneca PLC / Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">2197.HK: Clover Biopharmaceuticals - A global COVID vaccine supplier from pandemic to endemic</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">2197.HK / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 000513.SZ / DVAX.OQ / MRNA.OQ / 300122.SZ</td><td class="leftalignment">Clover Biopharmaceuticals Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Livzon Pharmaceutical Group Inc / Dynavax Technologies Corp / Moderna Inc / Chongqing Zhifei Biological Products Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AAPL / APPS / ARCC / CCI / CHTR / COST / CSL / DISH / EA / GBDC / INTC.O / JACK / MSFT / QUIK / SCM.N / SONY / SUNS / SVA / T / TTWO / VGR / WEN / AMZN.O / CMCSA.O / ORCC / ATVI.O / NVDA.O / HEAR / KLR / CSGS.O / VECO.O / VZ / NFLX / CRNT.O / LUMN / DOX.O / REGN.O / GLAD / WHF / MRNS / NKTR / 478160104 / 459200101 / GOOG.O / ACAD.O / MRCC / 36467W109 / PNNT / TNDM.O / MRNA.O / 092533108 / SLRC / HRZN / NMFC / PFLT / FDUS / ZNGA / TCPC / FB.O / TMUS / FDEV.L / TSLX / 563771203 / 82655M107 / 02005N100 / INO.O / RESN.O / COUP.O / AKTS.O / HLNE.O / IOVA / OCSL / MDB.O / BILI.O / CMBM / FCRD / STEP.O / ONDS.OQ / HUYA.K / 03823M100 / 390320109 / CCSI.OQ</td><td class="leftalignment">Apple Inc / Digital Turbine Inc / Ares Capital Corp / Crown Castle International Corp / Charter Communications Inc / Costco Wholesale Corp / Carlisle Companies Inc / DISH Network Corp / Electronic Arts Inc / Golub Capital Bdc Inc / Intel Corp / Jack in the Box Inc / Microsoft Corp / QuickLogic Corp / Stellus Capital Investment Corp / Sony Group Corp / SLR Senior Investment Corp / Sinovac Biotech Ltd / AT&T Inc / Take-Two Interactive Software Inc / Vector Group Ltd / Wendys Co / Amazon.com Inc / Comcast Corp / Owl Rock Capital Corp / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Kaleyra Inc / CSG Systems International Inc / Veeco Instruments Inc / Verizon Communications Inc / Netflix Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Gladstone Capital Corp / WhiteHorse Finance Inc / Marinus Pharmaceuticals Inc / Nektar Therapeutics / Johnson & Johnson / International Business Machines Corp / Alphabet Inc / ACADIA Pharmaceuticals Inc / Monroe Capital Corp / GameStop Corp / Pennantpark Investment Corp / Tandem Diabetes Care Inc / Moderna Inc / BlackRock Capital Investment Corp / SLR Investment Corp / Horizon Technology Finance Corp / New Mountain Finance Corp / PennantPark Floating Rate Capital Ltd / Fidus Investment Corp / Zynga Inc / BlackRock TCP Capital Corp / Meta Platforms Inc / T-Mobile US Inc / Frontier Developments PLC / Sixth Street Specialty Lending Inc / Mannatech Inc / Sify Technologies Ltd / Ally Financial Inc / Inovio Pharmaceuticals Inc / Resonant Inc / Coupa Software Inc / Akoustis Technologies Inc / Hamilton Lane Inc / Iovance Biotherapeutics Inc / Oaktree Specialty Lending Corp / MongoDB Inc / Bilibili Inc / Cambium Networks Corp / First Eagle Alternative Capital BDC Inc / StepStone Group Inc / Ondas Holdings Inc / HUYA Inc / Applied Minerals Inc / Great Elm Capital Corp / Consensus Cloud Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Cayman Islands / United Kingdom / India / Israel / Japan / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 07 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">DE0006969603 / US0028241000 / US0079031078 / US0116591092 / US0231351067 / US0320951017 / US0378331005 / US1924221039 / US1985161066 / US2435371073 / US28176E1082 / US3695501086 / US4448591028 / US4581401001 / US5184151042 / US5719032022 / US5949181045 / US5951121038 / US6541061031 / US67066G1040 / US75886F1075 / US7782961038 / US8305661055 / US8447411088 / US8636671013 / US8725401090 / US87612E1064 / US91347P1057 / US9182041080 / US92343V1044 / US9581021055 / US9839191015 / US3448491049 / US20030N1019 / US2533931026 / US00206R1023 / US9043111072 / US82706C1080 / US4103451021 / US8485741099 / US5500211090 / US25470M1099 / US64110D1046 / IE00B4BNMY34 / US9100471096 / DE000A1EWWW0 / US40412C1018 / US6936561009 / US7512121010 / US29414B1044 / US81762P1021 / US8725901040 / US55405Y1001 / US8086251076 / US5253271028 / US31189P1021 / US1220171060 / JE00BLG2ZQ72 / US0367521038 / US22822V1017 / US29444U7000 / US12685J1051 / US02079K1079 / US16119P1084 / US90138F1021 / CH0334081137 / US74967X1037 / US23355L1061 / US02156K1034 / US8753722037 / US74766Q1013 / US4622601007 / US09857L1089 / US98980G1022 / VGG312491084 / US04335A1051 / US0197701065 / US98585X1046 / US60770K1079 / US90041T1088 / US89377M1099 / US02875D1090 / US8334451098 / US86646P1030 / US56854Q2003 / US68062P1066 / US0090661010 / US55406W1036 / US15961R1059 / US90364P1057 / US5738741041 / IE00BKVD2N49 / US30260D1037 / US20717M1036 / US10920V1070 / US13781Y1038 / US30052F1003 / US88546E1055 / US8852601090 / US37637K1088 / US01675A1097 / US92561V1098</td><td class="leftalignment">Puma SE / Abbott Laboratories / Advanced Micro Devices Inc / Alaska Air Group Inc / Amazon.com Inc / Amphenol Corp / Apple Inc / Cognex Corp / Columbia Sportswear Co / Deckers Outdoor Corp / Edwards Lifesciences Corp / General Dynamics Corp / Humana Inc / Intel Corp / Lattice Semiconductor Corp / Marriott International Inc / Microsoft Corp / Micron Technology Inc / Nike Inc / NVIDIA Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Skechers USA Inc / Southwest Airlines Co / Stryker Corp / TJX Companies Inc / Target Corp / Universal Display Corp / VF Corp / Verizon Communications Inc / Western Digital Corp / Xilinx Inc / Foot Locker Inc / Comcast Corp / DICK'S Sporting Goods Inc / AT&T Inc / Under Armour Inc / Silicon Motion Technology Corp / HanesBrands Inc / Spirit AeroSystems Holdings Inc / Lululemon Athletica Inc / DISH Network Corp / NetApp Inc / Accenture PLC / United Airlines Holdings Inc / Adidas AG / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Epam Systems Inc / ServiceNow Inc / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / Science Applications International Corp / Leidos Holdings Inc / Fate Therapeutics Inc / Burlington Stores Inc / Quotient Ltd / Anthem Inc / Crown Castle International Corp / Equinix Inc / Cable One Inc / Alphabet Inc / Charter Communications Inc / Twilio Inc / CRISPR Therapeutics AG / RH / DXC Technology Co / Altice USA Inc / Tandem Diabetes Care Inc / Quanterix Corp / Iovance Biotherapeutics Inc / Booking Holdings Inc / Zscaler Inc / Establishment Labs Holdings Inc / Arvinas Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Moderna Inc / Turning Point Therapeutics Inc / Transmedics Group Inc / American Outdoor Brands Inc / Snowflake Inc. / Sumo Logic Inc / Marinus Pharmaceuticals Inc / Olema Pharmaceuticals Inc / Airbnb Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc / UiPath Inc / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc / Confluent Inc / Bright Health Group Inc / Cano Health Inc / EVgo Inc / Thoughtworks Holding Inc / Thorne Healthtech Inc / GitLab Inc / Allbirds Inc / Vicarious Surgical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Ireland / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">COVID-19 Experts - Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SVA / REGN.O / 478160104 / MRNA.O / 02005N100 / INO.O / 03823M100 / 390320109</td><td class="leftalignment">Sinovac Biotech Ltd / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Moderna Inc / Ally Financial Inc / Inovio Pharmaceuticals Inc / Applied Minerals Inc / Great Elm Capital Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / AIG.N / ALL.N / AXP.N / BA.N / C.N / CAH.N / CE.N / CF.N / COF.N / EOG.N / F.N / HIG.N / HLT.N / MRK.N / OXY.N / PFE.N / PM.N / PNW.N / TMX.N / TRV.N / UAL.N / USB.N / VNT.N / ZEN.N / NUE.N / HAL.N / DIS.N / WLK.N / GD.N / CR.N / AFG.N / R.N / RCL.N / ADM.N / IFF.N / LH.N / EMR.N / PCG.N / DVN.N / OLN.N / TGT.N / RKT.N / DVA.N / AZO.N / FDS.N / EQT.N / ATO.N / HWM.N / BYD.N / UGI.N / DNB.N / GPC.N / MKC.N / HRL.N / SAM.N / CLF.N / ABC.N / GME.N / TDY.N / COP.N / INTC.OQ / ADPT.OQ / AGL.N / CRUS.OQ / FAF.N / FISV.OQ / HOLX.OQ / KLAC.OQ / MKL.N / RGEN.OQ / SF.N / VMI.N / FL.N / POOL.OQ / TPR.N / UHAL.OQ / PEGA.OQ / LAMR.OQ / STLD.OQ / SRCL.OQ / MRCY.OQ / WTFC.OQ / NUAN.OQ / WYNN.OQ / PA1436583006 / MNST.OQ / OSH.N / LVS.N / OC.N / FRPT.OQ / BX.N / PODD.OQ / VMW.N / NVR.N / WRB.N / MRNA.OQ / CLH.N / AI.N / TRGP.N / Z.OQ / TRIP.OQ / WEN.OQ / BERY.N / WEX.N / RNG.N / WIX.OQ / ARMK.N / NCLH.N / FIVN.OQ / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / SITE.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / JHG.N / ROKU.OQ / PFG.OQ / XEL.OQ / QRTEA.OQ / CTRA.N / NFE.OQ / LYFT.O / BYND.OQ / UBER.N / FSLY.N / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / WTRG.N / DKNG.OQ / APA.OQ / FOUR.N / VRM.OQ / LMND.N / BEPC.N / DCT.OQ / PLTR.N / SHC.OQ / SKLZ.N / CLVT.N / SGFY.N / CHPT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / American International Group Inc / Allstate Corp / American Express Co / Boeing Co / Citigroup Inc / Cardinal Health Inc / Celanese Corp / CF Industries Holdings Inc / Capital One Financial Corp / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / Merck & Co Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Pinnacle West Capital Corp / Terminix Global Holdings Inc / Travelers Companies Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Nucor Corp / Halliburton Co / Walt Disney Co / Westlake Chemical Corp / General Dynamics Corp / Crane Co / American Financial Group Inc / Ryder System Inc / Royal Caribbean Cruises Ltd / Archer-Daniels-Midland Co / International Flavors & Fragrances Inc / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Devon Energy Corp / Olin Corp / Target Corp / Rocket Companies Inc / DaVita Inc / Autozone Inc / Factset Research Systems Inc / EQT Corp / Atmos Energy Corp / Howmet Aerospace Inc / Boyd Gaming Corp / UGI Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / McCormick & Company Inc / Hormel Foods Corp / Boston Beer Company Inc / Cleveland-Cliffs Inc / Amerisourcebergen Corp / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / agilon health Inc / Cirrus Logic Inc / First American Financial Corp / Fiserv Inc / Hologic Inc / KLA Corp / Markel Corp / Repligen Corp / Stifel Financial Corp / Valmont Industries Inc / Foot Locker Inc / Pool Corp / Tapestry Inc / Amerco / Pegasystems Inc / Lamar Advertising Co / Steel Dynamics Inc / Stericycle Inc / Mercury Systems Inc / Wintrust Financial Corp / Nuance Communications Inc / Wynn Resorts Ltd / Carnival Corp / Monster Beverage Corp / Oak Street Health Inc / Las Vegas Sands Corp / Owens Corning / Freshpet Inc / Blackstone Inc / Insulet Corp / VMware Inc / NVR Inc / W R Berkley Corp / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Targa Resources Corp / Zillow Group Inc / Tripadvisor Inc / Wendys Co / Berry Global Group Inc / WEX Inc / RingCentral Inc / Wix.Com Ltd / Aramark / Norwegian Cruise Line Holdings Ltd / Five9 Inc / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / SiteOne Landscape Supply Inc / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Janus Henderson Group PLC / Roku Inc / Principal Financial Group Inc / Xcel Energy Inc / Qurate Retail Inc / Coterra Energy Inc / New Fortress Energy Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Fastly Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Essential Utilities Inc / DraftKings Inc / APA Corp (US) / Shift4 Payments Inc / Vroom Inc / Lemonade Inc / Brookfield Renewable Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / Skillz Inc / CLARIVATE PLC / Signify Health Inc / ChargePoint Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / Liberia / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Electrical / Electronics / Engineering & Construction / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Initiation: Poised To Combat Consecutive COVID-19 Variant Epidemic Waves</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">US60770K1079 / US4622601007 / US0197701065 / US90041T1088</td><td class="leftalignment">Moderna Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Turning Point Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Tara Bancroft, Ph.D. / Brittany Woods, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: KRYS PIII Win in DEB; ABUS LNP Patent Upheld</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">ABUS.OQ / KRYS.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Arbutus Biopharma Corp / Krystal Biotech Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Dec. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / ALK.N / BA.N / BAC.N / BMY.N / C.N / CCL.N / CL.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / OXY.N / PFE.N / PM.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / NUE.N / DIS.N / UNH.N / TFX.N / UNP.N / RCL.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / NKE.N / IT.N / GWW.N / VZ.N / DVA.N / V.N / ACN.N / TWTR.N / HPQ.N / COP.N / INTC.OQ / AOS.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / ADSK.OQ / FISV.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / AMD.OQ / ENPH.OQ / FANG.OQ / PTC.OQ / NCLH.N / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / Alaska Air Group Inc / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Citigroup Inc / Carnival Corp / Colgate-Palmolive Co / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Union Pacific Corp / Royal Caribbean Cruises Ltd / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / DaVita Inc / Visa Inc / Accenture PLC / Twitter Inc / HP Inc / Conocophillips / Intel Corp / A O Smith Corp / Adobe Inc / Amgen Inc / Apple Inc / Autodesk Inc / Fiserv Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Pool Corp / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Diamondback Energy Inc / PTC Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Ireland / Liberia / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: COVID update: more on T cells, takes on COV-BOOST and omicron reinfection</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AZN.L / MRNA.OQ / BNTX.OQ</td><td class="leftalignment">AstraZeneca PLC / Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / Chad / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / ALLO / MBIO / RAD / WMT / GILD.O / EW / ONEM.O / ISRG / BMRN.O / REGN.O / VRTX.O / CYAD / SSNC.O / CCRN.O / CSTL.O / AMED.O / EXAS.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / ALNY.O / LHCG.O / TMDI / ENSG.O / 483548103 / MRNA.O / ADUS.O / GLAXOSM.LG / FATE.O / VBIV.O / INO.O / EVH / 100063846 / NVTA.K / 04280A100 / CRSP / CLLS.O / MTEM.O / VERU.O / 720795103 / MOTS.O / TMDX / DMTK.O / PNTG.O / HRMY.O / HGEN.O / VOR.O / 03823M100 / CRBU.O / ATXS.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / Mustang Bio Inc / Rite Aid Corp / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Intuitive Surgical Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Celyad Oncology SA / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Castle Biosciences Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Alnylam Pharmaceuticals Inc / LHC Group Inc / Titan Medical Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Fate Therapeutics Inc / VBI Vaccines Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Truist Financial Corp / Invitae Corp / Arrowhead Pharmaceuticals Inc / CRISPR Therapeutics AG / Cellectis SA / Molecular Templates Inc / Veru Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Transmedics Group Inc / DermTech Inc / Pennant Group Inc / Harmony Biosciences Holdings Inc / Humanigen Inc / Vor Biopharma Inc / Applied Minerals Inc / Caribou Biosciences Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: Flu vaccines/chicken outlook: reality checked, pretty fast (SAN/GSK/MRNA)</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ / GSK.L / SASY.PA / BNTX.OQ</td><td class="leftalignment">Moderna Inc / GlaxoSmithKline PLC / Sanofi SA / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COV-BOOST Supports the Status Quo; No Single Best Booster but Some to Avoid</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AZN / 71708110 / 478160104 / 80105N10 / 60770K10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Johnson & Johnson / Sanofi SA / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / Chad / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 Omicron variant - First data from South Africa suggests immune escape likely</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / ROG.S / GSK.L / REGN.OQ / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">The Long and the Short of it: Developments Down Under - Bank conduct, Battery Tech, Smart Agri, Iron Ore demand risks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">7201.T / 7261.T / AGL.AX / ANZ.AX / BHP.AX / NAB.AX / NEST.BO / QAN.AX / STO.AX / WBC.AX / WPL.AX / PPT.AX / IAG.AX / NFLX.OQ / FMG.AX / RDSA.L / MQG.AX / MRNA.OQ / BHPB.L / GOOGL.OQ / CWY.AX / KGN.AX / FB.PS / COL.AX / STLA.MI</td><td class="leftalignment">Nissan Motor Co Ltd / Mazda Motor Corp / AGL Energy Ltd / Australia and New Zealand Banking Group Ltd / BHP Group Ltd / National Australia Bank Ltd / Nestle India Ltd / Qantas Airways Ltd / Santos Ltd / Westpac Banking Corp / Woodside Petroleum Ltd / Perpetual Ltd / Insurance Australia Group Ltd / Netflix Inc / Fortescue Metals Group Ltd / Royal Dutch Shell PLC / Macquarie Group Ltd / Moderna Inc / BHP Group PLC / Alphabet Inc / Cleanaway Waste Management Ltd / Kogan.com Ltd / San Miguel Food and Beverage Inc / Coles Group Ltd / Stellantis NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / United Kingdom / India / Japan / Netherlands / Philippines / Papua New Guinea / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity / Environmental, Social, Governance</td><td class="leftalignment">Phineas Glover / Lydia Brunton / Alfred Chang</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Kiwoom Securities</td><td class="leftalignment">kiwoom 미 국 주 식 가 이드 weekly (2021.11.25~12.2)-12/02/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">27</td><td class="leftalignment">ADSK / BBY / GPS / LRCX / NTAP / VRTX / HPQ / MRNA / NCLH</td><td class="leftalignment">Autodesk Inc / Best Buy Co Inc / Gap Inc / Lam Research Corp / NetApp Inc / Vertex Pharmaceuticals Inc / HP Inc / Moderna Inc / Norwegian Cruise Line Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Won Ju Lee / Seong Jin Ji</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">ABUS (Buy): PT to $5.50 on Initial AB-836 Data</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABUS.O / MRNA.O / 04280A100</td><td class="leftalignment">Arbutus Biopharma Corp / Moderna Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Keay T. Nakae, CFA / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Positive Appeals Court LNP Decision Opens Path to Some Value & Cash for ROIV</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">G7627910 / 71708110 / 09075V10 / 60770K10</td><td class="leftalignment">Roivant Sciences Ltd / Pfizer Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Indonesia Market Strategy - CS Daily Insight - Omicron impact tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / PFE.N / MRNA.OQ</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Indonesia / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Gregorius Gary</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BNTX & MRNA: Takeaways from Sanofi's Vaccines Day</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US60770K1079 / US09075V1026</td><td class="leftalignment">Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Andrew Galler / Dr. Tim M. Anderson, MD</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Live@PSC: Discusses Omicron Vaccine Development Strategy and Timeline</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRNA IP Debates Continue - ABUS Patents Stand as Expected</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">60770K10 / G7627910</td><td class="leftalignment">Moderna Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Geoffrey Porges, MBBS / Mr. Rick Bienkowski, Ph.D. / Anna Baran, CFA / Greco Song, Ph.D. / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Dec. 01, 2021 / 2:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Emerging SARS-COv-2 Variant Is Revenue Growth Opportunity for Vaccine Developer</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">22UAy.DE / PFE.N / MRNA.OQ</td><td class="leftalignment">BioNTech SE / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Dec. 01, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 - Get Set for M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AZN / 71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Insurance Sector: Experts Project COVID "Winter Surge"; Potential Improvement Still Possible by Mid-2022, While Omicron Adds Uncertainty</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">HIG.N / RGA.N / AFL.N / AIG.N / PFE.N / HUM.N / MET.N / PRI.N / UNM.N / AMP.N / LNC.N / PRU.N / GL.N / AEL.N / MRNA.OQ / VOYA.N / BHF.OQ / PFG.OQ / EQH.N</td><td class="leftalignment">Hartford Financial Services Group Inc / Reinsurance Group of America Inc / Aflac Inc / American International Group Inc / Pfizer Inc / Humana Inc / MetLife Inc / Primerica Inc / Unum Group / Ameriprise Financial Inc / Lincoln National Corp / Prudential Financial Inc / Globe Life Inc / American Equity Investment Life Holding Co / Moderna Inc / Voya Financial Inc / Brighthouse Financial Inc / Principal Financial Group Inc / Equitable Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Financial Services / Insurance</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Andrew S. Kligerman / Ms. Wilma Burdis</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Australian Oil, Gas & LNG daily - Oil retreats again, COE to buy Orbost? WOR IBD, WPL taken to court</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">COE.AX / WOR.AX / WPL.AX / STO.AX / XOM.N / APA.AX / MRNA.OQ</td><td class="leftalignment">Cooper Energy Ltd / Worley Ltd / Woodside Petroleum Ltd / Santos Ltd / Exxon Mobil Corp / APA Group / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Papua New Guinea / United States</td><td class="leftalignment">Energy / Oil & Gas</td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Mr. Saul Kavonic / Sandy James / Mr. Alex Ren</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Moderna (MRNA: $352.43) adds $4 billion in MCap in November, highest in Biotechnology sector</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">92532F100 / 02043Q107 / MRNA.O / 00289Y107 / 501147102 / N90064101</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Abeona Therapeutics Inc / Krystal Biotech Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EA / INTC.O / MSFT / QCOM.O / SONY / TTWO / GILD.O / ATVI.O / NVDA.O / HEAR / NFLX / REGN.O / AMED.O / SWKS.O / LHCG.O / 36467W109 / ENSG.O / MRNA.O / ZNGA / FDEV.L / 82655M107 / INO.O / QRVO.O / BILI.O / HUYA.K / 03823M100 / MYPS</td><td class="leftalignment">Electronic Arts Inc / Intel Corp / Microsoft Corp / Qualcomm Inc / Sony Group Corp / Take-Two Interactive Software Inc / Gilead Sciences Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Netflix Inc / Regeneron Pharmaceuticals Inc / Amedisys Inc / Skyworks Solutions Inc / LHC Group Inc / GameStop Corp / Ensign Group Inc / Moderna Inc / Zynga Inc / Frontier Developments PLC / Sify Technologies Ltd / Inovio Pharmaceuticals Inc / Qorvo Inc / Bilibili Inc / HUYA Inc / Applied Minerals Inc / Playstudios Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / United Kingdom / India / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Omicron COVID-19 Strain Adds Uncertainty Into Year-end</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / REGN.O / MRNA.O / INO.O / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - A focused large-scale biologics specialist</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">207940.KS / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / 1177.HK / TEVA.TA / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / 005930.KS / 000100.KS / 008930.KS / SFZN.S / BIIB.OQ / 006280.KS / TEVA.N / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / 032830.KS / 128940.KS / ABBV.N / CTLT.N / 196170.KQ / 028260.KS / 2269.HK / 091990.KQ / 302440.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Sino Biopharmaceutical Ltd / Teva Pharmaceutical Industries Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Samsung Electronics Co Ltd / Yuhan Corp / Hanmi Science Co Ltd / Siegfried Holding AG / Biogen Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Samsung Life Insurance Co Ltd / Hanmi Pharm Co Ltd / Abbvie Inc / Catalent Inc / Alteogen Inc / Samsung C&T Corp / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Israel / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">302440.KS: SK Bioscience Co., Ltd. - A rising vaccine manufacturing and development powerhouse</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">302440.KS / 4502.T / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVAX.OQ / 000100.KS / 008930.KS / 006120.KS / 069620.KS / SFZN.S / 006280.KS / EBS.N / INO.OQ / MRNA.OQ / 068270.KS / 1099.HK / 034730.KS / 128940.KS / CTLT.N / 196170.KQ / 207940.KS / 2269.HK / 091990.KQ / 326030.KS / CVAC.OQ / PPGN.S / 2197.HK</td><td class="leftalignment">SK Bioscience Co Ltd / Takeda Pharmaceutical Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novavax Inc / Yuhan Corp / Hanmi Science Co Ltd / SK Discovery Co Ltd / Daewoong Pharma / Siegfried Holding AG / Green Cross Corp / Emergent BioSolutions Inc / Inovio Pharmaceuticals Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / SK Inc / Hanmi Pharm Co Ltd / Catalent Inc / Alteogen Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Biopharmaceuticals Co Ltd / CureVac NV / PolyPeptide Group AG / Clover Biopharmaceuticals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - A committed CMO player within Korean large pharmas</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">006280.KS / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / APNJ.J / NVAX.OQ / SFZN.S / 005250.KS / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / CTLT.N / 207940.KS / 2269.HK / 302440.KS</td><td class="leftalignment">Green Cross Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Aspen Pharmacare Holdings Ltd / Novavax Inc / Siegfried Holding AG / Green Cross Holdings / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Korea, Republic of / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Contract Manufacturing Sector: Visible growth pathways for Korean CMOs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">207940.KS / 302440.KS / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVAX.OQ / SFZN.S / 006280.KS / EBS.N / MRNA.OQ / 1099.HK / CTLT.N / 2269.HK</td><td class="leftalignment">Samsung Biologics Co Ltd / SK Bioscience Co Ltd / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novavax Inc / Siegfried Holding AG / Green Cross Corp / Emergent BioSolutions Inc / Moderna Inc / Sinopharm Group Co Ltd / Catalent Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">SPDB International Securities Limited</td><td class="leftalignment">浦银国际研究：Omicron变异株来袭：全球疫情添新变数</td><td class="leftalignment">Chinese</td><td class="rightalignment">9</td><td class="leftalignment">MRNA=US / MRK=US / 6185=HK / BNTX=US / 9939=HK / 2137=HK</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / CanSino Biologics Inc / BioNTech SE / Kintor Pharmaceutical Ltd / Brii Biosciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan Hu / Ms. Sharon Lam</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">KRYS (Buy): PT to $140 on Positive Topline B-VEC Data in DEB</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">501147102 / 92532F100 / 02043Q107 / MRNA.O / 00289Y107 / N90064101</td><td class="leftalignment">Krystal Biotech Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Abeona Therapeutics Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geulah Livshits, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: COVID update: omicron takes, T cell questions, molnu MOVE’s OUT</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AZN.L / GSK.L / MRNA.OQ / BNTX.OQ</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: GSK Aims for NASH; Baidu Buddies with Sanofi</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GSK.L / SASY.PA / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Crude, E&P, Integrated and Refiners: We Remain Constructive on Energy Sector</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HFC.N / MPC.N / PXD.N / IMO.TO / SU.TO / VLO.N / DVN.N / EQT.N / CVX.N / MRNA.OQ / CVE.TO / PSX.N / OVV.N</td><td class="leftalignment">HollyFrontier Corp / Marathon Petroleum Corp / Pioneer Natural Resources Co / Imperial Oil Ltd / Suncor Energy Inc / Valero Energy Corp / Devon Energy Corp / EQT Corp / Chevron Corp / Moderna Inc / Cenovus Energy Inc / Phillips 66 / Ovintiv Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Energy / Oil & Gas</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Manav Gupta / Mr. William J. Janela, CFA / Chris Baker / Vera Tang</td></tr>
<tr class="even"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Strategy to Combat New Omicron Variant Including Multiple Booster Candidates</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">11/27/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Moderna, Inc.: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/27/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">MRNA: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: mRNA to sweep flu vaccines? Let’s not put the chicken before the egg</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">SASY.PA / GSK.L / MRNA.OQ / BNTX.OQ</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for MRNA. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New South African SARS-CoV-2 Varriant Sends Market Lower and MRNA Shares Higher</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALLO / AMGN / C.N / DE / ICE / INCY / NBIX / NKE / QCOM.O / RARE / SEIC / VCTR / GILD.O / TRIT / ALKS.O / SQ / ARNA.O / FDS.N / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NDAQ / NKTR / LIFE.O / MSTR.O / PHAR.O / BIIB / MNKD.O / SPGI / ACAD.O / ALNY.O / COIN / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / CBOE.K / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Citigroup Inc / Deere & Co / Intercontinental Exchange Inc / Incyte Corp / Neurocrine Biosciences Inc / Nike Inc / Qualcomm Inc / Ultragenyx Pharmaceutical Inc / SEI Investments Co / Victory Capital Holdings Inc / Gilead Sciences Inc / Triterras Inc / Alkermes Plc / Block Inc / Arena Pharmaceuticals Inc / Factset Research Systems Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nasdaq Inc / Nektar Therapeutics / aTyr Pharma Inc / Microstrategy Inc / Pharming Group NV / Biogen Inc / MannKind Corp / S&P Global Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Coinbase Global Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Cboe Global Markets Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Cayman Islands / France / Ireland / Netherlands / El Salvador / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-3Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALLO / AMGN / INCY / NBIX / RARE / GILD.O / ALKS.O / ARNA.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NKTR / LIFE.O / PHAR.O / BIIB / MNKD.O / ACAD.O / ALNY.O / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Alkermes Plc / Arena Pharmaceuticals Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / aTyr Pharma Inc / Pharming Group NV / Biogen Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Cases and hospitalisation trends: UK hospitalisation rates lower vs rest of Europe - possible link to vaccine choice</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / 1099.HK</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/25/2021</td><td class="leftalignment">Kiwoom Securities</td><td class="leftalignment">kiwoom 미 국 주 식 가 이드 weekly (2021.11.18~11.25)-11/25/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">27</td><td class="leftalignment">ADSK / BBY / DLTR / GPS / MU / PTON / NVDA / ZM / HPQ / MRNA</td><td class="leftalignment">Autodesk Inc / Best Buy Co Inc / Dollar Tree Inc / Gap Inc / Micron Technology Inc / Peloton Interactive Inc / NVIDIA Corp / Zoom Video Communications Inc / HP Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Won Ju Lee / Seong Jin Ji</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BBY / DG / DLTR / EA / INTC.O / JACK / MSFT / MX / QCOM.O / SONY / TTWO / WEN / ATVI.O / NVDA.O / OGI / HEAR / MPWR.O / AMD.O / ADI.O / NFLX / SMTC.O / ADSK.O / TXN.O / CRUS.O / DKS / AVGO.O / XLNX.OQ / LIFE.O / SWKS.O / SYBX / 36467W109 / 514766104 / MRNA.O / NXPI.O / ZNGA / ENTA / FDEV.L / 82655M107 / XENT / INO.O / CLLS.O / NCNA.O / BILI.O / 84764T304 / ASO.OQ / FSTX.O / HUYA.K / CRXT.O</td><td class="leftalignment">Best Buy Co Inc / Dollar General Corp / Dollar Tree Inc / Electronic Arts Inc / Intel Corp / Jack in the Box Inc / Microsoft Corp / MagnaChip Semiconductor Corp / Qualcomm Inc / Sony Group Corp / Take-Two Interactive Software Inc / Wendys Co / Activision Blizzard Inc / NVIDIA Corp / OrganiGram Holdings Inc / Turtle Beach Corp / Monolithic Power Systems Inc / Advanced Micro Devices Inc / Analog Devices Inc / Netflix Inc / Semtech Corp / Autodesk Inc / Texas Instruments Inc / Cirrus Logic Inc / DICK'S Sporting Goods Inc / Broadcom Inc / Xilinx Inc / aTyr Pharma Inc / Skyworks Solutions Inc / Synlogic Inc / GameStop Corp / Landec Corp / Moderna Inc / NXP Semiconductors NV / Zynga Inc / Enanta Pharmaceuticals Inc / Frontier Developments PLC / Sify Technologies Ltd / Intersect Ent Inc / Inovio Pharmaceuticals Inc / Cellectis SA / NuCana PLC / Bilibili Inc / Speed Commerce Inc / Academy Sports and Outdoors Inc / F-Star Therapeutics Inc / HUYA Inc / Clarus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / India / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Vector Casa de Bolsa</td><td class="leftalignment">Las emisoras internacionales más operadas en el SIC-11/24/2021</td><td class="leftalignment">Spanish</td><td class="rightalignment">2</td><td class="leftalignment">AAPL / AMC / AMD / DIS / DVN / F / FB / GPS / NIO / NVDA / BABA / PYPL / MRNA / TSLA / WISH / BILI / SPCE.K / LCID</td><td class="leftalignment">Apple Inc / AMC Entertainment Holdings Inc / Advanced Micro Devices Inc / Walt Disney Co / Devon Energy Corp / Ford Motor Co / Meta Platforms Inc / Gap Inc / NIO Inc / NVIDIA Corp / Alibaba Group Holding Ltd / PayPal Holdings Inc / Moderna Inc / Tesla Inc / Wishpond Technologies Ltd / Bilibili Inc / Virgin Galactic Holdings Inc / Lucid Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">SITC 2021 Review: Early/Mid Progress Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LIFE.O / MRNA.O / INO.O / CLLS.O / FSTX.O</td><td class="leftalignment">aTyr Pharma Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Cellectis SA / F-Star Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Bermuda / Brazil / Canada / Switzerland / China / Cayman Islands / Germany / Denmark / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Iran, Islamic Republic of / Israel / Italy / Japan / Korea, Republic of / Kuwait / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Philippines / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Virgin Islands, British / Vietnam / South Africa / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Novo Nordisk Nabs DRNA; Danon Data from RCKT</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">RCKT.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Rocket Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BNTX & MRNA: Takeaways from the ACIP booster meeting</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US60770K1079 / US09075V1026</td><td class="leftalignment">Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Andrew Galler / Dr. Tim M. Anderson, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / SRPT.OQ / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / Sarepta Therapeutics Inc / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Nov. 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ACA / AMGN / ATRC / CGEN / CSII / EPIX / GE / ICPT / INCY / MBIO / RAD / WMT / ONEM.O / RLMD / FMTX / BWAY.O / SSNC.O / CUE / NKTR / CCRN.O / ABMD.O / ICAD.O / AMED.O / EXAS.O / ANGN.O / PHAR.O / BIIB / 478160104 / 00846U101 / 868168105 / NUVA.O / GOOG.O / CMMB / FREQ / DXCM.O / LHCG.O / MBRX.O / CBAY / HUMA / PODD.O / 02043Q107 / TNDM.O / ENSG.O / 483548103 / MRNA.O / VERO / BLRX / ADUS.O / GLAXOSM.LG / AGIO / FATE.O / TRVN / MDWD.O / 02005N100 / RXDX.O / CASI.O / VBLT.O / EVH / CFMS.O / CRBP.O / 100063846 / NVTA.K / EDIT / MDGL / CRSP / VREX / URGN.O / PLXP.O / IOVA / KALA.O / MTEM.O / VERU.O / SVRA.O / 720795103 / FIXX.O / MIST.O / TMDX / IDYA.O / DMTK.O / PNTG.O / ETNB.O / GMDA / BCYC / ZNTL.O / NMTR.O / NNOX / CMPS.OQ / HGEN.O / PMVP / AYLA / PRTG.O / SNSE.O / IMCR.O / VIRX.O / NKTX.O / 03823M100 / GANX.O / US00449L1026 / RZLT.O / SERA.OQ / ATXS.O / MDNA.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / Amgen Inc / AtriCure Inc / Compugen Ltd / Cardiovascular Systems Inc / ESSA Pharma Inc / General Electric Co / Intercept Pharmaceuticals Inc / Incyte Corp / Mustang Bio Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / Relmada Therapeutics Inc / Forma Therapeutics Holdings Inc / Brainsway Ltd / SS&C Technologies Holdings Inc / Cue Biopharma Inc / Nektar Therapeutics / Cross Country Healthcare Inc / ABIOMED Inc / ICAD Inc / Amedisys Inc / Exact Sciences Corp / Angion Biomedica Corp / Pharming Group NV / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / NuVasive Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Cymabay Therapeutics Inc / Humacyte Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Venus Concept Inc / BioLine RX Ltd / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Trevena Inc / Mediwound Ltd / Ally Financial Inc / Prometheus Biosciences Inc / CASI Pharmaceuticals Inc / Vascular Biogenics Ltd / Evolent Health Inc / Conformis Inc / Corbus Pharmaceuticals Holdings Inc / Truist Financial Corp / Invitae Corp / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Varex Imaging Corp / Urogen Pharma Ltd / PLx Pharma Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Molecular Templates Inc / Veru Inc / Savara Inc / Pieris Pharmaceuticals Inc / Homology Medicines Inc / Milestone Pharmaceuticals Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / DermTech Inc / Pennant Group Inc / 89Bio Inc / Gamida Cell Ltd / Bicycle Therapeutics PLC / Zentalis Pharmaceuticals Inc / 9 Meters Biopharma Inc / Nano-X Imaging Ltd / Compass Pathways PLC / Humanigen Inc / PMV Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Viracta Therapeutics Inc / Nkarta Inc / Applied Minerals Inc / Gain Therapeutics Inc / Achilles Therapeutics PLC / Rezolute Inc / Sera Prognostics Inc / Astria Therapeutics Inc / Medicenna Therapeutics Corp / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / Nigeria / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">FDA Grants EUA for COVID Vaccine Booster for All Adults 18+; Flu Data Soon</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Phase II/III ConquerRSV Trial Underway; Positive AZD8601 Data at AHA</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 29): First dose rate 79%, 76% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFIZ.NS / MRNA.OQ</td><td class="leftalignment">Pfizer Ltd / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">India / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.29）：ワクチン接種率は1回目が79%、2回目は76%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFIZ.NS / MRNA.OQ</td><td class="leftalignment">Pfizer Ltd / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">India / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Nov. 18, 2021 / 3:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.O / 75901B107 / ADVM.O / SIGHT.PA / MGTX.O / 54142F102 / 87166L100 / FIXX.O / AXLA.O / 77313F106 / PHGE.K / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">Moderna Inc / Regenxbio Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / Synlogic Inc / Homology Medicines Inc / Axcella Health Inc / Rocket Pharmaceuticals Inc / Biomx Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Intermoney Valores</td><td class="leftalignment">Rovi: Investor day 2021 - Intermoney Valores</td><td class="leftalignment">Spanish</td><td class="rightalignment">3</td><td class="leftalignment">ROVI=ES / MRNA=US</td><td class="leftalignment">Laboratorios Farmaceuticos ROVI SA / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Spain / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / MISCELLANEOUS / OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sr. Juan Ros R. Padilla</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">FIXX (Buy): pheNIX P2 Data Update Mid-2022; 3Q21 Results, PT to $25</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FIXX.O / MRNA.O / 75901B107 / ADVM.O / MGTX.O / 54142F102 / 87166L100 / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">Homology Medicines Inc / Moderna Inc / Regenxbio Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / Synlogic Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: COVID vaccine/therapeutics update: takes on recent newsflow</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">SASY.PA / MRNA.OQ / BNTX.OQ</td><td class="leftalignment">Sanofi SA / Moderna Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMT / ASML.AS / HD / LOW / SAP / SIX / W / AMZN.O / NICE / EQIX / PRPL / CUE / MRNA.O / SPLK.O / VBLT.O / MTEM.O / FIXX.O / GRWG / ONDS.OQ / 03823M100 / OTLY</td><td class="leftalignment">American Tower Corp / ASML Holding NV / Home Depot Inc / Lowe's Companies Inc / SAP SE / Six Flags Entertainment Corp / Wayfair Inc / Amazon.com Inc / Nice Ltd / Equinix Inc / Purple Innovation Inc / Cue Biopharma Inc / Moderna Inc / Splunk Inc / Vascular Biogenics Ltd / Molecular Templates Inc / Homology Medicines Inc / GrowGeneration Corp / Ondas Holdings Inc / Applied Minerals Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Germany / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback from Company Meeting with Investors</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.O / 03823M100</td><td class="leftalignment">Moderna Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: AAVIATE Safety OK, Waiting for Liftoff</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">Sector Commentary: Several Areas Left Behind in Current Rally</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RBLX=US / TWTR=US / DT=US / U=US / 7974=JP / AI=US / BYND=US / ISEE=US / REGN=US / RYAN=US / SHOP=US / NET=US / CNM=US / UPST=US / PTON=US / DVAX=US / MRNA=US / CPRX=US / COIN=US / AVXL=US / CLDX=US / RCUS=US / TSLA=US / CERE=US / PRLB=US / PRTA=US / BILL=US / NTLA=US / CRSP=US / ROKU=US / CDMO=US / GH=US / STNE=US / PINS=US / ZM=US / CRWD=US / FVRR=US / DDOG=US / OCGN=US / DKNG=US / PLTR=US / ASAN=US / TVTX=US / ABNB=US / AFRM=US / WISH=US / HAYW=US / CFLT=US / MNDY=US</td><td class="leftalignment">Roblox Corp / Twitter Inc / Dynatrace Inc / Unity Software Inc / Nintendo Co Ltd / C3.ai Inc / Beyond Meat Inc / Iveric Bio Inc / Regeneron Pharmaceuticals Inc / Ryan Specialty Group Holdings Inc / Shopify Inc / Cloudflare Inc / Core & Main Inc / Upstart Holdings Inc / Peloton Interactive Inc / Dynavax Technologies Corp / Moderna Inc / Catalyst Pharmaceuticals Inc / Coinbase Global Inc / Anavex Life Sciences Corp / Celldex Therapeutics Inc / Arcus Biosciences Inc / Tesla Inc / Cerevel Therapeutics Holdings Inc / Proto Labs Inc / Prothena Corporation PLC / Bill.com Holdings Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Roku Inc / Avid Bioservices Inc / Guardant Health Inc / StoneCo Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Fiverr International Ltd / Datadog Inc / Ocugen Inc / DraftKings Inc / Palantir Technologies Inc / Asana Inc / Travere Therapeutics Inc / Airbnb Inc / Affirm Holdings Inc / ContextLogic Inc / Hayward Holdings Inc / Confluent Inc / Monday.Com Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kenley Scott</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">MRNA-2752 Shows Synergy with Durvalumab in Advanced Solid Tumors</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">A.N / AAP.N / BBY.N / GPS.N / MDT.N / PFE.N / WMT.N / DE.N / TSN.N / HD.N / LOW.N / TGT.N / TJX.N / HPQ.N / AMAT.OQ / ADSK.OQ / CSCO.OQ / ROST.OQ / SJM.N / INTU.OQ / CPRT.OQ / DLTR.OQ / AMZN.OQ / NVDA.OQ / TDG.N / MRNA.OQ / ADI.OQ / KEYS.N / J.N / BBWI.N</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Best Buy Co Inc / Gap Inc / Medtronic PLC / Pfizer Inc / Walmart Inc / Deere & Co / Tyson Foods Inc / Home Depot Inc / Lowe's Companies Inc / Target Corp / TJX Companies Inc / HP Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Ross Stores Inc / J M Smucker Co / Intuit Inc / Copart Inc / Dollar Tree Inc / Amazon.com Inc / NVIDIA Corp / TransDigm Group Inc / Moderna Inc / Analog Devices Inc / Keysight Technologies Inc / Jacobs Engineering Group Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">339 / MRNA.O / DDDD.L / ALSEN.PA / 00289Y107 / 75901B107 / ADVM.O / SIGHT.PA / 81750R102 / MGTX.O / 501147102 / 299734103 / 87166L100 / FIXX.O / 77313F106 / PASG.O / N90064101 / 50015M109 / 83422E105 / 877619106 / 829399104 / 03820J100 / TNYA.O</td><td class="leftalignment">Core Economy Investment Group Ltd / Moderna Inc / 4D Pharma PLC / Sensorion SA / Abeona Therapeutics Inc / Regenxbio Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Seres Therapeutics Inc / MeiraGTx Holdings PLC / Krystal Biotech Inc / Evelo Biosciences Inc / Synlogic Inc / Homology Medicines Inc / Rocket Pharmaceuticals Inc / Passage Bio Inc / Uniqure NV / Kodiak Sciences Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / Applied Genetic Technologies Corp / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">SYBX (Buy, PT $10): Important Data for SYNB1934, SYNB8802 in 1H22</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">87166L100 / MRNA.O / FIXX.O</td><td class="leftalignment">Synlogic Inc / Moderna Inc / Homology Medicines Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Keay T. Nakae, CFA / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.28): First dose rate 78%, 74% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.28）：ワクチン接種率は1回目が78%、2回目は74%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRNA-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.O / JNJ / MRK / NVS / ALNY.O / ARWR.O / ATHX.O / RGLS.O / MON.O</td><td class="leftalignment">Moderna Inc / Johnson & Johnson / Merck & Co Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Athersys Inc / Regulus Therapeutics Inc / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABCL: Q3 Earnings Highlights; Overdelivering on Key Operating Metrics</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABCL.OQ / MRNA.OQ / 1952.HK</td><td class="leftalignment">Abcellera Biologics Inc / Moderna Inc / Everest Medicines Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">KRYS (Buy): B-VEC PIII Readout in 4Q21; Aesthetics in 2022; PT to $123</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">501147102 / 92532F100 / 02043Q107 / MRNA.O / 00289Y107 / N90064101</td><td class="leftalignment">Krystal Biotech Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Abeona Therapeutics Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geulah Livshits, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna tumbles 30.1% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Nov. 08, 2021 / 1:50PM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">VNiGM: In Hind(SIGHT) Don't Change the Filter! MRNA's Modality Moves</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MRNA.OQ / SIGHT.PA / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Moderna Inc / Gensight Biologics SA / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">William O'Neil + Co.: Sector Commentary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GOOS=US / QCOM=US / NVDA=US / FN=US / DDS=US / PENN=US / CAR=US / Z=US / NET=US / PTON=US / MRNA=US / PLNT=US / NEO=US / TSLA=US / CHGG=US / VRTV=US / TRUP=US / ABNB=US</td><td class="leftalignment">Canada Goose Holdings Inc / Qualcomm Inc / NVIDIA Corp / Fabrinet / Dillard's Inc / Penn National Gaming Inc / Avis Budget Group Inc / Zillow Group Inc / Cloudflare Inc / Peloton Interactive Inc / Moderna Inc / Planet Fitness Inc / Neogenomics Inc / Tesla Inc / Chegg Inc / Veritiv Corp / Trupanion Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kenley Scott</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Moderna: Post-Q3 update: turning of the tide?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Niall Alexander / Manos Mastorakis / Mr. Rajan Sharma</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / CGC / CHTR / CRY / MSFT / RAD / T / VCTR / WMT / WW / GILD.O / CMCSA.O / ONEM.O / XRAY.O / VZ / DOX.O / REGN.O / VRTX.O / SSNC.O / CCRN.O / AMED.O / BIIB / 459200101 / 00846U101 / 868168105 / GOOG.O / LHCG.O / PODD.O / MASI.O / ENSG.O / 483548103 / MRNA.O / STX.OQ / 771195104 / ADUS.O / TMUS / EVH / 100063846 / 720795103 / PNTG.O / FCRD / KDNY.O / LTH.N</td><td class="leftalignment">Arcosa Inc / Canopy Growth Corp / Charter Communications Inc / CryoLife Inc / Microsoft Corp / Rite Aid Corp / AT&T Inc / Victory Capital Holdings Inc / Walmart Inc / WW International Inc / Gilead Sciences Inc / Comcast Corp / 1Life Healthcare Inc / DENTSPLY SIRONA Inc / Verizon Communications Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Insulet Corp / Masimo Corp / Ensign Group Inc / Kaman Corp / Moderna Inc / Seagate Technology Holdings PLC / Roche Holding AG / Addus Homecare Corp / T-Mobile US Inc / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / First Eagle Alternative Capital BDC Inc / Chinook Therapeutics Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: Vaccines? Who needs ‘em. PFE raises the bar: X-reads for MRNA/ROG/others</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ / ROG.S / BNTX.OQ</td><td class="leftalignment">Moderna Inc / Roche Holding AG / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Nov. 05, 2021</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">AAPL / ALLO / AMGN / ATRC / CRY / CSII / EXEL / GBT / ICPT / INCY / INSP / IRTC / NBIX / OM / RARE / SAGE / ASND.O / GILD.O / EW / IART.O / SGEN / UTHR.O / PCSA.O / BMRN.O / DRRX.O / REGN.O / VRTX.O / NKTR / CCRN.O / STAA.O / AMED.O / EXAS.O / BIIB / 478160104 / MNKD.O / CMMB / ALNY.O / DXCM.O / LHCG.O / INFI.O / PODD.O / TNDM.O / MRNA.O / 771195104 / ADUS.O / SWAV / SRPT.O / AGIO / FATE.O / AERI.O / 02005N100 / AGRX.O / RXDX.O / APTO.O / AUPH.O / CFMS.O / VKTX / IONS.O / 04280A100 / MDGL / VRAY / NTLA / CRSP / IOVA / ATNX.O / 720795103 / PRVB.O / ORTX.O / BNGO.O / ARVN / XFOR.O / TMDX / PSNL.O / BCYC / ORIC.O / HGEN.O / 03823M100 / CLNN.O / CGTX.OQ</td><td class="leftalignment">Apple Inc / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / CryoLife Inc / Cardiovascular Systems Inc / Exelixis Inc / Global Blood Therapeutics Inc / Intercept Pharmaceuticals Inc / Incyte Corp / Inspire Medical Systems Inc / iRhythm Technologies Inc / Neurocrine Biosciences Inc / Outset Medical Inc / Ultragenyx Pharmaceutical Inc / SAGE Therapeutics Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Seagen Inc / United Therapeutics Corp / Processa Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / DURECT Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / STAAR Surgical Co / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / MannKind Corp / Chemomab Therapeutics Ltd / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / Roche Holding AG / Addus Homecare Corp / Shockwave Medical Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Ally Financial Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Aptose Biosciences Inc / Aurinia Pharmaceuticals Inc / Conformis Inc / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / ViewRay Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Personalis Inc / Bicycle Therapeutics PLC / Oric Pharmaceuticals Inc / Humanigen Inc / Applied Minerals Inc / Clene Inc. / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Runs the Table in COVID – MRNA Bubble Continues to Deflate</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K10 / PFE.N / 71708110</td><td class="leftalignment">Moderna Inc / Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q21 Review: Quarterly Volatility In a Biotech Bellwether</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRNA.O / VRTX.O</td><td class="leftalignment">Moderna Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRNA Model Update - Refreshing Our View after an Eventful 3Q</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K10</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / CAH.N / PNW.N / WMT.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / HD.N / LOW.N / TGT.N / JCI.N / DHI.N / SRE.N / TJX.N / ATO.N / VTR.N / AMAT.OQ / CSCO.OQ / JKHY.OQ / INTU.OQ / CPRT.OQ / TPR.N / NVDA.OQ / TDG.N / MRNA.OQ / ZTS.N / PYPL.OQ / WRK.N / VTRS.OQ / BBWI.N</td><td class="leftalignment">Advance Auto Parts Inc / Cardinal Health Inc / Pinnacle West Capital Corp / Walmart Inc / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Lowe's Companies Inc / Target Corp / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / TJX Companies Inc / Atmos Energy Corp / Ventas Inc / Applied Materials Inc / Cisco Systems Inc / Jack Henry & Associates Inc / Intuit Inc / Copart Inc / Tapestry Inc / NVIDIA Corp / TransDigm Group Inc / Moderna Inc / Zoetis Inc / PayPal Holdings Inc / Westrock Co / Viatris Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Moderna Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : 3Q Snapshot - The Straw That Broke The Camel's Back...For Now</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / BA.N / CAH.N / CCK.N / CE.N / CF.N / COF.N / EIX.N / EOG.N / F.N / HIG.N / HLT.N / IBM.N / ITT.N / KEY.N / MAN.N / NOC.N / PFE.N / PM.N / SC.N / STE.N / TMX.N / UAL.N / USB.N / VNT.N / ZEN.N / DGX.N / PXD.N / NUE.N / DIS.N / WLK.N / CMI.N / GD.N / AIZ.N / AFG.N / R.N / SPOT.N / EVR.N / PRI.N / ADM.N / IFF.N / MRO.N / LH.N / EMR.N / PCG.N / OLN.N / TGT.N / RKT.N / SNV.N / AZO.N / FDS.N / ATO.N / H.N / BYD.N / DNB.N / GPC.N / HRL.N / SAM.N / CVX.N / L.N / GME.N / COP.N / INTC.OQ / ORI.N / ADPT.OQ / CRUS.OQ / FISV.OQ / HOLX.OQ / RJF.N / TYL.N / FL.N / ZION.OQ / QCOM.OQ / ORLY.OQ / DFS.N / LAMR.OQ / MRCY.OQ / WTFC.OQ / UMPQ.OQ / PLUG.OQ / HAIN.OQ / PNFP.OQ / WOOF.OQ / WYNN.OQ / PA1436583006 / OPEN.OQ / TFC.N / OSH.N / LVS.N / THG.N / BRKb.N / OC.N / FRPT.OQ / ULTA.OQ / NVR.N / CFX.N / MRNA.OQ / CME.OQ / CLH.N / AI.N / AVGO.OQ / NEE.N / SABR.OQ / Z.OQ / FB.OQ / BFAM.N / WEX.N / RNG.N / ARMK.N / NCLH.N / SYF.N / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / CVNA.N / ROKU.OQ / PFG.OQ / KDP.N / STNE.OQ / NFE.OQ / LYFT.O / PINS.N / BYND.OQ / UBER.N / FSLY.N / GO.OQ / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / DCT.OQ / PLTR.N / SKLZ.N / CLVT.N / SGFY.N / CHPT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Boeing Co / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / CF Industries Holdings Inc / Capital One Financial Corp / Edison International / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / International Business Machines Corp / ITT Inc / KeyCorp / ManpowerGroup Inc / Northrop Grumman Corp / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / STERIS plc / Terminix Global Holdings Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Quest Diagnostics Inc / Pioneer Natural Resources Co / Nucor Corp / Walt Disney Co / Westlake Chemical Corp / Cummins Inc / General Dynamics Corp / Assurant Inc / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Evercore Inc / Primerica Inc / Archer-Daniels-Midland Co / International Flavors & Fragrances Inc / Marathon Oil Corp / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Olin Corp / Target Corp / Rocket Companies Inc / Synovus Financial Corp / Autozone Inc / Factset Research Systems Inc / Atmos Energy Corp / Hyatt Hotels Corp / Boyd Gaming Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / Hormel Foods Corp / Boston Beer Company Inc / Chevron Corp / Loews Corp / GameStop Corp / Conocophillips / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Cirrus Logic Inc / Fiserv Inc / Hologic Inc / Raymond James Financial Inc / Tyler Technologies Inc / Foot Locker Inc / Zions Bancorporation NA / Qualcomm Inc / O'Reilly Automotive Inc / Discover Financial Services / Lamar Advertising Co / Mercury Systems Inc / Wintrust Financial Corp / Umpqua Holdings Corp / Plug Power Inc / Hain Celestial Group Inc / Pinnacle Financial Partners Inc / Petco Health and Wellness Company Inc / Wynn Resorts Ltd / Carnival Corp / Opendoor Technologies Inc / Truist Financial Corp / Oak Street Health Inc / Las Vegas Sands Corp / Hanover Insurance Group Inc / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Ulta Beauty Inc / NVR Inc / Colfax Corp / Moderna Inc / CME Group Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / Nextera Energy Inc / Sabre Corp / Zillow Group Inc / Meta Platforms Inc / Bright Horizons Family Solutions Inc / WEX Inc / RingCentral Inc / Aramark / Norwegian Cruise Line Holdings Ltd / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Carvana Co / Roku Inc / Principal Financial Group Inc / Keurig Dr Pepper Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Fastly Inc / Grocery Outlet Holding Corp / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / Duck Creek Technologies Inc / Palantir Technologies Inc / Skillz Inc / CLARIVATE PLC / Signify Health Inc / ChargePoint Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Luxembourg / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Education / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Nov. 04, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Moderna: Q3 first take and call feedback</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Niall Alexander / Manos Mastorakis / Mr. Rajan Sharma</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Soft Spikevax Revenues and Guidance Sends Shares Lower; Target to $348</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">HCV Revisited (Again) - Revenue Miss, Lower Guide, Reiterate UP</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">60770K10 / 71708110</td><td class="leftalignment">Moderna Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on November 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / AES.N / AIG.N / APD.N / BDX.N / BP.L / EOG.N / IBM.N / OXY.N / SLB.N / SO.N / HAL.N / DUK.N / PH.N / K.N / VMC.N / XOM.N / MTD.N / BLL.N / NRG.N / PWR.N / HWM.N / ABC.N / IRM.N / NET.N / CNP.N / AAPL.OQ / MSFT.OQ / REGN.OQ / SBUX.OQ / AAON.OQ / MCHP.OQ / XRAY.OQ / PENN.OQ / DISH.OQ / CTXS.OQ / AMZN.OQ / ILMN.OQ / SWKS.OQ / MNST.OQ / 0700.HK / VIAC.OQ / RDSa.L / LYV.N / FIS.N / HBI.N / 9999.HK / MRNA.OQ / NWSA.OQ / FTNT.OQ / MSI.N / HII.N / BKR.N / EPAM.N / ZTS.N / GOGO.OQ / ZBH.N / FND.N / APTV.N / WELL.N / REG.OQ / LNT.OQ / LYFT.OQ / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pinterest Inc / AES Corp / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / BP PLC / EOG Resources Inc / International Business Machines Corp / Occidental Petroleum Corp / Schlumberger NV / Southern Co / Halliburton Co / Duke Energy Corp / Parker-Hannifin Corp / Kellogg Co / Vulcan Materials Co / Exxon Mobil Corp / Mettler-Toledo International Inc / Ball Corp / NRG Energy Inc / Quanta Services Inc / Howmet Aerospace Inc / Amerisourcebergen Corp / Iron Mountain Inc / Cloudflare Inc / CenterPoint Energy Inc / Apple Inc / Microsoft Corp / Regeneron Pharmaceuticals Inc / Starbucks Corp / Aaon Inc / Microchip Technology Inc / DENTSPLY SIRONA Inc / Penn National Gaming Inc / DISH Network Corp / Citrix Systems Inc / Amazon.com Inc / Illumina Inc / Skyworks Solutions Inc / Monster Beverage Corp / Tencent Holdings Ltd / ViacomCBS Inc / Royal Dutch Shell PLC / Live Nation Entertainment Inc / Fidelity National Information Services Inc / HanesBrands Inc / NetEase Inc / Moderna Inc / News Corp / Fortinet Inc / Motorola Solutions Inc / Huntington Ingalls Industries Inc / Baker Hughes Co / Epam Systems Inc / Zoetis Inc / Gogo Inc / Zimmer Biomet Holdings Inc / Floor & Decor Holdings Inc / Aptiv PLC / Welltower Inc / Regency Centers Corp / Alliant Energy Corp / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / United States / Jersey / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, Nov. 04, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Nov. 04, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: November 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / EOG.N / PNW.N / SO.N / WMT.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / HD.N / LOW.N / TGT.N / JCI.N / DHI.N / SRE.N / ATO.N / VTR.N / CSCO.OQ / JKHY.OQ / REGN.OQ / QCOM.OQ / MCHP.OQ / TPR.N / NVDA.OQ / ILMN.OQ / FIS.N / TDG.N / MRNA.OQ / FTNT.OQ / MSI.N / ZTS.N / PYPL.OQ / WRK.N / APTV.N / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / EOG Resources Inc / Pinnacle West Capital Corp / Southern Co / Walmart Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Lowe's Companies Inc / Target Corp / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Atmos Energy Corp / Ventas Inc / Cisco Systems Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Qualcomm Inc / Microchip Technology Inc / Tapestry Inc / NVIDIA Corp / Illumina Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Moderna Inc / Fortinet Inc / Motorola Solutions Inc / Zoetis Inc / PayPal Holdings Inc / Westrock Co / Aptiv PLC / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AAPL / AMGN / AOS / APP / APPS / CSWC / DISH / ECL / HRB / INCY / INSP / INTC.O / IRTC / IS / KLAC.O / MSFT / PNR / RNG / ROK / RSI / RXN / SAGE / T / U / WMT / WTS / MWA / ATVI.O / AKAM / VECO.O / IART.O / VZ / AQUA / GPN / REGN.O / VRTX.O / FRSH.OQ / AMED.O / EXAS.O / BIIB / 478160104 / DENN.O / LHCG.O / XPO / INFI.O / Z.O / 88162G103 / MRNA.O / ADUS.O / XYL / TMUS / AGRX.O / RXDX.O / SEDG.O / VRAY / TTD.O / UAA / EGHT.K / 83417M104 / FRG.O / DKNG / CGTX.OQ</td><td class="leftalignment">Apple Inc / Amgen Inc / A O Smith Corp / Applovin Corp / Digital Turbine Inc / Capital Southwest Corp / DISH Network Corp / Ecolab Inc / H & R Block Inc / Incyte Corp / Inspire Medical Systems Inc / Intel Corp / iRhythm Technologies Inc / Ironsource Ltd / KLA Corp / Microsoft Corp / Pentair PLC / RingCentral Inc / Rockwell Automation Inc / Rush Street Interactive Inc / Zurn Water Solutions Corp / SAGE Therapeutics Inc / AT&T Inc / Unity Software Inc / Walmart Inc / Watts Water Technologies Inc / Mueller Water Products Inc / Activision Blizzard Inc / Akamai Technologies Inc / Veeco Instruments Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Evoqua Water Technologies Corp / Global Payments Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Freshworks Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Denny's Corp / LHC Group Inc / XPO Logistics Inc / Infinity Pharmaceuticals Inc / Zillow Group Inc / Tetra Tech Inc / Moderna Inc / Addus Homecare Corp / Xylem Inc / T-Mobile US Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Solaredge Technologies Inc / ViewRay Inc / Trade Desk Inc / Under Armour Inc / 8x8 Inc / Solaredge Technologies Inc / Franchise Group Inc / DraftKings Inc / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Intermoney Valores</td><td class="leftalignment">Rovi: EBITDA 3T21 bate estimaciones. Guías mejoradas de nuevo - Intermoney Valores</td><td class="leftalignment">Spanish</td><td class="rightalignment">4</td><td class="leftalignment">ROVI=ES / MRNA=US</td><td class="leftalignment">Laboratorios Farmaceuticos ROVI SA / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Spain / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / ESTIMATE CHANGES / OPERATIONS / OPERATING RESULTS / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sr. Juan Ros R. Padilla</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / EOG.N / PFE.N / PNW.N / SO.N / WMT.N / PXD.N / HUM.N / MET.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / HD.N / EMR.N / JCI.N / DHI.N / SRE.N / ATO.N / VTR.N / COP.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / MCHP.OQ / TPR.N / ANSS.OQ / ILMN.OQ / EQIX.OQ / FIS.N / TDG.N / MRNA.OQ / FTNT.OQ / MSI.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Walmart Inc / Pioneer Natural Resources Co / Humana Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Atmos Energy Corp / Ventas Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Microchip Technology Inc / Tapestry Inc / ANSYS Inc / Illumina Inc / Equinix Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Moderna Inc / Fortinet Inc / Motorola Solutions Inc / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q21 Review: Another Strong Quarter, Early Pipeline Building</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">VRTX.O / MRNA.O</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Moderna Expands In Vivo Gene Editing Capabilities with Metagenomi Collaboration</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 SITC Late-Breakers Added – Updated Planner</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">45337C10 / 75886F10 / 640268108 / 58933Y10 / 98401F10 / 58949210 / 09075V10 / 60770K10 / 55609910 / 98887Q10 / N4444510 / 30315R10 / 37230320 / 95075A10</td><td class="leftalignment">Incyte Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Merck & Co Inc / Xencor Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / MacroGenics Inc / Zai Lab Ltd / Immatics NV / F-Star Therapeutics Inc / Genmab A/S / Werewolf Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Anna Baran, CFA / Jonathan Chang, Ph.D., CFA / Geoffrey Porges, MBBS / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: November 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / PFE.N / PNW.N / SO.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / EMR.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / VTR.N / PRU.N / COP.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / DISH.OQ / TPR.N / ANSS.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / FIS.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Ventas Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / DISH Network Corp / Tapestry Inc / ANSYS Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Moderna: Safety to the fore indeed: brief takes on mRNA adolescent COVID review delay</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Niall Alexander / Manos Mastorakis / Mr. Rajan Sharma</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Moderna decreases 4.6% in past quarter; Baillie Gifford & Co drops 8.0%</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Bespoke GT Consortium; Mammoth/VRTX Deal</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">VRTX.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Upgrading to Outperform, $200 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALNY.O / AMGN / EXEL / INCY / NBIX / ASND.O / GILD.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / BIIB / MRNA.O / SRPT.O / 04280A100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Amgen Inc / Exelixis Inc / Incyte Corp / Neurocrine Biosciences Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / Sarepta Therapeutics Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Trevor Allred</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Green Cross Corp: 3Q21 review: Historically high earnings; against previous headwinds. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">006280.KS / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: November 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / FLT.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / KIM.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / WEC.N / XOM.N / MTD.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / AWK.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / SBAC.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / MOS.N / FIS.N / ES.N / MRNA.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / FANG.OQ / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Fleetcor Technologies Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Kimco Realty Corp / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Mettler-Toledo International Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / American Water Works Company Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / SBA Communications Corp / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Mosaic Co / Fidelity National Information Services Inc / Eversource Energy / Moderna Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Diamondback Energy Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/30/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">MODERNA reduces its risk exposure and slightly improves to Neutral</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Moderna: Brief post-initiation company feedback: COVID, flu, oversights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Niall Alexander / Manos Mastorakis / Mr. Rajan Sharma</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Maternal RSV Vax Data Shows Impressive Newborn Protection</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N / AZN / 71708110 / 04635310 / 478160104 / 58933Y10 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Merck & Co Inc / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna tumbles 20.5% from 4 week high</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 3Q Earnings Season: What's on Tap for the Week Ahead</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRNA.O / AMGN.O / INCY.O / REGN.O / VRTX.O / RARE.O / CLVS.O / SAGE.O / PBYI.O / JNCE.O / ALLO.O</td><td class="leftalignment">Moderna Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback - Feedback from Sanofi post 3Q London analyst meeting</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SASY.PA / GSK.L / MRNA.OQ / RDUS.OQ</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Moderna Inc / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / RCL.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / XOM.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / CMCSA.OQ / MOS.N / FIS.N / AON.N / ES.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / Exxon Mobil Corp / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mosaic Co / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CYTR-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CYTR.PK / JNJ / NVS / AMGN.O / GSK / CRIS.O / SGEN.O / MRNA.O / CLDX.O / NWBO.PK / AOLS.PK</td><td class="leftalignment">CytRx Corp / Johnson & Johnson / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Moderna Inc / Celldex Therapeutics Inc / Northwest Biotherapeutics Inc / Aeolus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Tesla Shorts Scary October</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">TSLA.OQ / BAC.N / BMWG.DE / CP.TO / CRM.N / FSR.N / GM.N / IBM.N / SE.N / W.N / DIS.N / CMI.N / TRN.N / GBX.N / WAB.N / CAT.N / HD.N / V.N / OSK.N / NIO.N / INTC.OQ / AAPL.OQ / MSFT.OQ / PCAR.OQ / THO.N / WGO.N / AMZN.OQ / NVDA.OQ / CHTR.OQ / NFLX.OQ / CMCSA.OQ / TAMO.NS / DAIGn.DE / MRNA.OQ / 002594.SZ / 601633.SS / AMD.OQ / FB.OQ / NOW.N / AMC.N / GOOGL.OQ / WKHS.OQ / RACE.MI / SPGI.N / CVNA.N / UBER.N / NKLA.OQ / HYLN.N / RIDE.OQ / GOEV.OQ / STLA.MI / L87Ay.F / 9868.HK / LCID.OQ / 47K.F</td><td class="leftalignment">Tesla Inc / Bank of America Corp / Bayerische Motoren Werke AG / Canadian Pacific Railway Ltd / Salesforce.Com Inc / Fisker Inc / General Motors Co / International Business Machines Corp / Sea Ltd / Wayfair Inc / Walt Disney Co / Cummins Inc / Trinity Industries Inc / Greenbrier Companies Inc / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / Home Depot Inc / Visa Inc / Oshkosh Corp / NIO Inc / Intel Corp / Apple Inc / Microsoft Corp / Paccar Inc / Thor Industries Inc / Winnebago Industries Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Netflix Inc / Comcast Corp / Tata Motors Ltd / Daimler AG / Moderna Inc / BYD Co Ltd / Great Wall Motor Co Ltd / Advanced Micro Devices Inc / Meta Platforms Inc / ServiceNow Inc / AMC Entertainment Holdings Inc / Alphabet Inc / Workhorse Group Inc / Ferrari NV / S&P Global Inc / Carvana Co / Uber Technologies Inc / Nikola Corp / Hyliion Holdings Corp / Lordstown Motors Corp / Canoo Inc / Stellantis NV / Li Auto Inc / Xpeng Inc / Lucid Group Inc / Arrival SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / Germany / India / Luxembourg / Netherlands / United States</td><td class="leftalignment">Advertising / Apparel & Textiles / Appliances / Automotive / Broadcasting & Cable / Building & Building Materials / Consumer / Electronics / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Photography / Publishing / Retailing / Services / Tire & Rubber / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAP.N / AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / KO.N / MCK.N / MO.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / AON.N / ES.N / MRNA.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.26): First dose rate 77%, 70% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / 1099.HK / SVA.OQ</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.26）：ワクチン接種率は1回目が77%、2回目は70%</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / 1099.HK / SVA.OQ</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BEN.AX / BMY.N / BSX.N / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / F.N / GM.N / KO.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JKHY.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Jack Henry & Associates Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / France / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: mRNA safety revisited: still some scope to differentiate...(BNTX/MRNA/SAN)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRNA.OQ / 22UAy.DE / BNTX.OQ</td><td class="leftalignment">Moderna Inc / BioNTech SE / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">EVENT CALENDAR / GOVERNMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Starts Phase III Trial of CMV Vaccine mRNA-1647; Rich mRNA Vaccine Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / SHW.N / GWW.N / JCI.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / PYPL.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / W W Grainger Inc / Johnson Controls International PLC / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: The weekly fix: EU pharma data-pack</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOb.CO / NOVN.S / MORG.DE / GSK.L / UCB.BR / GLPG.AS / IPN.PA / ALM.MC / GRLS.MC / MRNA.OQ / SOBIV.ST / ARGX.BR / HCM.OQ / VIFN.S / IDIA.S / GMAB.CO / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / MorphoSys AG / GlaxoSmithKline PLC / Ucb SA / Galapagos NV / Ipsen SA / Almirall SA / Grifols SA / Moderna Inc / Swedish Orphan Biovitrum AB (publ) / argenx SE / HUTCHMED (China) Ltd / Vifor Pharma AG / Idorsia Ltd / Genmab A/S / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Positive COVID-19 Vaccine Data in Children 6-11yo; Booster Roll-out Underway</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: ESGCT Data; BIIB PIII Miss in ALS</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NEM.N / NSC.N / PFE.N / PNW.N / SO.N / TEL.PS / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / MTD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / APH.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / CHD.N / TWTR.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / ORLY.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / SWKS.O / CMCSA.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / MSCI.N / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / PLDT Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Mettler-Toledo International Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Twitter Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Skyworks Solutions Inc / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: COVID vaccine initiations and the mRNA outlook: the generalists 1-pager</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Moderna Inc / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Germany / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Moderna Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Moderna: Living in the digital world can be illusive. Initiate at Sell.</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Niall Alexander / Manos Mastorakis</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: mRNA vaccines: pandemic (mis)fortune still favours the brave (short term)</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRNA.OQ / BNTX.OQ / CVAC.OQ</td><td class="leftalignment">Moderna Inc / BioNTech SE / CureVac NV</td><td class="leftalignment"></td><td class="leftalignment">Germany / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis / Niall Alexander</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / SLB.N / SO.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / ROP.N / CAT.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / HCA.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / FIS.N / STX.AX / ADP.PA / AON.N / MRNA.OQ / CME.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Southern Co / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / HCA Healthcare Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Is Moderna Inc Due for a Rebound?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q21 Genetic Medicine Earnings Preview and Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">00289Y10 / 00773U10 / 02043Q10 / 46222210 / 04280A10 / 604749101 / Y9530810 / 60770K10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 82939910 / 87410C10 / 24343R10 / 75629V10 / 14203810 / 38870X10</td><td class="leftalignment">Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Alnylam Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / WAVE Life Sciences Ltd / Moderna Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Caribou Biosciences Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United Kingdom / Ireland / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">FDA Grants EUA for COVID Booster; Can Be Used Following Other COVID Vaccines</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector - Readacross from JNJ 3Q21 results and Roche/Atea's Ph-2 update on oral COVID drug candidate</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">068270.KS / 091990.KQ / JNJ.N / MRK.N / PFE.N / AMGN.OQ / 000100.KS / RO.S / 006280.KS / MRNA.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Yuhan Corp / Roche Holding AG / Green Cross Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">02043Q107 / 339 / 800677106 / MRNA.O / 199800.KN / 75901B107 / ADVM.O / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / 77313F106 / PHGE.K / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Sangamo Therapeutics Inc / Moderna Inc / ToolGen Inc / Regenxbio Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Rocket Pharmaceuticals Inc / Biomx Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">LOGC (Buy, $20): SUNRISE Worth Waking Up For?</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">54142F102 / 02043Q107 / 339 / 800677106 / MRNA.O / 199800.KN / 75901B107 / ADVM.O / 45826J105 / 28106W103 / MGTX.O / H17182108 / 501147102 / FIXX.O / 77313F106 / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">LogicBio Therapeutics Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Sangamo Therapeutics Inc / Moderna Inc / ToolGen Inc / Regenxbio Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Rocket Pharmaceuticals Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: KOL Discussion—Jim Wilson, PhD</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 04280A100 / ADVM.O / SIGHT.PA / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / N71542109 / 03820J100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Keay T. Nakae, CFA / Geulah Livshits, PhD, PHD / Daniil Gataulin, PhD / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CRSP CTX110 Data Doubts; FIXX PKU Ups & Downs</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">CRSP.BN / FIXX.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">CRISPR Therapeutics AG / Homology Medicines Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: In Vivo Gene Therapy—Company Feedback</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">66987V10 / NVAX.O / G3910J112 / 92532F100 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 75915K200 / TNYA.O</td><td class="leftalignment">Novartis AG / Novavax Inc / GlaxoSmithKline PLC / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Regulus Therapeutics Inc / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Mix-And-Match COVID Vax Coming to EUAs Soon; Still Favors mRNAs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">SAN / 71708110 / 478160104 / 09075V10 / 60770K10 / F5548N10</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Johnson & Johnson / BioNTech SE / Moderna Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">VRBPAC Votes for Booster Approval as Expected</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K10</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">SITC 2021 Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107 / 31189P102 / 462260100 / 98401F105 / H17182108 / 41358P106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 00166B105 / 67080M103 / 73730P108 / 81181C104 / 68236R103 / 03890D108 / 002120202 / 81728A108 / 00449L102 / 87978U108</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Fate Therapeutics Inc / Iovance Biotherapeutics Inc / Xencor Inc / CRISPR Therapeutics AG / Harpoon Therapeutics Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / ALX Oncology Holdings Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Seagen Inc / Oncorus Inc / Aravive Inc / aTyr Pharma Inc / Sensei Biotherapeutics Inc / Achilles Therapeutics PLC / Tempest Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Upgrading to Overweight with $445 Target; VRBPAC Votes 19-0 to Approve Booster</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: KOL Discussion—George Church, PhD</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 04280A100 / ADVM.O / SIGHT.PA / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / N71542109 / 03820J100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Keay T. Nakae, CFA / Geulah Livshits, PhD, PHD / Daniil Gataulin, PhD / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 2.8% Y/Y Including COVID-19 Vaccine Volume Benefit (-1.7% Without)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra / Jialin (Jay) Jin</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: Cell tx, I/O, & CDMO—Company Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">66987V10 / NVAX.O / G3910J112 / 92532F100 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / N71542109 / 03820J100 / 75915K200</td><td class="leftalignment">Novartis AG / Novavax Inc / GlaxoSmithKline PLC / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Regulus Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - 2021 Capital Markets Day - key takeaways</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / AZN.L / DHR.N / LUN.CO / MRCG.DE / SATG.DE / CRL.N / UCB.BR / RGEN.OQ / SFZN.S / IPN.PA / ORNBV.HE / ALM.MC / MRNA.OQ / 068270.KS / CTLT.N / 207940.KS / 2269.HK / 091990.KQ / GMAB.CO / PPGN.S</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / AstraZeneca PLC / Danaher Corp / H Lundbeck A/S / Merck KGaA / Sartorius AG / Charles River Laboratories International Inc / Ucb SA / Repligen Corp / Siegfried Holding AG / Ipsen SA / Orion Oyj / Almirall SA / Moderna Inc / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / Genmab A/S / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Elizabeth Walton / Ms Jo Walton / Mr. Dominic Lunn / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: Gene Editing—Company Feedback</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NVAX.O / 92532F100 / 75886F107 / 02043Q107 / 339 / 800677106 / MRNA.O / 00289Y107 / ABUS.O / 75901B107 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / XCUR.O / PASG.O / IMTX.O / N90064101 / 83422E105 / N71542109 / 03820J100 / 75915K200 / TNYA.O</td><td class="leftalignment">Novavax Inc / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Sangamo Therapeutics Inc / Moderna Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Solid Biosciences Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Regulus Therapeutics Inc / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Phase 2 Take 2; SNY’s Protein COVID Vax Shows Strong Responses, Robust Boosting</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">F5548N10 / 71708110 / 60770K10 / G3910J11</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Moderna best performer of NASDAQ-100 Index in 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: RNA Therapies—Company Feedback</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">RNA.OQ / 02043Q107 / MRNA.O / ARCT.O / ABUS.O / 04280A100 / NBSE.O / XCUR.O / 05370A108 / N71542109</td><td class="leftalignment">Avidity Biosciences Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Arbutus Biopharma Corp / Arrowhead Pharmaceuticals Inc / NeuBase Therapeutics Inc / Exicure Inc / Avidity Biosciences Inc / ProQR Therapeutics NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Keay T. Nakae, CFA / Geulah Livshits, PhD, PHD / Daniil Gataulin, PhD / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR Voyage Continues w/ PFE; ALLO's On Hold</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.23）：ワクチン接種率は1回目が72%、2回目は62%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.23): First dose rate 72%, fully vaccinated 62%</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / AXP.N / CAH.N / CCK.N / CE.N / COF.N / EIX.N / GPS.N / HLT.N / MAN.N / MO.N / NOC.N / PFE.N / PHM.N / PM.N / SC.N / TMX.N / U.N / USB.N / VNT.N / ZEN.N / PXD.N / DELL.N / NUE.N / X.N / JBL.N / DIS.N / GD.N / AIZ.N / CR.N / AFG.N / R.N / SPOT.N / RCL.N / PRI.N / LH.N / EMR.N / PCG.N / TGT.N / AVY.N / RKT.N / SNV.N / ACN.N / H.N / DNB.N / GPC.N / HRL.N / SAM.N / CVX.N / MHK.N / L.N / GME.N / GPK.N / OSK.N / INTC.OQ / ORI.N / ADPT.OQ / CSL.N / FAF.N / RJF.N / TTC.N / TYL.N / FL.N / QCOM.OQ / ORLY.OQ / GILD.OQ / BRKS.OQ / STLD.OQ / MRCY.OQ / UMPQ.OQ / PLUG.OQ / HAIN.OQ / PNFP.OQ / WYNN.OQ / PA1436583006 / CRI.N / BIIB.OQ / OPEN.OQ / BRKR.OQ / EXP.N / OSH.N / LVS.N / THG.N / BRKb.N / OC.N / FRPT.OQ / CFX.N / MRNA.OQ / CME.OQ / CLH.N / AI.N / AVGO.OQ / NXPI.OQ / CZR.OQ / TRGP.N / SABR.OQ / Z.OQ / ALSN.N / FB.OQ / WEX.N / RNG.N / ALLE.N / ARMK.N / NCLH.N / SNOW.N / FIVN.OQ / ANET.N / SYF.N / CTLT.N / AXTA.N / LBRDK.O / QRVO.OQ / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / ROKU.OQ / MDB.OQ / PFG.OQ / CDAY.N / PLAN.N / STNE.OQ / CPRI.N / NFE.OQ / BYND.OQ / UBER.N / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / JAMF.OQ / DCT.OQ / PLTR.N / SHC.OQ / DASH.N / CERT.OQ / SKLZ.N / DRVN.OQ / SGFY.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / American Express Co / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / Capital One Financial Corp / Edison International / Gap Inc / Hilton Worldwide Holdings Inc / ManpowerGroup Inc / Altria Group Inc / Northrop Grumman Corp / Pfizer Inc / Pultegroup Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Terminix Global Holdings Inc / Unity Software Inc / US Bancorp / Vontier Corp / Zendesk Inc / Pioneer Natural Resources Co / Dell Technologies Inc / Nucor Corp / United States Steel Corp / Jabil Inc / Walt Disney Co / General Dynamics Corp / Assurant Inc / Crane Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Royal Caribbean Cruises Ltd / Primerica Inc / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Synovus Financial Corp / Accenture PLC / Hyatt Hotels Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / Hormel Foods Corp / Boston Beer Company Inc / Chevron Corp / Mohawk Industries Inc / Loews Corp / GameStop Corp / Graphic Packaging Holding Co / Oshkosh Corp / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Carlisle Companies Inc / First American Financial Corp / Raymond James Financial Inc / Toro Co / Tyler Technologies Inc / Foot Locker Inc / Qualcomm Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Azenta Inc / Steel Dynamics Inc / Mercury Systems Inc / Umpqua Holdings Corp / Plug Power Inc / Hain Celestial Group Inc / Pinnacle Financial Partners Inc / Wynn Resorts Ltd / Carnival Corp / Carter's Inc / Biogen Inc / Opendoor Technologies Inc / Bruker Corp / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Hanover Insurance Group Inc / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Colfax Corp / Moderna Inc / CME Group Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Targa Resources Corp / Sabre Corp / Zillow Group Inc / Allison Transmission Holdings Inc / Meta Platforms Inc / WEX Inc / RingCentral Inc / Allegion PLC / Aramark / Norwegian Cruise Line Holdings Ltd / Snowflake Inc. / Five9 Inc / Arista Networks Inc / Synchrony Financial / Catalent Inc / Axalta Coating Systems Ltd / Liberty Broadband Corp / Qorvo Inc / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Roku Inc / MongoDB Inc / Principal Financial Group Inc / Ceridian HCM Holding Inc / Anaplan Inc / StoneCo Ltd / Capri Holdings Ltd / New Fortress Energy Inc / Beyond Meat Inc / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / DoorDash Inc / Certara Inc / Skillz Inc / Driven Brands Holdings Inc / Signify Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Oct. 05, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Third SpikeVax Dose Authorized by EMA; VRBPAC to Review Booster on October 14th</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Mix-And-Match COVID Vax Data Imminent; What’s Coming and Who’s At Risk?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIG.N / AIRP.PA / ALB.N / AN.N / AXP.N / BA.N / BAC.N / BMY.N / CB.N / CCI.N / CI.N / CL.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / JPM.N / KO.N / LLY.N / MMC.N / NEM.N / OXY.N / PFE.N / PHM.N / PPCJ.J / RHI.N / SC.N / T.N / TMO.N / WFC.N / WMT.N / ACI.N / AA.N / PG.N / HUM.N / NUE.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / DT.N / IPG.N / UNP.N / SPOT.N / GS.N / CLX.N / MCD.N / HD.N / LOW.N / MRO.N / UPS.N / MMM.N / XOM.N / DVN.N / NKE.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / PWR.N / V.N / ACN.N / WSM.N / JLL.N / HAE.N / SAM.N / CRL.N / CVX.N / COP.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / AGL.N / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / RGEN.OQ / SIVB.OQ / ZION.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / LNG.A / MRCY.OQ / NVDA.OQ / PACW.OQ / ISRG.OQ / ILMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / BIIB.OQ / TPX.N / TFC.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / CMG.N / FIS.N / STX.AX / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / PAG.N / TDC.N / TNDM.OQ / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / NLSN.N / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / ZNGA.OQ / EPAM.N / PSX.N / WDC.OQ / NOW.N / SRPT.OQ / PANW.N / FANG.OQ / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / OLLI.OQ / NVCR.OQ / PSTG.N / TMUS.OQ / IONS.OQ / TWLO.N / COUP.OQ / LW.N / ATUS.N / IOVA.OQ / ROKU.OQ / CBRE.N / FB.PS / STNE.OQ / CTRA.N / TER.OQ / NWL.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / LFG.AX / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">American International Group Inc / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / AutoNation Inc / American Express Co / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Newmont Corporation / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Alcoa Corp / Procter & Gamble Co / Humana Inc / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / Dynatrace Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / Quanta Services Inc / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / agilon health Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Repligen Corp / SVB Financial Group / Zions Bancorporation NA / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / PacWest Bancorp / Intuitive Surgical Inc / Illumina Inc / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Biogen Inc / Tempur Sealy International Inc / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Penske Automotive Group Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Nielsen Holdings PLC / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Zynga Inc / Epam Systems Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Diamondback Energy Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Novocure Ltd / Pure Storage Inc / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Roku Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Coterra Energy Inc / Teradyne Inc / Newell Brands Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Liberty Financial Group Ltd / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Merck's molnupiravir data and read-across to Celltrion stocks</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">068270.KS / 091990.KQ / MRCG.DE / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / NVAX.OQ / INO.OQ / MRNA.OQ / CVAC.OQ / ABCL.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Merck KGaA / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / CureVac NV / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: EDITing Effect Elusive; PFE Fine-Tunes PIII</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">91390310 / 75991610 / 91324P10 / 71708110 / 44485910 / 88355610 / 94184810 / 04635310 / 75886F10 / 53245710 / 02343610 / 50187A10 / 58933Y10 / 88033G40 / 87918A10 / 03675210 / 40412C10 / 67181A10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / G3910J11 / 05370A10 / F5548N10 / 00288U10 / 00404A10 / 12552310 / 04683R10</td><td class="leftalignment">Universal Health Services Inc / Repligen Corp / UnitedHealth Group Inc / Pfizer Inc / Humana Inc / Thermo Fisher Scientific Inc / Waters Corp / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Amedisys Inc / LHC Group Inc / Merck & Co Inc / Tenet Healthcare Corp / Teladoc Health Inc / Anthem Inc / HCA Healthcare Inc / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC / Avidity Biosciences Inc / Sanofi SA / Abcellera Biologics Inc / Acadia Healthcare Company Inc / Cigna Corp / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mr. Whit Mayo / Stephanie Davis, CFA / Mr. Puneet Souda / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (4 October-): JCR Pharmaceuticals up sharply, Shionogi still gaining, sector outperformed TOPIX</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4502.T / 4507.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（10月4日～）: JCRファーマ急進、塩野義は続伸、医薬品セクターはTOPIX対比アウトパフォーム</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4507.T / 4552.T / 4502.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / AMGN.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Amgen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 10.3.21</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 01988P10 / 00282410 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 44485910 / 45253H10 / 07181310 / 10113710 / 04635310 / 43644010 / 64125C10 / 37555810 / 15678210 / 03116210 / 75886F10 / 46120E60 / 11679410 / M2572210 / 45232710 / 02343610 / 09062X10 / 01625510 / 30063P10 / 478160104 / 640268108 / 075887109 / 00422510 / 02043Q10 / 67070410 / 40637H10 / 207410101 / 205306103 / 45784P10 / 25213110 / 50187A10 / 58502B10 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 02311120 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 05463X10 / 45780L10 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 40412C10 / G5960L10 / 46222210 / 18946410 / 04004760 / 21232630 / 04280A10 / 05337M104 / 23283X20 / 40131M10 / 604749101 / 63230710 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 67181A10 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 58949210 / 09627Y10 / 68071010 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 04685N10 / 13089P10 / 34633R10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 45332Y10 / 80405P10 / N4482110 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / 16961L10 / 65443P10 / 82939910 / 87410C10 / 19240Q20 / 00288U10 / 36870G10 / 64128810 / 00404A10 / N6960510 / 28036F10 / 51506910 / N5749R10 / 24343R10 / 75629V10 / 26622P10 / 52634L10 / 23003110 / 49705R10 / 38246G10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / N5151710 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 75382E10 / 29251M10 / 81064810 / G637AM10 / 15117B20 / 00038020 / 82489T10 / 00653Q10 / 12552310 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 87427V10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Abbott Laboratories / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / ImmunoGen Inc / Baxter International Inc / Boston Scientific Corp / AstraZeneca PLC / Hologic Inc / Neurocrine Biosciences Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Bruker Corp / Compugen Ltd / Illumina Inc / Amedisys Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Becton Dickinson and Co / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / NuVasive Inc / Halozyme Therapeutics Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / LHC Group Inc / MEDNAX Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Amarin Corporation PLC / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / AxoGen Inc / Inogen Inc / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / HCA Healthcare Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Arrowhead Pharmaceuticals Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Mirum Pharmaceuticals Inc / Natera Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Olink Holding AB (publ) / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Inari Medical Inc / Satsuma Pharmaceuticals Inc / InflaRx NV / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / Chinook Therapeutics Inc / 908 Devices Inc. / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Cogent Biosciences Inc / Abcellera Biologics Inc / Gemini Therapeutics Inc / Neuropace Inc / Acadia Healthcare Company Inc / Pharvaris NV / Edgewise Therapeutics Inc / Landos Biopharma Inc / Merus NV / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Doximity Inc / LENSAR Inc / Cullinan Oncology Inc / Kinnate Biopharma Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Rapt Therapeutics Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Celldex Therapeutics Inc / Abcam PLC / Shockwave Medical Inc / Adapthealth Corp / Cigna Corp / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Talkspace Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary --Oct .01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / BAX / CSII / GBT / INCY / OM / PRTA / RAD / WMT / EW / ONEM.O / XRAY.O / UTHR.O / ALGN.O / REGN.O / SSNC.O / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / MNKD.O / ANGO.O / LHCG.O / 02043Q107 / ENSG.O / 483548103 / MRNA.O / BBI.O / 771195104 / ADUS.O / GLAXOSM.LG / SWAV / SPRO.O / TRVN / 02005N100 / VBIV.O / AUPH.O / 189464100 / EVH / 100063846 / EDIT / VRAY / FLGT.O / GTHX / ATNX.O / NCNA.O / APLS.O / 720795103 / ARVN / DMAC.O / TMDX / PNTG.O / ZNTL.O / ABST.TO / 03823M100 / CLNN.O</td><td class="leftalignment">Arcosa Inc / Baxter International Inc / Cardiovascular Systems Inc / Global Blood Therapeutics Inc / Incyte Corp / Outset Medical Inc / Prothena Corporation PLC / Rite Aid Corp / Walmart Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / DENTSPLY SIRONA Inc / United Therapeutics Corp / Align Technology Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / MannKind Corp / AngioDynamics Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Brickell Biotech Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Shockwave Medical Inc / Spero Therapeutics Inc / Trevena Inc / Ally Financial Inc / VBI Vaccines Inc / Aurinia Pharmaceuticals Inc / Clovis Oncology Inc / Evolent Health Inc / Truist Financial Corp / Editas Medicine Inc / ViewRay Inc / Fulgent Genetics Inc / G1 Therapeutics Inc / Athenex Inc / NuCana PLC / Apellis Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / DiaMedica Therapeutics Inc / Transmedics Group Inc / Pennant Group Inc / Zentalis Pharmaceuticals Inc / Absolute Software Corp / Applied Minerals Inc / Clene Inc.</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK Data Lets Some Air Out of COVID Vaccine Bubble</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K10 / MRK.N / 71708110 / MRNA.OQ / 58933Y10 / 09075V10</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / Pfizer Inc / Moderna Inc / Merck & Co Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Oct 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / AMGN.OQ / NVAX.OQ / 006280.KS / BION.BO / TEVA.N / MRNA.OQ / 068270.KS / 086900.KQ / 0460.HK / ABBV.N / 207940.KS / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Amgen Inc / Novavax Inc / Green Cross Corp / Biocon Ltd / Teva Pharmaceutical Industries Ltd / Moderna Inc / Celltrion Inc / Medy Tox Inc / Sihuan Pharmaceutical Holdings Group Ltd / Abbvie Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United Kingdom / India / Israel / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">4Q21 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 09061G101 / 75886F107 / AADI / 02043Q107 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 00287Y109 / 29251M106 / 023111206 / 45773H201 / 03835T200 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 462260100 / 558868105 / 98401F105 / 23284F105 / 29014R103 / 039697107 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 088786108 / G46188101 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 501575104 / 14147L108 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 03835L207 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105 / 15673T100 / 670703107 / 87990A106 / 87978U108</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Aadi Bioscience Inc / Alnylam Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Amarin Corporation PLC / Inovio Pharmaceuticals Inc / Aptose Biosciences Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Xencor Inc / CytomX Therapeutics Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Bicycle Therapeutics PLC / Horizon Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Aptevo Therapeutics Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc / Century Therapeutics Inc / Nuvalent Inc / Tenaya Therapeutics Inc / Tempest Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna in top 1% performers of NASDAQ-100 Index in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Kiwoom Securities</td><td class="leftalignment">kiwoom 미 국 주 식 가 이드 weekly (2021.09.23~09.30)-09/30/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">26</td><td class="leftalignment">ASML / CF / CFG / DLTR / DVN / EA / KLAC / MELI / PTON / MRNA</td><td class="leftalignment">ASML Holding NV / CF Industries Holdings Inc / Citizens Financial Group Inc / Dollar Tree Inc / Devon Energy Corp / Energy Absolute PCL / KLA Corp / Mercadolibre Inc / Peloton Interactive Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / Thailand / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Won Ju Lee / Seong Jin Ji</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CTAS / DLTR / EA / FOCS / GBT / INCY / MSFT / PZZA / RNG / SAP / SONY / TTWO / AMZN.O / NICE / ATVI.O / HEAR / VG / EQIX / VZ / NFLX / UTHR.O / ITRI.O / MNKD.O / 36467W109 / MRNA.O / WPRT.O / TSLA.O / PCYO.O / AMRS.O / ZNGA / FB.O / FDEV.L / 82655M107 / VBIV.O / AUPH.O / SPXC / EDIT / VRAY / NCNA.O / EGHT.K / BILI.O / ZM.O / HUYA.K</td><td class="leftalignment">Cintas Corp / Dollar Tree Inc / Electronic Arts Inc / Focus Financial Partners Inc / Global Blood Therapeutics Inc / Incyte Corp / Microsoft Corp / Papa John's International Inc / RingCentral Inc / SAP SE / Sony Group Corp / Take-Two Interactive Software Inc / Amazon.com Inc / Nice Ltd / Activision Blizzard Inc / Turtle Beach Corp / Vonage Holdings Corp / Equinix Inc / Verizon Communications Inc / Netflix Inc / United Therapeutics Corp / Itron Inc / MannKind Corp / GameStop Corp / Moderna Inc / Westport Fuel Systems Inc / Tesla Inc / Pure Cycle Corp / Amyris Inc / Zynga Inc / Meta Platforms Inc / Frontier Developments PLC / Sify Technologies Ltd / VBI Vaccines Inc / Aurinia Pharmaceuticals Inc / SPX Corp / Editas Medicine Inc / ViewRay Inc / NuCana PLC / 8x8 Inc / Bilibili Inc / Zoom Video Communications Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / United Kingdom / India / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Moderna, Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Coronavirus Vaccines Post Solid, Broad Preclinical Efficacy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">VBIV.O / MRNA.O</td><td class="leftalignment">VBI Vaccines Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Trevor Allred</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ / AMGN.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / BMRN.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / ALNY.OQ / SRPT.OQ / ABBV.N / MRTX.OQ / FATE.OQ / NVTA.N / NTRA.OQ / NTLA.OQ / 6160.HK / BBIO.OQ / 22UAy.DE</td><td class="leftalignment">Moderna Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Biomarin Pharmaceutical Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Invitae Corp / Natera Inc / Intellia Therapeutics Inc / Beigene Ltd / BridgeBio Pharma Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">BB Banco de Investimento S.A.</td><td class="leftalignment">Monitor Diário BDRX-09/28/2021</td><td class="leftalignment">Portuguese</td><td class="rightalignment">9</td><td class="leftalignment">MELI34 / B1NT34 / BABA34 / TSLA34 / FBOK34 / GOGL34 / M1RN34 / MSFT34 / AMZO34 / AAPL34</td><td class="leftalignment">Mercadolibre Inc / BioNTech SE / Alibaba Group Holding Ltd / Tesla Inc / Meta Platforms Inc / Alphabet Inc / Moderna Inc / Microsoft Corp / Amazon.com Inc / Apple Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Jose Roberto dos Anjos / Renato Od</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Moderna, Inc. (MRNA) - COVID booster strategy</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: U.S. Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">TSLA.OQ / CRM.N / SE.N / W.N / DIS.N / HD.N / V.N / AAPL.OQ / MSFT.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / NFLX.OQ / CMCSA.OQ / MRNA.OQ / AMD.OQ / FB.OQ / AMC.N / GOOGL.OQ / SQ.N / SPGI.N / CVNA.N / UBER.N / 9988.HK</td><td class="leftalignment">Tesla Inc / Salesforce.Com Inc / Sea Ltd / Wayfair Inc / Walt Disney Co / Home Depot Inc / Visa Inc / Apple Inc / Microsoft Corp / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Netflix Inc / Comcast Corp / Moderna Inc / Advanced Micro Devices Inc / Meta Platforms Inc / AMC Entertainment Holdings Inc / Alphabet Inc / Block Inc / S&P Global Inc / Carvana Co / Uber Technologies Inc / Alibaba Group Holding Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ALB.N / BAX / BE / BSX / CAT / CLH / CMI / CSL / DAN / DAR / DE / EEFT.O / ENS / FDX / GS / INTC.O / JCI / JEF / MA / MDT / NEP / ORA / QCOM.O / RBC / RSG / RXN / SGE.L / TUP / USM / WM / BYND.O / KN / BWA.N / ASTE.O / CRVL.O / MPWR.O / EW.N / PZZA.O / IO.N / FCEL.O / LSTR.O / OSUR.O / CREE.O / CRUS.OQ / ICUI.OQ / AMSC.OQ / VRTS.OQ / POOL.OQ / NBIX.OQ / CALM.OQ / CHRW.OQ / UTHR.OQ / PLUG.OQ / MRVL.OQ / SIVB.O / TRMB.O / QDEL.O / ITRI.O / NATI.O / PEB.NZ / BJRI.OQ / LHCG.O / SPWR.O / IOSP.OQ / ATNI.OQ / XPO / EHTH.O / CSIQ.O / FSLR.O / MASI.O / ENSG.OQ / MPAA.OQ / MRNA.O / DECK.N / BBI.O / TWIN.O / CSII.O / AGCO.K / GNRC.K / TSLA.O / AMRC.K / AMRS.OQ / AMD.OQ / 98419M100 / ENPH.O / CG.O / FIVE.OQ / GMED.K / PRTA.OQ / HASI.N / GOOGL.O / ARES.K / ASPN.K / 69354N106 / VCEL.O / TBK.O / UQ1.F / SEDG.O / RUN.O / APLS.OQ / WKHS.O / WCN.TO / AQMS.O / WPRT.TO / WEED.TO / AQB.O / SGH.O / ROKU.O / MDB.O / APTV.K / 83417M104 / 720795103 / SMAR.K / LOVE.OQ / FOCS.OQ / ARVN.OQ / ESTC.N / CWENa.K / SWAV.O / PING.K / BILL.K / AVNT.K / 02081G201 / RWRh.V / ABST.TO / US03783T1034</td><td class="leftalignment">Albemarle Corp / Baxter International Inc / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Carlisle Companies Inc / Dana Inc / Darling Ingredients Inc / Deere & Co / Euronet Worldwide Inc / EnerSys / FedEx Corp / Goldman Sachs Group Inc / Intel Corp / Johnson Controls International PLC / Jefferies Financial Group Inc / Mastercard Inc / Medtronic PLC / Nextera Energy Partners LP / Ormat Technologies Inc / Qualcomm Inc / Regal Rexnord Corp / Republic Services Inc / Zurn Water Solutions Corp / Sage Group PLC / Tupperware Brands Corp / United States Cellular Corp / Waste Management Inc / Beyond Meat Inc / Knowles Corp / Borgwarner Inc / Astec Industries Inc / CorVel Corp / Monolithic Power Systems Inc / Edwards Lifesciences Corp / Papa John's International Inc / ION Geophysical Corp / Fuelcell Energy Inc / Landstar System Inc / OraSure Technologies Inc / Wolfspeed Inc / Cirrus Logic Inc / ICU Medical Inc / American Superconductor Corp / Virtus Investment Partners Inc / Pool Corp / Neurocrine Biosciences Inc / Cal-Maine Foods Inc / CH Robinson Worldwide Inc / United Therapeutics Corp / Plug Power Inc / Marvell Technology Inc / SVB Financial Group / Trimble Inc / Quidel Corp / Itron Inc / National Instruments Corp / Pacific Edge Ltd / BJ's Restaurants Inc / LHC Group Inc / SunPower Corp / Innospec Inc / ATN International Inc / XPO Logistics Inc / eHealth Inc / Canadian Solar Inc / First Solar Inc / Masimo Corp / Ensign Group Inc / Motorcar Parts of America Inc / Moderna Inc / Deckers Outdoor Corp / Brickell Biotech Inc / Twin Disc Inc / Cardiovascular Systems Inc / AGCO Corp / Generac Holdings Inc / Tesla Inc / Ameresco Inc / Amyris Inc / Advanced Micro Devices Inc / Xylem Inc / Enphase Energy Inc / Carlyle Group Inc / Five Below Inc / Globus Medical Inc / Prothena Corporation PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / Alphabet Inc / Ares Management Corp / Aspen Aerogels Inc / PRA Group Inc / Vericel Corp / Triumph Bancorp Inc / Uniqure NV / Solaredge Technologies Inc / Sunrun Inc / Apellis Pharmaceuticals Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Westport Fuel Systems Inc / Canopy Growth Corp / AquaBounty Technologies Inc / SMART Global Holdings Inc. / Roku Inc / MongoDB Inc / Aptiv PLC / Solaredge Technologies Inc / Pieris Pharmaceuticals Inc / Smartsheet Inc / Lovesac Co / Focus Financial Partners Inc / Arvinas Inc / Elastic NV / Clearway Energy Inc / Shockwave Medical Inc / Ping Identity Holding Corp / Bill.com Holdings Inc / Avient Corp / Alphatec Holdings Inc / Strathmore Plus Energy Corp / Absolute Software Corp / AppHarvest Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / Netherlands / New Zealand / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">PFE Feedback From Meeting With Investors</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">09/26/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Novartis Nabs Arctos; AGTC Safety in Focus</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">AGTC.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Applied Genetic Technologies Corp / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / DRRX.O / RIGL.O / SSNC.O / ISR / SRDX.O / INCY.OQ / EPIX.OQ / SGMO.OQ / CCRN.O / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / CORT.O / CRTX.O / ATRC.OQ / LHCG.O / CYCC.OQ / INFI.OQ / LMAT.O / 02043Q107 / ENSG.OQ / TNDM.O / SLP.OQ / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / MRTX.OQ / AERI.O / TRVN.O / GOOGL.O / ALDX.OQ / 02005N100 / AGRX.OQ / CASI.OQ / MRNS.O / INO.O / VBLT.O / NVRO.N / EVH.N / TDOC.N / CFMS.O / VYGR.OQ / 100063846 / IONS.OQ / SSKN.OQ / SYRS.OQ / SLNO.OQ / PLXP.O / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / ATNX.O / NCNA.O / SYBX.O / DNLI.OQ / CUE.OQ / 720795103 / PRVB.OQ / ORTX.OQ / SWAV.O / XFOR.OQ / PDSB.OQ / BWAY.TA / ORGO.O / ONCT.OQ / BCYC.O / A71.F / XAIR.OQ / PSNL.O / NBSE.O / DMTK.O / FREQ.OQ / PNTG.OQ / BXRX.OQ / ONEM.OQ / ORIC.OQ / ZNTL.OQ / US97382D3035 / AYLA.O / HGEN.O / US74275C2052 / ABST.TO / PRTG.OQ / REGW.M3 / 03823M100 / RZLT.O / HUMA.OQ / ATXS.OQ / CRXT.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / DURECT Corp / Rigel Pharmaceuticals Inc / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Incyte Corp / ESSA Pharma Inc / Sangamo Therapeutics Inc / Cross Country Healthcare Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Corcept Therapeutics Inc / Cortexyme Inc / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / LeMaitre Vascular Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Simulations Plus Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Alphabet Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Agile Therapeutics Inc / CASI Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Evolent Health Inc / Teladoc Health Inc / Conformis Inc / Voyager Therapeutics Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / Syros Pharmaceuticals Inc / Soleno Therapeutics Inc / PLx Pharma Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Athenex Inc / NuCana PLC / Synlogic Inc / Denali Therapeutics Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / X4 Pharmaceuticals Inc / PDS Biotechnology Corp / Brainsway Ltd / Organogenesis Holdings Inc / Oncternal Therapeutics Inc / Bicycle Therapeutics PLC / Ascendis Pharma A/S / Beyond Air Inc / Personalis Inc / NeuBase Therapeutics Inc / DermTech Inc / Frequency Therapeutics Inc / Pennant Group Inc / Baudax Bio Inc / 1Life Healthcare Inc / Oric Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Windtree Therapeutics Inc / Ayala Pharmaceuticals Inc / Humanigen Inc / Processa Pharmaceuticals Inc / Absolute Software Corp / Portage Biotech Inc / Regency World Consulting Ltd / Applied Minerals Inc / Rezolute Inc / Humacyte Inc / Astria Therapeutics Inc / Clarus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / India / Ireland / Israel / Nigeria / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">It's All Politics; CDC Director Undermines ACIP and Vax Regs, Good for PFE</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / 71708110 / 60770K10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Booster EUA Arrives In Time; Positive ACIP Meeting and Increasing Competition</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">71708110 / 478160104 / 09075V10 / 60770K10 / F5548N10</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / BioNTech SE / Moderna Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRNA.O / 87166L100 / FIXX.O</td><td class="leftalignment">Moderna Inc / Synlogic Inc / Homology Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FDX / KKR / MSFT.O / GILD.O / AMGN.O / AAPL.O / NVDA.O / HEAR.O / UPS.N / EXPD.O / RIGL.O / ATVI.OQ / TTWO.OQ / SGMO.OQ / NFLX.O / BIIB.O / CRTX.O / 36467W109 / XPO / 02043Q107 / MRNA.O / GLAXOSM.LG / TSLA.O / ZNGA.O / EA.O / CG.O / MRTX.OQ / FDEV.L / 82655M107 / G29183103 / 02005N100 / MRNS.O / VYGR.OQ / IONS.OQ / SYRS.OQ / APL.PS / SLNO.OQ / VERU.OQ / MTEM.O / ATNX.O / SYBX.O / DNLI.OQ / BILI.O / ORTX.OQ / ORGO.O / BCYC.O / PRTG.OQ / REGW.M3 / HUYA.K / 03823M100 / TBLA.OQ</td><td class="leftalignment">FedEx Corp / KKR & Co Inc / Microsoft Corp / Gilead Sciences Inc / Amgen Inc / Apple Inc / NVIDIA Corp / Turtle Beach Corp / United Parcel Service Inc / Expeditors International of Washington Inc / Rigel Pharmaceuticals Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / Sangamo Therapeutics Inc / Netflix Inc / Biogen Inc / Cortexyme Inc / GameStop Corp / XPO Logistics Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Zynga Inc / Electronic Arts Inc / Carlyle Group Inc / Mirati Therapeutics Inc / Frontier Developments PLC / Sify Technologies Ltd / Eaton Corporation PLC / Ally Financial Inc / Marinus Pharmaceuticals Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Syros Pharmaceuticals Inc / Apollo Global Capital Inc / Soleno Therapeutics Inc / Veru Inc / Molecular Templates Inc / Athenex Inc / Synlogic Inc / Denali Therapeutics Inc / Bilibili Inc / Orchard Therapeutics PLC / Organogenesis Holdings Inc / Bicycle Therapeutics PLC / Portage Biotech Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc / Taboola.com Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Ireland / Israel / Nigeria / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Moderna Inc (MRNA) - Financial Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">305</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (21 September-): Terumo, Sysmex, and other healthcare stocks continue to gain</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4543.T / 6869.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / CSL.AX / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Terumo Corp / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / CSL Ltd / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（9月21日～）: テルモとシスメックスなどヘルスケア銘柄が続伸</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4543.T / 6869.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / CSL.AX / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Terumo Corp / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / CSL Ltd / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Spate of Catalysts Highlighting Quality Biotech Name</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGW.M3 / MRNA.O / 03823M100</td><td class="leftalignment">Regency World Consulting Ltd / Moderna Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">SYBX (Buy, PT$10): '1618 Shows Effect in PKU Patients. '1934 Potentially Better</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">87166L100 / MRNA.O / FIXX.O</td><td class="leftalignment">Synlogic Inc / Moderna Inc / Homology Medicines Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Keay T. Nakae, CFA / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Astellas AAV on Hold; ABBV Grabs Hold of '314</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Narrowed VRBPAC Rec for PFE/BNTX Highlights Limits of Booster Opp’y for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K10 / 22UAy.DE / PFE.N / 71708110 / 09075V10</td><td class="leftalignment">Moderna Inc / BioNTech SE / Pfizer Inc / Pfizer Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 38, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="even"><td class="leftalignment">09/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not Sitting Still – VRBPAC Endorses PFE Boosters for High Risk, HCW’s and 65+</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / 71708110 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Daina Graybosch, Ph.D. / Anna Baran, CFA / Na Sun / Greco Song, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not If but When; VRBPAC Documents Positive for PFE Booster Approval</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N / 71708110 / 04635310 / 478160104 / 02043Q10 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Alnylam Pharmaceuticals Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Daina Graybosch, Ph.D. / Anna Baran, CFA / Na Sun / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, Sep. 15, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Sep. 15, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 8.6% Y/Y Including COVID-19 Vaccine Volume Benefit (+3.4% Without)</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AEE / PGR / INTU.O / PNFP.O / MRNA.O / EXC.O</td><td class="leftalignment">Ameren Corp / Progressive Corp / Intuit Inc / Pinnacle Financial Partners Inc / Moderna Inc / Exelon Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Everest-Providence BD deal conference call key takeaways. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / PFE.N / 2196.HK / MRNA.OQ</td><td class="leftalignment">Everest Medicines Ltd / Pfizer Inc / Shanghai Fosun Pharmaceutical Group Co Ltd / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Suspending Coverage</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ALGS MAA Filing as Expected, PFIC Delay a Minor Negative - PT to $32</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">604749101 / 60770K10</td><td class="leftalignment">Mirum Pharmaceuticals Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 199800 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / ToolGen Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: PKU Trial Put on Hold; ProQR Partners w/ Lilly</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 199800 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / ToolGen Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 37, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Sep. 10, 2021 / 11:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / HUM / IVC / MDT / RAD / UNH / WMT / GILD.O / RMD.N / HCA.N / CYH.N / EW.N / SSNC.O / UTHR.OQ / BMRN.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / MNKD.O / LHCG.O / CYCC.OQ / ENSG.OQ / 483548103 / MRNA.O / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / GBT.OQ / APLS.OQ / 100063846 / EDIT.OQ / TCMD.OQ / IRTC.OQ / SLNO.OQ / FIXX.OQ / 720795103 / SWAV.O / PNTG.OQ / ONEM.OQ / HGEN.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Invacare Corp / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Editas Medicine Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Soleno Therapeutics Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Pennant Group Inc / 1Life Healthcare Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Vital Signs - Charts of the Day: ABIT, MEG, USIO, VERV, HYZN, AMRK, ISSC, AEHR, AMBA, AMR, METC, RKLB, MTTR, RDW, CIFR, GSHD, PIRS, ALVR, CABA, CCCC, MRNA, NRIX, PLXP, GEVO, GSM, BMRC< UPST, GDRX, AFRM, MSGM, SPRT, CFLT, ASAN, JAMF, SBLK, GNK, ZIM, and ES</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRNA.OQ / 4FAP.F / ABIT.PK / AFRM.OQ / ALVR.OQ / AMBA.OQ / AMRK.OQ / ASAN.N / CABA.OQ / CCCC.OQ / CFLT.OQ / CIFR.OQ / ES.N / GDRX.OQ / GEVO.OQ / GNK.N / GSHD.OQ / HYZN.OQ / METC.OQ / MSGM.OQ / NRIX.OQ / PIRS.OQ / PLXP.OQ / RKLB.OQ / VERV.OQ / MEG.N / AEHR.OQ / ZBH.N / GSM.AX / USIO.OQ / JAMF.OQ</td><td class="leftalignment">Moderna Inc / Star Bulk Carriers Corp / Athena Bitcoin Global / Affirm Holdings Inc / Allovir Inc / Ambarella Inc / A-Mark Precious Metals Inc / Asana Inc / Cabaletta Bio Inc / C4 Therapeutics Inc / Confluent Inc / Cipher Mining Inc / Eversource Energy / Goodrx Holdings Inc / Gevo Inc / Genco Shipping & Trading Ltd / Goosehead Insurance Inc / Hyzon Motors Inc / Ramaco Resources Inc / Motorsport Games Inc / Nurix Therapeutics Inc / Pieris Pharmaceuticals Inc / PLx Pharma Inc / Rocket Lab USA Inc / Verve Therapeutics Inc / Montrose Environmental Group Inc / Aehr Test Systems / Zimmer Biomet Holdings Inc / Golden State Mining Ltd / Usio Inc / Jamf Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Cayman Islands / United States / Marshall Islands</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Sep. 10, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">MRNA R&D Day Points to Future Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRNA Annual R&D Day - Takeaway</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K10</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">R&D Day Highlights New Vaccine Candidates and Genome-Editing Venture</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : R&D Day Takeaways - MRNA Speaks, Market Adds $10B+ in Cap</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRNA Commits to RSV With Adult Pivotal Plan and Maternal Vax Coming</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ / 71708110 / 478160104 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Moderna Inc / Pfizer Inc / Johnson & Johnson / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Anna Baran, CFA / Na Sun / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Sep. 09, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 19): First dose rate 60%, 48% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / PFE.N / AZN.L / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.19）：国内ワクチン接種率、1回目が60%、2回目が48%に</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / PFE.N / AZN.L / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Gives mRNA-3351 to Institute for Life Changing Medicines for Crigler-Najjar</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BSX / DE / FDS / GS / LL / MCO / MDT / MSFT.O / QCOM.O / SYK / TPR / HEAR.O / EW.N / ALGN.O / URBN.O / ABMD.OQ / ATVI.OQ / IART.OQ / TTWO.OQ / BMRN.OQ / SWKS.OQ / NFLX.O / BIIB.O / DXCM.O / 36467W109 / MRNA.O / CSII.O / AGCO.K / ZNGA.O / EA.O / CG.O / FDEV.L / 82655M107 / SPGI.K / IRTC.OQ / APL.PS / FIXX.OQ / BILI.O / FOCS.OQ / CPRI.N / SWAV.O / HUYA.K</td><td class="leftalignment">Boston Scientific Corp / Deere & Co / Factset Research Systems Inc / Goldman Sachs Group Inc / LL Flooring Holdings Inc / Moody's Corp / Medtronic PLC / Microsoft Corp / Qualcomm Inc / Stryker Corp / Tapestry Inc / Turtle Beach Corp / Edwards Lifesciences Corp / Align Technology Inc / Urban Outfitters Inc / ABIOMED Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Biomarin Pharmaceutical Inc / Skyworks Solutions Inc / Netflix Inc / Biogen Inc / Dexcom Inc / GameStop Corp / Moderna Inc / Cardiovascular Systems Inc / AGCO Corp / Zynga Inc / Electronic Arts Inc / Carlyle Group Inc / Frontier Developments PLC / Sify Technologies Ltd / S&P Global Inc / iRhythm Technologies Inc / Apollo Global Capital Inc / Homology Medicines Inc / Bilibili Inc / Focus Financial Partners Inc / Capri Holdings Ltd / Shockwave Medical Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Ireland / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: GT Safety in Focus; New Roadblock for Astellas</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Women in Biotech Progress - Yet Challenges Remain</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O / MRNA.O</td><td class="leftalignment">Biogen Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Maldives / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Thailand Tourism Sector: Bottoming out: Decent recovery next year</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AOT.BK / MINT.BK / 0045.HK / 0069.HK / 0520.HK / ACCP.PA / AIA.NZ / JFC.PS / PFE.N / SYD.AX / WTB.L / AZN.L / MAHB.KL / 0694.HK / CHH.N / ASR.N / FRAG.DE / 1179.HK / 000089.SZ / 600009.SS / IHG.L / 600004.SS / DPZ.N / 600258.SS / DMP.AX / CENTEL.BK / PAC.N / ADP.PA / 2006.HK / H.TO / OMAB.OQ / MRNA.OQ / 1099.HK / JUBI.BO / HTHT.OQ / FHZN.S / ERW.BK / MEL.MC / MAR.OQ / MAXS.PS / AENA.MC / PIZZA.PS / AWC.BK / SHR.BK</td><td class="leftalignment">Airports of Thailand PCL / Minor International PCL / Hongkong and Shanghai Hotels Ltd / Shangri-La Asia Ltd / Xiabuxiabu Catering Management (China) Holdings Co Ltd / Accor SA / Auckland International Airport Ltd / Jollibee Foods Corp / Pfizer Inc / Sydney Airport / Whitbread PLC / AstraZeneca PLC / Malaysia Airports Holdings Bhd / Beijing Capital International Airport Co Ltd / Choice Hotels International Inc / Grupo Aeroportuario del Sureste SAB de CV / Fraport AG Frankfurt Airport Services Worldwide / Huazhu Group Ltd / Shenzhen Airport Co Ltd / Shanghai International Airport Co Ltd / InterContinental Hotels Group PLC / Guangzhou Baiyun International Airport Co Ltd / Domino's Pizza Inc / BTG Hotels Group Co Ltd / Domino's Pizza Enterprises Ltd / Central Plaza Hotel PCL / Grupo Aeroportuario del Pacifico SAB de CV / Aeroports de Paris SA / Shanghai Jin Jiang Capital Co Ltd / Hydro One Ltd / Grupo Aeroportuario del Centro Norte SAB de CV / Moderna Inc / Sinopharm Group Co Ltd / Jubilant Foodworks Ltd / Huazhu Group Ltd / Flughafen Zuerich AG / Erawan Group PCL / Melia Hotels International SA / Marriott International Inc / Max's Group Inc / Aena SME SA / Shakey's Pizza Asia Ventures Inc / Asset World Corp PCL / S Hotels and Resorts PCL</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / Hong Kong / India / Mexico / Malaysia / New Zealand / Philippines / Thailand / United States</td><td class="leftalignment">Consumer / Leisure & Entertainment / Lodging & Restaurants</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Thaniya Kevalee / Ms. Siriporn Sothikul</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / CAH.N / CE.N / COF.N / CRM.N / EIX.N / EOG.N / F.N / FCX.N / GPS.N / HLT.N / KEY.N / MO.N / NOC.N / OXY.N / PFE.N / PHM.N / PM.N / SC.N / STE.N / TXT.N / U.N / USB.N / ZEN.N / PXD.N / NUE.N / X.N / BKI.N / JBL.N / DIS.N / LEA.N / WLK.N / GD.N / CR.N / DE.N / AFG.N / R.N / SPOT.N / PRI.N / MRO.N / GLW.N / LH.N / PCG.N / DVN.N / TGT.N / RKT.N / SNV.N / KSS.N / OKE.N / BYD.N / DNB.N / SAM.N / MHK.N / GME.N / OSK.N / COP.N / INTC.OQ / ORI.N / ADPT.OQ / AMAT.OQ / CSL.N / CSCO.OQ / LRCX.OQ / RJF.N / RGEN.OQ / FL.N / QCOM.OQ / CREE.OQ / ORLY.OQ / TPR.N / PEGA.OQ / MRCY.OQ / UMPQ.OQ / EWBC.OQ / PLUG.OQ / HAIN.OQ / MRVL.OQ / EQIX.OQ / WOOF.OQ / CRI.N / OPEN.OQ / BRKR.OQ / EXP.N / OSH.N / LVS.N / BRKb.N / OC.N / FRPT.OQ / PODD.OQ / ES.N / MRNA.OQ / CLH.N / AI.N / NEE.N / TSLA.OQ / NXPI.OQ / TRGP.N / HII.N / Z.OQ / WEN.OQ / FB.OQ / WEX.N / RNG.N / SNOW.N / SYF.N / CTLT.N / AXTA.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / ROKU.OQ / SMAR.N / AVLR.N / ESTC.N / PLAN.N / STNE.OQ / CPRI.N / NFE.OQ / PINS.N / BYND.OQ / UBER.N / CRWD.OQ / GO.OQ / TXG.OQ / DDOG.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / GOCO.OQ / NCNO.OQ / JAMF.OQ / DCT.OQ / PLTR.N / SHC.OQ / DASH.N / CERT.OQ / SKLZ.N / DRVN.OQ / CLVT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Cardinal Health Inc / Celanese Corp / Capital One Financial Corp / Salesforce.Com Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / Gap Inc / Hilton Worldwide Holdings Inc / KeyCorp / Altria Group Inc / Northrop Grumman Corp / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / STERIS plc / Textron Inc / Unity Software Inc / US Bancorp / Zendesk Inc / Pioneer Natural Resources Co / Nucor Corp / United States Steel Corp / Black Knight Inc / Jabil Inc / Walt Disney Co / Lear Corp / Westlake Chemical Corp / General Dynamics Corp / Crane Co / Deere & Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Primerica Inc / Marathon Oil Corp / Corning Inc / Laboratory Corporation of America Holdings / PG&E Corp / Devon Energy Corp / Target Corp / Rocket Companies Inc / Synovus Financial Corp / Kohls Corp / ONEOK Inc / Boyd Gaming Corp / Dun & Bradstreet Holdings Inc / Boston Beer Company Inc / Mohawk Industries Inc / GameStop Corp / Oshkosh Corp / Conocophillips / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Applied Materials Inc / Carlisle Companies Inc / Cisco Systems Inc / Lam Research Corp / Raymond James Financial Inc / Repligen Corp / Foot Locker Inc / Qualcomm Inc / Wolfspeed Inc / O'Reilly Automotive Inc / Tapestry Inc / Pegasystems Inc / Mercury Systems Inc / Umpqua Holdings Corp / East West Bancorp Inc / Plug Power Inc / Hain Celestial Group Inc / Marvell Technology Inc / Equinix Inc / Petco Health and Wellness Company Inc / Carter's Inc / Opendoor Technologies Inc / Bruker Corp / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Insulet Corp / Eversource Energy / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Targa Resources Corp / Huntington Ingalls Industries Inc / Zillow Group Inc / Wendys Co / Meta Platforms Inc / WEX Inc / RingCentral Inc / Snowflake Inc. / Synchrony Financial / Catalent Inc / Axalta Coating Systems Ltd / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Roku Inc / Smartsheet Inc / Avalara Inc / Elastic NV / Anaplan Inc / StoneCo Ltd / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Grocery Outlet Holding Corp / 10X Genomics Inc / Datadog Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / Gohealth Inc / nCino Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / DoorDash Inc / Certara Inc / Skillz Inc / Driven Brands Holdings Inc / CLARIVATE PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: September 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIRP.PA / ALB.N / AXP.N / BA.N / BAC.N / BAX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / IBM.N / JNJ.N / JPM.N / LLY.N / LMT.N / MDT.N / OXY.N / PFE.N / PM.N / PPCJ.J / RHI.N / SC.N / SLB.N / T.N / TMO.N / U.N / WAT.N / WFC.N / WMT.N / ACI.N / SPG.N / PG.N / HUM.N / NUE.N / CPB.N / HAL.N / DHR.N / UNH.N / IPG.N / SPOT.N / GS.N / CLX.N / VLO.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / KR.N / PCG.N / XOM.N / DVN.N / AMT.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / JCI.N / ORCL.N / VFC.N / V.N / ACN.N / WSM.N / PLD.N / JLL.N / HAE.N / SAM.N / BLK.N / CRL.N / CVX.N / IRM.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / REGN.OQ / RGEN.OQ / QDEL.OQ / SNPS.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / STLD.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / ERIE.OQ / NVDA.OQ / PLUG.OQ / MTCH.OQ / ISRG.OQ / BLUE.OQ / GRMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / SBNY.OQ / ACAD.OQ / EXR.N / MKTX.OQ / MPWR.OQ / LVS.N / NOV.N / DXCM.OQ / MS.N / CMG.N / FIS.N / STX.AX / HES.N / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / JAZZ.OQ / TDC.N / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / EPAM.N / PSX.N / NOW.N / SRPT.OQ / FANG.OQ / ABBV.N / BLDR.N / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / ARES.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / NVCR.OQ / PSTG.N / IONS.OQ / TWLO.N / COUP.OQ / LW.N / AYX.N / IOVA.OQ / ROKU.OQ / ZS.OQ / FB.PS / STNE.OQ / NFE.OQ / LYFT.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / MRVI.OQ / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Humana Inc / Nucor Corp / Campbell Soup Co / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / Kroger Co / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Johnson Controls International PLC / Oracle Corp / VF Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Prologis Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Iron Mountain Inc / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Repligen Corp / Quidel Corp / Synopsys Inc / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / Erie Indemnity Co / NVIDIA Corp / Plug Power Inc / Match Group Inc / Intuitive Surgical Inc / bluebird bio Inc / Garmin Ltd / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Nov Inc / Dexcom Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Hess Corp / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Jazz Pharmaceuticals PLC / Teradata Corp / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Epam Systems Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / Builders FirstSource Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / Ares Management Corp / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Novocure Ltd / Pure Storage Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Roku Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Maravai LifeSciences Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Sep-2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 004170.KS / 069620.KS / 006280.KS / 078930.KS / MRNA.OQ / 068270.KS / 086900.KQ / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Shinsegae Inc / Daewoong Pharma / Green Cross Corp / GS Holdings Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippines Market Strategy - New report: COVID-19 Tracker-first dose vaccination picks up in August despite lockdown and Delta surge</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Philippines Market Strategy: COVID-19 Tracker: First dose vaccination picks up in August despite lockdown and Delta surge</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Moderna (MRNA: $376.69) adds $12 billion in MCap in August, leads Biotechnology sector gains</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Moderna Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / OCGN / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Ocugen Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - Quick take: Our thoughts on Donga news report; vaccine CMO opportunity still overlooked</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">006280.KS / JNJ.N / EBS.N / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Johnson & Johnson / Emergent BioSolutions Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">08/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Chardan Initiates TNYA; Roche Gets in Shape</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / OCGN / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Ocugen Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Full Approval of mRNA-1273 Could Occur Late November—Focus Remains on Durability of Booster Dose</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE / INTC.O / QCOM.O / W / GILD.O / WCC / KMX.N / AVGO.O / CRUS.OQ / UTHR.OQ / SWKS.OQ / MRNA.O / 00826A109 / FIVE.OQ / PANW.K / QRVO.O / ETSY.O / AKTS.OQ / CVNA.N / PRPL.O / NBSE.O / PTON.OQ / GRWG.O / HGEN.O / REGW.M3</td><td class="leftalignment">Deere & Co / Intel Corp / Qualcomm Inc / Wayfair Inc / Gilead Sciences Inc / Wesco International Inc / Carmax Inc / Broadcom Inc / Cirrus Logic Inc / United Therapeutics Corp / Skyworks Solutions Inc / Moderna Inc / Affymax Inc / Five Below Inc / Palo Alto Networks Inc / Qorvo Inc / ETSY Inc / Akoustis Technologies Inc / Carvana Co / Purple Innovation Inc / NeuBase Therapeutics Inc / Peloton Interactive Inc / GrowGeneration Corp / Humanigen Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Rocket Hold Lifts; the Broad Is SEND(ing) It!</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">RCKT.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Rocket Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 33, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Pfizer Inc / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, MRNA</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">4502.T / ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / HUM / IVC / MDT / RAD / ROG / SYK / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / EW.N / SSNC.O / ISR / SRDX.O / NOVN.OQ / EPIX.OQ / ICPT.OQ / ISRG.OQ / CCRN.O / ICAD.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ANGO.OQ / MBRX.OQ / ATRC.OQ / LHCG.O / BLRX.TA / ENSG.OQ / 483548103 / MRNA.O / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / MDXG.O / AXGN.O / FATE.OQ / GOOGL.O / CBAY.OQ / MRNS.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / ZBH.N / SPNE.O / 100063846 / SSKN.OQ / VREX.OQ / 45780L104 / IPIX.PK / MBIO.OQ / CUE.OQ / 720795103 / MOTS.O / ORTX.OQ / SWAV.O / BWAY.TA / FREQ.OQ / PNTG.OQ / APRE.O / VERO.O / ETNB.O / AYLA.O / FMTX.O / NNOX.O / 03823M100 / N69603145</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Humana Inc / Invacare Corp / Medtronic PLC / Rite Aid Corp / Rogers Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Novan Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AngioDynamics Inc / Moleculin Biotech Inc / AtriCure Inc / LHC Group Inc / BioLine RX Ltd / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / MiMedx Group Inc / AxoGen Inc / Fate Therapeutics Inc / Alphabet Inc / Cymabay Therapeutics Inc / Marinus Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / SeaSpine Holdings Corp / Truist Financial Corp / STRATA Skin Sciences Inc / Varex Imaging Corp / Inogen Inc / Innovation Pharmaceuticals Inc / Mustang Bio Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / Brainsway Ltd / Frequency Therapeutics Inc / Pennant Group Inc / Aprea Therapeutics Inc / Venus Concept Inc / 89Bio Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">INTC.O / IVC / MSFT.O / QCOM.O / ROG / SYK / AMGN.O / NVDA.O / HEAR.O / MPWR.O / SMTC.O / AVGO.O / CSCO.OQ / CRUS.OQ / ATVI.OQ / NOVN.OQ / XLNX.OQ / TTWO.OQ / ADS.N / SWKS.OQ / TXN.OQ / EXAS.O / NFLX.O / BIIB.O / 478160104 / 00846U101 / 36467W109 / BLRX.TA / 514766104 / MRNA.O / 771195104 / NXPI.O / AMD.OQ / ZNGA.O / EA.O / ADI.OQ / FDEV.L / 82655M107 / CBAY.OQ / ZBH.N / 45780L104 / IPIX.PK / BILI.O / APRE.O / DKNG.O / 84764T304 / HUYA.K / 03823M100</td><td class="leftalignment">Intel Corp / Invacare Corp / Microsoft Corp / Qualcomm Inc / Rogers Corp / Stryker Corp / Amgen Inc / NVIDIA Corp / Turtle Beach Corp / Monolithic Power Systems Inc / Semtech Corp / Broadcom Inc / Cisco Systems Inc / Cirrus Logic Inc / Activision Blizzard Inc / Novan Inc / Xilinx Inc / Take-Two Interactive Software Inc / Alliance Data Systems Corp / Skyworks Solutions Inc / Texas Instruments Inc / Exact Sciences Corp / Netflix Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / GameStop Corp / BioLine RX Ltd / Landec Corp / Moderna Inc / Roche Holding AG / NXP Semiconductors NV / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Frontier Developments PLC / Sify Technologies Ltd / Cymabay Therapeutics Inc / Zimmer Biomet Holdings Inc / Inogen Inc / Innovation Pharmaceuticals Inc / Bilibili Inc / Aprea Therapeutics Inc / DraftKings Inc / Speed Commerce Inc / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 16): Over half the population in Japan had at least one vaccination</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / NYT.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / New York Times Co / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.16）：国内人口のおよそ半数が1回目のワクチン接種完了</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / NYT.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / New York Times Co / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Women Leaders in Biotechnology Inspire from Kendall Square</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BIIB.O / MRNA.O</td><td class="leftalignment">Biogen Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Moderna, Inc. In Global Neoantigens  Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA=US</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 7.7% Y/Y Including COVID-19 Vaccine Volume Benefit (+4.2% Without)</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / 87166L100 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Synlogic Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">FIXX (Buy PT $30): PT Unchanged After 2Q21 Housekeeping Updates</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">FIXX.O / MRNA.O / 75901B107 / 00773U108 / MGTX.O / 54142F102 / 87166L100 / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">Homology Medicines Inc / Moderna Inc / Regenxbio Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / Synlogic Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BLUE Drops EU; PFE/BNTX & MRNA 3rd Dose</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 32, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="even"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: 3rd COVID-19 Vaccine Dose Authorized for Immunosuppressed Individuals; ACIP to Vote on 3rd Dose Today</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA.O / 00653A107 / 87166L100 / FIXX.O / XCUR.O / IMTX.O / IMVT.O</td><td class="leftalignment">Moderna Inc / Adaptimmune Therapeutics PLC / Synlogic Inc / Homology Medicines Inc / Exicure Inc / Immatics NV / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">SYBX (Buy, PT $10): Multiple 2H21 Data Readouts Ahead</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">87166L100 / MRNA.O / FIXX.O</td><td class="leftalignment">Synlogic Inc / Moderna Inc / Homology Medicines Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Keay T. Nakae, CFA / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: New England Journal of Medicine Publication of MRNA's Teen COVE Trial Supports Use in Adolescents Aged 12-17 Years</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Mayo Clinic Study—MRNA Vaccine Is Two-Fold More Effective at Preventing SAR-CoV-2 Infection than PFE/BNTX in Delta Era</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O / ARCT.O / ARCT.OQ</td><td class="leftalignment">Moderna Inc / Arcturus Therapeutics Holdings Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRNA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.O / JNJ / MRK / NVS / ALNY.O / ARWR.O / ATHX.O / RGLS.O / MON.O</td><td class="leftalignment">Moderna Inc / Johnson & Johnson / Merck & Co Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Athersys Inc / Regulus Therapeutics Inc / Monument Circle Acquisition Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">92532F100 / 02043Q107 / 339 / 800677106 / MRNA.O / 199800.KN / 00289Y107 / 75901B107 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / 77313F106 / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Sangamo Therapeutics Inc / Moderna Inc / ToolGen Inc / Abeona Therapeutics Inc / Regenxbio Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Rocket Pharmaceuticals Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Fundamental Research Corp</td><td class="leftalignment">All Eyes on Inflation Data This Week</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRNA=US / ABX=CA / GCM=CA / SOI=CA / GRG=CA / TF=CA / ENRT=US / AUMN=US / HAN=CA / CORA=GB / TUD=CA / AUMN=CA / RFR=CA / DBG=CA / PLTR=US / VYGR=CA / PULL=CA / FIOR=CA / TAAT=CA / INCA=CA / AYUR=CA / CYBN=US / PLTR=AT</td><td class="leftalignment">Moderna Inc / Barrick Gold Corp / GCM Mining Corp / Sirios Resources Inc / Golden Arrow Resources Corp / Timbercreek Financial Corp / Enertopia Corp / Golden Minerals Co / Hannan Metals Ltd / Cora Gold Ltd / Tudor Gold Corp / Golden Minerals Co / Renforth Resources Inc / Doubleview Gold Corp / Palantir Technologies Inc / Voyager Digital Ltd / Pure Extracts Technologies Corp / Fiore Cannabis Ltd / TAAT Global Alternatives Inc / Inca One Gold Corp / Ayurcann Holdings Corp / Cybin Inc / Palantir Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Virgin Islands, British</td><td class="leftalignment">Consumer / Financial Services / Healthcare / Metals & Minerals / Real Estate / Technology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Siddharth Rajeev</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Moderna reports 128% sequential rise in Quarterly Net Profit</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna soars 41.2% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">KRYS (Buy, PT $125): A CF Trial Start & 2 Clinical Readouts Slated for 3Q-4Q21</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">501147102 / 92532F100 / 02043Q107 / MRNA.O / 00289Y107 / N90064101</td><td class="leftalignment">Krystal Biotech Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Abeona Therapeutics Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geulah Livshits, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">LOGC (Buy, PT $20): On Track for Late-21 MMA Updates</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">54142F102 / 02043Q107 / 339 / 800677106 / MRNA.O / 199800.KN / 75901B107 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / H17182108 / 501147102 / FIXX.O / 77313F106 / N90064101 / 83422E105 / 03820J100</td><td class="leftalignment">LogicBio Therapeutics Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Sangamo Therapeutics Inc / Moderna Inc / ToolGen Inc / Regenxbio Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Rocket Pharmaceuticals Inc / Uniqure NV / Solid Biosciences Inc / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / DDDD.L / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 81750R102 / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / 87166L100 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / 4D Pharma PLC / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Synlogic Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / AZO / BAX / BE / BSX / CAT / CCI.N / CI / CLH / CMI / CNC / CSL / DAN / DE / DG / EL.N / ENS / FDX / FLS / GS / INTC.O / ITT / JCI / KKR / KR / MDT / MS / NEP / ORA / QCOM.O / ROP / RSG / SRCL.O / TEL / UNH / W / WM / ACI.N / AMZN.O / AAPL.O / BWA.N / WTS.N / NVDA.O / SQ / UPS.N / RMD.N / MPWR.O / SBUX.O / INSP.N / ADSK.O / V.N / EW.N / IO.N / FCEL.O / EXPD.O / LSTR.O / CREE.O / NET.N / AVGO.O / ATVI.OQ / AMSC.OQ / IART.OQ / CHRW.OQ / TTWO.OQ / UTHR.OQ / PLUG.OQ / MRVL.OQ / TXN.OQ / TEAM.O / TRMB.O / ITRI.O / GNSS.O / 0700.HK / DPZ / OLED.O / NDAQ.O / ATRC.OQ / BIDU.O / SPWR.O / XPO / CSIQ.O / FSLR.O / LULU.O / 02043Q107 / ULTA.O / MRNA.O / TMDX.OQ / TWIN.O / 771195104 / AGCO.K / TSLA.O / NXPI.O / AMRC.K / AMRS.OQ / ADI.OQ / ENPH.O / FB.O / CG.O / PANW.K / PRTA.OQ / HASI.N / GOOGL.O / QRVO.O / SEDG.O / ZG.OQ / RUN.O / IONS.OQ / WKHS.O / WCN.TO / AQMS.O / SPGI.K / FLGT.OQ / APL.PS / WPRT.TO / SNAP.K / PLXP.O / AQB.O / WDAY.O / ROKU.O / MDB.O / APTV.K / 720795103 / CBOE.Z / ESTC.N / CWENa.K / CRSP.BN / FTDR.O / UBER.K / BCYC.O / CRWD.O / VG.O / DKNG.O / AVNT.K / 02081G201 / GRWG.O / RWRh.V</td><td class="leftalignment">Albemarle Corp / Autozone Inc / Baxter International Inc / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Crown Castle International Corp / Cigna Corp / Clean Harbors Inc / Cummins Inc / Centene Corp / Carlisle Companies Inc / Dana Inc / Deere & Co / Dollar General Corp / Estee Lauder Companies Inc / EnerSys / FedEx Corp / Flowserve Corp / Goldman Sachs Group Inc / Intel Corp / ITT Inc / Johnson Controls International PLC / KKR & Co Inc / Kroger Co / Medtronic PLC / Morgan Stanley / Nextera Energy Partners LP / Ormat Technologies Inc / Qualcomm Inc / Roper Technologies Inc / Republic Services Inc / Stericycle Inc / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Waste Management Inc / Albertsons Companies Inc / Amazon.com Inc / Apple Inc / Borgwarner Inc / Watts Water Technologies Inc / NVIDIA Corp / Block Inc / United Parcel Service Inc / Resmed Inc / Monolithic Power Systems Inc / Starbucks Corp / Inspire Medical Systems Inc / Autodesk Inc / Visa Inc / Edwards Lifesciences Corp / ION Geophysical Corp / Fuelcell Energy Inc / Expeditors International of Washington Inc / Landstar System Inc / Wolfspeed Inc / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / American Superconductor Corp / Integra Lifesciences Holdings Corp / CH Robinson Worldwide Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Plug Power Inc / Marvell Technology Inc / Texas Instruments Inc / Atlassian Corporation PLC / Trimble Inc / Itron Inc / Genasys Inc / Tencent Holdings Ltd / Domino's Pizza Inc / Universal Display Corp / Nasdaq Inc / AtriCure Inc / Baidu Inc / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Ulta Beauty Inc / Moderna Inc / Transmedics Group Inc / Twin Disc Inc / Roche Holding AG / AGCO Corp / Tesla Inc / NXP Semiconductors NV / Ameresco Inc / Amyris Inc / Analog Devices Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Palo Alto Networks Inc / Prothena Corporation PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / Alphabet Inc / Qorvo Inc / Solaredge Technologies Inc / Zillow Group Inc / Sunrun Inc / Ionis Pharmaceuticals Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / S&P Global Inc / Fulgent Genetics Inc / Apollo Global Capital Inc / Westport Fuel Systems Inc / Snap Inc / PLx Pharma Inc / AquaBounty Technologies Inc / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Pieris Pharmaceuticals Inc / Cboe Global Markets Inc / Elastic NV / Clearway Energy Inc / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / Bicycle Therapeutics PLC / CrowdStrike Holdings Inc / Vonage Holdings Corp / DraftKings Inc / Avient Corp / Alphatec Holdings Inc / GrowGeneration Corp / Strathmore Plus Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: mRNA M&A; NVS Hold Lifted 2 Years Later</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Adding MTUM Stocks to Our Trifecta List</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ALB.N / AZO / CCI.N / CI / CNC / CSL / DG / EL.N / GS / KKR / MDT / MS / ROP / TEL / UNH / W / AMZN.O / AAPL.O / NVDA.O / SQ / MPWR.O / SBUX.O / ADSK.O / V.N / NET.N / AVGO.O / ATVI.OQ / IART.OQ / TTWO.OQ / UTHR.OQ / MRVL.OQ / TXN.OQ / TEAM.O / 0700.HK / DPZ / OLED.O / NDAQ.O / BIDU.O / XPO / CSIQ.O / LULU.O / ULTA.O / MRNA.O / NXPI.O / ADI.OQ / FB.O / CG.O / PANW.K / QRVO.O / SPGI.K / FLGT.OQ / APL.PS / SNAP.K / WDAY.O / ROKU.O / MDB.O / APTV.K / CBOE.Z / ESTC.N / CRSP.BN / FTDR.O / UBER.K / CRWD.O / VG.O / DKNG.O / GRWG.O</td><td class="leftalignment">Albemarle Corp / Autozone Inc / Crown Castle International Corp / Cigna Corp / Centene Corp / Carlisle Companies Inc / Dollar General Corp / Estee Lauder Companies Inc / Goldman Sachs Group Inc / KKR & Co Inc / Medtronic PLC / Morgan Stanley / Roper Technologies Inc / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Amazon.com Inc / Apple Inc / NVIDIA Corp / Block Inc / Monolithic Power Systems Inc / Starbucks Corp / Autodesk Inc / Visa Inc / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / United Therapeutics Corp / Marvell Technology Inc / Texas Instruments Inc / Atlassian Corporation PLC / Tencent Holdings Ltd / Domino's Pizza Inc / Universal Display Corp / Nasdaq Inc / Baidu Inc / XPO Logistics Inc / Canadian Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Moderna Inc / NXP Semiconductors NV / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Palo Alto Networks Inc / Qorvo Inc / S&P Global Inc / Fulgent Genetics Inc / Apollo Global Capital Inc / Snap Inc / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Cboe Global Markets Inc / Elastic NV / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Vonage Holdings Corp / DraftKings Inc / GrowGeneration Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 06, 2021</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BSX / CI / CVS / GE / MDT / SGE.L / SYK / AMGN.O / AAPL.O / NOVN.S / RMD.N / INSP.N / EW.N / INCY.OQ / NBIX.OQ / UTHR.OQ / EXEL.OQ / VRTX.OQ / NKTR.O / CCRN.O / ICAD.O / STAA.O / AMED.O / BIIB.O / ALNY.OQ / MNKD.O / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / PODD.O / 02043Q107 / TNDM.O / SPRO.OQ / MRNA.O / TMDX.OQ / 771195104 / CSII.O / ADUS.O / FATE.OQ / AERI.O / CNCE.OQ / FLXN.OQ / ALDX.OQ / MDWD.O / XENT.OQ / VBIV.O / MRNS.O / APS.TO / OTIC.O / NVRO.N / VCEL.O / VRAY.OQ / MCRB.OQ / CERC.OQ / GKOS.K / ZBH.N / CFMS.O / GBT.OQ / APLS.OQ / EDIT.OQ / NTLA.O / SYRS.OQ / TCMD.OQ / IRTC.OQ / VREX.OQ / URGN.O / IOVA.OQ / KALA.O / ATNX.O / FENC.O / NCNA.O / 720795103 / PRVB.OQ / BNGO.OQ / ARVN.OQ / ALLO.OQ / ORTX.OQ / CRSP.BN / SWAV.O / XFOR.OQ / ISEE.O / KRTX.OQ / PSNL.O / DMTK.O / BXRX.OQ / HGEN.O / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Boston Scientific Corp / Cigna Corp / CVS Health Corp / General Electric Co / Medtronic PLC / Sage Group PLC / Stryker Corp / Amgen Inc / Apple Inc / Novartis AG / Resmed Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Exelixis Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / ICAD Inc / STAAR Surgical Co / Amedisys Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Pacira Biosciences Inc / Aldeyra Therapeutics Inc / Mediwound Ltd / Intersect Ent Inc / VBI Vaccines Inc / Marinus Pharmaceuticals Inc / Aptose Biosciences Inc / Otonomy Inc / Nevro Corp / Vericel Corp / ViewRay Inc / Seres Therapeutics Inc / Avalo Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Varex Imaging Corp / Urogen Pharma Ltd / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Fennec Pharmaceuticals Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Provention Bio Inc / Bionano Genomics Inc / Arvinas Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / X4 Pharmaceuticals Inc / Iveric Bio Inc / Karuna Therapeutics Inc / Personalis Inc / DermTech Inc / Baudax Bio Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / India / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">ALB.N / AMT / AXP / BKI / CCI.N / CI / CRM.N / DLR / GLW / GS / INTC.O / ITT / MCD / MCO / MS / MSFT.O / NICE.TA / ORA / QCOM.O / QUIK.O / T.N / W / WMT / 4716.T / AMZN.O / BYND.O / MWA / AAPL.O / NVDA.O / DISH.O / SAPG.DE / UPS.N / SBAC.O / RMD.N / OUT / RDWR.O / TREE.O / CRNT.O / PZZA.O / CHTR.O / NUAN.O / DOX.O / NET.N / HPE / GTT / CSCO.OQ / CSGS.OQ / AKAM.OQ / PLUG.OQ / EXPE.OQ / MRVL.OQ / VRNT.OQ / ICAD.O / EGAN.O / ITRI.O / AMED.O / EQIX.O / SYNA.O / NFLX.O / CEVA.O / 92343V104 / 20030N101 / 459200101 / DPZ / OLED.O / ACAD.O / 315616102 / DXCM.O / CCOI.O / CME.O / PODD.O / LLNW.OQ / 02043Q107 / SPRO.OQ / MRNA.O / TMDX.OQ / TSLA.O / ANGI.O / ZNGA.O / EA.O / SPLK.O / FB.O / HASI.N / SFM.O / RNG.N / WIX.O / CHGG.N / GOOGL.O / FIVN.O / ALDX.OQ / 563771203 / SNOW.K / APPS.O / VRAY.OQ / ETSY.O / WING.O / SHOP.K / ZG.OQ / RUN.O / SPXC.K / TMUS.OQ / IAC.O / WCN.TO / NTLA.O / SYRS.OQ / TTD.OQ / IRTC.OQ / TWLO.K / CVNA.N / IOVA.OQ / ATUS.K / KALA.O / RDFN.O / ROKU.O / CARG.O / WSC.OQ / APTV.K / EGHT.K / 83417M104 / BKNG.O / 720795103 / AVYA.K / EVER.OQ / PRVB.OQ / FOCS.OQ / ZM.OQ / CMBM.OQ / KRTX.OQ / PTON.OQ / DDOG.O / REZI.K / FVRR.K / FSLY.K / BXRX.OQ / VG.O / DKNG.O / CXDO.O / RXT.O / FROG.O / NMFC.O / TEUM.PK / ONDS.OQ / LMND.K / REGW.M3</td><td class="leftalignment">Albemarle Corp / American Tower Corp / American Express Co / Black Knight Inc / Crown Castle International Corp / Cigna Corp / Salesforce.Com Inc / Digital Realty Trust Inc / Corning Inc / Goldman Sachs Group Inc / Intel Corp / ITT Inc / McDonald's Corp / Moody's Corp / Morgan Stanley / Microsoft Corp / Nice Ltd / Ormat Technologies Inc / Qualcomm Inc / QuickLogic Corp / AT&T Inc / Wayfair Inc / Walmart Inc / Oracle Corp Japan / Amazon.com Inc / Beyond Meat Inc / Mueller Water Products Inc / Apple Inc / NVIDIA Corp / DISH Network Corp / SAP SE / United Parcel Service Inc / SBA Communications Corp / Resmed Inc / OUTFRONT Media Inc / Radware Ltd / Lendingtree Inc / Ceragon Networks Ltd / Papa John's International Inc / Charter Communications Inc / Nuance Communications Inc / Amdocs Ltd / Cloudflare Inc / Hewlett Packard Enterprise Co / GTT Communications Inc / Cisco Systems Inc / CSG Systems International Inc / Akamai Technologies Inc / Plug Power Inc / Expedia Group Inc / Marvell Technology Inc / Verint Systems Inc / ICAD Inc / eGain Corp / Itron Inc / Amedisys Inc / Equinix Inc / Synaptics Inc / Netflix Inc / CEVA Inc / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / Domino's Pizza Inc / Universal Display Corp / ACADIA Pharmaceuticals Inc / F5 Inc / Dexcom Inc / Cogent Communications Holdings Inc / CME Group Inc / Insulet Corp / Limelight Networks Inc / Alnylam Pharmaceuticals Inc / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / Tesla Inc / Angi Inc / Zynga Inc / Electronic Arts Inc / Splunk Inc / Meta Platforms Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Sprouts Farmers Market Inc / RingCentral Inc / Wix.Com Ltd / Chegg Inc / Alphabet Inc / Five9 Inc / Aldeyra Therapeutics Inc / Mannatech Inc / Snowflake Inc. / Digital Turbine Inc / ViewRay Inc / ETSY Inc / Wingstop Inc / Shopify Inc / Zillow Group Inc / Sunrun Inc / SPX Corp / T-Mobile US Inc / IAC/Interactivecorp / Waste Connections Inc / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Trade Desk Inc / iRhythm Technologies Inc / Twilio Inc / Carvana Co / Iovance Biotherapeutics Inc / Altice USA Inc / Kala Pharmaceuticals Inc / Redfin Corp / Roku Inc / CarGurus Inc / Willscot Mobile Mini Holdings Corp / Aptiv PLC / 8x8 Inc / Solaredge Technologies Inc / Booking Holdings Inc / Pieris Pharmaceuticals Inc / Avaya Holdings Corp / EverQuote Inc / Provention Bio Inc / Focus Financial Partners Inc / Zoom Video Communications Inc / Cambium Networks Corp / Karuna Therapeutics Inc / Peloton Interactive Inc / Datadog Inc / Resideo Technologies Inc / Fiverr International Ltd / Fastly Inc / Baudax Bio Inc / Vonage Holdings Corp / DraftKings Inc / Crexendo Inc / Rackspace Technology Inc / Jfrog Ltd / New Mountain Finance Corp / Pareteum Corp / Ondas Holdings Inc / Lemonade Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / India / Israel / Japan / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">ALB / ALL / ARW / BDX / CCO / DFS / DIS / FND / GEL / IPG / OGE / OKE / OMC / PPL / STZ / TAP.N / WMB / WRK / AUD.N / CMCSA.O / WWE / IRM / WCC / EPC / SBGI.O / SIRI.O / CHTR.O / ILMN.O / TECH.O / MNST.O / DIOD.O / NFLX.O / NXST.O / VIAC.O / DISCA.O / CCOI.O / H.TO / PODD.O / MRNA.O / AMCX.O / NMFC.N / SLM.O / BERY.K / FOXA.O / PSXP.K / SFM.O / HMTV.O / FLXN.O / ON.O / GKOS.K / CABO.N / NTRA.O / TGNA.K / OMF / NTLA.O / LGFb.N / CVNA.K / ATUS.N / IOVA.O / BOMN.O / ROKU.O / OCSL.O / SWCH.K / SFIX.O / BKNG.O / EQH / SPOT.K / SSP.O / AVRO.O / AUTL.O / GH.O / AXNX.O / IHRT.O / BCSF.K / ORCC.K / VZIO.N / DBRG.N / CFLT.O</td><td class="leftalignment">Albemarle Corp / Allstate Corp / Arrow Electronics Inc / Becton Dickinson and Co / Clear Channel Outdoor Holdings Inc / Discover Financial Services / Walt Disney Co / Floor & Decor Holdings Inc / Genesis Energy LP / Interpublic Group of Companies Inc / OGE Energy Corp / ONEOK Inc / Omnicom Group Inc / PPL Corp / Constellation Brands Inc / Molson Coors Beverage Co / Williams Companies Inc / Westrock Co / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Iron Mountain Inc / Wesco International Inc / Edgewell Personal Care Co / Sinclair Broadcast Group Inc / Sirius XM Holdings Inc / Charter Communications Inc / Illumina Inc / Bio-Techne Corp / Monster Beverage Corp / Diodes Inc / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Discovery Inc / Cogent Communications Holdings Inc / Hydro One Ltd / Insulet Corp / Moderna Inc / AMC Networks Inc / New Mountain Finance Corp / SLM Corp / Berry Global Group Inc / Fox Corp / Phillips 66 Partners LP / Sprouts Farmers Market Inc / Hemisphere Media Group Inc / Pacira Biosciences Inc / ON Semiconductor Corp / Glaukos Corp / Cable One Inc / Natera Inc / Tegna Inc / OneMain Holdings Inc / Intellia Therapeutics Inc / Lions Gate Entertainment Corp / Carvana Co / Altice USA Inc / Iovance Biotherapeutics Inc / Boston Omaha Corp / Roku Inc / Oaktree Specialty Lending Corp / Switch Inc / Stitch Fix Inc / Booking Holdings Inc / Equitable Holdings Inc / Spotify Technology SA / E W Scripps Co / AVROBIO Inc / Autolus Therapeutics PLC / Guardant Health Inc / Axonics Inc / iHeartMedia Inc / Bain Capital Specialty Finance Inc / Owl Rock Capital Corp / Vizio Holding Corp / DigitalBridge Group Inc / Confluent Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Downgrading to Neutral, $445 Target; Future Spikevax Growth Appears Baked In</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Guotai JunAn (HK) Retail Rsch</td><td class="leftalignment">莫德纳 Moderna-二季度表现强劲，等待未来的增长点-08/06/2021</td><td class="leftalignment">Chinese</td><td class="rightalignment">2</td><td class="leftalignment">MRNA</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chloe Kim</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : 2Q Snapshot - Saving the World Even Though Valued Like Saving the Universe</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: 2Q21 Earnings—Solid Performance Should Go Through '22, but Uncertainties Remain as COVID Revenues Decline in '23</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">2Q21 Review: The Dream Is Alive, But Valuation Moves Us to Sidelines; Downgrade to Perform</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2Q21 Earnings: Model Updates and Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K10 / F5548N10</td><td class="leftalignment">Moderna Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, Aug. 05, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Aug. 05, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Key takeaways from expert call on recent COVID-19 Delta variant case surge</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / SASY.PA / 2196.HK / MRNA.OQ / BGNE.OQ / 2269.HK / 1877.HK</td><td class="leftalignment">Pfizer Inc / Sanofi SA / Shanghai Fosun Pharmaceutical Group Co Ltd / Moderna Inc / Beigene Ltd / WuXi Biologics (Cayman) Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / France / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MCK: Solid Results Across the Board</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MCK.N / JNJ.N / MRNA.OQ</td><td class="leftalignment">Mckesson Corp / Johnson & Johnson / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Fundamental Research Corp</td><td class="leftalignment">Highly Positive Data Supporting Vaccine Efficacy</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRNA=US / AAPL=US / CBK=CA / SSV=CA / UEX=CA / SMP=CA / VYGR=US / AZS=AU / KIDZ=CA / CBI=CA / BNXA=CA / BLLG=CA / GBAR=CA / PULL=CA / NEXE=CA / TAAT=CA</td><td class="leftalignment">Moderna Inc / Apple Inc / Copperbank Resources Corp / Southern Silver Exploration Corp / Uex Corp / Southern Empire Resources Corp / Voyager Therapeutics Inc / Azure Minerals Ltd / Kidoz Inc / Colibri Resource Corp / Banxa Holdings Inc / Blue Lagoon Resources Inc / Monarch Mining Corp / Pure Extracts Technologies Corp / NEXE Innovations Inc / TAAT Global Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Anguilla / Australia / Canada / United States</td><td class="leftalignment">Consumer / Financial Services / Healthcare / Info. Tech./Computers / Metals & Minerals / Retailing</td><td class="leftalignment">Latin America / North America / Australasia</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Siddharth Rajeev</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Fast-Track Designation for RSV Vaccine Candidate, mRNA-1345 in Older Adults—Key Will Be Durability of Antibody Titer</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AIRP.PA / ALB.N / ALK.N / AXP.N / BA.N / BAC.N / BAX.N / BDX.N / C.N / CCL.N / CI.N / COF.N / CRM.N / DAL.N / FCX.N / GM.N / GPS.N / JNJ.N / JPM.N / KMB.N / LLY.N / LSI.N / LUV.N / MDT.N / MO.N / NEM.N / PFE.N / PM.N / SC.N / T.N / TMO.N / U.N / WAT.N / WFC.N / PG.N / NUE.N / CPB.N / W.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / D.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / DVN.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / PKI.N / VZ.N / WST.N / MUR.N / KSS.N / ORCL.N / PWR.N / COG.N / EFX.N / V.N / EW.N / CPT.N / HWM.N / ACN.N / PLD.N / CHD.N / AIV.N / HAE.N / MKC.N / MAA.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / MHK.N / GME.N / INTC.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / ATVI.OQ / MSFT.OQ / PBCT.OQ / TEAM.OQ / REGN.OQ / SIVB.OQ / QDEL.OQ / CACC.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / GILD.OQ / DFS.N / COST.OQ / CPRT.OQ / INCY.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / TPR.N / NBIX.OQ / CTXS.OQ / AMZN.OQ / MANH.OQ / NVDA.OQ / BMRN.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / EXAS.OQ / ALGN.OQ / VRTX.OQ / JBLU.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / TFC.N / ACAD.OQ / CG.TO / DPZ.N / MOS.N / DLR.N / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / STX.AX / MA.N / IVZ.N / TDC.N / MRNA.OQ / MSCI.N / AVGO.OQ / FTNT.OQ / MU.OQ / GNRC.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / EPAM.N / SPLK.OQ / PSX.N / SRPT.OQ / GMED.N / ALLY.N / PRGO.N / COTY.N / COMM.OQ / NCLH.N / GOOGL.OQ / SAGE.OQ / HUBS.N / WBA.OQ / TDOC.N / PYPL.OQ / GBT.OQ / IONS.OQ / RETA.OQ / COUP.OQ / LW.N / AYX.N / DXC.N / CVNA.N / IOVA.OQ / AXON.OQ / WDAY.OQ / ROKU.OQ / BKNG.OQ / CBRE.N / FB.PS / CPRI.N / NFE.OQ / PINS.N / FSLY.N / CRWD.OQ / RTX.N / LMND.N / GOCO.OQ / CVAC.OQ / AMWL.N / PLTR.N / VTRS.OQ / TSP.OQ / HON.OQ</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Citigroup Inc / Carnival Corp / Cigna Corp / Capital One Financial Corp / Salesforce.Com Inc / Delta Air Lines Inc / Freeport-McMoRan Inc / General Motors Co / Gap Inc / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Life Storage Inc / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Wayfair Inc / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Dominion Energy Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / PerkinElmer Inc / Verizon Communications Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Kohls Corp / Oracle Corp / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Camden Property Trust / Howmet Aerospace Inc / Accenture PLC / Prologis Inc / Church & Dwight Co Inc / Apartment Investment and Management Co / Haemonetics Corp / McCormick & Company Inc / Mid-America Apartment Communities Inc / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Mohawk Industries Inc / GameStop Corp / Intel Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Activision Blizzard Inc / Microsoft Corp / People's United Financial Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / SVB Financial Group / Quidel Corp / Credit Acceptance Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Costco Wholesale Corp / Copart Inc / Incyte Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Tapestry Inc / Neurocrine Biosciences Inc / Citrix Systems Inc / Amazon.com Inc / Manhattan Associates Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Exact Sciences Corp / Align Technology Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Mosaic Co / Digital Realty Trust Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Invesco Ltd / Teradata Corp / Moderna Inc / MSCI Inc / Broadcom Inc / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Epam Systems Inc / Splunk Inc / Phillips 66 / Sarepta Therapeutics Inc / Globus Medical Inc / Ally Financial Inc / Perrigo Company PLC / Coty Inc / CommScope Holding Company Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Iovance Biotherapeutics Inc / Axon Enterprise Inc / Workday Inc / Roku Inc / Booking Holdings Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Fastly Inc / CrowdStrike Holdings Inc / Raytheon Technologies Corp / Lemonade Inc / Gohealth Inc / CureVac NV / American Well Corp / Palantir Technologies Inc / Viatris Inc / TuSimple Holdings Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / France / United Kingdom / Ireland / Luxembourg / Netherlands / Panama / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Philippines Market Strategy: Vaccination rate picks up significantly, but lockdowns to impact earnings</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BPI.PS / JNJ.N / PFE.N / AZN.L / RLC.PS / MRNA.OQ / SVA.OQ / PGOLD.PS / CNPF.PS / HOME.PS</td><td class="leftalignment">Bank of the Philippine Islands / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Robinsons Land Corp / Moderna Inc / Sinovac Biotech Ltd / Puregold Price Club Inc / Century Pacific Food Inc / AllHome Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Hazel Tanedo / Mr. Justin J. Cimafranca</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / OCX / NVAX.O / ICPT.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / KMDA.TA / 266605104 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 503459604 / 199800.KN / VKTX.O / ADMA.O / CFRX.O / ALSEN.PA / CLBS.O / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / MDGL.O / LYS.PA / IVAA.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / NGM.O / FIXX.O / MBIO.O / 46583P102 / AKRO.O / NBSE.O / LCTX.K / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / ETNB.O / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / 19249J109 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / OncoCyte Corp / Novavax Inc / Intercept Pharmaceuticals Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Kamada Ltd / DURECT Corp / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / La Jolla Pharmaceutical Co / ToolGen Inc / Viking Therapeutics Inc / ADMA Biologics Inc / ContraFect Corp / Sensorion SA / Caladrius Biosciences Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Madrigal Pharmaceuticals Inc / Lysogene SA / Inventiva SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / NGM Biopharmaceuticals Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / Lineage Cell Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / 89Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / CohBar Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Aug-2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 004170.KS / 069620.KS / 006280.KS / 078930.KS / MRNA.OQ / 068270.KS / 086900.KQ / 0460.HK / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Shinsegae Inc / Daewoong Pharma / Green Cross Corp / GS Holdings Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Sihuan Pharmaceutical Holdings Group Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - 2Q21 review: OP miss by increased SG&A items, but stronger 3Q21E seasonality on track</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">006280.KS / PFE.N / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: DRNA Cleared in AUD; ALNY Collab w/ PeptiDream</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ALNY.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna soars 54.3% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CRY.N / CVS / HAE / HUM / MDT / RAD / SYK / UNH / WMT / GILD.O / TFX.N / ANIK.O / NOVN.S / RMD.N / XRAY.O / HCA.N / CYH.N / COO.N / INSP.N / CERS.O / EW.N / ALGN.O / OSUR.O / DRRX.O / SSNC.O / ISR / SRDX.O / ABMD.OQ / ICUI.OQ / INCY.OQ / IART.OQ / NBIX.OQ / ICPT.OQ / BMRN.OQ / ISRG.OQ / BLUE.OQ / CCRN.O / STAA.O / IDXX.O / INMD.O / MMSI.O / AMED.O / CGEN.O / EXAS.O / BIIB.O / 025816109 / 478160104 / 00846U101 / 881624209 / 868168105 / ANGO.OQ / NUVA.O / ACAD.O / GLPG.AS / ATRC.OQ / DXCM.O / LHCG.O / B8FGn.DE / INFI.OQ / LMAT.O / ALCLS.PA / ARAY.O / PODD.O / MASI.O / 02043Q107 / ENSG.OQ / KIDS.O / 483548103 / MRNA.O / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / GMED.K / PRTA.OQ / AXGN.O / AGIO.OQ / AERI.O / GOOGL.O / MDWD.O / 02005N100 / AGRX.OQ / XENT.OQ / VKTX.O / NVRO.N / SIEN.O / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / CERC.OQ / GKOS.K / ZBH.N / CFMS.O / SPNE.O / NVCR.OQ / 100063846 / SSKN.OQ / SENS.A / TCMD.OQ / IRTC.OQ / SRTS.O / MDGL.O / VREX.OQ / 45780L104 / SLNO.OQ / PLXP.O / KALA.O / 720795103 / SWAV.O / KRTX.OQ / XAIR.OQ / PNTG.OQ / RLMD.OQ / VERO.O / NNOX.O / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Haemonetics Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Teleflex Inc / Anika Therapeutics Inc / Novartis AG / Resmed Inc / DENTSPLY SIRONA Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Inspire Medical Systems Inc / Cerus Corp / Edwards Lifesciences Corp / Align Technology Inc / OraSure Technologies Inc / DURECT Corp / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / ABIOMED Inc / ICU Medical Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / bluebird bio Inc / Cross Country Healthcare Inc / STAAR Surgical Co / IDEXX Laboratories Inc / Inmode Ltd / Merit Medical Systems Inc / Amedisys Inc / Compugen Ltd / Exact Sciences Corp / Biogen Inc / American Express Co / Johnson & Johnson / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Superior Industries International Inc / AngioDynamics Inc / NuVasive Inc / ACADIA Pharmaceuticals Inc / Galapagos NV / AtriCure Inc / Dexcom Inc / LHC Group Inc / Biofrontera AG / Infinity Pharmaceuticals Inc / LeMaitre Vascular Inc / Cellectis SA / Accuray Inc / Insulet Corp / Masimo Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / OrthoPediatrics Corp / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Globus Medical Inc / Prothena Corporation PLC / AxoGen Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Alphabet Inc / Mediwound Ltd / Ally Financial Inc / Agile Therapeutics Inc / Intersect Ent Inc / Viking Therapeutics Inc / Nevro Corp / Sientra Inc / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Avalo Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / SeaSpine Holdings Corp / Novocure Ltd / Truist Financial Corp / STRATA Skin Sciences Inc / Senseonics Holdings Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Sensus Healthcare Inc / Madrigal Pharmaceuticals Inc / Varex Imaging Corp / Inogen Inc / Soleno Therapeutics Inc / PLx Pharma Inc / Kala Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Karuna Therapeutics Inc / Beyond Air Inc / Pennant Group Inc / Relmada Therapeutics Inc / Venus Concept Inc / Nano-X Imaging Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Third Time Might Be the Charm, Get Ready for Another COVID Shot</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Dilip Joseph / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Vaults into RSV Race, Can They Leapfrog GSK/JNJ for Another Blockbuster?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GSK.L / JNJ.N / PFE.N / 71708110 / 478160104 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Pfizer Inc / Pfizer Inc / Johnson & Johnson / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Intermoney Valores</td><td class="leftalignment">Rovi - EBITDA 2T21 bate estimaciones. Guías mejoradas de nuevo - Intermoney Valores</td><td class="leftalignment">Spanish</td><td class="rightalignment">3</td><td class="leftalignment">ROVI=ES / MRNA=US</td><td class="leftalignment">Laboratorios Farmaceuticos ROVI SA / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Spain / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / ESTIMATE CHANGES / OPERATIONS / OPERATING RESULTS / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sr. Juan Ros R. Padilla</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - Growing faster for longer; Raise TP to SFr750 and reiterate Outperform</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / DHR.N / LUN.CO / MRCG.DE / SATG.DE / PKI.N / BANB.S / CRL.N / UCB.BR / SFZN.S / IPN.PA / ORNBV.HE / GXIG.DE / ALM.MC / GRLS.MC / MRNA.OQ / 068270.KS / CTLT.N / PINFRAL.MX / 207940.KS / 2269.HK / GMAB.CO / PPGN.S</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / Danaher Corp / H Lundbeck A/S / Merck KGaA / Sartorius AG / PerkinElmer Inc / Bachem Holding AG / Charles River Laboratories International Inc / Ucb SA / Siegfried Holding AG / Ipsen SA / Orion Oyj / Gerresheimer AG / Almirall SA / Grifols SA / Moderna Inc / Celltrion Inc / Catalent Inc / Promotora y Operadora de Infraestructura SAB de CV / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Genmab A/S / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Korea, Republic of / Mexico / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr Matthew J. Weston / Ms Jo Walton / Elizabeth Walton / Mr. Dominic Lunn / European Pharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAX / BSX / CRY.N / HAE / INTC.O / MDT / MSFT.O / QCOM.O / RAD / SBH.N / SYK / WMT / AMZN.O / AAPL.O / TFX.N / NVDA.O / ANIK.O / HEAR.O / RMD.N / XRAY.O / COO.N / INSP.N / CERS.O / EW.N / ALGN.O / OSUR.O / NET.N / ISR / SRDX.O / ABMD.OQ / ATVI.OQ / ICUI.OQ / IART.OQ / NBIX.OQ / TTWO.OQ / ISRG.OQ / STAA.O / IDXX.O / INMD.O / MMSI.O / NFLX.O / 025816109 / 478160104 / ANGO.OQ / NUVA.O / ATRC.OQ / DXCM.O / 36467W109 / B8FGn.DE / LMAT.O / ALCLS.PA / ARAY.O / PODD.O / MASI.O / KIDS.O / MRNA.O / TMDX.OQ / CSII.O / TSLA.O / ZNGA.O / EA.O / FB.O / GMED.K / PRTA.OQ / AXGN.O / TWTR.K / FDEV.L / AERI.O / GOOGL.O / 82655M107 / AGRX.OQ / SNOW.K / XENT.OQ / NVRO.N / SIEN.O / VCEL.O / APPS.O / VRAY.OQ / CERC.OQ / GKOS.K / ZBH.N / CFMS.O / SHOP.K / SPNE.O / SSKN.OQ / SENS.A / TCMD.OQ / TTD.OQ / IRTC.OQ / SRTS.O / TWLO.K / VREX.OQ / 45780L104 / SNAP.K / OKTA.O / PLXP.O / 720795103 / BILI.O / DOCU.O / SMAR.K / SWAV.O / ZM.OQ / CRWD.O / XAIR.OQ / DDOG.O / VERO.O / FSLY.K / BILL.K / NNOX.O / HUYA.K</td><td class="leftalignment">Baxter International Inc / Boston Scientific Corp / CryoLife Inc / Haemonetics Corp / Intel Corp / Medtronic PLC / Microsoft Corp / Qualcomm Inc / Rite Aid Corp / Sally Beauty Holdings Inc / Stryker Corp / Walmart Inc / Amazon.com Inc / Apple Inc / Teleflex Inc / NVIDIA Corp / Anika Therapeutics Inc / Turtle Beach Corp / Resmed Inc / DENTSPLY SIRONA Inc / Cooper Companies Inc / Inspire Medical Systems Inc / Cerus Corp / Edwards Lifesciences Corp / Align Technology Inc / OraSure Technologies Inc / Cloudflare Inc / IsoRay Inc / Surmodics Inc / ABIOMED Inc / Activision Blizzard Inc / ICU Medical Inc / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Intuitive Surgical Inc / STAAR Surgical Co / IDEXX Laboratories Inc / Inmode Ltd / Merit Medical Systems Inc / Netflix Inc / American Express Co / Johnson & Johnson / AngioDynamics Inc / NuVasive Inc / AtriCure Inc / Dexcom Inc / GameStop Corp / Biofrontera AG / LeMaitre Vascular Inc / Cellectis SA / Accuray Inc / Insulet Corp / Masimo Corp / OrthoPediatrics Corp / Moderna Inc / Transmedics Group Inc / Cardiovascular Systems Inc / Tesla Inc / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Globus Medical Inc / Prothena Corporation PLC / AxoGen Inc / Twitter Inc / Frontier Developments PLC / Aerie Pharmaceuticals Inc / Alphabet Inc / Sify Technologies Ltd / Agile Therapeutics Inc / Snowflake Inc. / Intersect Ent Inc / Nevro Corp / Sientra Inc / Vericel Corp / Digital Turbine Inc / ViewRay Inc / Avalo Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Shopify Inc / SeaSpine Holdings Corp / STRATA Skin Sciences Inc / Senseonics Holdings Inc / Tactile Systems Technology Inc / Trade Desk Inc / iRhythm Technologies Inc / Sensus Healthcare Inc / Twilio Inc / Varex Imaging Corp / Inogen Inc / Snap Inc / Okta Inc / PLx Pharma Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / DocuSign Inc / Smartsheet Inc / Shockwave Medical Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Beyond Air Inc / Datadog Inc / Venus Concept Inc / Fastly Inc / Bill.com Holdings Inc / Nano-X Imaging Ltd / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Manufacturing Site Visit; Story Broadening Beyond the Clinic</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ALCLS.PA / MRNA.O</td><td class="leftalignment">Cellectis SA / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (26 July-): Results season begins; focus on Chugai, M3, Takeda</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4502.T / 4519.T / 4503.T / 4507.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（7月26日～）: 決算発表スタート、注目は中外薬、M3、武田薬</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4519.T / 4502.T / 4503.T / 4507.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">M3 Inc / Chugai Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: ADVM abandons DME; (+) EMA opinion for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MRNA.OQ / ADVM.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Moderna Inc / Adverum Biotechnologies Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - 1H21 Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LONN.S / MRNA.OQ</td><td class="leftalignment">Lonza Group AG / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.12): Japan now at over 70mn total doses</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.12）：国内ワクチン総接種、7,000万回を超える</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: UK COVID Vaccine Community Cohort Reinforces the Need to Define an Antibody Protection Threshold or Rely on Boosters</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ALB.N / AMT / BAX / BSX / CCI.N / CI / CNC / COST.O / CRY.N / CSL / DG / ECL.N / EL.N / FDX / GE / GS / HAE / INTC.O / JPM / KKR / KR / LL / LRCX.O / MA / MDT / MS / MSFT.O / NEP / O / RBC / ROP / RSG / SGE.L / SWI / SYK / T.N / TEL / TUP / UNH / URI / AMZN.O / AAPL.O / TFX.N / ASTE.O / NVDA.O / ANIK.O / DTE.N / SAPG.DE / SQ / HEAR.O / NOVN.S / CRVL.O / RMD.N / MPWR.O / TREE.O / HCA.N / SBUX.O / COO.N / INSP.N / HRB.N / CERS.O / FISV.O / ADSK.O / V.N / EW.N / DLTR.O / CHD.N / CSGP.O / ALGN.O / OSUR.O / ENR.N / NET.N / AVGO.O / ISR / TSCO.O / SRDX.O / ABMD.OQ / CRUS.OQ / ATVI.OQ / ICUI.OQ / INCY.OQ / POOL.OQ / IART.OQ / CALM.OQ / TTWO.OQ / UTHR.OQ / AKAM.OQ / PLUG.OQ / ISRG.OQ / MRVL.OQ / PDFS.OQ / TXN.OQ / TEAM.O / SIVB.O / STAA.O / IDXX.O / INMD.O / MMSI.O / NATI.O / ANSS.O / NFLX.O / 025816109 / 478160104 / ANGO.OQ / 0700.HK / DPZ / NUVA.O / BJRI.OQ / OLED.O / 146229109 / NDAQ.O / 749685103 / ATRC.OQ / BIDU.O / DXCM.O / 36467W109 / ATNI.OQ / 089302103 / B8FGn.DE / EHTH.O / LMAT.O / CSIQ.O / IPGP.O / ARAY.O / PODD.O / LULU.O / MASI.O / ENSG.OQ / KIDS.O / ULTA.O / MRNA.O / TMDX.OQ / FRPT.O / CSII.O / GNRC.K / GLAXOSM.LG / TSLA.O / BCOM.TA / NXPI.O / AMRC.K / QSR.TO / EA.O / ADI.OQ / FB.O / CG.O / FIVE.OQ / GMED.K / PANW.K / MPLX.K / AXGN.O / FATE.OQ / FDEV.L / GOOGL.O / 82655M107 / ARES.K / NVRO.N / SIEN.O / VCEL.O / TBK.O / QRVO.O / GKOS.K / CFMS.O / SPNE.O / UQ1.F / TMUS.OQ / APLS.OQ / SSKN.OQ / SENS.A / SPGI.K / 34959J108 / TCMD.OQ / FLGT.OQ / IRTC.OQ / APL.PS / SRTS.O / UAA / HLNE.OQ / 45780L104 / SNAP.K / PLXP.O / ROKU.O / MDB.O / APTV.K / 720795103 / BILI.O / LOVE.OQ / 039697107 / FOCS.OQ / FTCH.N / ESTC.N / CRSP.BN / FTDR.O / SWAV.O / UBER.K / CRWD.O / PING.K / FVRR.K / ONEM.OQ / BILL.K / DKNG.O / GRWG.O / RXT.O / NNOX.O / HUYA.K / 390320109 / 744285206</td><td class="leftalignment">Albemarle Corp / American Tower Corp / Baxter International Inc / Boston Scientific Corp / Crown Castle International Corp / Cigna Corp / Centene Corp / Costco Wholesale Corp / CryoLife Inc / Carlisle Companies Inc / Dollar General Corp / Ecolab Inc / Estee Lauder Companies Inc / FedEx Corp / General Electric Co / Goldman Sachs Group Inc / Haemonetics Corp / Intel Corp / JPMorgan Chase & Co / KKR & Co Inc / Kroger Co / LL Flooring Holdings Inc / Lam Research Corp / Mastercard Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / Realty Income Corp / Regal Rexnord Corp / Roper Technologies Inc / Republic Services Inc / Sage Group PLC / SolarWinds Corp / Stryker Corp / AT&T Inc / TE Connectivity Ltd / Tupperware Brands Corp / UnitedHealth Group Inc / United Rentals Inc / Amazon.com Inc / Apple Inc / Teleflex Inc / Astec Industries Inc / NVIDIA Corp / Anika Therapeutics Inc / DTE Energy Co / SAP SE / Block Inc / Turtle Beach Corp / Novartis AG / CorVel Corp / Resmed Inc / Monolithic Power Systems Inc / Lendingtree Inc / HCA Healthcare Inc / Starbucks Corp / Cooper Companies Inc / Inspire Medical Systems Inc / H & R Block Inc / Cerus Corp / Fiserv Inc / Autodesk Inc / Visa Inc / Edwards Lifesciences Corp / Dollar Tree Inc / Church & Dwight Co Inc / CoStar Group Inc / Align Technology Inc / OraSure Technologies Inc / Energizer Holdings Inc / Cloudflare Inc / Broadcom Inc / IsoRay Inc / Tractor Supply Co / Surmodics Inc / ABIOMED Inc / Cirrus Logic Inc / Activision Blizzard Inc / ICU Medical Inc / Incyte Corp / Pool Corp / Integra Lifesciences Holdings Corp / Cal-Maine Foods Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Akamai Technologies Inc / Plug Power Inc / Intuitive Surgical Inc / Marvell Technology Inc / PDF Solutions Inc / Texas Instruments Inc / Atlassian Corporation PLC / SVB Financial Group / STAAR Surgical Co / IDEXX Laboratories Inc / Inmode Ltd / Merit Medical Systems Inc / National Instruments Corp / ANSYS Inc / Netflix Inc / American Express Co / Johnson & Johnson / AngioDynamics Inc / Tencent Holdings Ltd / Domino's Pizza Inc / NuVasive Inc / BJ's Restaurants Inc / Universal Display Corp / Carter's Inc / Nasdaq Inc / RPM International Inc / AtriCure Inc / Baidu Inc / Dexcom Inc / GameStop Corp / ATN International Inc / Big Lots Inc / Biofrontera AG / eHealth Inc / LeMaitre Vascular Inc / Canadian Solar Inc / IPG Photonics Corp / Accuray Inc / Insulet Corp / Lululemon Athletica Inc / Masimo Corp / Ensign Group Inc / OrthoPediatrics Corp / Ulta Beauty Inc / Moderna Inc / Transmedics Group Inc / Freshpet Inc / Cardiovascular Systems Inc / Generac Holdings Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / B Communications Ltd / NXP Semiconductors NV / Ameresco Inc / Restaurant Brands International Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Five Below Inc / Globus Medical Inc / Palo Alto Networks Inc / MPLX LP / AxoGen Inc / Fate Therapeutics Inc / Frontier Developments PLC / Alphabet Inc / Sify Technologies Ltd / Ares Management Corp / Nevro Corp / Sientra Inc / Vericel Corp / Triumph Bancorp Inc / Qorvo Inc / Glaukos Corp / Conformis Inc / SeaSpine Holdings Corp / Uniqure NV / T-Mobile US Inc / Apellis Pharmaceuticals Inc / STRATA Skin Sciences Inc / Senseonics Holdings Inc / S&P Global Inc / Fortive Corp / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Apollo Global Capital Inc / Sensus Healthcare Inc / Under Armour Inc / Hamilton Lane Inc / Inogen Inc / Snap Inc / PLx Pharma Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Pieris Pharmaceuticals Inc / Bilibili Inc / Lovesac Co / Ardelyx Inc / Focus Financial Partners Inc / Farfetch Ltd / Elastic NV / CRISPR Therapeutics AG / Frontdoor Inc / Shockwave Medical Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Fiverr International Ltd / 1Life Healthcare Inc / Bill.com Holdings Inc / DraftKings Inc / GrowGeneration Corp / Rackspace Technology Inc / Nano-X Imaging Ltd / HUYA Inc / Great Elm Capital Corp / Proxim Wireless Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Israel / Nigeria / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 2Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Junshi joining mRNA deal spree; China mRNA R&D playing catch up</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / 1093.HK / 2196.HK / MRNA.OQ / 300142.SZ / BGNE.OQ / 2269.HK / IMAB.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / CSPC Pharmaceutical Group Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Moderna Inc / Walvax Biotechnology Co Ltd / Beigene Ltd / WuXi Biologics (Cayman) Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Hong Kong / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: 2H21 Outlook: Sector fundamentals remain strong, quantifying company catalysts</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">0867.HK / 1515.HK / 1066.HK / 1093.HK / PFE.N / AZN.L / 1177.HK / NOVN.S / 0241.HK / 0853.HK / 2196.HK / 000538.SZ / 600196.SS / 600276.SS / MRNA.OQ / JD.OQ / BGNE.OQ / 2269.HK / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / 1951.HK / 2500.HK / 6618.HK / 9618.HK / GTH.OQ / 1952.HK / 2142.HK / 2160.HK</td><td class="leftalignment">China Medical System Holdings Ltd / China Resources Medical Holdings Company Ltd / Shandong Weigao Group Medical Polymer Co Ltd / CSPC Pharmaceutical Group Ltd / Pfizer Inc / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Novartis AG / Alibaba Health Information Technology Ltd / Microport Scientific Corp / Shanghai Fosun Pharmaceutical Group Co Ltd / Yunnan Baiyao Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Jiangsu Hengrui Pharmaceuticals Co Ltd / Moderna Inc / JD.Com Inc / Beigene Ltd / WuXi Biologics (Cayman) Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Jinxin Fertility Group Ltd / Venus Medtech Hangzhou Inc / JD Health International Inc / JD.Com Inc / Genetron Holdings Ltd / Everest Medicines Ltd / Hbm Holdings Ltd / Microport Cardioflow Medtech Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Gene editing tech investments in Prime & Shape</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2Q21 Genetic Medicine Earnings Preview and Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">00289Y10 / 00773U10 / 02043Q10 / 46222210 / 04280A10 / 604749101 / SIOX / Y9530810 / 60770K10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 87410C10 / 24343R10 / 75629V10</td><td class="leftalignment">Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Alnylam Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Sio Gene Therapies Inc / WAVE Life Sciences Ltd / Moderna Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Talaris Therapeutics Inc / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Iran, Islamic Republic of / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 10% Including COVID-19 Vaccine Volume Benefit (+5% Without)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - 1H21 Results Preview - CS in line for 1H21, 4%  ahead on EPS by FY23E</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LONN.S / ROG.S / MRCG.DE / NZYMB.CO / MRNA.OQ / 207940.KS</td><td class="leftalignment">Lonza Group AG / Roche Holding AG / Merck KGaA / Novozymes A/S / Moderna Inc / Samsung Biologics Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston / Fr. Barbora Blaha</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMAT.O / CCO / CE / CP / CPE / DD / DIS / DK / HBI / HUN / IPG / KLAC.O / KNX / LRCX.O / MCD / MPC / MRO / NSC / OMC / R / ASML.O / AUD.N / CMCSA.O / WWE / JBHT.O / SBGI.O / ODFL.O / HUBG.O / GTN / WERN.O / SIRI.O / CHRW.O / CHTR.O / EXPD.O / LSTR.O / MU.O / TSCO.O / NFLX.O / NXST.O / VIAC.O / QSR / DISCA.O / CDNS.O / STX.O / XPO / SAIA.O / MRNA.O / AMCX.O / WEN.O / WDC.O / FOXA.O / HMTV.O / CABO.N / TGNA.K / LGFb.N / SNDR.N / ATUS.N / BOMN.O / ROKU.O / SPOT.K / SSP.O / DELL.K / IHRT.O / VZIO.N</td><td class="leftalignment">Applied Materials Inc / Clear Channel Outdoor Holdings Inc / Celanese Corp / Canadian Pacific Railway Ltd / Callon Petroleum Co / Dupont De Nemours Inc / Walt Disney Co / Delek US Holdings Inc / HanesBrands Inc / Huntsman Corp / Interpublic Group of Companies Inc / KLA Corp / Knight-Swift Transportation Holdings Inc / Lam Research Corp / McDonald's Corp / Marathon Petroleum Corp / Marathon Oil Corp / Norfolk Southern Corp / Omnicom Group Inc / Ryder System Inc / ASML Holding NV / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / J B Hunt Transport Services Inc / Sinclair Broadcast Group Inc / Old Dominion Freight Line Inc / Hub Group Inc / Gray Television Inc / Werner Enterprises Inc / Sirius XM Holdings Inc / CH Robinson Worldwide Inc / Charter Communications Inc / Expeditors International of Washington Inc / Landstar System Inc / Micron Technology Inc / Tractor Supply Co / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Restaurant Brands International Inc / Discovery Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / XPO Logistics Inc / Saia Inc / Moderna Inc / AMC Networks Inc / Wendys Co / Western Digital Corp / Fox Corp / Hemisphere Media Group Inc / Cable One Inc / Tegna Inc / Lions Gate Entertainment Corp / Schneider National Inc / Altice USA Inc / Boston Omaha Corp / Roku Inc / Spotify Technology SA / E W Scripps Co / Dell Technologies Inc / iHeartMedia Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: NIH-Sponsored Study of Low Dose (25µg) mRNA-1273 Shows Durable Responses at 7+ Months Post-Vaccination</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: MRNA initiates in influenza; ABUS is greenlit</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MRNA.OQ / ABUS.OQ / EBS / 66987V10 / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Moderna Inc / Arbutus Biopharma Corp / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Taiwan vaccine order could generate sales of US$300 mn in 2021. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2330.TW / 2196.HK / 600196.SS / 2317.TW / PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Hon Hai Precision Industry Co Ltd / Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / Taiwan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Vital Signs - Charts of the Day: EVH, CNTG, SEB, SPCE, NLST, ARCH, GDP, OAS, AR, SWN, RRC, RAPT, CRTX, MRNA, PRTA, BIIB, SMLR, AVNS, SAVA, and QRHC</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">QRHC.OQ / AR.N / RRC.N / SEB.A / SWN.N / CRTX.OQ / MRNA.OQ / EVH.N / SMLR.PK / ARCH.N / AVNS.N / NLST.PK / RAPT.OQ / OAS.OQ / 39K.MU</td><td class="leftalignment">Quest Resource Holding Corp / Antero Resources Corp / Range Resources Corp / Seaboard Corp / Southwestern Energy Co / Cortexyme Inc / Moderna Inc / Evolent Health Inc / Semler Scientific Inc / Arch Resources Inc / Avanos Medical Inc / Netlist Inc / Rapt Therapeutics Inc / Oasis Petroleum Inc / Centogene NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States / Serbia</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 10): Over 25% of adults in Japan have received at least first dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.10）：ワクチン接種比率、人口の25％を超える</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: First Patient Dosed with Influenza Vaccine—Combination Strategy with COVID-19 Booster and RSV to Follow</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Initiates Phase I/II Study of Seasonal Flu Vaccine mRNA-1010</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: July 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / AL.N / ALK.N / AXP.N / BA.N / BAC.N / BDX.N / C.N / CL.N / COF.N / CRM.N / CVS.N / DAL.N / ECL.N / EIX.N / EOG.N / F.N / GPS.N / IBM.N / JPM.N / KO.N / LLY.N / LUV.N / MO.N / OXY.N / PFE.N / PM.N / SC.N / SEE.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / CPB.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / DE.N / CAT.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / BLL.N / VZ.N / NYT.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / NEU.N / EFX.N / EQT.N / V.N / ACN.N / WSM.N / ESI.N / HAE.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / FISV.OQ / HOLX.OQ / HBAN.OQ / LRCX.OQ / MSFT.OQ / ROL.N / THO.N / ALKS.OQ / QDEL.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / COST.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / CSGP.OQ / ERIE.OQ / NVDA.OQ / FFIV.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / GPN.N / VRTX.OQ / JBLU.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / TFC.N / SBNY.OQ / ACAD.OQ / CG.TO / DPZ.N / MKTX.OQ / LVS.N / DISCA.OQ / MS.N / STX.AX / RPRX.OQ / HES.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / LOPE.OQ / MSCI.N / VRSK.OQ / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / APO.N / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / ADT.N / FANG.OQ / BFAM.N / RNG.N / COMM.OQ / MAR.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / BWXT.K / PEN.N / NVCR.OQ / TMUS.OQ / IONS.OQ / IAC.OQ / NTNX.OQ / RETA.OQ / COUP.OQ / AYX.N / DXC.N / IOVA.OQ / WDAY.OQ / ROKU.OQ / SWCH.N / IQV.N / BKNG.OQ / FB.PS / UAL.OQ / STNE.OQ / FSLY.N / CRWD.OQ / PTON.OQ / NLOK.OQ / RTX.N / AMWL.N / VTRS.OQ / PLTK.OQ</td><td class="leftalignment">Abbott Laboratories / Air Lease Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Becton Dickinson and Co / Citigroup Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Southwest Airlines Co / Altria Group Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Sealed Air Corp / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / New York Times Co / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / NewMarket Corp / Equifax Inc / EQT Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Element Solutions Inc / Haemonetics Corp / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Fiserv Inc / Hologic Inc / Huntington Bancshares Inc / Lam Research Corp / Microsoft Corp / Rollins Inc / Thor Industries Inc / Alkermes Plc / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Costco Wholesale Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / CoStar Group Inc / Erie Indemnity Co / NVIDIA Corp / F5 Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Grand Canyon Education Inc / MSCI Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Apollo Global Management Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / ADT Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / RingCentral Inc / CommScope Holding Company Inc / Marriott International Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / BWX Technologies Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Nutanix Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Alteryx Inc / DXC Technology Co / Iovance Biotherapeutics Inc / Workday Inc / Roku Inc / Switch Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / StoneCo Ltd / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / American Well Corp / Viatris Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Luxembourg / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 pandemic overview: July 2021 update</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">4507.T / JNJ.N / PFE.N / AZN.L / SASY.PA / MRCG.DE / LONN.S / GSK.L / NVAX.OQ / INO.OQ / MRNA.OQ / 1099.HK / CVAC.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / Sinopharm Group Co Ltd / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Switzerland / Chile / China / Germany / France / United Kingdom / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ABT / ACN / AMAT.O / AMT / ARW / CCI / CP / DLR / DY / GPS / INTC.O / KLAC.O / LB / LRCX.O / NSC / T / TPR / USM / XLNX.O / ASND.O / ASML.O / IRM / AAPL.O / CSCO.O / NVDA.O / SBAC.O / CONE.O / SGMO.O / AMD.O / VZ / NTAP.O / CTSH.O / MU.O / HPQ / HPE / AVGO.O / BLUE.O / MKSI.O / EQIX.O / MANT.O / DXCM.O / STX.O / CNSL.O / CCOI.O / CVLT.O / SAIC.N / MRNA.O / ZIOP.O / CACI.N / JNPR.K / BAH.N / SLM.O / EPAM.K / WDC.O / MEIP.O / FOXA.O / LDOS.N / FATE.O / QURE.O / ANET.K / CYAD.O / PSTG.K / TMUS.O / VYGR.O / ADAP.O / EDIT.O / NTLA.O / NTNX.O / CRSP.O / UNIT.O / CLLS.O / ZYME.K / IOVA.O / SWCH.K / AVT.O / AUTL.O / STRO.O / CPRI.K / DELL.K / TPTX.O / PGEN.O / BEAM.O / OM.O / LUMN.K / GRCL.O / 87975H100 / DBRG.N / TASK.O</td><td class="leftalignment">Abbott Laboratories / Accenture PLC / Applied Materials Inc / American Tower Corp / Arrow Electronics Inc / Crown Castle International Corp / Canadian Pacific Railway Ltd / Digital Realty Trust Inc / Dycom Industries Inc / Gap Inc / Intel Corp / KLA Corp / Bath & Body Works Inc / Lam Research Corp / Norfolk Southern Corp / AT&T Inc / Tapestry Inc / United States Cellular Corp / Xilinx Inc / Ascendis Pharma A/S / ASML Holding NV / Iron Mountain Inc / Apple Inc / Cisco Systems Inc / NVIDIA Corp / SBA Communications Corp / CyrusOne Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / Verizon Communications Inc / NetApp Inc / Cognizant Technology Solutions Corp / Micron Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / bluebird bio Inc / MKS Instruments Inc / Equinix Inc / ManTech International Corp / Dexcom Inc / Seagate Technology Holdings PLC / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Commvault Systems Inc / Science Applications International Corp / Moderna Inc / ZIOPHARM Oncology Inc / CACI International Inc / Juniper Networks Inc / Booz Allen Hamilton Holding Corp / SLM Corp / Epam Systems Inc / Western Digital Corp / MEI Pharma Inc / Fox Corp / Leidos Holdings Inc / Fate Therapeutics Inc / Uniqure NV / Arista Networks Inc / Celyad Oncology SA / Pure Storage Inc / T-Mobile US Inc / Voyager Therapeutics Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / CRISPR Therapeutics AG / Uniti Group Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Switch Inc / Avnet Inc / Autolus Therapeutics PLC / Sutro Biopharma Inc / Capri Holdings Ltd / Dell Technologies Inc / Turning Point Therapeutics Inc / Precigen Inc / Beam Therapeutics Inc / Outset Medical Inc / Lumen Technologies Inc / Gracell Biotechnologies Inc / Telus International Cda Inc / DigitalBridge Group Inc / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Additional Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ACA / ALB.N / BOX.N / BSX / CCI.N / CI / CNC / CRM.N / CSL / EL.N / INTC.O / KKR / MDT / MS / MSFT.O / NOW / QCOM.O / ROP / TEL / UNH / W / YUM / ZEN / TME / 4716.T / AMZN.O / AAPL.O / NVDA.O / ADBE.O / CTXS.O / SAPG.DE / RMD.N / MPWR.O / SBUX.O / INSP.N / ADSK.O / EW.N / NET.N / AVGO.O / ATVI.OQ / IART.OQ / TTWO.OQ / ISRG.OQ / MRVL.OQ / TXN.OQ / MGRC.O / TEAM.O / ITRI.O / PCTY.O / LPSN.O / 478160104 / AYX / 0700.HK / DPZ / OLED.O / NDAQ.O / ATRC.OQ / BIDU.O / XPO / CSIQ.O / LULU.O / ULTA.O / MRNA.O / TMDX.OQ / JACK.O / CSII.O / NXPI.O / ADI.OQ / FB.O / CG.O / PANW.K / 848637104 / GOOGL.O / PAYC.K / QRVO.O / SHOP.K / SPGI.K / BABA.K / TTD.OQ / FLGT.OQ / APL.PS / COUP.O / TWLO.K / SNAP.K / OKTA.O / WDAY.O / ROKU.O / TXMD.O / MDB.O / APTV.K / EGHT.K / ZS.OQ / IQ.O / DOCU.O / SMAR.K / FOCS.OQ / ESTC.N / CRSP.BN / FTDR.O / SWAV.O / ZM.OQ / UBER.K / CRWD.O / DDOG.O / TCOM.O / VG.O / BILL.K / DKNG.O / BLCT.OQ / GRWG.O / FROG.O / 30260D103</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Box Inc / Boston Scientific Corp / Crown Castle International Corp / Cigna Corp / Centene Corp / Salesforce.Com Inc / Carlisle Companies Inc / Estee Lauder Companies Inc / Intel Corp / KKR & Co Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / ServiceNow Inc / Qualcomm Inc / Roper Technologies Inc / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Yum! Brands Inc / Zendesk Inc / Tencent Music Entertainment Group / Oracle Corp Japan / Amazon.com Inc / Apple Inc / NVIDIA Corp / Adobe Inc / Citrix Systems Inc / SAP SE / Resmed Inc / Monolithic Power Systems Inc / Starbucks Corp / Inspire Medical Systems Inc / Autodesk Inc / Edwards Lifesciences Corp / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Intuitive Surgical Inc / Marvell Technology Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / Itron Inc / Paylocity Holding Corp / LivePerson Inc / Johnson & Johnson / Alteryx Inc / Tencent Holdings Ltd / Domino's Pizza Inc / Universal Display Corp / Nasdaq Inc / AtriCure Inc / Baidu Inc / XPO Logistics Inc / Canadian Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Moderna Inc / Transmedics Group Inc / Jack in the Box Inc / Cardiovascular Systems Inc / NXP Semiconductors NV / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Palo Alto Networks Inc / Splunk Inc / Alphabet Inc / Paycom Software Inc / Qorvo Inc / Shopify Inc / S&P Global Inc / Alibaba Group Holding Ltd / Trade Desk Inc / Fulgent Genetics Inc / Apollo Global Capital Inc / Coupa Software Inc / Twilio Inc / Snap Inc / Okta Inc / Workday Inc / Roku Inc / TherapeuticsMD Inc / MongoDB Inc / Aptiv PLC / 8x8 Inc / Zscaler Inc / iQIYI Inc / DocuSign Inc / Smartsheet Inc / Focus Financial Partners Inc / Elastic NV / CRISPR Therapeutics AG / Frontdoor Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Datadog Inc / Trip.com Group Ltd / Vonage Holdings Corp / Bill.com Holdings Inc / DraftKings Inc / BlueCity Holdings Ltd / GrowGeneration Corp / Jfrog Ltd / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Japan / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ACA / ALB.N / BOX.N / BSX / CCI.N / CI / CNC / CRM.N / CSL / EL.N / INTC.O / KKR / MDT / MS / MSFT.O / NOW / QCOM.O / ROP / TEL / UNH / W / YUM / ZEN / TME / 4716.T / AMZN.O / AAPL.O / NVDA.O / ADBE.O / CTXS.O / SAPG.DE / RMD.N / MPWR.O / SBUX.O / INSP.N / ADSK.O / EW.N / NET.N / AVGO.O / ATVI.OQ / IART.OQ / TTWO.OQ / ISRG.OQ / MRVL.OQ / TXN.OQ / MGRC.O / TEAM.O / ITRI.O / PCTY.O / LPSN.O / 478160104 / AYX / 0700.HK / DPZ / OLED.O / NDAQ.O / ATRC.OQ / BIDU.O / XPO / CSIQ.O / LULU.O / ULTA.O / MRNA.O / TMDX.OQ / JACK.O / CSII.O / NXPI.O / ADI.OQ / FB.O / CG.O / PANW.K / 848637104 / GOOGL.O / PAYC.K / QRVO.O / SHOP.K / SPGI.K / BABA.K / TTD.OQ / FLGT.OQ / APL.PS / COUP.O / TWLO.K / SNAP.K / OKTA.O / WDAY.O / ROKU.O / TXMD.O / MDB.O / APTV.K / EGHT.K / ZS.OQ / IQ.O / DOCU.O / SMAR.K / FOCS.OQ / ESTC.N / CRSP.BN / FTDR.O / SWAV.O / ZM.OQ / UBER.K / CRWD.O / DDOG.O / TCOM.O / VG.O / BILL.K / DKNG.O / BLCT.OQ / GRWG.O / FROG.O / MSGE.K / 30260D103</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Box Inc / Boston Scientific Corp / Crown Castle International Corp / Cigna Corp / Centene Corp / Salesforce.Com Inc / Carlisle Companies Inc / Estee Lauder Companies Inc / Intel Corp / KKR & Co Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / ServiceNow Inc / Qualcomm Inc / Roper Technologies Inc / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Yum! Brands Inc / Zendesk Inc / Tencent Music Entertainment Group / Oracle Corp Japan / Amazon.com Inc / Apple Inc / NVIDIA Corp / Adobe Inc / Citrix Systems Inc / SAP SE / Resmed Inc / Monolithic Power Systems Inc / Starbucks Corp / Inspire Medical Systems Inc / Autodesk Inc / Edwards Lifesciences Corp / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Intuitive Surgical Inc / Marvell Technology Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / Itron Inc / Paylocity Holding Corp / LivePerson Inc / Johnson & Johnson / Alteryx Inc / Tencent Holdings Ltd / Domino's Pizza Inc / Universal Display Corp / Nasdaq Inc / AtriCure Inc / Baidu Inc / XPO Logistics Inc / Canadian Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Moderna Inc / Transmedics Group Inc / Jack in the Box Inc / Cardiovascular Systems Inc / NXP Semiconductors NV / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Palo Alto Networks Inc / Splunk Inc / Alphabet Inc / Paycom Software Inc / Qorvo Inc / Shopify Inc / S&P Global Inc / Alibaba Group Holding Ltd / Trade Desk Inc / Fulgent Genetics Inc / Apollo Global Capital Inc / Coupa Software Inc / Twilio Inc / Snap Inc / Okta Inc / Workday Inc / Roku Inc / TherapeuticsMD Inc / MongoDB Inc / Aptiv PLC / 8x8 Inc / Zscaler Inc / iQIYI Inc / DocuSign Inc / Smartsheet Inc / Focus Financial Partners Inc / Elastic NV / CRISPR Therapeutics AG / Frontdoor Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Datadog Inc / Trip.com Group Ltd / Vonage Holdings Corp / Bill.com Holdings Inc / DraftKings Inc / BlueCity Holdings Ltd / GrowGeneration Corp / Jfrog Ltd / Madison Square Garden Entertainment Corp / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Japan / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / ACN / AEP.N / AGR / AMAT.O / AMT / ARW / CCI / DLR / DY / GPS / INTC.O / KLAC.O / LB / LRCX.O / STZ / T / TAP.N / TPR / USM / WEC / XLNX.O / ASML.O / IRM / AAPL.O / CSCO.O / NVDA.O / SBAC.O / CONE.O / SGMO.O / AMD.O / VZ / NTAP.O / CTSH.O / MU.O / HPQ / HPE / AVGO.O / BLUE.O / MKSI.O / EQIX.O / MANT.O / DXCM.O / STX.O / CNSL.O / CCOI.O / CVLT.O / SAIC.N / MRNA.O / ZIOP.O / CACI.N / JNPR.K / BAH.N / SLM.O / EPAM.K / WDC.O / MEIP.O / LDOS.N / FATE.O / QURE.O / ANET.K / CYAD.O / PSTG.K / TMUS.O / VYGR.O / ADAP.O / EDIT.O / NTLA.O / NTNX.O / CRSP.O / UNIT.O / CLLS.O / ZYME.K / IOVA.O / SWCH.K / AVT.O / AUTL.O / STRO.O / LNT.O / CPRI.K / DELL.K / TPTX.O / PGEN.O / BEAM.O / LUMN.K / GRCL.O / 87975H100 / DBRG.N / TASK.O</td><td class="leftalignment">Abbott Laboratories / Accenture PLC / American Electric Power Company Inc / Avangrid Inc / Applied Materials Inc / American Tower Corp / Arrow Electronics Inc / Crown Castle International Corp / Digital Realty Trust Inc / Dycom Industries Inc / Gap Inc / Intel Corp / KLA Corp / Bath & Body Works Inc / Lam Research Corp / Constellation Brands Inc / AT&T Inc / Molson Coors Beverage Co / Tapestry Inc / United States Cellular Corp / WEC Energy Group Inc / Xilinx Inc / ASML Holding NV / Iron Mountain Inc / Apple Inc / Cisco Systems Inc / NVIDIA Corp / SBA Communications Corp / CyrusOne Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / Verizon Communications Inc / NetApp Inc / Cognizant Technology Solutions Corp / Micron Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / bluebird bio Inc / MKS Instruments Inc / Equinix Inc / ManTech International Corp / Dexcom Inc / Seagate Technology Holdings PLC / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Commvault Systems Inc / Science Applications International Corp / Moderna Inc / ZIOPHARM Oncology Inc / CACI International Inc / Juniper Networks Inc / Booz Allen Hamilton Holding Corp / SLM Corp / Epam Systems Inc / Western Digital Corp / MEI Pharma Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Uniqure NV / Arista Networks Inc / Celyad Oncology SA / Pure Storage Inc / T-Mobile US Inc / Voyager Therapeutics Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / CRISPR Therapeutics AG / Uniti Group Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Switch Inc / Avnet Inc / Autolus Therapeutics PLC / Sutro Biopharma Inc / Alliant Energy Corp / Capri Holdings Ltd / Dell Technologies Inc / Turning Point Therapeutics Inc / Precigen Inc / Beam Therapeutics Inc / Lumen Technologies Inc / Gracell Biotechnologies Inc / Telus International Cda Inc / DigitalBridge Group Inc / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">June Clinical Trial Tracker—Focus on Oncology</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O / MEIP.O / FATE.O / CYAD.O / CLLS.O / ZYME.K / AUTL.O / STRO.O / TPTX.O / PGEN.O / GRCL.O</td><td class="leftalignment">Moderna Inc / MEI Pharma Inc / Fate Therapeutics Inc / Celyad Oncology SA / Cellectis SA / Zymeworks Inc / Autolus Therapeutics PLC / Sutro Biopharma Inc / Turning Point Therapeutics Inc / Precigen Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / China / Cayman Islands / France / United Kingdom / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippine Market Strategy - Finding Alpha: Vaccines and mobility</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MEG.PS / PFE.N / SMPH.PS / AZN.L / MRNA.OQ / SVA.OQ</td><td class="leftalignment">Megaworld Corp / Pfizer Inc / SM Prime Holdings Inc / AstraZeneca PLC / Moderna Inc / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Hazel Tanedo</td></tr>
<tr class="even"><td class="leftalignment">07/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SIGHT in both eyes; ARWR pause in CF</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Dollar Stability Limiting Runaway Inflation</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACA / ALB.N / CCI.N / CI / CNC / CSL / EL.N / KKR / MDT / MS / ROP / TEL / UNH / W / YUM / AMZN.O / AAPL.O / NVDA.O / MPWR.O / SBUX.O / ADSK.O / NET.N / AVGO.O / ATVI.OQ / IART.OQ / TTWO.OQ / MRVL.OQ / TXN.OQ / MGRC.O / TEAM.O / ITRI.O / 0700.HK / DPZ / OLED.O / NDAQ.O / BIDU.O / XPO / CSIQ.O / LULU.O / ULTA.O / MRNA.O / NXPI.O / ADI.OQ / FB.O / CG.O / PANW.K / QRVO.O / SPGI.K / FLGT.OQ / APL.PS / SNAP.K / WDAY.O / ROKU.O / MDB.O / APTV.K / FOCS.OQ / ESTC.N / CRSP.BN / FTDR.O / UBER.K / CRWD.O / VG.O / DKNG.O / GRWG.O</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Crown Castle International Corp / Cigna Corp / Centene Corp / Carlisle Companies Inc / Estee Lauder Companies Inc / KKR & Co Inc / Medtronic PLC / Morgan Stanley / Roper Technologies Inc / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Yum! Brands Inc / Amazon.com Inc / Apple Inc / NVIDIA Corp / Monolithic Power Systems Inc / Starbucks Corp / Autodesk Inc / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Marvell Technology Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / Itron Inc / Tencent Holdings Ltd / Domino's Pizza Inc / Universal Display Corp / Nasdaq Inc / Baidu Inc / XPO Logistics Inc / Canadian Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Moderna Inc / NXP Semiconductors NV / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Palo Alto Networks Inc / Qorvo Inc / S&P Global Inc / Fulgent Genetics Inc / Apollo Global Capital Inc / Snap Inc / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Focus Financial Partners Inc / Elastic NV / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Vonage Holdings Corp / DraftKings Inc / GrowGeneration Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 02 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BSX / MDT / SGE.L / GILD.O / EXEL.OQ / ISRG.OQ / VRTX.OQ / LIFE.O / AMED.O / BIIB.O / 478160104 / ALNY.OQ / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / 02043Q107 / SPRO.OQ / MRNA.O / 771195104 / CSII.O / GLAXOSM.LG / FATE.OQ / MDWD.O / 02005N100 / INO.O / NVRO.N / VCEL.O / MCRB.OQ / NVCR.OQ / APLS.OQ / NVTA.K / NTLA.O / IRTC.OQ / IOVA.OQ / ACHV.O / BNGO.OQ / ORTX.OQ / CRSP.BN / SWAV.O / IDYA.OQ / KRTX.OQ / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Boston Scientific Corp / Medtronic PLC / Sage Group PLC / Gilead Sciences Inc / Exelixis Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Alnylam Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Spero Therapeutics Inc / Moderna Inc / Roche Holding AG / Cardiovascular Systems Inc / Glaxo Smithkline Consumer Nigeria PLC / Fate Therapeutics Inc / Mediwound Ltd / Ally Financial Inc / Inovio Pharmaceuticals Inc / Nevro Corp / Vericel Corp / Seres Therapeutics Inc / Novocure Ltd / Apellis Pharmaceuticals Inc / Invitae Corp / Intellia Therapeutics Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Achieve Life Sciences Inc / Bionano Genomics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / IDEAYA Biosciences Inc / Karuna Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / Nigeria / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Jul 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 005930.KS / 006280.KS / MRNA.OQ / 068270.KS / 086900.KQ / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Samsung Electronics Co Ltd / Green Cross Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Lots to Write Home About – 2H21 Shaping Up as a Catalyst Rich Period</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 881624209 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G30401106 / 023111206 / G50871105 / 45773H201 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 805111101 / 98401F105 / 23284F105 / 03168L105 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 87166L100 / 088786108 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02083G100 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 74366E102 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 75382E109 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 50107A104 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Endo International PLC / Amarin Corporation PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Savara Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Synlogic Inc / Bicycle Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Alpine Immune Sciences Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Rapt Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Kronos Bio Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Really Committed: €400M/Yr for mRNA Flu, COVID, Maybe RSV; Cautious COVID View</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">F5548N10 / 71708110 / 58933Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Merck & Co Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CADI.BO: Cadila Healthcare - Quick Take - Covid-19 vaccine interim Ph 3 data - comparable to Covishield but lower than Covaxin</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CADI.BO / JNJ.N / PFIZ.BO / MRNA.OQ</td><td class="leftalignment">Cadila Healthcare Ltd / Johnson & Johnson / Pfizer Ltd / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">India / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">Long-term Investment Strategy Uses Short Selling to Augment Holdings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / GME.N / AAPL.OQ / MSFT.OQ / AMZN.OQ / NVDA.OQ / NFLX.OQ / GOOG.OQ / MRNA.OQ / AMD.OQ / FB.OQ / AMC.N</td><td class="leftalignment">Pfizer Inc / GameStop Corp / Apple Inc / Microsoft Corp / Amazon.com Inc / NVIDIA Corp / Netflix Inc / Alphabet Inc / Moderna Inc / Advanced Micro Devices Inc / Meta Platforms Inc / AMC Entertainment Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Moderna in top 1% performers of NASDAQ market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna soars 98% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CLH / ENS / FDS / INTC.O / MSFT.O / ROP / AMZN.O / HEAR.O / SMTC.O / ATVI.OQ / XLNX.OQ / TTWO.OQ / EXPE.OQ / VRTX.OQ / NFLX.O / ACAD.O / 36467W109 / MRNA.O / JACK.O / NXPI.O / AMD.OQ / ZNGA.O / TRIP.O / EA.O / VTNR.O / 848637104 / 82655M107 / MDWD.O / 02005N100 / VCEL.O / BABA.K / IOVA.OQ / ACHV.O / STM.BN / BKNG.O / BILI.O / CRSP.BN / UBER.K / KRTX.OQ / HUYA.K</td><td class="leftalignment">Clean Harbors Inc / EnerSys / Factset Research Systems Inc / Intel Corp / Microsoft Corp / Roper Technologies Inc / Amazon.com Inc / Turtle Beach Corp / Semtech Corp / Activision Blizzard Inc / Xilinx Inc / Take-Two Interactive Software Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / Netflix Inc / ACADIA Pharmaceuticals Inc / GameStop Corp / Moderna Inc / Jack in the Box Inc / NXP Semiconductors NV / Advanced Micro Devices Inc / Zynga Inc / Tripadvisor Inc / Electronic Arts Inc / Vertex Energy Inc / Splunk Inc / Sify Technologies Ltd / Mediwound Ltd / Ally Financial Inc / Vericel Corp / Alibaba Group Holding Ltd / Iovance Biotherapeutics Inc / Achieve Life Sciences Inc / STMicroelectronics NV / Booking Holdings Inc / Bilibili Inc / CRISPR Therapeutics AG / Uber Technologies Inc / Karuna Therapeutics Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / India / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Moderna, Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US60770K1079</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback from Meetings with VRTX & MRNA Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">VRTX.OQ / MRNA.O / CRSP.BN</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Moderna Inc / CRISPR Therapeutics AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna climbs 17.2% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BAC / INTC.O / MS / PNC / WCC / AMD.O / MRNA.O / FOXA.O / UNVR.K / PFGC.K / IOVA.O / KDP.N / UBER.K / DASH.N</td><td class="leftalignment">Bank of America Corp / Intel Corp / Morgan Stanley / PNC Financial Services Group Inc / Wesco International Inc / Advanced Micro Devices Inc / Moderna Inc / Fox Corp / Univar Solutions Inc / Performance Food Group Co / Iovance Biotherapeutics Inc / Keurig Dr Pepper Inc / Uber Technologies Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: COVID-19 Vaccine Demonstrates Activity against Key Variants of Concern Albeit Reduced Relative to Ancestral Strain</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">mRNA-1273 EUA in India; Retains Activity Against Delta Variant</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: NTLA publishes landmark CRISPR data in NEJM</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">CRSP.BN / NTLA.OQ / EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">CRISPR Therapeutics AG / Intellia Therapeutics Inc / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Green Cross Corp: New report: Market not giving credits on the vaccine CMO initiative; upgrade on CMO prospects in FY22E and beyond. Upgrade to OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">006280.KS / MRNA.OQ / 207940.KS</td><td class="leftalignment">Green Cross Corp / Moderna Inc / Samsung Biologics Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - Market not giving credits on the vaccine CMO initiative; upgrade on CMO prospects in FY22E and beyond</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">006280.KS / JNJ.N / PFE.N / AZN.L / NVAX.OQ / EBS.N / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Emergent BioSolutions Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Moderna, Inc. (MRNA) - INITIATING COVERAGE - COVID-19 vaccine leading the performance</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report,  MRNA</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ACIP Report on Rare Myocarditis in Young People Sending MRNA Shares Lower</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : Highlights from Our Management Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CBER Director Concerned Slowing Vaccination Rate Could Re-start COVID Fire</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 09075V10 / 60770K10 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">EU Orders Another 150M COVID Vaccine Doses for Delivery in 2022</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: DHR to buy Aldevron; CVAC C19 vaccine misses</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 6.18.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 00282410 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 58949210 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710 / 00288U10 / 90184D10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Abbott Laboratories / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc / Abcellera Biologics Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">U.S. Government Orders Another 200 Million COVID Vaccine Doses</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 9.4% Including COVID-19 Vaccine Volume Benefit</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CAH.N / JNJ.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MCK: Quick Thoughts on the U.S. Purchase of Incremental COVID Vaccine Doses from Moderna</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.OQ / MCK.N / PFE.N</td><td class="leftalignment">Moderna Inc / Mckesson Corp / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AJG / AON / COO / DRI / GPS / IP / KR / LB / MMC / RL / TPR / VFC / WRK / BRO / CREE.O / MRNA.O / NXPI.O / AMBA.O / FIVN.O / WLTW.O / CPRI.K / BRP.O / ZI.O / ALGM.O</td><td class="leftalignment">Arthur J Gallagher & Co / Aon PLC / Cooper Companies Inc / Darden Restaurants Inc / Gap Inc / International Paper Co / Kroger Co / Bath & Body Works Inc / Marsh & McLennan Companies Inc / Ralph Lauren Corp / Tapestry Inc / VF Corp / Westrock Co / Brown & Brown Inc / Wolfspeed Inc / Moderna Inc / NXP Semiconductors NV / Ambarella Inc / Five9 Inc / Willis Towers Watson PLC / Capri Holdings Ltd / BRP Group Inc / ZoomInfo Technologies Inc / Allegro Microsystems Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Encouraging Novavax Phase 3 Data, Does Not Pose Significant Threat to Moderna in US/EU Markets</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BAC / CMG / COO / CP / DK / HFC / JNJ / JPM / MPC / NSC / OLN / PNC / PSX / STT / STZ / TFC / TOL / USB / VLO / WLK / PBF / CONE.O / SGMO.O / BLUE.O / MRNA.O / ZIOP.O / ARCT.O / FATE.O / AFMD.O / CYAD.O / ADAP.O / EDIT.O / NTLA.O / CRSP.O / CLLS.O / SWCH.K / AUTL.O / RAPT.O / PGEN.O / BEAM.O / GRCL.O</td><td class="leftalignment">Bank of America Corp / Chipotle Mexican Grill Inc / Cooper Companies Inc / Canadian Pacific Railway Ltd / Delek US Holdings Inc / HollyFrontier Corp / Johnson & Johnson / JPMorgan Chase & Co / Marathon Petroleum Corp / Norfolk Southern Corp / Olin Corp / PNC Financial Services Group Inc / Phillips 66 / State Street Corp / Constellation Brands Inc / Truist Financial Corp / Toll Brothers Inc / US Bancorp / Valero Energy Corp / Westlake Chemical Corp / PBF Energy Inc / CyrusOne Inc / Sangamo Therapeutics Inc / bluebird bio Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / Fate Therapeutics Inc / Affimed NV / Celyad Oncology SA / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Cellectis SA / Switch Inc / Autolus Therapeutics PLC / Rapt Therapeutics Inc / Precigen Inc / Beam Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Three's Company - NVAX a Serious Contender to mRNA in the COVID Booster Market</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Daina Graybosch, Ph.D. / Mr. Rick Bienkowski, Ph.D. / Dilip Joseph</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / AMT / BE / BSX / CAT / CCI.N / CI / CLH / CMG / CMI / COST.O / CRM.N / DAN / DE / DHI / DLR / ECL.N / EL.N / ENS / FDX / GS / INTC.O / JCI / JPM / K / KKR / LRCX.O / MDT / MS / MSFT.O / NEP / NOW / O / ORA / ROP / RSG / T.N / UNH / URI / WM / ZEN / 4716.T / AMZN.O / EBAY.O / GILD.O / AAPL.O / FIS / BWA.N / NVDA.O / ADBE.O / DTE.N / SAPG.DE / SQ / NOVN.S / SBAC.O / HRB.N / ADSK.O / EW.N / ARE.N / DLTR.O / IO.N / CSGP.O / FCEL.O / ALGN.O / BLK.N / CREE.O / NET.N / AVGO.O / JBHT.OQ / ATVI.OQ / XLNX.OQ / AMSC.OQ / BMRN.OQ / AKAM.OQ / PLUG.OQ / ISRG.OQ / VRTX.OQ / SWKS.OQ / TEAM.O / SIVB.O / TRMB.O / EGAN.O / ITRI.O / PCTY.O / ANSS.O / LPSN.O / EQIX.O / NFLX.O / 92343V104 / 459200101 / ALNY.OQ / 0700.HK / DPZ / ATRC.OQ / SPWR.O / CSIQ.O / FSLR.O / IPGP.O / 02043Q107 / MRNA.O / TMDX.OQ / TWIN.O / CSII.O / AGCO.K / GLAXOSM.LG / TSLA.O / AMRC.K / AMRS.OQ / QSR.TO / ENPH.O / FB.O / CG.O / HASI.N / AGIO.OQ / RNG.N / FATE.OQ / WIX.O / GOOGL.O / PAYC.K / SABR.O / ARES.K / APS.TO / HUBS.K / SHOP.K / SEDG.O / RUN.O / TMUS.OQ / WKHS.O / WCN.TO / AQMS.O / BABA.K / 34959J108 / TTD.OQ / APL.PS / COUP.O / WPRT.TO / TWLO.K / UAA / HLNE.OQ / WDAY.O / APTV.K / EGHT.K / DOCU.O / CWENa.K / CRSP.BN / SWAV.O / XFOR.OQ / UBER.K / A71.F / NLOK.O / BILL.K / AVNT.K / 02081G201 / FMTX.O / RWRh.V / STEP.O / 03823M100</td><td class="leftalignment">Albemarle Corp / American Tower Corp / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Crown Castle International Corp / Cigna Corp / Clean Harbors Inc / Chipotle Mexican Grill Inc / Cummins Inc / Costco Wholesale Corp / Salesforce.Com Inc / Dana Inc / Deere & Co / D R Horton Inc / Digital Realty Trust Inc / Ecolab Inc / Estee Lauder Companies Inc / EnerSys / FedEx Corp / Goldman Sachs Group Inc / Intel Corp / Johnson Controls International PLC / JPMorgan Chase & Co / Kellogg Co / KKR & Co Inc / Lam Research Corp / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / ServiceNow Inc / Realty Income Corp / Ormat Technologies Inc / Roper Technologies Inc / Republic Services Inc / AT&T Inc / UnitedHealth Group Inc / United Rentals Inc / Waste Management Inc / Zendesk Inc / Oracle Corp Japan / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Apple Inc / Fidelity National Information Services Inc / Borgwarner Inc / NVIDIA Corp / Adobe Inc / DTE Energy Co / SAP SE / Block Inc / Novartis AG / SBA Communications Corp / H & R Block Inc / Autodesk Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Dollar Tree Inc / ION Geophysical Corp / CoStar Group Inc / Fuelcell Energy Inc / Align Technology Inc / BlackRock Inc / Wolfspeed Inc / Cloudflare Inc / Broadcom Inc / J B Hunt Transport Services Inc / Activision Blizzard Inc / Xilinx Inc / American Superconductor Corp / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Plug Power Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / Skyworks Solutions Inc / Atlassian Corporation PLC / SVB Financial Group / Trimble Inc / eGain Corp / Itron Inc / Paylocity Holding Corp / ANSYS Inc / LivePerson Inc / Equinix Inc / Netflix Inc / Verizon Communications Inc / International Business Machines Corp / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Domino's Pizza Inc / AtriCure Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / IPG Photonics Corp / Alnylam Pharmaceuticals Inc / Moderna Inc / Transmedics Group Inc / Twin Disc Inc / Cardiovascular Systems Inc / AGCO Corp / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Ameresco Inc / Amyris Inc / Restaurant Brands International Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Agios Pharmaceuticals Inc / RingCentral Inc / Fate Therapeutics Inc / Wix.Com Ltd / Alphabet Inc / Paycom Software Inc / Sabre Corp / Ares Management Corp / Aptose Biosciences Inc / HubSpot Inc / Shopify Inc / Solaredge Technologies Inc / Sunrun Inc / T-Mobile US Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Alibaba Group Holding Ltd / Fortive Corp / Trade Desk Inc / Apollo Global Capital Inc / Coupa Software Inc / Westport Fuel Systems Inc / Twilio Inc / Under Armour Inc / Hamilton Lane Inc / Workday Inc / Aptiv PLC / 8x8 Inc / DocuSign Inc / Clearway Energy Inc / CRISPR Therapeutics AG / Shockwave Medical Inc / X4 Pharmaceuticals Inc / Uber Technologies Inc / Ascendis Pharma A/S / NortonLifeLock Inc / Bill.com Holdings Inc / Avient Corp / Alphatec Holdings Inc / Forma Therapeutics Holdings Inc / Strathmore Plus Energy Corp / StepStone Group Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Japan / Nigeria / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">To RSV or Not to RSV? Prevention Could Generate $10bn in Vaccine Sales 2030</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / 60770K10</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Cell and Gene Therapy Newsletter Companion</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP.O / CLLS.O / SGMO.O / BLUE.O / MRNA.O / ZIOP.O / ARCT.O / FATE.O / AFMD.O / CYAD.O / EDIT.O / NTLA.O / CRSP.O / AUTL.O / PGEN.O / BEAM.O / GRCL.O</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Cellectis SA / Sangamo Therapeutics Inc / bluebird bio Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / Fate Therapeutics Inc / Affimed NV / Celyad Oncology SA / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Autolus Therapeutics PLC / Precigen Inc / Beam Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / France / United Kingdom / Croatia / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Nick M. Abbott / Mr. Yanan Zhu / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) NBSE platform data; BLUE resuming trials</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Growth Outpacing Safety While Yields Fall</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">AMT / CCI.N / CI / CMG / CMI / COST.O / DHI / DLR / ECL.N / EL.N / FDX / GS / INTC.O / JPM / KKR / LRCX.O / MS / MSFT.O / O / ROP / T.N / UNH / URI / AMZN.O / EBAY.O / GILD.O / AAPL.O / FIS / NVDA.O / DTE.N / SAPG.DE / SQ / NOVN.S / SBAC.O / HRB.N / EW.N / ARE.N / DLTR.O / CSGP.O / ALGN.O / NET.N / AVGO.O / ATVI.OQ / XLNX.OQ / BMRN.OQ / AKAM.OQ / ISRG.OQ / SWKS.OQ / SIVB.O / ANSS.O / EQIX.O / NFLX.O / 92343V104 / 459200101 / ALNY.OQ / 0700.HK / DPZ / IPGP.O / MRNA.O / GLAXOSM.LG / TSLA.O / QSR.TO / FB.O / FATE.OQ / GOOGL.O / TMUS.OQ / 34959J108 / UAA / UBER.K / NLOK.O / 03823M100</td><td class="leftalignment">American Tower Corp / Crown Castle International Corp / Cigna Corp / Chipotle Mexican Grill Inc / Cummins Inc / Costco Wholesale Corp / D R Horton Inc / Digital Realty Trust Inc / Ecolab Inc / Estee Lauder Companies Inc / FedEx Corp / Goldman Sachs Group Inc / Intel Corp / JPMorgan Chase & Co / KKR & Co Inc / Lam Research Corp / Morgan Stanley / Microsoft Corp / Realty Income Corp / Roper Technologies Inc / AT&T Inc / UnitedHealth Group Inc / United Rentals Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Apple Inc / Fidelity National Information Services Inc / NVIDIA Corp / DTE Energy Co / SAP SE / Block Inc / Novartis AG / SBA Communications Corp / H & R Block Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Dollar Tree Inc / CoStar Group Inc / Align Technology Inc / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / Xilinx Inc / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Intuitive Surgical Inc / Skyworks Solutions Inc / SVB Financial Group / ANSYS Inc / Equinix Inc / Netflix Inc / Verizon Communications Inc / International Business Machines Corp / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Domino's Pizza Inc / IPG Photonics Corp / Moderna Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Restaurant Brands International Inc / Meta Platforms Inc / Fate Therapeutics Inc / Alphabet Inc / T-Mobile US Inc / Fortive Corp / Under Armour Inc / Uber Technologies Inc / NortonLifeLock Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Nigeria / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Files for Expanded Use of COVID-19 Vaccine in Adolescents in the U.S. Unlocking Market of 60M+ Individuals</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Files for mRNA-1273 EUA in Teens; See Years of COVID Vaccine Revenues</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Samsung Biologics (207940.KS, Not Covered) - 2021 Asia Healthcare Corporate Day takeaways</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">207940.KS / LLY.N / GSK.L / BIIB.OQ / MRNA.OQ</td><td class="leftalignment">Samsung Biologics Co Ltd / Eli Lilly and Co / GlaxoSmithKline PLC / Biogen Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Jun. 09, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Moderna Inc (MRNA) - Financial Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">283</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ACN / AXP / CMG / CP / DRI / EEFT.O / FLT / IP / JNJ / MCD / NCR / NSC / PEN / YUM / ASND.O / PAYX.O / FIS / SQ / WEX / SGMO.O / SBUX.O / FISV.O / ARGX.O / GPN / JKHY.O / CTSH.O / ISRG.O / DXC / CAKE.O / BLUE.O / WU / QSR / MRNA.O / ADP.O / JACK.O / ZIOP.O / EPAM.K / PFSI.K / FATE.O / QURE.O / AGTC.O / AFMD.O / CDK.O / QTWO.K / SHOP.K / CYAD.O / PYPL.O / VYGR.O / ADAP.O / EDIT.O / NTLA.O / CRSP.O / CLLS.O / IOVA.O / CDLX.O / EVOP.O / AUTL.O / KZR.O / AXNX.O / RPAY.OQ / FTCH.K / RAPT.O / PGEN.O / BEAM.O / BILL.K / GRCL.O / 87975H100</td><td class="leftalignment">Accenture PLC / American Express Co / Chipotle Mexican Grill Inc / Canadian Pacific Railway Ltd / Darden Restaurants Inc / Euronet Worldwide Inc / Fleetcor Technologies Inc / International Paper Co / Johnson & Johnson / McDonald's Corp / NCR Corp / Norfolk Southern Corp / Penumbra Inc / Yum! Brands Inc / Ascendis Pharma A/S / Paychex Inc / Fidelity National Information Services Inc / Block Inc / WEX Inc / Sangamo Therapeutics Inc / Starbucks Corp / Fiserv Inc / argenx SE / Global Payments Inc / Jack Henry & Associates Inc / Cognizant Technology Solutions Corp / Intuitive Surgical Inc / DXC Technology Co / Cheesecake Factory Inc / bluebird bio Inc / Western Union Co / Restaurant Brands International Inc / Moderna Inc / Automatic Data Processing Inc / Jack in the Box Inc / ZIOPHARM Oncology Inc / Epam Systems Inc / PennyMac Financial Services Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Affimed NV / CDK Global Inc / Q2 Holdings Inc / Shopify Inc / Celyad Oncology SA / PayPal Holdings Inc / Voyager Therapeutics Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Cellectis SA / Iovance Biotherapeutics Inc / Cardlytics Inc / EVO Payments Inc / Autolus Therapeutics PLC / Kezar Life Sciences Inc / Axonics Inc / Repay Holdings Corp / Farfetch Ltd / Rapt Therapeutics Inc / Precigen Inc / Beam Therapeutics Inc / Bill.com Holdings Inc / Gracell Biotechnologies Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Jun. 07, 2021 / 2:45PM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Files for Teen COVID Vaccine Approval in EU & Canada, U.S. Soon; Target to $246</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Files for Expanded Use of COVID-19 Vaccine in Adolescents in the EU/Canada, Unlocking Market of 100M+ People</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Vital Signs - Charts of the Day: ATOM, MRVI, CELC, IDT, XPEL, HOFT, CELH, FAT, NVMI, CLFD, BTU, SD, TALO, TRGP, LEV, SKIN, CBNK, BAP, SMTI, NOTV, MRNA, TECH, VRAY, PAVM, PDSB, NESR, WFRD, HLX, CLB, NEXA, VHI, SUP, WLMS, TLYS, ZUMZ, ODP, OLO, PHR, CRNC, an</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">APP.OQ / SUP.N / SMTI.OQ / TECH.OQ / VHI.N / HOFT.OQ / LEV.AT / IDT.N / ZUMZ.OQ / HLX.N / CBNK.OQ / SD.N / CLFD.OQ / MRNA.OQ / PHR.N / CELH.OQ / NVMI.TA / TRGP.N / TLYS.N / ODP.OQ / VRAY.OQ / PAVM.OQ / ATOM.OQ / NESR.OQ / CELC.OQ / NEXA.N / TALO.N / PDSB.OQ / XPEL.OQ / CRNC.OQ / MRVI.OQ / WLMS.A / OLO.N / NOTV.OQ / SKIN.OQ / WFRD.OQ</td><td class="leftalignment">Applovin Corp / Superior Industries International Inc / Sanara Medtech Inc / Bio-Techne Corp / Valhi Inc / Hooker Furnishings Corp / N Leventeris SA / IDT Corp / Zumiez Inc / Helix Energy Solutions Group Inc / Capital Bancorp Inc / SandRidge Energy Inc / Clearfield Inc / Moderna Inc / Phreesia Inc / Celsius Holdings Inc / Nova Ltd / Targa Resources Corp / Tillys Inc / ODP Corp / ViewRay Inc / PAVmed Inc / Atomera Inc / National Energy Services Reunited Corp / Celcuity Inc / Nexa Resources SA / Talos Energy Inc / PDS Biotechnology Corp / Xpel Inc / Cerence Inc / Maravai LifeSciences Holdings Inc / Williams Industrial Services Group Inc / Olo Inc / Inotiv Inc / Beauty Health Co / Weatherford International PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Greece / Ireland / Israel / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: REPL results; LOGC & ALNY clinical progress</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">REPL.OQ / EBS / ISEE / ARCT / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / SIOX / N71542109 / 03820J100</td><td class="leftalignment">Replimune Group Inc / Emergent BioSolutions Inc / Iveric Bio Inc / Arcturus Therapeutics Holdings Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / GILD.O / AMGN.O / HCA.N / CYH.N / COO.N / ICPT.OQ / UTHR.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / DXCM.O / LHCG.O / ALCLS.PA / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / MRNA.O / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / PRTA.OQ / TRVN.O / GOOGL.O / INO.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / 100063846 / IRTC.OQ / ATXI.OQ / 720795103 / ALLO.OQ / 21833P103 / BWAY.TA / ONCT.OQ / PSNL.O / NBSE.O / BXRX.OQ / ETNB.O / ORIC.OQ / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Trevena Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / iRhythm Technologies Inc / Avenue Therapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Oncternal Therapeutics Inc / Personalis Inc / NeuBase Therapeutics Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Jun. 03, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT / AMAT.O / CHD / CL / CLX / EL / KLAC.O / KMB / KNX / KO / LRCX.O / OLN / PEG / PG / RMBS.O / SPB / STZ / TAP.N / WLK / ASML.O / JBHT.O / EPC / NVDA.O / HUBG.O / CONE.O / NTAP.O / SMTC.O / SNPS.O / ARCC.O / MU.O / AGL.N / MNST.O / REAL.O / AINV.O / NUVA.O / FSK / DXCM.O / CDNS.O / TDG.N / XPO / BKCC.O / NOG.A / MRNA.O / ZIOP.O / SLRC.O / GBDC.O / LUNG.O / NMFC.N / GWRE.K / HTGC.K / TCPC.O / COTY.K / FATE.O / AFMD.O / CYAD.O / ADAP.O / GSBD.K / CLLS.O / CGBD.O / OCSL.O / ORSTED.CO / PEP.O / SMAR.K / KDP.N / AUTL.O / BBDC.K / TPVG.K / KZR.O / NWL.O / TPTX.O / EXC.O / BCSF.K / NARI.O / DASH.N / SKLZ.N / GRCL.O / OSCR.N</td><td class="leftalignment">Abbott Laboratories / Applied Materials Inc / Church & Dwight Co Inc / Colgate-Palmolive Co / Clorox Co / Estee Lauder Companies Inc / KLA Corp / Kimberly-Clark Corp / Knight-Swift Transportation Holdings Inc / Coca-Cola Co / Lam Research Corp / Olin Corp / Public Service Enterprise Group Inc / Procter & Gamble Co / Rambus Inc / Spectrum Brands Holdings Inc / Constellation Brands Inc / Molson Coors Beverage Co / Westlake Chemical Corp / ASML Holding NV / J B Hunt Transport Services Inc / Edgewell Personal Care Co / NVIDIA Corp / Hub Group Inc / CyrusOne Inc / NetApp Inc / Semtech Corp / Synopsys Inc / Ares Capital Corp / Micron Technology Inc / agilon health Inc / Monster Beverage Corp / RealReal Inc / Apollo Investment Corp / NuVasive Inc / FS KKR Capital Corp / Dexcom Inc / Cadence Design Systems Inc / TransDigm Group Inc / XPO Logistics Inc / BlackRock Capital Investment Corp / Northern Oil and Gas Inc / Moderna Inc / ZIOPHARM Oncology Inc / SLR Investment Corp / Golub Capital Bdc Inc / Pulmonx Corp / New Mountain Finance Corp / Guidewire Software Inc / Hercules Capital Inc / BlackRock TCP Capital Corp / Coty Inc / Fate Therapeutics Inc / Affimed NV / Celyad Oncology SA / Adaptimmune Therapeutics PLC / Goldman Sachs BDC Inc / Cellectis SA / TCG BDC Inc / Oaktree Specialty Lending Corp / Orsted A/S / PepsiCo Inc / Smartsheet Inc / Keurig Dr Pepper Inc / Autolus Therapeutics PLC / Barings BDC Inc / Triplepoint Venture Growth BDC Corp / Kezar Life Sciences Inc / Newell Brands Inc / Turning Point Therapeutics Inc / Exelon Corp / Bain Capital Specialty Finance Inc / Inari Medical Inc / DoorDash Inc / Skillz Inc / Gracell Biotechnologies Inc / Oscar Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Cayman Islands / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">May Clinical Trial Tracker—Focus on Oncology</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O / ZIOP.O / FATE.O / AFMD.O / CYAD.O / ADAP.O / CLLS.O / AUTL.O / TPTX.O / GRCL.O</td><td class="leftalignment">Moderna Inc / ZIOPHARM Oncology Inc / Fate Therapeutics Inc / Affimed NV / Celyad Oncology SA / Adaptimmune Therapeutics PLC / Cellectis SA / Autolus Therapeutics PLC / Turning Point Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / China / Cayman Islands / France / United Kingdom / Croatia / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AGCO.N / AGNC.OQ / AEE.N / AEP.N / ALL.N / AN.N / AXP.N / C.N / CAH.N / CE.N / CF.N / COF.N / CRM.N / ED.N / EIX.N / F.N / HIG.N / KEY.N / MO.N / PHM.N / RYN.N / SC.N / TMX.N / U.N / NUE.N / BKI.N / DIS.N / OGE.N / GD.N / URI.N / CR.N / DE.N / AFG.N / R.N / SPOT.N / AMG.N / GS.N / PRI.N / IFF.N / JWN.N / PCG.N / TDS.N / HCA.N / KSS.N / SRE.N / EXC.N / ATO.N / LNT.N / BC.N / DNB.N / MKC.N / SAM.N / CNA.N / CVX.N / MHK.N / GPK.N / OSK.N / INTC.OQ / ADPT.OQ / ANAT.OQ / CSCO.OQ / FISV.OQ / KLAC.OQ / PBCT.OQ / TEAM.OQ / PII.N / RJF.N / RGEN.OQ / FL.N / ZION.OQ / QCOM.OQ / DFS.N / POOL.OQ / TPR.N / UHAL.OQ / MRCY.OQ / UMPQ.OQ / CSGP.OQ / EWBC.OQ / MKSI.OQ / TREE.OQ / EQIX.OQ / FNB.N / EXP.N / OSH.N / LVS.N / WAL.N / DISCA.OQ / THG.N / CMG.N / BRKb.N / OC.N / IVZ.N / ACM.N / PODD.OQ / LULU.OQ / ES.N / WRB.N / MRNA.OQ / CLH.N / AVGO.OQ / NEE.N / BAH.N / TRGP.N / MSP.N / SPLK.OQ / ABBV.N / BFAM.N / FOXA.OQ / RNG.N / FIVN.OQ / GOOGL.OQ / PAYC.N / SYF.N / CTLT.N / ANTM.N / LBRDK.O / QRVO.OQ / SEDG.OQ / TDOC.N / ZBH.N / PEN.N / TMUS.OQ / HPE.N / RETA.OQ / TWLO.N / COUP.OQ / INVH.N / CVNA.N / PFG.OQ / XEL.OQ / SMAR.N / DOCU.OQ / CDAY.N / AVLR.N / ELAN.N / ESTC.N / PLAN.N / STNE.OQ / PINS.N / BYND.OQ / UBER.N / FSLY.N / GO.OQ / TXG.OQ / DDOG.OQ / SPCE.N / AZEK.N / APA.OQ / VRM.OQ / BLI.OQ / NCNO.OQ / BIGC.OQ / JAMF.OQ / DCT.OQ / FROG.OQ / AMWL.N</td><td class="leftalignment">AGCO Corp / AGNC Investment Corp / Ameren Corp / American Electric Power Company Inc / Allstate Corp / AutoNation Inc / American Express Co / Citigroup Inc / Cardinal Health Inc / Celanese Corp / CF Industries Holdings Inc / Capital One Financial Corp / Salesforce.Com Inc / Consolidated Edison Inc / Edison International / Ford Motor Co / Hartford Financial Services Group Inc / KeyCorp / Altria Group Inc / Pultegroup Inc / Rayonier Inc / Santander Consumer USA Holdings Inc / Terminix Global Holdings Inc / Unity Software Inc / Nucor Corp / Black Knight Inc / Walt Disney Co / OGE Energy Corp / General Dynamics Corp / United Rentals Inc / Crane Co / Deere & Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Affiliated Managers Group Inc / Goldman Sachs Group Inc / Primerica Inc / International Flavors & Fragrances Inc / Nordstrom Inc / PG&E Corp / Telephone and Data Systems Inc / HCA Healthcare Inc / Kohls Corp / Sempra Energy / Exelon Corp / Atmos Energy Corp / Alliant Energy Corp / Brunswick Corp / Dun & Bradstreet Holdings Inc / McCormick & Company Inc / Boston Beer Company Inc / CNA Financial Corp / Chevron Corp / Mohawk Industries Inc / Graphic Packaging Holding Co / Oshkosh Corp / Intel Corp / Adaptive Biotechnologies Corp / American National Group Inc / Cisco Systems Inc / Fiserv Inc / KLA Corp / People's United Financial Inc / Atlassian Corporation PLC / Polaris Inc / Raymond James Financial Inc / Repligen Corp / Foot Locker Inc / Zions Bancorporation NA / Qualcomm Inc / Discover Financial Services / Pool Corp / Tapestry Inc / Amerco / Mercury Systems Inc / Umpqua Holdings Corp / CoStar Group Inc / East West Bancorp Inc / MKS Instruments Inc / Lendingtree Inc / Equinix Inc / FNB Corp / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Western Alliance Bancorp / Discovery Inc / Hanover Insurance Group Inc / Chipotle Mexican Grill Inc / Berkshire Hathaway Inc / Owens Corning / Invesco Ltd / AECOM / Insulet Corp / Lululemon Athletica Inc / Eversource Energy / W R Berkley Corp / Moderna Inc / Clean Harbors Inc / Broadcom Inc / Nextera Energy Inc / Booz Allen Hamilton Holding Corp / Targa Resources Corp / Datto Holding Corp / Splunk Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Fox Corp / RingCentral Inc / Five9 Inc / Alphabet Inc / Paycom Software Inc / Synchrony Financial / Catalent Inc / Anthem Inc / Liberty Broadband Corp / Qorvo Inc / Solaredge Technologies Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / Penumbra Inc / T-Mobile US Inc / Hewlett Packard Enterprise Co / Reata Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Invitation Homes Inc / Carvana Co / Principal Financial Group Inc / Xcel Energy Inc / Smartsheet Inc / DocuSign Inc / Ceridian HCM Holding Inc / Avalara Inc / Elanco Animal Health Inc / Elastic NV / Anaplan Inc / StoneCo Ltd / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Fastly Inc / Grocery Outlet Holding Corp / 10X Genomics Inc / Datadog Inc / Virgin Galactic Holdings Inc / Azek Company Inc / APA Corp (US) / Vroom Inc / Berkeley Lights Inc / nCino Inc / Bigcommerce Holdings Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Jfrog Ltd / American Well Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Containers & Packing / Defense / Education / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AAP / ABT / AXP / AZO / COF / COST.O / CRI / FND / GPS / GS / HBI / HD / LB / LH / LNC / LOW / MCD / PVH / RKT / RL / SIG / TJX / TPR / USB / VFC / WAL / YUM / ROST.O / DXC / CAKE.O / URBN.O / REAL.O / PROG.O / ORLY.O / SBNY.O / CME.O / TW.O / LULU.O / TNDM.OQ / ULTA.O / MRNA.O / SCHW.K / SLM.O / VOYA.K / PFSI.K / BURL.K / NVTA.N / WING.O / NTRA.O / GOOS.TO / CVNA.K / SFIX.O / CBOE.Z / CPRI.K / FTCH.K / VRM.O / ASO.O / EAR.O / HMPT.O / TDUP.O</td><td class="leftalignment">Advance Auto Parts Inc / Abbott Laboratories / American Express Co / Autozone Inc / Capital One Financial Corp / Costco Wholesale Corp / Carter's Inc / Floor & Decor Holdings Inc / Gap Inc / Goldman Sachs Group Inc / HanesBrands Inc / Home Depot Inc / Bath & Body Works Inc / Laboratory Corporation of America Holdings / Lincoln National Corp / Lowe's Companies Inc / McDonald's Corp / PVH Corp / Rocket Companies Inc / Ralph Lauren Corp / Signet Jewelers Ltd / TJX Companies Inc / Tapestry Inc / US Bancorp / VF Corp / Western Alliance Bancorp / Yum! Brands Inc / Ross Stores Inc / DXC Technology Co / Cheesecake Factory Inc / Urban Outfitters Inc / RealReal Inc / Progenity Inc / O'Reilly Automotive Inc / Signature Bank / CME Group Inc / Tradeweb Markets Inc / Lululemon Athletica Inc / Tandem Diabetes Care Inc / Ulta Beauty Inc / Moderna Inc / Charles Schwab Corp / SLM Corp / Voya Financial Inc / PennyMac Financial Services Inc / Burlington Stores Inc / Invitae Corp / Wingstop Inc / Natera Inc / Canada Goose Holdings Inc / Carvana Co / Stitch Fix Inc / Cboe Global Markets Inc / Capri Holdings Ltd / Farfetch Ltd / Vroom Inc / Academy Sports and Outdoors Inc / Eargo Inc / Home Point Capital Inc / ThredUp Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: NIH Initiates Mixed-Booster Study; Data 3Q21 Could Support Expanded Booster Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AXP / COF / DFS / INTC.O / MS / MSFT.O / NPO / QCOM.O / T.N / 4716.T / GILD.O / AMGN.O / FIS / NVDA.O / SPOT.N / SQ / HEAR.O / LSCC.O / SMTC.O / FISV.O / GPN / AVGO.O / JKHY.OQ / ATVI.OQ / TTWO.OQ / UTHR.OQ / MRVL.OQ / VRTX.OQ / LIFE.O / BIIB.O / 92343V104 / 78442P106 / 36467W109 / 02043Q107 / MRNA.O / ZNGA.O / EA.O / AMBA.O / 82655M107 / G29183103 / INO.O / APPS.O / 63938C108 / CATB.OQ / PYPL.O / TMUS.OQ / TTD.OQ / IRTC.OQ / BILI.O / 21833P103 / ZM.OQ / ONCT.OQ / NBSE.O / SONM.O / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">American Express Co / Capital One Financial Corp / Discover Financial Services / Intel Corp / Morgan Stanley / Microsoft Corp / EnPro Industries Inc / Qualcomm Inc / AT&T Inc / Oracle Corp Japan / Gilead Sciences Inc / Amgen Inc / Fidelity National Information Services Inc / NVIDIA Corp / Spotify Technology SA / Block Inc / Turtle Beach Corp / Lattice Semiconductor Corp / Semtech Corp / Fiserv Inc / Global Payments Inc / Broadcom Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Marvell Technology Inc / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Verizon Communications Inc / SLM Corp / GameStop Corp / Alnylam Pharmaceuticals Inc / Moderna Inc / Zynga Inc / Electronic Arts Inc / Ambarella Inc / Sify Technologies Ltd / Eaton Corporation PLC / Inovio Pharmaceuticals Inc / Digital Turbine Inc / Navient Corp / Astria Therapeutics Inc / PayPal Holdings Inc / T-Mobile US Inc / Trade Desk Inc / iRhythm Technologies Inc / Bilibili Inc / Corbus Pharmaceuticals Holdings Inc / Zoom Video Communications Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Sonim Technologies Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / India / Ireland / Israel / Japan / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CAH.N / CC.N / CL.N / COF.N / CRM.N / ECL.N / EIX.N / EOG.N / F.N / FCX.N / FDX.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KMB.N / LLY.N / LMT.N / MRK.N / SC.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / AAL.L / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / NKE.N / LIN.N / OLN.N / IT.N / TGT.N / AVY.N / RKT.N / BLL.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / VFC.N / NRG.N / PWR.N / NEU.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / HAE.N / PVH.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / INTC.OQ / CTSH.OQ / ABMD.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / JKHY.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / SIVB.OQ / QDEL.OQ / QCOM.OQ / INTU.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / STLD.OQ / AMZN.OQ / LNG.A / MRCY.OQ / NVDA.OQ / SBAC.OQ / BMRN.OQ / PACW.OQ / TREE.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / TXN.OQ / CMCSA.OQ / BIIB.OQ / TPX.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / WAL.N / MS.N / FIS.N / STX.AX / RPRX.OQ / HES.N / MA.N / AWI.N / FSLR.OQ / CNK.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / NEE.N / TSLA.OQ / LPLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / LDOS.N / RNG.N / COMM.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / SQ.N / IONS.OQ / IAC.OQ / TTD.OQ / COUP.OQ / UAA.N / AYX.N / DXC.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / QRTEA.OQ / FB.PS / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / LMND.N / AMWL.N / VTRS.OQ / HON.OQ</td><td class="leftalignment">Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Cardinal Health Inc / Chemours Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Linde PLC / Olin Corp / Gartner Inc / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / VF Corp / NRG Energy Inc / Quanta Services Inc / NewMarket Corp / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Haemonetics Corp / PVH Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Jack Henry & Associates Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Quidel Corp / Qualcomm Inc / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Lendingtree Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Western Alliance Bancorp / Morgan Stanley / Fidelity National Information Services Inc / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Cinemark Holdings Inc / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / LPL Financial Holdings Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / Leidos Holdings Inc / RingCentral Inc / CommScope Holding Company Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Block Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Trade Desk Inc / Coupa Software Inc / Under Armour Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Lemonade Inc / American Well Corp / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-1Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / AMGN.O / UTHR.OQ / VRTX.OQ / LIFE.O / BIIB.O / 02043Q107 / MRNA.O / INO.O / CATB.OQ / ONCT.OQ / NBSE.O / REGW.M3 / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Astria Therapeutics Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4th Science Day Demonstrates "Leader of the Pack"</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA.O / 03823M100</td><td class="leftalignment">Moderna Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AEE / AEP.N / AGR / ALB / ALE / AMT / APD / ASH / ATO / AVB / AWK / AWR / AZO / BAC / BEP / BIP / BKH / BP / C / CB / CCI / CCK / CCO / CE / CMG / CMS / CNP / COP / CP / CPK / CPT / CVX / CWT / D / DD / DIS / DLR / DOW / DRI / DTE / DUK / DY / ED / EIX / EMN / ES / ETR / FE / FMC / FND / GPS / GS / HD / HE / HES / HIG / HUN / IDA / IFF / IPG / JPM / LIN / LOW / MCD / MUR / NEP / NI / NJR / NSC / NTRS.O / OGE / OLN / OMC / OXY / PCG / PEG / PNC / PNM / PNW / POR / PPG / PPL / RE / RH / RL / RNR / RPM / SHW / SJI / SJW / SO / SR / SRE / SWX / SYY / T / TFC / TOL / TPR / UDR / USB / USM / VFC / WEC / WLK / AMZN.O / CNQ.TO / ET / AUD.N / CMCSA.O / WWE / IRM / OGS / AAPL.O / SBGI.O / SU.TO / XOM / SBAC.O / SIRI.O / CONE.O / SGMO.O / VZ / NWN / SBUX.O / HXL.N / CHTR.O / FTS.TO / EMA.TO / CAKE.O / NEE / LYB / TSCO.O / TEAM.O / BLUE.O / ORLY.O / ACGL.O / EQIX.O / WOOF.O / NFLX.O / NXST.O / VIAC.O / RDSb / DISCA.O / BJRI.O / CNSL.O / CCOI.O / H.TO / WRB.N / MRNA.O / ZIOP.O / AQN / AMCX.O / FOXA.O / HMTV.O / MAR.O / FATE.O / QURE.O / FLXN.O / AGTC.O / AXTA.K / NVTA.N / WING.O / CABO.N / NTRA.O / TGNA.K / PFGC.K / TMUS.O / OMF / VYGR.O / EDIT.O / NTLA.O / USFD.K / TWLO.K / CRSP.O / NGVT.K / LGFb.N / UNIT.O / CLLS.O / ATUS.N / BOMN.O / ROKU.O / ORSTED.CO / SWCH.K / XEL.O / SPOT.K / SSP.O / EVRG.K / AVRO.O / AUTL.O / GH.O / LNT.O / CPRI.K / IHRT.O / EXC.O / WTRG.K / PGEN.O / BEAM.O / BIPC.K / AVNT.K / BEPC.K / NWE.O / LUMN.K / GRCL.O / VZIO.N / PATH.N</td><td class="leftalignment">Ameren Corp / American Electric Power Company Inc / Avangrid Inc / Albemarle Corp / ALLETE Inc / American Tower Corp / Air Products and Chemicals Inc / Ashland Global Holdings Inc / Atmos Energy Corp / Avalonbay Communities Inc / American Water Works Company Inc / American States Water Co / Autozone Inc / Bank of America Corp / Brookfield Renewable Partners LP / Brookfield Infrastructure Partners LP / Black Hills Corp / BP PLC / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Crown Holdings Inc / Clear Channel Outdoor Holdings Inc / Celanese Corp / Chipotle Mexican Grill Inc / CMS Energy Corp / CenterPoint Energy Inc / Conocophillips / Canadian Pacific Railway Ltd / Chesapeake Utilities Corp / Camden Property Trust / Chevron Corp / California Water Service Group / Dominion Energy Inc / Dupont De Nemours Inc / Walt Disney Co / Digital Realty Trust Inc / Dow Inc / Darden Restaurants Inc / DTE Energy Co / Duke Energy Corp / Dycom Industries Inc / Consolidated Edison Inc / Edison International / Eastman Chemical Co / Eversource Energy / Entergy Corp / FirstEnergy Corp / FMC Corp / Floor & Decor Holdings Inc / Gap Inc / Goldman Sachs Group Inc / Home Depot Inc / Hawaiian Electric Industries Inc / Hess Corp / Hartford Financial Services Group Inc / Huntsman Corp / Idacorp Inc / International Flavors & Fragrances Inc / Interpublic Group of Companies Inc / JPMorgan Chase & Co / Linde PLC / Lowe's Companies Inc / McDonald's Corp / Murphy Oil Corp / Nextera Energy Partners LP / NiSource Inc / New Jersey Resources Corp / Norfolk Southern Corp / Northern Trust Corp / OGE Energy Corp / Olin Corp / Omnicom Group Inc / Occidental Petroleum Corp / PG&E Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / PNM Resources Inc / Pinnacle West Capital Corp / Portland General Electric Co / PPG Industries Inc / PPL Corp / Everest Re Group Ltd / RH / Ralph Lauren Corp / Renaissancere Holdings Ltd / RPM International Inc / Sherwin-Williams Co / South Jersey Industries Inc / SJW Group / Southern Co / Spire Inc / Sempra Energy / Southwest Gas Holdings Inc / Sysco Corp / AT&T Inc / Truist Financial Corp / Toll Brothers Inc / Tapestry Inc / UDR Inc / US Bancorp / United States Cellular Corp / VF Corp / WEC Energy Group Inc / Westlake Chemical Corp / Amazon.com Inc / Canadian Natural Resources Ltd / Energy Transfer LP / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Iron Mountain Inc / ONE Gas Inc / Apple Inc / Sinclair Broadcast Group Inc / Suncor Energy Inc / Exxon Mobil Corp / SBA Communications Corp / Sirius XM Holdings Inc / CyrusOne Inc / Sangamo Therapeutics Inc / Verizon Communications Inc / Northwest Natural Holding Co / Starbucks Corp / Hexcel Corp / Charter Communications Inc / Fortis Inc / Emera Inc / Cheesecake Factory Inc / Nextera Energy Inc / LyondellBasell Industries NV / Tractor Supply Co / Atlassian Corporation PLC / bluebird bio Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Equinix Inc / Petco Health and Wellness Company Inc / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Royal Dutch Shell PLC / Discovery Inc / BJ's Restaurants Inc / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Hydro One Ltd / W R Berkley Corp / Moderna Inc / ZIOPHARM Oncology Inc / Algonquin Power & Utilities Corp / AMC Networks Inc / Fox Corp / Hemisphere Media Group Inc / Marriott International Inc / Fate Therapeutics Inc / Uniqure NV / Pacira Biosciences Inc / Applied Genetic Technologies Corp / Axalta Coating Systems Ltd / Invitae Corp / Wingstop Inc / Cable One Inc / Natera Inc / Tegna Inc / Performance Food Group Co / T-Mobile US Inc / OneMain Holdings Inc / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / US Foods Holding Corp / Twilio Inc / CRISPR Therapeutics AG / Ingevity Corp / Lions Gate Entertainment Corp / Uniti Group Inc / Cellectis SA / Altice USA Inc / Boston Omaha Corp / Roku Inc / Orsted A/S / Switch Inc / Xcel Energy Inc / Spotify Technology SA / E W Scripps Co / Evergy Inc / AVROBIO Inc / Autolus Therapeutics PLC / Guardant Health Inc / Alliant Energy Corp / Capri Holdings Ltd / iHeartMedia Inc / Exelon Corp / Essential Utilities Inc / Precigen Inc / Beam Therapeutics Inc / Brookfield Infrastructure Corp / Avient Corp / Brookfield Renewable Corp / NorthWestern Corp / Lumen Technologies Inc / Gracell Biotechnologies Inc / Vizio Holding Corp / UiPath Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Initiates Rolling BLA Submission for Full Authorization of COVID-19 Vaccine in the US</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ACA / ALB.N / BE / BMI / CAT / CCI.N / CI / CLH / CMI / CNC / COST.O / CSL / CSWC / DAN / DE / EL.N / ENS / HON / INTC.O / JCI / KKR / MDT / MS / MSFT.O / NEP / ORA / PNR / RSG / SCM.N / TEL / UNH / W / WM / YUM / ACI.N / TME / AMZN.O / MWA / AAPL.O / BWA.N / WTS.N / NVDA.O / SQ / HEAR.O / MPWR.O / SBUX.O / SMTC.O / IO.N / FCEL.O / LSTR.O / ARCC.O / GLAD.O / CREE.O / NET.N / AVGO.O / AOS.N / ATVI.OQ / AMSC.OQ / IART.OQ / TTWO.OQ / ICPT.OQ / PLUG.OQ / MRVL.OQ / TXN.OQ / MGRC.O / TEAM.O / TRMB.O / ITRI.O / 0700.HK / OLED.O / NDAQ.O / DXCM.O / 36467W109 / ICE.N / GAIN.O / SPWR.O / XPO / CSIQ.O / FSLR.O / LULU.O / 02043Q107 / TNDM.O / ULTA.O / 88162G103 / MRNA.O / TWIN.O / 771195104 / CSII.O / AGCO.K / ADUS.O / SLRC.O / TSLA.O / NXPI.O / AMRC.K / AMRS.OQ / XYL / SUNS.O / AMD.OQ / FDUS.O / ZNGA.O / EA.O / ADI.OQ / ENPH.O / FB.O / TCPC.O / CG.O / PANW.K / MRCC.O / PRTA.OQ / 44045A102 / HASI.N / FATE.OQ / TWTR.K / WIX.O / 82655M107 / QRVO.O / ETSY.O / SHOP.K / SEDG.O / RUN.O / WKHS.O / WCN.TO / AQMS.O / SPGI.K / NTLA.O / TTD.OQ / APL.PS / COUP.O / WPRT.TO / SNAP.K / OKTA.O / 00973N102 / WDAY.O / ROKU.O / MDB.O / APTV.K / BILI.O / FOCS.OQ / TPVG.K / ESTC.N / CWENa.K / CRSP.BN / FTDR.O / UBER.K / CRWD.O / ETNB.O / VG.O / BILL.K / DKNG.O / AVNT.K / 02081G201 / GRWG.O / RWRh.V / NMFC.O / 100004825 / HUYA.K / 390320109</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Bloom Energy Corp / Badger Meter Inc / Caterpillar Inc / Crown Castle International Corp / Cigna Corp / Clean Harbors Inc / Cummins Inc / Centene Corp / Costco Wholesale Corp / Carlisle Companies Inc / Capital Southwest Corp / Dana Inc / Deere & Co / Estee Lauder Companies Inc / EnerSys / Honeywell International Inc / Intel Corp / Johnson Controls International PLC / KKR & Co Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / Ormat Technologies Inc / Pentair PLC / Republic Services Inc / Stellus Capital Investment Corp / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Waste Management Inc / Yum! Brands Inc / Albertsons Companies Inc / Tencent Music Entertainment Group / Amazon.com Inc / Mueller Water Products Inc / Apple Inc / Borgwarner Inc / Watts Water Technologies Inc / NVIDIA Corp / Block Inc / Turtle Beach Corp / Monolithic Power Systems Inc / Starbucks Corp / Semtech Corp / ION Geophysical Corp / Fuelcell Energy Inc / Landstar System Inc / Ares Capital Corp / Gladstone Capital Corp / Wolfspeed Inc / Cloudflare Inc / Broadcom Inc / A O Smith Corp / Activision Blizzard Inc / American Superconductor Corp / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Intercept Pharmaceuticals Inc / Plug Power Inc / Marvell Technology Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / Trimble Inc / Itron Inc / Tencent Holdings Ltd / Universal Display Corp / Nasdaq Inc / Dexcom Inc / GameStop Corp / Intercontinental Exchange Inc / Gladstone Investment Corp / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ulta Beauty Inc / Tetra Tech Inc / Moderna Inc / Twin Disc Inc / Roche Holding AG / Cardiovascular Systems Inc / AGCO Corp / Addus Homecare Corp / SLR Investment Corp / Tesla Inc / NXP Semiconductors NV / Ameresco Inc / Amyris Inc / Xylem Inc / SLR Senior Investment Corp / Advanced Micro Devices Inc / Fidus Investment Corp / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Enphase Energy Inc / Meta Platforms Inc / BlackRock TCP Capital Corp / Carlyle Group Inc / Palo Alto Networks Inc / Monroe Capital Corp / Prothena Corporation PLC / Horizon Technology Finance Corp / Hannon Armstrong Sustainable Infrastructure Capital Inc / Fate Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Sify Technologies Ltd / Qorvo Inc / ETSY Inc / Shopify Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / S&P Global Inc / Intellia Therapeutics Inc / Trade Desk Inc / Apollo Global Capital Inc / Coupa Software Inc / Westport Fuel Systems Inc / Snap Inc / Okta Inc / Akoustis Technologies Inc / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Bilibili Inc / Focus Financial Partners Inc / Triplepoint Venture Growth BDC Corp / Elastic NV / Clearway Energy Inc / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / 89Bio Inc / Vonage Holdings Corp / Bill.com Holdings Inc / DraftKings Inc / Avient Corp / Alphatec Holdings Inc / GrowGeneration Corp / Strathmore Plus Energy Corp / New Mountain Finance Corp / Enterprise Financial Services Corp / HUYA Inc / Great Elm Capital Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / India / Ireland / Israel / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEE / AEP.N / AGR / ALB / ALE / AMT / APD / ASH / ATO / AWK / AWR / BAC / BEP / BIP / BKH / BP / C / CB / CCI / CCO / CE / CMS / CNP / COP / CPK / CVX / CWT / D / DD / DIS / DLR / DOW / DTE / DUK / DY / ED / EIX / EMN / ES / ETR / FE / FMC / GS / HE / HES / HIG / HUN / IDA / IFF / IPG / JPM / LIN / MUR / NEP / NI / NJR / NTRS.O / OGE / OLN / OMC / OXY / PCG / PEG / PNC / PNM / PNW / POR / PPG / PPL / RE / RNR / RPM / SHW / SJI / SJW / SO / SR / SRE / SWX / T / TFC / USB / USM / WEC / WLK / CNQ.TO / AUD.N / CMCSA.O / WWE / IRM / OGS / SBGI.O / SU.TO / XOM / SBAC.O / SIRI.O / CONE.O / SGMO.O / VZ / NWN / HXL.N / CHTR.O / FTS.TO / EMA.TO / NEE / LYB / TEAM.O / BLUE.O / ACGL.O / EQIX.O / NFLX.O / NXST.O / VIAC.O / RDSb / DISCA.O / CNSL.O / CCOI.O / H.TO / WRB.N / MRNA.O / ZIOP.O / AQN / AMCX.O / FOXA.O / HMTV.O / FATE.O / QURE.O / AGTC.O / AXTA.K / CABO.N / NTRA.O / TGNA.K / TMUS.O / OMF / VYGR.O / EDIT.O / NTLA.O / TWLO.K / CRSP.O / NGVT.K / LGFb.N / UNIT.O / CLLS.O / ATUS.N / BOMN.O / ROKU.O / ORSTED.CO / SWCH.K / XEL.O / SPOT.K / SSP.O / EVRG.K / AVRO.O / AUTL.O / GH.O / LNT.O / IHRT.O / EXC.O / WTRG.K / PGEN.O / BEAM.O / BIPC.K / AVNT.K / BEPC.K / NWE.O / LUMN.K / GRCL.O / VZIO.N / PATH.N</td><td class="leftalignment">Ameren Corp / American Electric Power Company Inc / Avangrid Inc / Albemarle Corp / ALLETE Inc / American Tower Corp / Air Products and Chemicals Inc / Ashland Global Holdings Inc / Atmos Energy Corp / American Water Works Company Inc / American States Water Co / Bank of America Corp / Brookfield Renewable Partners LP / Brookfield Infrastructure Partners LP / Black Hills Corp / BP PLC / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Clear Channel Outdoor Holdings Inc / Celanese Corp / CMS Energy Corp / CenterPoint Energy Inc / Conocophillips / Chesapeake Utilities Corp / Chevron Corp / California Water Service Group / Dominion Energy Inc / Dupont De Nemours Inc / Walt Disney Co / Digital Realty Trust Inc / Dow Inc / DTE Energy Co / Duke Energy Corp / Dycom Industries Inc / Consolidated Edison Inc / Edison International / Eastman Chemical Co / Eversource Energy / Entergy Corp / FirstEnergy Corp / FMC Corp / Goldman Sachs Group Inc / Hawaiian Electric Industries Inc / Hess Corp / Hartford Financial Services Group Inc / Huntsman Corp / Idacorp Inc / International Flavors & Fragrances Inc / Interpublic Group of Companies Inc / JPMorgan Chase & Co / Linde PLC / Murphy Oil Corp / Nextera Energy Partners LP / NiSource Inc / New Jersey Resources Corp / Northern Trust Corp / OGE Energy Corp / Olin Corp / Omnicom Group Inc / Occidental Petroleum Corp / PG&E Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / PNM Resources Inc / Pinnacle West Capital Corp / Portland General Electric Co / PPG Industries Inc / PPL Corp / Everest Re Group Ltd / Renaissancere Holdings Ltd / RPM International Inc / Sherwin-Williams Co / South Jersey Industries Inc / SJW Group / Southern Co / Spire Inc / Sempra Energy / Southwest Gas Holdings Inc / AT&T Inc / Truist Financial Corp / US Bancorp / United States Cellular Corp / WEC Energy Group Inc / Westlake Chemical Corp / Canadian Natural Resources Ltd / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Iron Mountain Inc / ONE Gas Inc / Sinclair Broadcast Group Inc / Suncor Energy Inc / Exxon Mobil Corp / SBA Communications Corp / Sirius XM Holdings Inc / CyrusOne Inc / Sangamo Therapeutics Inc / Verizon Communications Inc / Northwest Natural Holding Co / Hexcel Corp / Charter Communications Inc / Fortis Inc / Emera Inc / Nextera Energy Inc / LyondellBasell Industries NV / Atlassian Corporation PLC / bluebird bio Inc / Arch Capital Group Ltd / Equinix Inc / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Royal Dutch Shell PLC / Discovery Inc / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Hydro One Ltd / W R Berkley Corp / Moderna Inc / ZIOPHARM Oncology Inc / Algonquin Power & Utilities Corp / AMC Networks Inc / Fox Corp / Hemisphere Media Group Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Axalta Coating Systems Ltd / Cable One Inc / Natera Inc / Tegna Inc / T-Mobile US Inc / OneMain Holdings Inc / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Twilio Inc / CRISPR Therapeutics AG / Ingevity Corp / Lions Gate Entertainment Corp / Uniti Group Inc / Cellectis SA / Altice USA Inc / Boston Omaha Corp / Roku Inc / Orsted A/S / Switch Inc / Xcel Energy Inc / Spotify Technology SA / E W Scripps Co / Evergy Inc / AVROBIO Inc / Autolus Therapeutics PLC / Guardant Health Inc / Alliant Energy Corp / iHeartMedia Inc / Exelon Corp / Essential Utilities Inc / Precigen Inc / Beam Therapeutics Inc / Brookfield Infrastructure Corp / Avient Corp / Brookfield Renewable Corp / NorthWestern Corp / Lumen Technologies Inc / Gracell Biotechnologies Inc / Vizio Holding Corp / UiPath Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Cell and Gene Therapy Newsletter Companion</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CLLS.O / BEAM.O / SGMO.O / BLUE.O / MRNA.O / ZIOP.O / FATE.O / QURE.O / AGTC.O / VYGR.O / EDIT.O / NTLA.O / CRSP.O / AVRO.O / AUTL.O / PGEN.O / GRCL.O</td><td class="leftalignment">Cellectis SA / Beam Therapeutics Inc / Sangamo Therapeutics Inc / bluebird bio Inc / Moderna Inc / ZIOPHARM Oncology Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / AVROBIO Inc / Autolus Therapeutics PLC / Precigen Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / Croatia / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Nick M. Abbott / Mr. Yanan Zhu / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: June 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">000100.KS / 145020.KQ / PFE.N / AZN.L / 006280.KS / MRNA.OQ / 068270.KS / 086900.KQ / 207940.KS / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Pfizer Inc / AstraZeneca PLC / Green Cross Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Promising efficacy signals from SIGHT and MRNA</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / ISEE / ARCT / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / SIOX / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Iveric Bio Inc / Arcturus Therapeutics Holdings Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Mid-Cycle Sentiment: 2017 vs. 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ACA / ALB.N / CCI.N / CI / CNC / CSL / EL.N / KKR / MDT / MS / TEL / UNH / W / YUM / ACI.N / TME / AMZN.O / AAPL.O / NVDA.O / SQ / MPWR.O / SBUX.O / SMTC.O / NET.N / AVGO.O / ATVI.OQ / IART.OQ / TTWO.OQ / MRVL.OQ / TXN.OQ / MGRC.O / TEAM.O / TRMB.O / ITRI.O / 0700.HK / OLED.O / NDAQ.O / ICE.N / XPO / CSIQ.O / LULU.O / ULTA.O / MRNA.O / CSII.O / ADUS.O / TSLA.O / NXPI.O / ADI.OQ / FB.O / CG.O / PANW.K / FATE.OQ / TWTR.K / WIX.O / QRVO.O / ETSY.O / SHOP.K / RUN.O / SPGI.K / NTLA.O / TTD.OQ / APL.PS / COUP.O / SNAP.K / OKTA.O / 00973N102 / WDAY.O / ROKU.O / MDB.O / APTV.K / FOCS.OQ / ESTC.N / CRSP.BN / FTDR.O / UBER.K / CRWD.O / VG.O / BILL.K / DKNG.O / GRWG.O</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Crown Castle International Corp / Cigna Corp / Centene Corp / Carlisle Companies Inc / Estee Lauder Companies Inc / KKR & Co Inc / Medtronic PLC / Morgan Stanley / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Yum! Brands Inc / Albertsons Companies Inc / Tencent Music Entertainment Group / Amazon.com Inc / Apple Inc / NVIDIA Corp / Block Inc / Monolithic Power Systems Inc / Starbucks Corp / Semtech Corp / Cloudflare Inc / Broadcom Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Marvell Technology Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / Trimble Inc / Itron Inc / Tencent Holdings Ltd / Universal Display Corp / Nasdaq Inc / Intercontinental Exchange Inc / XPO Logistics Inc / Canadian Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Moderna Inc / Cardiovascular Systems Inc / Addus Homecare Corp / Tesla Inc / NXP Semiconductors NV / Analog Devices Inc / Meta Platforms Inc / Carlyle Group Inc / Palo Alto Networks Inc / Fate Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Qorvo Inc / ETSY Inc / Shopify Inc / Sunrun Inc / S&P Global Inc / Intellia Therapeutics Inc / Trade Desk Inc / Apollo Global Capital Inc / Coupa Software Inc / Snap Inc / Okta Inc / Akoustis Technologies Inc / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Focus Financial Partners Inc / Elastic NV / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Vonage Holdings Corp / Bill.com Holdings Inc / DraftKings Inc / GrowGeneration Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Moderna (MRNA: $185.01) adds $3 billion in MCap in May, highest in Biotechnology sector</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.28.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / UNH / WMT / NOVN.S / RMD.N / HCA.N / CYH.N / EW.N / XOMA.O / EXEL.OQ / BLUE.OQ / CCRN.O / AMED.O / 00846U101 / 868168105 / MBRX.OQ / ATRC.OQ / LHCG.O / ALCLS.PA / BLRX.TA / ENSG.OQ / 483548103 / MRNA.O / MD.N / 771195104 / ADUS.O / USPH.N / AUP.TO / GOOGL.O / INO.O / EVH.N / TDOC.N / CERC.OQ / APLS.OQ / 100063846 / NTLA.O / SYRS.OQ / SLNO.OQ / IOVA.OQ / SVRA.O / 720795103 / PRVB.OQ / ALLO.OQ / XFOR.OQ / 21833P103 / BWAY.TA / A71.F / NBSE.O / PNTG.OQ / HGEN.O / RZLT.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / XOMA Corp / Exelixis Inc / bluebird bio Inc / Cross Country Healthcare Inc / Amedisys Inc / Agilent Technologies Inc / Superior Industries International Inc / Moleculin Biotech Inc / AtriCure Inc / LHC Group Inc / Cellectis SA / BioLine RX Ltd / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Aurinia Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Teladoc Health Inc / Avalo Therapeutics Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Soleno Therapeutics Inc / Iovance Biotherapeutics Inc / Savara Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Allogene Therapeutics Inc / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Ascendis Pharma A/S / NeuBase Therapeutics Inc / Pennant Group Inc / Humanigen Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">MRNA (Buy, $188): Science Day—investments in informatics, mRNA & delivery</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.O / 339 / 03152W109 / 800677106 / 199800.KN / 75901B107 / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / N90064101 / 03820J100</td><td class="leftalignment">Moderna Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / ToolGen Inc / Regenxbio Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Uniqure NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AMAT.O / AR / CHD / CL / CLR / CLX / CNX / COG / COST.O / CPE / DOW / DVN / EL / EOG / EQT / EXR / GPS / HUN / KMB / KO / LB / LRCX.O / LSI / MDT / MGY / MRO / PG / PXD / RKT / RRC / SM / SPB / STZ / SWN / SYY / TAP.N / TPR / WLL / YUM / EPC / ARCC.O / LPI / CAKE.O / HPQ / MNST.O / REAL.O / AINV.O / FSK / DXCM.O / PSEC.O / BKCC.O / ULTA.O / NOG.A / MRNA.O / TRIN.O / JACK.O / SLRC.O / GBDC.O / NMFC.N / ESTE.K / MTDR.K / HTGC.K / TCPC.O / PDCE.O / FANG.O / BCEI.K / PFSI.K / COTY.K / TSLX.K / WING.O / OLLI.O / PFGC.K / USFD.K / LGFb.N / GSBD.K / HLNE.O / CDEV.O / CGBD.O / OCSL.O / PEP.O / KDP.N / BRY.O / BBDC.K / TPVG.K / NWL.O / DELL.K / BCSF.K / ORCC.K / OAS.O / CHK.O / HMPT.O</td><td class="leftalignment">Applied Materials Inc / Antero Resources Corp / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Coterra Energy Inc / Costco Wholesale Corp / Callon Petroleum Co / Dow Inc / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Extra Space Storage Inc / Gap Inc / Huntsman Corp / Kimberly-Clark Corp / Coca-Cola Co / Bath & Body Works Inc / Lam Research Corp / Life Storage Inc / Medtronic PLC / Magnolia Oil & Gas Corp / Marathon Oil Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Rocket Companies Inc / Range Resources Corp / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Sysco Corp / Molson Coors Beverage Co / Tapestry Inc / Whiting Petroleum Corp / Yum! Brands Inc / Edgewell Personal Care Co / Ares Capital Corp / Laredo Petroleum Inc / Cheesecake Factory Inc / HP Inc / Monster Beverage Corp / RealReal Inc / Apollo Investment Corp / FS KKR Capital Corp / Dexcom Inc / Prospect Capital Corp / BlackRock Capital Investment Corp / Ulta Beauty Inc / Northern Oil and Gas Inc / Moderna Inc / Trinity Capital Inc / Jack in the Box Inc / SLR Investment Corp / Golub Capital Bdc Inc / New Mountain Finance Corp / Earthstone Energy Inc / Matador Resources Co / Hercules Capital Inc / BlackRock TCP Capital Corp / PDC Energy Inc / Diamondback Energy Inc / Civitas Resources Inc / PennyMac Financial Services Inc / Coty Inc / Sixth Street Specialty Lending Inc / Wingstop Inc / Ollie's Bargain Outlet Holdings Inc / Performance Food Group Co / US Foods Holding Corp / Lions Gate Entertainment Corp / Goldman Sachs BDC Inc / Hamilton Lane Inc / Centennial Resource Development Inc / TCG BDC Inc / Oaktree Specialty Lending Corp / PepsiCo Inc / Keurig Dr Pepper Inc / Berry Corporation (Bry) / Barings BDC Inc / Triplepoint Venture Growth BDC Corp / Newell Brands Inc / Dell Technologies Inc / Bain Capital Specialty Finance Inc / Owl Rock Capital Corp / Oasis Petroleum Inc / Chesapeake Energy Corp / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Science Day Highlights Moderna's mRNA Leadership; Continued Focus on COVID</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Science Day Highlights mRNA Advancements That Could Support Next Wave of Therapeutic Candidates</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways from MRNA's Fourth Annual Science Day</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">60770K10</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, May 27, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Positive TeenCOVE Data Paves Way for EUA Sumbission in Early June</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways from Our Group Meeting with MRNA Management</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">60770K10</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Moderna reports EPS of $-1.96; Institutional Ownership up 4%</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AVB / AZO / CLR / COG / CPT / EPD / RH / SYK / UDR / WSM / YUM / MU.O / PROG.O / EXAS.O / RDSb / MRNA.O / NVTA.N / NTRA.O / CLLS.O / GH.O / ABNB.O</td><td class="leftalignment">Avalonbay Communities Inc / Autozone Inc / Continental Resources Inc / Coterra Energy Inc / Camden Property Trust / Enterprise Products Partners LP / RH / Stryker Corp / UDR Inc / Williams-Sonoma Inc / Yum! Brands Inc / Micron Technology Inc / Progenity Inc / Exact Sciences Corp / Royal Dutch Shell PLC / Moderna Inc / Invitae Corp / Natera Inc / Cellectis SA / Guardant Health Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: TeenCOVE Non-Inferiority Could Support Vaccine Authorization in Adolescents as Early as 3Q21</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Ex-US Collaboration Agreements Support Global Manufacturing Targets for COVID-19 Vaccine</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: NeuBase is a Chardan Top Pick for 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">NBSE.OQ / EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">NeuBase Therapeutics Inc / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ALB.N / BAX / BE / BSX / CAT / CLH / CMI / DAN / DE / ENS / HUM / JCI / LRCX.O / MDT / NEP / ORA / QCOM.O / RSG / WM / BYND.O / BWA.N / RMD.N / EW.N / FCEL.O / CREE.O / AVGO.O / AMSC.OQ / PLUG.OQ / BLUE.OQ / TRMB.O / ITRI.O / AMED.O / 459200101 / OLED.O / ATRC.OQ / SPWR.O / CSIQ.O / FSLR.O / MRNA.O / TWIN.O / AGCO.K / TSLA.O / CDXS.O / NXPI.O / AMRC.K / AMRS.OQ / ENPH.O / HASI.N / AUP.TO / ASPN.K / CERC.OQ / SEDG.O / RUN.O / WKHS.O / WCN.TO / AQMS.O / SPGI.K / WPRT.TO / 00973N102 / IOVA.OQ / APTV.K / 720795103 / EVER.OQ / 875372203 / CWENa.K / XFOR.OQ / 21833P103 / NBSE.O / 00972D105 / AVNT.K / RWRh.V / 010196103</td><td class="leftalignment">Albemarle Corp / Baxter International Inc / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Dana Inc / Deere & Co / EnerSys / Humana Inc / Johnson Controls International PLC / Lam Research Corp / Medtronic PLC / Nextera Energy Partners LP / Ormat Technologies Inc / Qualcomm Inc / Republic Services Inc / Waste Management Inc / Beyond Meat Inc / Borgwarner Inc / Resmed Inc / Edwards Lifesciences Corp / Fuelcell Energy Inc / Wolfspeed Inc / Broadcom Inc / American Superconductor Corp / Plug Power Inc / bluebird bio Inc / Trimble Inc / Itron Inc / Amedisys Inc / International Business Machines Corp / Universal Display Corp / AtriCure Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Moderna Inc / Twin Disc Inc / AGCO Corp / Tesla Inc / Codexis Inc / NXP Semiconductors NV / Ameresco Inc / Amyris Inc / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Aurinia Pharmaceuticals Inc / Aspen Aerogels Inc / Avalo Therapeutics Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / S&P Global Inc / Westport Fuel Systems Inc / Akoustis Technologies Inc / Iovance Biotherapeutics Inc / Aptiv PLC / Pieris Pharmaceuticals Inc / EverQuote Inc / Tandem Diabetes Care Inc / Clearway Energy Inc / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / NeuBase Therapeutics Inc / Akebia Therapeutics Inc / Avient Corp / Strathmore Plus Energy Corp / Aksys Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">RSV Could Be the Next $10bn Vaccine Market. Who’s Best Positioned?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">71708110 / 04635310 / 75886F10 / 478160104 / 58933Y10 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Merck & Co Inc / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (from 24 May): Focus on stocks with strong earnings and themes, now that results releases are over</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / PFE.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / GKOS.N / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Glaukos Corp / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（5月24日～）: 決算発表一巡、好業績とテーマ性のある銘柄物色に注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / PFE.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / GKOS.N / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Glaukos Corp / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">F2Q21 Review: Focus Shifts to Upcoming R&D Day</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NBSE.O / MRNA.O</td><td class="leftalignment">NeuBase Therapeutics Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">mRNA-1273 Approvals in Japan and South Korea; Science Day Next Thursday 5/27</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Moderna Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippines Market Strategy - New report: COVID-19 tracker-pace of vaccination picks up in May as vaccine supply doubles</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Philippines Market Strategy: COVID-19 tracker: Pace of vaccination picks up in May as vaccine supply doubles</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: AUTL's next-gen CD19 CAR-T; CTX001 follow-up</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 15% Including COVID-19 Vaccine Volume Benefit</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.14.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for MRNA. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SGE.L / SYK / UNH / WMT / NOVN.S / HCA.N / CYH.N / EW.N / ISR / INCY.OQ / BCRX.OQ / ICPT.OQ / UTHR.OQ / NKTR.O / CCRN.O / ICAD.O / LIFE.O / AMED.O / CGEN.O / BIIB.O / 00846U101 / 868168105 / ALNY.OQ / MBRX.OQ / MNKD.O / ATRC.OQ / LHCG.O / CYCC.OQ / B8FGn.DE / INFI.OQ / ALCLS.PA / 02043Q107 / ENSG.OQ / 483548103 / MRNA.O / TMDX.OQ / BBI.O / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / FLXN.OQ / GOOGL.O / 02005N100 / CASI.OQ / XENT.OQ / CBAY.OQ / VBIV.O / CLRB.OQ / OTIC.O / INO.O / VBLT.O / FBIO.OQ / EVH.N / TDOC.N / CFMS.O / APLS.OQ / 100063846 / SSKN.OQ / FLGT.OQ / MDGL.O / SRRA.O / URGN.O / IOVA.OQ / VERU.OQ / CLXT.O / MTEM.O / SVRA.O / SYBX.O / CUE.OQ / FIXX.OQ / 720795103 / BNGO.OQ / ALLO.OQ / MRKR.OQ / ORTX.OQ / SWAV.O / XFOR.OQ / PDSB.OQ / 21833P103 / ORGO.O / IDYA.OQ / BCYC.O / XAIR.OQ / DMTK.O / FREQ.OQ / PNTG.OQ / RLMD.OQ / ETNB.O / HGEN.O / NNOX.O / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / IsoRay Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Nektar Therapeutics / Cross Country Healthcare Inc / ICAD Inc / aTyr Pharma Inc / Amedisys Inc / Compugen Ltd / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Biofrontera AG / Infinity Pharmaceuticals Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / Brickell Biotech Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / Pacira Biosciences Inc / Alphabet Inc / Ally Financial Inc / CASI Pharmaceuticals Inc / Intersect Ent Inc / Cymabay Therapeutics Inc / VBI Vaccines Inc / Cellectar Biosciences Inc / Otonomy Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Fortress Biotech Inc / Evolent Health Inc / Teladoc Health Inc / Conformis Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / STRATA Skin Sciences Inc / Fulgent Genetics Inc / Madrigal Pharmaceuticals Inc / Sierra Oncology Inc / Urogen Pharma Ltd / Iovance Biotherapeutics Inc / Veru Inc / Calyxt Inc / Molecular Templates Inc / Savara Inc / Synlogic Inc / Cue Biopharma Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Bionano Genomics Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / X4 Pharmaceuticals Inc / PDS Biotechnology Corp / Corbus Pharmaceuticals Holdings Inc / Organogenesis Holdings Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Beyond Air Inc / DermTech Inc / Frequency Therapeutics Inc / Pennant Group Inc / Relmada Therapeutics Inc / 89Bio Inc / Humanigen Inc / Nano-X Imaging Ltd / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / India / Ireland / Israel / Nigeria / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, May 13, 2021 / 11:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CDC Opens the Door to Teens; Plus Re-vaccination and Variant Vaccines</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Dilip Joseph</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 1Q21 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / 4901.T / A.N / BDX.N / LLY.N / PFE.N / RECI.MI / STDM.PA / TMO.N / WAT.N / ROG.S / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / WST.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / MRNA.OQ / VIFN.S / 2269.HK / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Fujifilm Holdings Corp / Agilent Technologies Inc / Becton Dickinson and Co / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Roche Holding AG / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / West Pharmaceutical Services Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Moderna Inc / Vifor Pharma AG / WuXi Biologics (Cayman) Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Intermoney Valores</td><td class="leftalignment">Rovi: Sólidos resultados 1T21, guías 2021 reiteradas - Intermoney Valores</td><td class="leftalignment">Spanish</td><td class="rightalignment">3</td><td class="leftalignment">ROVI=ES / MRNA=US</td><td class="leftalignment">Laboratorios Farmaceuticos ROVI SA / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Spain / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sr. Juan Ros R. Padilla</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Quantum Research Group, LLC</td><td class="leftalignment">IPO of NuGenerex Immuno-Oncology Reveals Generex's Undervaluation</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GNBT=US / PFE=US / AZN=US / JNJ=US / NVAX=US / MRNA=US</td><td class="leftalignment">Generex Biotechnology Corp / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">INITIATING COVERAGE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Karl Egeland</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / CLBS.O / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / NBSE.O / 77313F106 / XCUR.O / PASG.O / N90064101 / N71542109 / 03820J100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Caladrius Biosciences Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Exicure Inc / Passage Bio Inc / Uniqure NV / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">AskBio (subsidiary, unrated Bayer): Optimizing yield & quality (CGMMS feedback)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">02043Q107 / 339 / 03152W109 / MRNA.O / ARCT.O / 199800.KN / 00289Y107 / 03879J100 / CBIO / 75901B107 / 04280A100 / SIGHT.PA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / NBSE.O / 77313F106 / XCUR.O / PASG.O / N90064101 / N71542109 / 03820J100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Exicure Inc / Passage Bio Inc / Uniqure NV / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Moderna sinks 15.9% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / ICPT.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / VKTX.O / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / MDGL.O / LYS.PA / IVAA.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / NGM.O / 87166L100 / FIXX.O / MBIO.O / AXLA.O / AKRO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / ETNB.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Viking Therapeutics Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Madrigal Pharmaceuticals Inc / Lysogene SA / Inventiva SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / NGM Biopharmaceuticals Inc / Synlogic Inc / Homology Medicines Inc / Mustang Bio Inc / Axcella Health Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / 89Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: MRNA booster results; AVRO regulatory hurdles</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MRNA.OQ / EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Moderna Inc / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">OCGN (Neutral, PT $8): All eyes on EUA filing/authorization for COVAXIN</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OCGN.O / MRNA.O / ARCT.O</td><td class="leftalignment">Ocugen Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / BE / BSX / CAT / CF / CI / CLH / CMG / CMI / COST.O / DAN / DE / DHI / DLR / EL.N / EMN / ENS / FDX / INTC.O / JCI / JPM / K / KKR / LRCX.O / MCO / MDT / MS / MSFT.O / NEP / NTRS.O / O / ORA / ROP / RSG / SCI / SCM.N / T.N / UNH / URI / WM / AMZN.O / EBAY.O / WCC / AAPL.O / FIS / BWA.N / NVDA.O / DTE.N / SAPG.DE / SQ / NOVN.S / TREE.O / HRB.N / KMX.N / EW.N / ARE.N / CSGP.O / FCEL.O / ALGN.O / CREE.O / AVGO.O / ABMD.OQ / ATVI.OQ / XLNX.OQ / AMSC.OQ / HSIC.OQ / TTWO.OQ / ICPT.OQ / UTHR.OQ / AKAM.OQ / PLUG.OQ / ISRG.OQ / SWKS.OQ / NKTR.O / SIVB.O / TRMB.O / ITRI.O / ANSS.O / EQIX.O / NFLX.O / 92343V104 / 459200101 / 0700.HK / DPZ / ATRC.OQ / SPWR.O / CSIQ.O / FSLR.O / IPGP.O / ALCLS.PA / VMW / MRNA.O / TMDX.OQ / TWIN.O / 771195104 / CSII.O / AGCO.K / GLAXOSM.LG / TSLA.O / AMRC.K / AMRS.OQ / QSR.TO / AMD.OQ / FDUS.O / ZNGA.O / EA.O / ENPH.O / FB.O / HASI.N / TWTR.K / GOOGL.O / PAYC.K / APPS.O / SEDG.O / RUN.O / TMUS.OQ / WKHS.O / WCN.TO / AQMS.O / TTD.OQ / FLGT.OQ / WPRT.TO / UAA / SNAP.K / IOVA.OQ / CLXT.O / ROKU.O / VICp.V / APTV.K / ALLO.OQ / CWENa.K / SWAV.O / UBER.K / PTON.OQ / NLOK.O / DKNG.O / AVNT.K / 02081G201 / RWRh.V / REGW.M3 / 03823M100 / 390320109</td><td class="leftalignment">Albemarle Corp / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / CF Industries Holdings Inc / Cigna Corp / Clean Harbors Inc / Chipotle Mexican Grill Inc / Cummins Inc / Costco Wholesale Corp / Dana Inc / Deere & Co / D R Horton Inc / Digital Realty Trust Inc / Estee Lauder Companies Inc / Eastman Chemical Co / EnerSys / FedEx Corp / Intel Corp / Johnson Controls International PLC / JPMorgan Chase & Co / Kellogg Co / KKR & Co Inc / Lam Research Corp / Moody's Corp / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / Northern Trust Corp / Realty Income Corp / Ormat Technologies Inc / Roper Technologies Inc / Republic Services Inc / Service Corporation International / Stellus Capital Investment Corp / AT&T Inc / UnitedHealth Group Inc / United Rentals Inc / Waste Management Inc / Amazon.com Inc / eBay Inc / Wesco International Inc / Apple Inc / Fidelity National Information Services Inc / Borgwarner Inc / NVIDIA Corp / DTE Energy Co / SAP SE / Block Inc / Novartis AG / Lendingtree Inc / H & R Block Inc / Carmax Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / CoStar Group Inc / Fuelcell Energy Inc / Align Technology Inc / Wolfspeed Inc / Broadcom Inc / ABIOMED Inc / Activision Blizzard Inc / Xilinx Inc / American Superconductor Corp / Henry Schein Inc / Take-Two Interactive Software Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Akamai Technologies Inc / Plug Power Inc / Intuitive Surgical Inc / Skyworks Solutions Inc / Nektar Therapeutics / SVB Financial Group / Trimble Inc / Itron Inc / ANSYS Inc / Equinix Inc / Netflix Inc / Verizon Communications Inc / International Business Machines Corp / Tencent Holdings Ltd / Domino's Pizza Inc / AtriCure Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / IPG Photonics Corp / Cellectis SA / VMware Inc / Moderna Inc / Transmedics Group Inc / Twin Disc Inc / Roche Holding AG / Cardiovascular Systems Inc / AGCO Corp / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Ameresco Inc / Amyris Inc / Restaurant Brands International Inc / Advanced Micro Devices Inc / Fidus Investment Corp / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Meta Platforms Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Twitter Inc / Alphabet Inc / Paycom Software Inc / Digital Turbine Inc / Solaredge Technologies Inc / Sunrun Inc / T-Mobile US Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Trade Desk Inc / Fulgent Genetics Inc / Westport Fuel Systems Inc / Under Armour Inc / Snap Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Roku Inc / Victory Capital Corp / Aptiv PLC / Allogene Therapeutics Inc / Clearway Energy Inc / Shockwave Medical Inc / Uber Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / DraftKings Inc / Avient Corp / Alphatec Holdings Inc / Strathmore Plus Energy Corp / Regency World Consulting Ltd / Applied Minerals Inc / Great Elm Capital Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / India / Ireland / Nigeria / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q21 Review: Platform Advancing; More Material Updates Coming up</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALCLS.PA / UTHR.OQ / MRNA.O / IOVA.OQ / CLXT.O / ALLO.OQ</td><td class="leftalignment">Cellectis SA / United Therapeutics Corp / Moderna Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Virtual BioInsights Northeast Bus Tour Roundup</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">75886F107 / 02043Q107 / 023111206 / 868459108 / G11196105 / 558868105 / 67576A100 / 60770K107 / 492327101 / 760273102 / 24344T101</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amarin Corporation PLC / Supernus Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / Madrigal Pharmaceuticals Inc / Ocular Therapeutix Inc / Moderna Inc / Keros Therapeutics Inc / Repare Therapeutics Inc / Deciphera Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">FIXX (Buy, $30): 2000L scale and a focus on analytics (CGMMS feedback)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">FIXX.O / MRNA.O / 75901B107 / SLDB / 00773U108 / MGTX.O / 54142F102 / 87166L100 / N90064101 / 03820J100</td><td class="leftalignment">Homology Medicines Inc / Moderna Inc / Regenxbio Inc / Solid Biosciences Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / Synlogic Inc / Uniqure NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.7.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 07, 2021</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / GE / HUM / MDT / RAD / SGE.L / SYK / UNH / WMT / GILD.O / AMGN.O / AAPL.O / NOVN.S / HCA.N / CYH.N / INSP.N / EW.N / DRRX.O / INCY.OQ / NBIX.OQ / EPIX.OQ / ICPT.OQ / UTHR.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / MNKD.O / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / ALCLS.PA / BLRX.TA / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / ENTA.O / FATE.OQ / AUP.TO / AERI.O / TRVN.O / GLMD.OQ / GOOGL.O / ALDX.OQ / MDWD.O / 02005N100 / AGRX.OQ / CBAY.OQ / APS.TO / VKTX.O / NVRO.N / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / GKOS.K / ZBH.N / CFMS.O / GBT.OQ / 100063846 / EDIT.OQ / NVTA.K / ADAP.O / NTLA.O / SYRS.OQ / TCMD.OQ / FLGT.OQ / IRTC.OQ / MDGL.O / VREX.OQ / SLNO.OQ / IOVA.OQ / VERU.OQ / KALA.O / ATNX.O / FIXX.OQ / 720795103 / PRVB.OQ / ARVN.OQ / ALLO.OQ / MRKR.OQ / CRSP.BN / XFOR.OQ / 21833P103 / DTIL.O / IMUX.O / TPTX.O / ONCT.OQ / KRTX.OQ / PSNL.O / PNTG.OQ / BXRX.OQ / ETNB.O / ORIC.OQ / PHGE.K / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / General Electric Co / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / DURECT Corp / Incyte Corp / Neurocrine Biosciences Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / BioLine RX Ltd / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Galmed Pharmaceuticals Ltd / Alphabet Inc / Aldeyra Therapeutics Inc / Mediwound Ltd / Ally Financial Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Aptose Biosciences Inc / Viking Therapeutics Inc / Nevro Corp / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Global Blood Therapeutics Inc / Truist Financial Corp / Editas Medicine Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Madrigal Pharmaceuticals Inc / Varex Imaging Corp / Soleno Therapeutics Inc / Iovance Biotherapeutics Inc / Veru Inc / Kala Pharmaceuticals Inc / Athenex Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Arvinas Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / CRISPR Therapeutics AG / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Precision BioSciences Inc / Immunic Inc / Turning Point Therapeutics Inc / Oncternal Therapeutics Inc / Karuna Therapeutics Inc / Personalis Inc / Pennant Group Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Biomx Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / India / Ireland / Israel / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">MRNA (Buy, $188): A profitable quarter and C19 variant neutralization</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.O / ARCT / 339 / 03152W109 / 800677106 / 199800.KN / 75901B107 / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / N90064101 / 03820J100</td><td class="leftalignment">Moderna Inc / Arcturus Therapeutics Holdings Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / ToolGen Inc / Regenxbio Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Uniqure NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACA / ALB.N / AMN / AMT / AXP / BKI / CCI.N / CHE / CI / CNC / CVS / DLR / HUM / KKR / MSFT.O / NICE.TA / NKE / ORA / RAD / RBC / RXN / T.N / TPR / UNH / WMT / ZEN / AMZN.O / BYND.O / GILD.O / FIS / WTS.N / KLR / SAPG.DE / SQ / HEAR.O / INTU.O / NOVN.S / RDWR.O / HCA.N / CYH.N / HRB.N / PZZA.O / CHTR.O / IO.N / DRRX.O / DOX.O / NET.N / ATVI.OQ / INCY.OQ / EPIX.OQ / TTWO.OQ / ICPT.OQ / AKAM.OQ / EXPE.OQ / BLUE.OQ / VRNT.OQ / CCRN.O / EGAN.O / AMED.O / PCTY.O / EQIX.O / SYNA.O / NFLX.O / GPRO.O / 478160104 / 92343V104 / 20030N101 / 459200101 / 00846U101 / 868168105 / DPZ / OLED.O / PBH.N / ACAD.O / LHCG.O / 36467W109 / CCOI.O / ALCLS.PA / LULU.O / 02043Q107 / ENSG.OQ / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / BLN.V / ADUS.O / USPH.N / GLAXOSM.LG / SLRC.O / TSLA.O / SUNS.O / ZNGA.O / EA.O / FB.O / ENTA.O / SFM.O / RNG.N / FATE.OQ / AUP.TO / TRVN.O / GLMD.OQ / GOOGL.O / ALDX.OQ / 82655M107 / 02005N100 / CBAY.OQ / VKTX.O / APPS.O / VRAY.OQ / EVH.N / TDOC.N / WING.O / SHOP.K / PYPL.O / SPXC.K / TMUS.OQ / 100063846 / ADAP.O / CDXC.OQ / NTLA.O / SYRS.OQ / FLGT.OQ / IRTC.OQ / TWLO.K / MDGL.O / UAA / CVNA.N / IOVA.OQ / ROKU.O / CARG.O / APTV.K / EGHT.K / FIXX.OQ / 720795103 / BILI.O / PRVB.OQ / FOCS.OQ / ALLO.OQ / MRKR.OQ / CRSP.BN / XFOR.OQ / 21833P103 / DTIL.O / IMUX.O / ZM.OQ / CMBM.OQ / KRTX.OQ / PTON.OQ / DDOG.O / PNTG.OQ / FSLY.K / ETNB.O / VG.O / ORIC.OQ / BILL.K / PHGE.K / RXT.O / HGEN.O / FROG.O / NMFC.O / ONDS.OQ / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / AMN Healthcare Services Inc / American Tower Corp / American Express Co / Black Knight Inc / Crown Castle International Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Digital Realty Trust Inc / Humana Inc / KKR & Co Inc / Microsoft Corp / Nice Ltd / Nike Inc / Ormat Technologies Inc / Rite Aid Corp / Regal Rexnord Corp / Zurn Water Solutions Corp / AT&T Inc / Tapestry Inc / UnitedHealth Group Inc / Walmart Inc / Zendesk Inc / Amazon.com Inc / Beyond Meat Inc / Gilead Sciences Inc / Fidelity National Information Services Inc / Watts Water Technologies Inc / Kaleyra Inc / SAP SE / Block Inc / Turtle Beach Corp / Intuit Inc / Novartis AG / Radware Ltd / HCA Healthcare Inc / Community Health Systems Inc / H & R Block Inc / Papa John's International Inc / Charter Communications Inc / ION Geophysical Corp / DURECT Corp / Amdocs Ltd / Cloudflare Inc / Activision Blizzard Inc / Incyte Corp / ESSA Pharma Inc / Take-Two Interactive Software Inc / Intercept Pharmaceuticals Inc / Akamai Technologies Inc / Expedia Group Inc / bluebird bio Inc / Verint Systems Inc / Cross Country Healthcare Inc / eGain Corp / Amedisys Inc / Paylocity Holding Corp / Equinix Inc / Synaptics Inc / Netflix Inc / GoPro Inc / Johnson & Johnson / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Domino's Pizza Inc / Universal Display Corp / Prestige Consumer Healthcare Inc / ACADIA Pharmaceuticals Inc / LHC Group Inc / GameStop Corp / Cogent Communications Holdings Inc / Cellectis SA / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Blackline Safety Corp / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / SLR Investment Corp / Tesla Inc / SLR Senior Investment Corp / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Enanta Pharmaceuticals Inc / Sprouts Farmers Market Inc / RingCentral Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Trevena Inc / Galmed Pharmaceuticals Ltd / Alphabet Inc / Aldeyra Therapeutics Inc / Sify Technologies Ltd / Ally Financial Inc / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Digital Turbine Inc / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Wingstop Inc / Shopify Inc / PayPal Holdings Inc / SPX Corp / T-Mobile US Inc / Truist Financial Corp / Adaptimmune Therapeutics PLC / Chromadex Corp / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Twilio Inc / Madrigal Pharmaceuticals Inc / Under Armour Inc / Carvana Co / Iovance Biotherapeutics Inc / Roku Inc / CarGurus Inc / Aptiv PLC / 8x8 Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / Provention Bio Inc / Focus Financial Partners Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / CRISPR Therapeutics AG / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Precision BioSciences Inc / Immunic Inc / Zoom Video Communications Inc / Cambium Networks Corp / Karuna Therapeutics Inc / Peloton Interactive Inc / Datadog Inc / Pennant Group Inc / Fastly Inc / 89Bio Inc / Vonage Holdings Corp / Oric Pharmaceuticals Inc / Bill.com Holdings Inc / Biomx Inc / Rackspace Technology Inc / Humanigen Inc / Jfrog Ltd / New Mountain Finance Corp / Ondas Holdings Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / India / Israel / Nigeria / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">ALE / ALL / ALV / ALV.N / AR / ARW / ASH / ATR / AXP / BRC / BWA / C / CCO / CE / CLR / CMG / CNP / CNX / COG / CPE / DHR / DIS / DOW / DVN / ED / EMN / EOG / EQT / FND / HUN / IP / IPG / MCHP.O / MGA / MGY / MRO / MTD / MUR / OGE / OI / OLN / OMC / PPG / PPL / PXD / RPM / RRC / SEE / SHW / SM / SON / STT / STZ / SWN / TAP.N / WLK / WLL / AUD.N / CMCSA.O / WWE / IRM / WCC / FIS / BWA.N / EPC / SBGI.O / MGA.N / SIRI.O / GPK / HXL.N / CHTR.O / EXPE.O / SLGN.O / LPI / GEF / LYB / BE.N / MNST.O / CALA.O / DIOD.O / NFLX.O / NXST.O / VIAC.O / DISCA.O / PODD.O / DAN.N / NOG.A / MRNA.O / ZIOP.O / AMCX.O / NMFC.N / ESTE.K / EPAM.K / MTDR.K / YELP.K / PDCE.O / BERY.K / FANG.O / MEIP.O / BCEI.K / FOXA.O / SFM.O / HMTV.O / AGTC.O / AXTA.K / WING.O / CABO.N / TGNA.K / CYAD.O / NTLA.O / ADNT.N / NGVT.K / LGFb.N / CDEV.O / CVNA.K / ATUS.N / IOVA.O / BOMN.O / ROKU.O / OCSL.O / EQH / SPOT.K / SSP.O / EVRG.K / AUTL.O / BRY.O / AXNX.O / LNT.O / IHRT.O / EPAC.K / CRNC.O / OAS.O / WTRG.K / AVNT.K / ROOT.O / CHK.O / HMPT.O / VZIO.N</td><td class="leftalignment">ALLETE Inc / Allstate Corp / Autoliv Inc / Autoliv Inc / Antero Resources Corp / Arrow Electronics Inc / Ashland Global Holdings Inc / Aptargroup Inc / American Express Co / Brady Corp / Borgwarner Inc / Citigroup Inc / Clear Channel Outdoor Holdings Inc / Celanese Corp / Continental Resources Inc / Chipotle Mexican Grill Inc / CenterPoint Energy Inc / CNX Resources Corp / Coterra Energy Inc / Callon Petroleum Co / Danaher Corp / Walt Disney Co / Dow Inc / Devon Energy Corp / Consolidated Edison Inc / Eastman Chemical Co / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Huntsman Corp / International Paper Co / Interpublic Group of Companies Inc / Microchip Technology Inc / Magna International Inc / Magnolia Oil & Gas Corp / Marathon Oil Corp / Mettler-Toledo International Inc / Murphy Oil Corp / OGE Energy Corp / O-I Glass Inc / Olin Corp / Omnicom Group Inc / PPG Industries Inc / PPL Corp / Pioneer Natural Resources Co / RPM International Inc / Range Resources Corp / Sealed Air Corp / Sherwin-Williams Co / SM Energy Co / Sonoco Products Co / State Street Corp / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Westlake Chemical Corp / Whiting Petroleum Corp / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Iron Mountain Inc / Wesco International Inc / Fidelity National Information Services Inc / Borgwarner Inc / Edgewell Personal Care Co / Sinclair Broadcast Group Inc / Magna International Inc / Sirius XM Holdings Inc / Graphic Packaging Holding Co / Hexcel Corp / Charter Communications Inc / Expedia Group Inc / Silgan Holdings Inc / Laredo Petroleum Inc / Greif Inc / LyondellBasell Industries NV / Bloom Energy Corp / Monster Beverage Corp / Calithera Biosciences Inc / Diodes Inc / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Discovery Inc / Insulet Corp / Dana Inc / Northern Oil and Gas Inc / Moderna Inc / ZIOPHARM Oncology Inc / AMC Networks Inc / New Mountain Finance Corp / Earthstone Energy Inc / Epam Systems Inc / Matador Resources Co / Yelp Inc / PDC Energy Inc / Berry Global Group Inc / Diamondback Energy Inc / MEI Pharma Inc / Civitas Resources Inc / Fox Corp / Sprouts Farmers Market Inc / Hemisphere Media Group Inc / Applied Genetic Technologies Corp / Axalta Coating Systems Ltd / Wingstop Inc / Cable One Inc / Tegna Inc / Celyad Oncology SA / Intellia Therapeutics Inc / Adient PLC / Ingevity Corp / Lions Gate Entertainment Corp / Centennial Resource Development Inc / Carvana Co / Altice USA Inc / Iovance Biotherapeutics Inc / Boston Omaha Corp / Roku Inc / Oaktree Specialty Lending Corp / Equitable Holdings Inc / Spotify Technology SA / E W Scripps Co / Evergy Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Axonics Inc / Alliant Energy Corp / iHeartMedia Inc / Enerpac Tool Group Corp / Cerence Inc / Oasis Petroleum Inc / Essential Utilities Inc / Avient Corp / Root Inc / Chesapeake Energy Corp / Home Point Capital Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">mRNA-1273 Driving Revenues, Profit, Cash; Patent Concerns Hitting Shares</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q21 Review: Starting to Plan for 2022 and Beyond</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRNA.O / 478160104</td><td class="leftalignment">Moderna Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Manufacturing Targets Intact; Variant Coverage and Booster Success Remain Key</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : 1Q Snapshot - The MRNA Rollercoaster Shows No Sign of Stopping Soon</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Patents a sideshow to 3 M’s - market share, manufacturing, margins. PT to $83</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">60770K10</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, May 06, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, May 06, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AIT / BWA / CCO / COST.O / DIS / FLT / GM.N / IPG / KNX / MSM / NI / OMC / PEG / PNC / PNW / RKT / SRE / WAT / WRK / AUD.N / CMCSA.O / WWE / JBHT.O / BWA.N / SBGI.O / JBT / HUBG.O / SIRI.O / NWN / ARNA.O / CHTR.O / FTS.TO / CTSH.O / BRX / BLUE.O / NFLX.O / BRKR.O / NXST.O / ASOS.L / VIAC.O / DISCA.O / XPO / BKCC.O / TNDM.OQ / MRNA.O / JACK.O / AMCX.O / WEN.O / TCPC.O / UIHC.O / FOXA.O / HMTV.O / LGIH.O / TSLX.K / ZALG.DE / HUBS.K / NVRO.K / QRVO.O / GKOS.K / WING.O / CABO.N / TGNA.K / PYPL.O / IONS.O / TWLO.K / LGFb.N / TRVG.O / ATUS.N / CGBD.O / BOMN.O / ROKU.O / SPOT.K / SSP.O / CDAY.K / DELL.K / TPTX.O / IHRT.O / EXC.O / LUMN.K / SKLZ.N / VZIO.N</td><td class="leftalignment">Applied Industrial Technologies Inc / Borgwarner Inc / Clear Channel Outdoor Holdings Inc / Costco Wholesale Corp / Walt Disney Co / Fleetcor Technologies Inc / General Motors Co / Interpublic Group of Companies Inc / Knight-Swift Transportation Holdings Inc / MSC Industrial Direct Co Inc / NiSource Inc / Omnicom Group Inc / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Rocket Companies Inc / Sempra Energy / Waters Corp / Westrock Co / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / J B Hunt Transport Services Inc / Borgwarner Inc / Sinclair Broadcast Group Inc / John Bean Technologies Corp / Hub Group Inc / Sirius XM Holdings Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Charter Communications Inc / Fortis Inc / Cognizant Technology Solutions Corp / Brixmor Property Group Inc / bluebird bio Inc / Netflix Inc / Bruker Corp / Nexstar Media Group Inc / ASOS PLC / ViacomCBS Inc / Discovery Inc / XPO Logistics Inc / BlackRock Capital Investment Corp / Tandem Diabetes Care Inc / Moderna Inc / Jack in the Box Inc / AMC Networks Inc / Wendys Co / BlackRock TCP Capital Corp / United Insurance Holdings Corp / Fox Corp / Hemisphere Media Group Inc / LGI Homes Inc / Sixth Street Specialty Lending Inc / Zalando SE / HubSpot Inc / Nevro Corp / Qorvo Inc / Glaukos Corp / Wingstop Inc / Cable One Inc / Tegna Inc / PayPal Holdings Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Lions Gate Entertainment Corp / Trivago NV / Altice USA Inc / TCG BDC Inc / Boston Omaha Corp / Roku Inc / Spotify Technology SA / E W Scripps Co / Ceridian HCM Holding Inc / Dell Technologies Inc / Turning Point Therapeutics Inc / iHeartMedia Inc / Exelon Corp / Lumen Technologies Inc / Skillz Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / United Kingdom / Luxembourg / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Encouraging Preliminary Data Supports Potential Success for Variant-Specific COVID-19 Booster</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Moderna, Inc - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AME / CMI / CRM.N / CSL / CVS / GE / INTC.O / KKR / MDT / MSFT.O / NICE.TA / RXN / SGE.L / T.N / AMZN.O / AMGN.O / AAPL.O / WTS.N / NVDA.O / DISH.O / HEAR.O / OUT / MPWR.O / VECO.O / INSP.N / SMTC.O / GPN / DRRX.O / AOS.N / CSCO.OQ / CRUS.OQ / JKHY.OQ / ATVI.OQ / INCY.OQ / TTWO.OQ / AKAM.OQ / VRTX.OQ / TXN.OQ / LPSN.O / EXAS.O / BIIB.O / 478160104 / AYX / DENN.O / 36467W109 / AIMC.O / 02043Q107 / 514766104 / MRNA.O / TMDX.OQ / NXPI.O / AMRC.K / ZNGA.O / EA.O / ADI.OQ / FB.O / HASI.N / RNG.N / 82655M107 / PAYC.K / SABR.O / AGRX.OQ / ANET.K / APS.TO / MCRB.OQ / ZBH.N / ZG.OQ / TMUS.OQ / NVTA.K / APL.PS / UAA / VREX.OQ / EGHT.K / BILI.O / ARVN.OQ / ZM.OQ / VG.O / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">AMETEK Inc / Cummins Inc / Salesforce.Com Inc / Carlisle Companies Inc / CVS Health Corp / General Electric Co / Intel Corp / KKR & Co Inc / Medtronic PLC / Microsoft Corp / Nice Ltd / Zurn Water Solutions Corp / Sage Group PLC / AT&T Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Watts Water Technologies Inc / NVIDIA Corp / DISH Network Corp / Turtle Beach Corp / OUTFRONT Media Inc / Monolithic Power Systems Inc / Veeco Instruments Inc / Inspire Medical Systems Inc / Semtech Corp / Global Payments Inc / DURECT Corp / A O Smith Corp / Cisco Systems Inc / Cirrus Logic Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Incyte Corp / Take-Two Interactive Software Inc / Akamai Technologies Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / LivePerson Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Alteryx Inc / Denny's Corp / GameStop Corp / Altra Industrial Motion Corp / Alnylam Pharmaceuticals Inc / Landec Corp / Moderna Inc / Transmedics Group Inc / NXP Semiconductors NV / Ameresco Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / RingCentral Inc / Sify Technologies Ltd / Paycom Software Inc / Sabre Corp / Agile Therapeutics Inc / Arista Networks Inc / Aptose Biosciences Inc / Seres Therapeutics Inc / Zimmer Biomet Holdings Inc / Zillow Group Inc / T-Mobile US Inc / Invitae Corp / Apollo Global Capital Inc / Under Armour Inc / Varex Imaging Corp / 8x8 Inc / Bilibili Inc / Arvinas Inc / Zoom Video Communications Inc / Vonage Holdings Corp / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Netherlands / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q21 Review: Biotech Jewel on the Cheap; Upgrading to Outperform with $205 PT</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN.O / VRTX.OQ / BIIB.O / 478160104 / 02043Q107 / MRNA.O / REGW.M3 / 03823M100</td><td class="leftalignment">Amgen Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Alnylam Pharmaceuticals Inc / Moderna Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 05 04</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AYI.N / KO.N / CRM.N / NKE.N / ORCL.N / ACN.N / UDR.N / KRC.N / GTN.N / JWa.N / OTEX.OQ / MRNA.OQ / AVGO.OQ / HPP.N / PPC.OQ / PYPL.OQ / PLNT.N / TMUS.OQ / SQ.N / WBT.N / SITC.N</td><td class="leftalignment">Acuity Brands Inc / Coca-Cola Co / Salesforce.Com Inc / Nike Inc / Oracle Corp / Accenture PLC / UDR Inc / Kilroy Realty Corp / Gray Television Inc / John Wiley & Sons Inc / Open Text Corp / Moderna Inc / Broadcom Inc / Hudson Pacific Properties Inc / Pilgrims Pride Corp / PayPal Holdings Inc / Planet Fitness Inc / T-Mobile US Inc / Block Inc / Welbilt Inc / Site Centers Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment">Apparel & Textiles / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Electrical / Food / Info. Tech./Software / Leisure & Entertainment / Machinery / Publishing / Real Estate / Semiconductors / Technology / Telecommunications</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Indonesia Healthcare Sector - New report: Bi-weekly vaccination tracker (Apr-May) - New cases stable, independent vaccines to start on 9 May 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRNA.OQ / 1099.HK</td><td class="leftalignment">Moderna Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Indonesia / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Khun Steven Ho</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: April 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ALB.N / AN.N / AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CL.N / CNC.N / COF.N / CRM.N / ED.N / EIX.N / EOG.N / FCX.N / GE.N / GM.N / GPS.N / IBM.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / MRK.N / OXY.N / TXT.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / DHR.N / DIS.N / UNH.N / FE.N / URI.N / DE.N / CAT.N / SPOT.N / AMG.N / GS.N / CLX.N / HON.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / LIN.N / OLN.N / TGT.N / AVY.N / PKI.N / VZ.N / NYT.N / KSS.N / HRB.N / ORCL.N / KMX.N / PWR.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / AIV.N / HAE.N / LB.TO / BLK.N / CVX.N / MHK.N / NWS.AX / IRM.N / NCR.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / COHR.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / PII.N / REGN.OQ / SIVB.OQ / XLNX.OQ / QDEL.OQ / QCOM.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / VSAT.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / NVDA.OQ / BMRN.OQ / PACW.OQ / EXPE.OQ / TREE.OQ / MRVL.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / SGEN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / BIIB.OQ / SNX.N / TPX.N / SBNY.OQ / AGO.N / ACAD.OQ / MOS.N / MKTX.OQ / DXCM.OQ / WAL.N / MS.N / STX.AX / MA.N / AWI.N / FSLR.OQ / IVZ.N / CLR.N / QGEN.N / TDC.N / SATS.OQ / MRNA.OQ / NWSA.OQ / AGCO.N / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / NXPI.OQ / ADSGN.F / LPLA.OQ / AMD.OQ / XYL.N / SLM.OQ / ENPH.OQ / TRIP.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / RNG.N / MAR.OQ / PTC.OQ / GOOGL.OQ / PAYC.N / EQC.N / HUBS.N / ETSY.OQ / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / IONS.OQ / RETA.OQ / TWLO.N / COUP.OQ / CDEV.OQ / AYX.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / PEP.OQ / ZS.OQ / FB.PS / STNE.OQ / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / RTX.N / CARR.N / LMND.N / AMWL.N / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / AutoNation Inc / Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / Consolidated Edison Inc / Edison International / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Occidental Petroleum Corp / Textron Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Affiliated Managers Group Inc / Goldman Sachs Group Inc / Clorox Co / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Linde PLC / Olin Corp / Target Corp / Avery Dennison Corp / PerkinElmer Inc / Verizon Communications Inc / New York Times Co / Kohls Corp / H & R Block Inc / Oracle Corp / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Haemonetics Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Mohawk Industries Inc / News Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Coherent Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / SVB Financial Group / Xilinx Inc / Quidel Corp / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / ViaSat Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Expedia Group Inc / Lendingtree Inc / Marvell Technology Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Seagen Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Biogen Inc / TD Synnex Corp / Tempur Sealy International Inc / Signature Bank / Assured Guaranty Ltd / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Dexcom Inc / Western Alliance Bancorp / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Invesco Ltd / Continental Resources Inc / Qiagen NV / Teradata Corp / EchoStar Corp / Moderna Inc / News Corp / AGCO Corp / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / Adidas AG / LPL Financial Holdings Inc / Advanced Micro Devices Inc / Xylem Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / RingCentral Inc / Marriott International Inc / PTC Inc / Alphabet Inc / Paycom Software Inc / Equity Commonwealth / HubSpot Inc / ETSY Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Centennial Resource Development Inc / Alteryx Inc / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / PepsiCo Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / American Well Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Germany / Ireland / Luxembourg / Netherlands / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">WHO Emergency Use Listing and 500M Gavi COVAX Supply Agreement</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">ABT / AEE / AEP.N / AGR / ALC / ALE / AME / AMT / AON / ATO / ATR / AZO / BAC / BAX / BDX / BKH / BP / BRC / BSX / CCI / CCO / CL / CMG / CMS / CNP / COO / COP / COST.O / CVX / D / DIS / DK / DLR / DOW / DRI / DTE / DUK / DVN / DY / EAT / ED / EIX / EL / ES / ETM / ETR / FE / FND / FRC / FRT / GPS / HD / HE / HES / HFC / IDA / IEX / IFF / IPG / JNJ / LOW / MA / MCD / MDT / MPC / MUR / NKE / NSC / OGE / OLN / OMC / OXY / PCG / PEG / PEN / PNM / PNW / POR / PPL / PSX / RH / RKT / RL / ROP / SM / SO / SPG / STZ / SYK / SYY / T / TFX / TPR / USM / VFC / VLO / W / WAL / WEC / XLNX.O / TROW.O / AMZN.O / CMCSA.O / EW / WWE / IRM / AAPL.O / CSCO.O / SBGI.O / SU.TO / JBT / PEB.N / XOM / GTN / PBF / SBAC.O / SIRI.O / CONE.O / SGMO.O / IART.O / VZ / SBUX.O / SNPS.O / ROST.O / CHTR.O / EXPE.O / DLTR.O / GPN / FTS.TO / ISRG.O / EMA.TO / CAKE.O / NEE / LYB / TSCO.O / REAL.O / NDSN.O / SIVB.O / BLUE.O / MMSI.O / ORLY.O / ACGL.O / EQIX.O / WOOF.O / NFLX.O / RRGB.O / CMCO.O / NXST.O / SBNY.O / NUVA.O / TXRH.O / VIAC.O / DENN.O / QSR / RDSb / DXCM.O / DISCA.O / BJRI.O / CNSL.O / CLMT.O / CCOI.O / HST.N / H.TO / PODD.O / BKCC.O / TNDM.OQ / MRNA.O / JACK.O / ZIOP.O / AQN / NXPI.O / LUNG.O / ADSGn.DE / STAG.K / AMCX.O / ESTE.K / FB.O / GMED.K / PFSI.K / FOXA.O / HMTV.O / MAR.O / FATE.O / QURE.O / GOOGL.O / AFMD.O / NVRO.K / TBK.O / QRVO.O / GKOS.K / WING.O / CABO.N / ZBH / TGNA.K / CYAD.O / SPNE.O / PFGC.K / NVCR.O / TMUS.O / VYGR.O / WLTW.O / ADAP.O / EDIT.O / NTLA.O / USFD.K / CRSP.O / UAA / LGFb.N / UNIT.O / CLLS.O / ATUS.N / IOVA.O / BOMN.O / HESM.K / ROKU.O / SWCH.K / XEL.O / CDLX.O / INSP.K / SPOT.K / SSP.O / EVRG.K / AVRO.O / AUTL.O / AXNX.O / NWL.O / LNT.O / CPRI.K / SWAV.O / TPTX.O / UBER.K / IHRT.O / AVTR.K / EXC.O / EPAC.K / PGEN.O / BEAM.O / NARI.O / AVNT.K / NWE.O / OM.O / LUMN.K / EAR.O / CHX.O / GRCL.O / HMPT.O / VZIO.N</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / American Electric Power Company Inc / Avangrid Inc / Alcon AG / ALLETE Inc / AMETEK Inc / American Tower Corp / Aon PLC / Atmos Energy Corp / Aptargroup Inc / Autozone Inc / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Black Hills Corp / BP PLC / Brady Corp / Boston Scientific Corp / Crown Castle International Corp / Clear Channel Outdoor Holdings Inc / Colgate-Palmolive Co / Chipotle Mexican Grill Inc / CMS Energy Corp / CenterPoint Energy Inc / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chevron Corp / Dominion Energy Inc / Walt Disney Co / Delek US Holdings Inc / Digital Realty Trust Inc / Dow Inc / Darden Restaurants Inc / DTE Energy Co / Duke Energy Corp / Devon Energy Corp / Dycom Industries Inc / Brinker International Inc / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / Eversource Energy / Audacy Inc / Entergy Corp / FirstEnergy Corp / Floor & Decor Holdings Inc / First Republic Bank / Federal Realty Investment Trust / Gap Inc / Home Depot Inc / Hawaiian Electric Industries Inc / Hess Corp / HollyFrontier Corp / Idacorp Inc / IDEX Corp / International Flavors & Fragrances Inc / Interpublic Group of Companies Inc / Johnson & Johnson / Lowe's Companies Inc / Mastercard Inc / McDonald's Corp / Medtronic PLC / Marathon Petroleum Corp / Murphy Oil Corp / Nike Inc / Norfolk Southern Corp / OGE Energy Corp / Olin Corp / Omnicom Group Inc / Occidental Petroleum Corp / PG&E Corp / Public Service Enterprise Group Inc / Penumbra Inc / PNM Resources Inc / Pinnacle West Capital Corp / Portland General Electric Co / PPL Corp / Phillips 66 / RH / Rocket Companies Inc / Ralph Lauren Corp / Roper Technologies Inc / SM Energy Co / Southern Co / Simon Property Group Inc / Constellation Brands Inc / Stryker Corp / Sysco Corp / AT&T Inc / Teleflex Inc / Tapestry Inc / United States Cellular Corp / VF Corp / Valero Energy Corp / Wayfair Inc / Western Alliance Bancorp / WEC Energy Group Inc / Xilinx Inc / T Rowe Price Group Inc / Amazon.com Inc / Comcast Corp / Edwards Lifesciences Corp / World Wrestling Entertainment Inc / Iron Mountain Inc / Apple Inc / Cisco Systems Inc / Sinclair Broadcast Group Inc / Suncor Energy Inc / John Bean Technologies Corp / Pebblebrook Hotel Trust / Exxon Mobil Corp / Gray Television Inc / PBF Energy Inc / SBA Communications Corp / Sirius XM Holdings Inc / CyrusOne Inc / Sangamo Therapeutics Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Starbucks Corp / Synopsys Inc / Ross Stores Inc / Charter Communications Inc / Expedia Group Inc / Dollar Tree Inc / Global Payments Inc / Fortis Inc / Intuitive Surgical Inc / Emera Inc / Cheesecake Factory Inc / Nextera Energy Inc / LyondellBasell Industries NV / Tractor Supply Co / RealReal Inc / Nordson Corp / SVB Financial Group / bluebird bio Inc / Merit Medical Systems Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Equinix Inc / Petco Health and Wellness Company Inc / Netflix Inc / Red Robin Gourmet Burgers Inc / Columbus McKinnon Corp / Nexstar Media Group Inc / Signature Bank / NuVasive Inc / Texas Roadhouse Inc / ViacomCBS Inc / Denny's Corp / Restaurant Brands International Inc / Royal Dutch Shell PLC / Dexcom Inc / Discovery Inc / BJ's Restaurants Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Hydro One Ltd / Insulet Corp / BlackRock Capital Investment Corp / Tandem Diabetes Care Inc / Moderna Inc / Jack in the Box Inc / ZIOPHARM Oncology Inc / Algonquin Power & Utilities Corp / NXP Semiconductors NV / Pulmonx Corp / Adidas AG / STAG Industrial Inc / AMC Networks Inc / Earthstone Energy Inc / Meta Platforms Inc / Globus Medical Inc / PennyMac Financial Services Inc / Fox Corp / Hemisphere Media Group Inc / Marriott International Inc / Fate Therapeutics Inc / Uniqure NV / Alphabet Inc / Affimed NV / Nevro Corp / Triumph Bancorp Inc / Qorvo Inc / Glaukos Corp / Wingstop Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Tegna Inc / Celyad Oncology SA / SeaSpine Holdings Corp / Performance Food Group Co / Novocure Ltd / T-Mobile US Inc / Voyager Therapeutics Inc / Willis Towers Watson PLC / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Intellia Therapeutics Inc / US Foods Holding Corp / CRISPR Therapeutics AG / Under Armour Inc / Lions Gate Entertainment Corp / Uniti Group Inc / Cellectis SA / Altice USA Inc / Iovance Biotherapeutics Inc / Boston Omaha Corp / Hess Midstream LP / Roku Inc / Switch Inc / Xcel Energy Inc / Cardlytics Inc / Inspire Medical Systems Inc / Spotify Technology SA / E W Scripps Co / Evergy Inc / AVROBIO Inc / Autolus Therapeutics PLC / Axonics Inc / Newell Brands Inc / Alliant Energy Corp / Capri Holdings Ltd / Shockwave Medical Inc / Turning Point Therapeutics Inc / Uber Technologies Inc / iHeartMedia Inc / Avantor Inc / Exelon Corp / Enerpac Tool Group Corp / Precigen Inc / Beam Therapeutics Inc / Inari Medical Inc / Avient Corp / NorthWestern Corp / Outset Medical Inc / Lumen Technologies Inc / Eargo Inc / ChampionX Corp / Gracell Biotechnologies Inc / Home Point Capital Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">April Clinical Trial Tracker - Focus on Oncology</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O / ZIOP.O / FATE.O / AFMD.O / CYAD.O / ADAP.O / CLLS.O / AUTL.O / TPTX.O / GRCL.O</td><td class="leftalignment">Moderna Inc / ZIOPHARM Oncology Inc / Fate Therapeutics Inc / Affimed NV / Celyad Oncology SA / Adaptimmune Therapeutics PLC / Cellectis SA / Autolus Therapeutics PLC / Turning Point Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / China / Cayman Islands / France / United Kingdom / Croatia / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: QURE hold cleared as ADVM sees SUSAR</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADVM.OQ / UQ1.F / EBS / ISEE / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Adverum Biotechnologies Inc / Uniqure NV / Emergent BioSolutions Inc / Iveric Bio Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">MRNA - Embedded Expectations Analysis - 2021 04 30</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna jumps 31.1% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">BAX / BSX / CHE / CNC / CRY.N / HUM / MDT / SYK / UNH / GILD.O / AMGN.O / NOVN.S / RMD.N / CYH.N / EW.N / IART.OQ / NBIX.OQ / BMRN.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 881624209 / ALNY.OQ / ACAD.O / ATRC.OQ / DXCM.O / CYCC.OQ / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / MRNA.O / BBI.O / AGIO.OQ / ALDX.OQ / 02005N100 / CLRB.OQ / INO.O / VKTX.O / TDOC.N / CFMS.O / NVCR.OQ / APLS.OQ / MDGL.O / IOVA.OQ / 720795103 / ALLO.OQ / MRKR.OQ / ORTX.OQ / CRSP.BN / SWAV.O / BWAY.TA / KRTX.OQ / NBSE.O / CRDF.OQ / FMTX.O / REGW.M3 / 03823M100</td><td class="leftalignment">Baxter International Inc / Boston Scientific Corp / Chemed Corp / Centene Corp / CryoLife Inc / Humana Inc / Medtronic PLC / Stryker Corp / UnitedHealth Group Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Teva Pharmaceutical Industries Ltd / Alnylam Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / Cyclacel Pharmaceuticals Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Moderna Inc / Brickell Biotech Inc / Agios Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Cellectar Biosciences Inc / Inovio Pharmaceuticals Inc / Viking Therapeutics Inc / Teladoc Health Inc / Conformis Inc / Novocure Ltd / Apellis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / Brainsway Ltd / Karuna Therapeutics Inc / NeuBase Therapeutics Inc / Cardiff Oncology Inc / Forma Therapeutics Holdings Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AON / BK / F.N / FTI / ICE / LH / MCD / NLY / O / QCOM.O / RE / RJF / TMO / EBAY.O / HT / AAPL.O / DOL.TO / ORLY.O / QSR / DISCA.O / CCS.N / MRNA.O / ADP.O / FB.O / WLTW.O / SNDR.N / TEVA.K / XEL.O / EQH / MORF.O</td><td class="leftalignment">Aon PLC / Bank of New York Mellon Corp / Ford Motor Co / TechnipFMC PLC / Intercontinental Exchange Inc / Laboratory Corporation of America Holdings / McDonald's Corp / Annaly Capital Management Inc / Realty Income Corp / Qualcomm Inc / Everest Re Group Ltd / Raymond James Financial Inc / Thermo Fisher Scientific Inc / eBay Inc / Hersha Hospitality Trust / Apple Inc / Dollarama Inc / O'Reilly Automotive Inc / Restaurant Brands International Inc / Discovery Inc / Century Communities Inc / Moderna Inc / Automatic Data Processing Inc / Meta Platforms Inc / Willis Towers Watson PLC / Schneider National Inc / Teva Pharmaceutical Industries Ltd / Xcel Energy Inc / Equitable Holdings Inc / Morphic Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Additional Capital Investments Support Increased Manufacturing Guidance for 2021/2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Moderna Increases 2022 COVID Vaccine Dose Guidance to 3 Billion</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 1Q21 Results Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">SASY.PA / AZN.L / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / REGN.OQ / MRNA.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Moderna Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Apr. 28, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - Quick Take: 1Q21 review -Uneventful results; ongoing restructuring efforts, while maintain our working thesis on vaccine CMO initiative</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">006280.KS / MRK.N / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Merck & Co Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Three-bagger Moderna soars 282%</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRM.N / FDS / MSFT.O / NOW / ORA / HEAR.O / CSGP.O / ATVI.OQ / SGMS.OQ / CHKP.OQ / TTWO.OQ / BIIB.O / 92343V104 / 833034101 / 36467W109 / MRNA.O / FRPT.O / JACK.O / TSLA.O / NXPI.O / ZNGA.O / EA.O / GOOGL.O / 82655M107 / PAYC.K / SNOW.K / SHOP.K / SPGI.K / CVNA.N / WDAY.O / BILI.O / ZM.OQ / NBSE.O / DDOG.O / DKNG.O / GAN.O / ZI.OQ / HUYA.K</td><td class="leftalignment">Salesforce.Com Inc / Factset Research Systems Inc / Microsoft Corp / ServiceNow Inc / Ormat Technologies Inc / Turtle Beach Corp / CoStar Group Inc / Activision Blizzard Inc / Scientific Games Corp / Check Point Software Technologies Ltd / Take-Two Interactive Software Inc / Biogen Inc / Verizon Communications Inc / Snap-On Inc / GameStop Corp / Moderna Inc / Freshpet Inc / Jack in the Box Inc / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Electronic Arts Inc / Alphabet Inc / Sify Technologies Ltd / Paycom Software Inc / Snowflake Inc. / Shopify Inc / S&P Global Inc / Carvana Co / Workday Inc / Bilibili Inc / Zoom Video Communications Inc / NeuBase Therapeutics Inc / Datadog Inc / DraftKings Inc / Gan Ltd / ZoomInfo Technologies Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / India / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Fill/Finish Partnership with Sanofi Supports US Manufacture of 200M Additional Doses Beginning in 3Q21</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / ISEE / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / SIOX / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Iveric Bio Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / ALB.N / AXP / BAC.N / BAX / BE / BSX / C.N / CAT / CCI.N / CI / CLH / CMI / COF / CSL / DAN / DE / EL.N / ENS / GS / JCI / JEF / JPM / KKR / MDT / MS / MSFT.O / NEP / NOW / ORA / PNC.N / RSG / T.N / TEL / UNH / USB / W / WFC.N / WM / TME / AMZN.O / GILD.O / AAPL.O / BWA.N / NVDA.O / NOVN.S / MPWR.O / SBUX.O / SMTC.O / EW.N / FCEL.O / LSTR.O / CREE.O / NET.N / AVGO.O / AMSC.OQ / IART.OQ / NBIX.OQ / TTWO.OQ / PLUG.OQ / MRVL.OQ / BLUE.OQ / TXN.OQ / MGRC.O / TEAM.O / SIVB.O / TRMB.O / ITRI.O / GNSS.O / NFLX.O / 478160104 / 92343V104 / 459200101 / 316773100 / 0700.HK / OLED.O / NDAQ.O / ATRC.OQ / DXCM.O / G02602103 / 029899101 / SPWR.O / XPO / CSIQ.O / FSLR.O / PODD.O / LULU.O / 02043Q107 / TNDM.O / 514766104 / MRNA.O / BBI.O / TWIN.O / CSII.O / AGCO.K / ADUS.O / TSLA.O / AMRC.K / AMRS.OQ / ENPH.O / FB.O / CG.O / HASI.N / RNG.N / WIX.O / CLRB.OQ / 174610105 / QRVO.O / ETSY.O / SEDG.O / ZG.OQ / RUN.O / TMUS.OQ / WKHS.O / WCN.TO / AQMS.O / SPGI.K / TTD.OQ / APL.PS / COUP.O / WPRT.TO / SNAP.K / OKTA.O / IOVA.OQ / RDFN.O / WDAY.O / ROKU.O / MDB.O / APTV.K / 720795103 / OSS.O / FOCS.OQ / ESTC.N / MRKR.OQ / CWENa.K / CRSP.BN / FTDR.O / UBER.K / CRWD.O / PTON.OQ / VG.O / DKNG.O / AVNT.K / 02081G201 / RWRh.V / 120248964</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / American Express Co / Bank of America Corp / Baxter International Inc / Bloom Energy Corp / Boston Scientific Corp / Citigroup Inc / Caterpillar Inc / Crown Castle International Corp / Cigna Corp / Clean Harbors Inc / Cummins Inc / Capital One Financial Corp / Carlisle Companies Inc / Dana Inc / Deere & Co / Estee Lauder Companies Inc / EnerSys / Goldman Sachs Group Inc / Johnson Controls International PLC / Jefferies Financial Group Inc / JPMorgan Chase & Co / KKR & Co Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / ServiceNow Inc / Ormat Technologies Inc / PNC Financial Services Group Inc / Republic Services Inc / AT&T Inc / TE Connectivity Ltd / UnitedHealth Group Inc / US Bancorp / Wayfair Inc / Wells Fargo & Co / Waste Management Inc / Tencent Music Entertainment Group / Amazon.com Inc / Gilead Sciences Inc / Apple Inc / Borgwarner Inc / NVIDIA Corp / Novartis AG / Monolithic Power Systems Inc / Starbucks Corp / Semtech Corp / Edwards Lifesciences Corp / Fuelcell Energy Inc / Landstar System Inc / Wolfspeed Inc / Cloudflare Inc / Broadcom Inc / American Superconductor Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Plug Power Inc / Marvell Technology Inc / bluebird bio Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / SVB Financial Group / Trimble Inc / Itron Inc / Genasys Inc / Netflix Inc / Johnson & Johnson / Verizon Communications Inc / International Business Machines Corp / Fifth Third Bancorp / Tencent Holdings Ltd / Universal Display Corp / Nasdaq Inc / AtriCure Inc / Dexcom Inc / Amdocs Ltd / American States Water Co / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Insulet Corp / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Landec Corp / Moderna Inc / Brickell Biotech Inc / Twin Disc Inc / Cardiovascular Systems Inc / AGCO Corp / Addus Homecare Corp / Tesla Inc / Ameresco Inc / Amyris Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / RingCentral Inc / Wix.Com Ltd / Cellectar Biosciences Inc / Citizens Financial Group Inc / Qorvo Inc / ETSY Inc / Solaredge Technologies Inc / Zillow Group Inc / Sunrun Inc / T-Mobile US Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / S&P Global Inc / Trade Desk Inc / Apollo Global Capital Inc / Coupa Software Inc / Westport Fuel Systems Inc / Snap Inc / Okta Inc / Iovance Biotherapeutics Inc / Redfin Corp / Workday Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Pieris Pharmaceuticals Inc / One Stop Systems Inc / Focus Financial Partners Inc / Elastic NV / Marker Therapeutics Inc / Clearway Energy Inc / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Vonage Holdings Corp / DraftKings Inc / Avient Corp / Alphatec Holdings Inc / Strathmore Plus Energy Corp / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Philippines / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">1Q21 Genetic Medicine Earnings Preview and Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">00289Y10 / 00773U10 / 02043Q10 / 46222210 / 04280A10 / 604749101 / Y9530810 / 60770K10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10</td><td class="leftalignment">Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Alnylam Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / WAVE Life Sciences Ltd / Moderna Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Chardan's 5th GMs Manufacturing Summit is here</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for MRNA.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Recommends JNJ Vax Again, CDC and FDA Provide Cautions but No Restrictions</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / 71708110 / 04635310 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Danielle J. Antalffy / Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mani Foroohar, M.D. / Andrew Berens, M.D. / Rebecca Wang, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">04/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Rotational Bull Supports Diversity, Not Caution</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">ACA / ALB.N / CI / CSII / CSL / EL.N / FB / FOCS / KKR / MDT / MS / TEL / UNH / W / TME / AMZN.O / AAPL.O / NVDA.O / MPWR.O / SBUX.O / SMTC.O / NET.N / AVGO.O / IART.OQ / TTWO.OQ / MRVL.OQ / TXN.OQ / MGRC.O / TEAM.O / ITRI.O / NFLX.O / 0700.HK / OLED.O / NDAQ.O / XPO / CSIQ / CSIQ.O / LULU.O / MRNA.O / CSII.O / ADUS.O / FB.O / CG.O / RNG.N / WIX.O / QRVO.O / ETSY.O / RUN.O / SPGI.K / TTD.OQ / APL.PS / COUP.O / SNAP.K / OKTA.O / IOVA.OQ / WDAY.O / ROKU.O / MDB.O / FOCS.OQ / ESTC.N / CRSP.BN / FTDR.O / UBER.K / CRWD.O / PTON.OQ / VG.O / DKNG.O / DKNG</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Cigna Corp / Cardiovascular Systems Inc / Carlisle Companies Inc / Estee Lauder Companies Inc / Meta Platforms Inc / Focus Financial Partners Inc / KKR & Co Inc / Medtronic PLC / Morgan Stanley / TE Connectivity Ltd / UnitedHealth Group Inc / Wayfair Inc / Tencent Music Entertainment Group / Amazon.com Inc / Apple Inc / NVIDIA Corp / Monolithic Power Systems Inc / Starbucks Corp / Semtech Corp / Cloudflare Inc / Broadcom Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Marvell Technology Inc / Texas Instruments Inc / McGrath RentCorp / Atlassian Corporation PLC / Itron Inc / Netflix Inc / Tencent Holdings Ltd / Universal Display Corp / Nasdaq Inc / XPO Logistics Inc / Canadian Solar Inc / Canadian Solar Inc / Lululemon Athletica Inc / Moderna Inc / Cardiovascular Systems Inc / Addus Homecare Corp / Meta Platforms Inc / Carlyle Group Inc / RingCentral Inc / Wix.Com Ltd / Qorvo Inc / ETSY Inc / Sunrun Inc / S&P Global Inc / Trade Desk Inc / Apollo Global Capital Inc / Coupa Software Inc / Snap Inc / Okta Inc / Iovance Biotherapeutics Inc / Workday Inc / Roku Inc / MongoDB Inc / Focus Financial Partners Inc / Elastic NV / CRISPR Therapeutics AG / Frontdoor Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Vonage Holdings Corp / DraftKings Inc / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Philippines / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Ari Wald, CFA, CMT</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / FDS / HELE.O / HON / HUM / MCO / MDT / RAD / SYK / UNH / WMT / GILD.O / HCA.N / CYH.N / EW.N / INCY.OQ / BMRN.OQ / ISRG.OQ / VRTX.OQ / CCRN.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / LHCG.O / CME.O / ENSG.OQ / 483548103 / MRNA.O / MD.N / ADUS.O / USPH.N / FIVE.OQ / GOOGL.O / INO.O / EVH.N / TDOC.N / ZBH.N / CFMS.O / 100063846 / SPGI.K / 720795103 / PNTG.OQ / REGW.M3</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Factset Research Systems Inc / Helen of Troy Ltd / Honeywell International Inc / Humana Inc / Moody's Corp / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / CME Group Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Five Below Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / Conformis Inc / Truist Financial Corp / S&P Global Inc / Pieris Pharmaceuticals Inc / Pennant Group Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">The Long and the Short of it: Developments Down Under - Climate Change, Climate Leaders, New targets, Coal</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AGL.AX / BHP.AX / C.N / JPM.N / PFE.N / RIO.AX / RIO.L / STO.AX / TOTF.PA / WPL.AX / ILU.AX / NKE.N / ORG.AX / STT.N / BLK.N / CVX.N / BPT.AX / AMZN.OQ / NHC.AX / FMG.AX / COE.AX / NESN.S / 2331.HK / MSB.AX / WHC.AX / ORE.AX / MRNA.OQ / BHPB.L / TSLA.OQ / ADSGN.F / AZJ.AX / GOOGL.OQ / S32.AX / UBSG.S / SRENH.S / NCZ.AX</td><td class="leftalignment">AGL Energy Ltd / BHP Group Ltd / Citigroup Inc / JPMorgan Chase & Co / Pfizer Inc / Rio Tinto Ltd / Rio Tinto PLC / Santos Ltd / TotalEnergies SE / Woodside Petroleum Ltd / Iluka Resources Ltd / Nike Inc / Origin Energy Ltd / State Street Corp / BlackRock Inc / Chevron Corp / Beach Energy Ltd / Amazon.com Inc / New Hope Corporation Ltd / Fortescue Metals Group Ltd / Cooper Energy Ltd / Nestle SA / Li Ning Co Ltd / Mesoblast Ltd / Whitehaven Coal Ltd / Allkem Ltd / Moderna Inc / BHP Group PLC / Tesla Inc / Adidas AG / Aurizon Holdings Ltd / Alphabet Inc / South32 Ltd / UBS Group AG / Swiss Re AG / New Century Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Cayman Islands / Germany / France / United Kingdom / Papua New Guinea / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity / Environmental, Social, Governance</td><td class="leftalignment">Phineas Glover / Alfred Chang</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: MRNA - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRNA</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID Vax Preclinical Data Encouraging, Ph1/2 Data Expected in Q3</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US / SAN=FR / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Sanofi SA / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LBPS=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / DDDD=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">4D Pharma PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / 4D Pharma PLC / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">NH Investment & Securities (Previously Woori Research)</td><td class="leftalignment">모더나-한국에 자회사 만들 예정-04/19/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">5</td><td class="leftalignment">MRNA</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Byungguk Park</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Japanese COVID-19 vaccine development status - pay attention to Shionogi data</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4507.T / 4502.T / JNJ.N / PFE.N / AZN.L / 4552.T / 4568.T / MRNA.OQ / SVA.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / JCR Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 国内の新型コロナウイルス/COVID-19 ワクチン開発の状況-塩野義のデータに注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">12</td><td class="leftalignment">4507.T / 4502.T / JNJ.N / PFE.N / AZN.L / 4552.T / 4568.T / MRNA.OQ / SVA.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / JCR Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: TSHA now pivotal-stage; JNJ C19 safety pause</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.16.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">SYBX=US / ROG=CH / OPTI=US / EVLO=US / MRNA=US / ALNY=US / KLDO=US / SYN=US / ARCT=US / OGEN=US / PTCT=US / ASMB=US / MCRB=US / FIXX=US / SBTX=US / IBTB=SE / FBRX=US</td><td class="leftalignment">Synlogic Inc / Roche Holding AG / Optec International Inc / Evelo Biosciences Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Kaleido Biosciences Inc / Synthetic Biologics Inc / Arcturus Therapeutics Holdings Inc / Oragenics Inc / PTC Therapeutics Inc / Assembly Biosciences Inc / Seres Therapeutics Inc / Homology Medicines Inc / Silverback Therapeutics Inc / Infant Bacterial Therapeutics AB / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ukraine / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">SYBX (Buy, $10): KOL Call-SYNB8802 success is likely in enteric hyperoxaluria</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SYBX=US / ROG=CH / OPTI=US / EVLO=US / MRNA=US / ALNY=US / KLDO=US / SYN=US / ARCT=US / OGEN=US / PTCT=US / ASMB=US / MCRB=US / FIXX=US / SBTX=US / IBTB=SE / FBRX=US</td><td class="leftalignment">Synlogic Inc / Roche Holding AG / Optec International Inc / Evelo Biosciences Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Kaleido Biosciences Inc / Synthetic Biologics Inc / Arcturus Therapeutics Holdings Inc / Oragenics Inc / PTC Therapeutics Inc / Assembly Biosciences Inc / Seres Therapeutics Inc / Homology Medicines Inc / Silverback Therapeutics Inc / Infant Bacterial Therapeutics AB / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ukraine / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACI=US / FSTX=US / AAPL=US / IBM=US / MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / INTC=US / MSFT=US / C=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / INCY=US / BAC=US / USB=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / NVS=US / VZ=US / URI=US / TSM=US / CCI=US / UPS=US / AZN=US / GSK=US / JNJ=US / TTWO=US / ATVI=US / PNC=US / CMCSA=US / UNH=US / DISH=US / INTU=US / NUAN=US / APPS=US / HRB=US / CTL=US / CME=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / QUIK=US / REGN=US / SBAC=US / VG=US / WSC=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / GME=US / FB=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / IGMS=US / RNG=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / VIAC=US / INO=US / HSBC=US / DISCA=US / PDD=US / CCOI=US / LLNW=US / LUMN=US / BBVA=US / 700-HK=US / UBI-PAR=US / TSLA=US / ZNGA=US / EA=US / TMUS=US / MGNX=US / GTT=US / XNCR=US / AVYA=US / GOOGL=US / TSLX=US / FIVN=US / BABA=US / NVTA=US / MRUS=US / APVO=US / DZSI=US / TEUM=US / ATUS=US / BILI=US / HUYA=US / ZM=US / FSLY=US / ONCT=US / CMBM=US / DMTK=US / BNTX=US / DKNG=US / INBX=US / KDNY=US / CRSR=US / RXT=US / ONDS=US / PLTK=US / DOCN=US</td><td class="leftalignment">Albertsons Companies Inc / F-Star Therapeutics Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Microsoft Corp / Citigroup Inc / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Incyte Corp / Bank of America Corp / US Bancorp / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / Novartis AG / Verizon Communications Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / PNC Financial Services Group Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / QuickLogic Corp / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / GameStop Corp / Meta Platforms Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / IGM Biosciences Inc / RingCentral Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Inovio Pharmaceuticals Inc / HSBC Holdings PLC / Discovery Inc / Pinduoduo Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Lumen Technologies Inc / Banco Bilbao Vizcaya Argentaria SA / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tesla Inc / Zynga Inc / Electronic Arts Inc / T-Mobile US Inc / MacroGenics Inc / GTT Communications Inc / Xencor Inc / Avaya Holdings Corp / Alphabet Inc / Sixth Street Specialty Lending Inc / Five9 Inc / Alibaba Group Holding Ltd / Invitae Corp / Merus NV / Aptevo Therapeutics Inc / DZS Inc / Pareteum Corp / Altice USA Inc / Bilibili Inc / HUYA Inc / Zoom Video Communications Inc / Fastly Inc / Oncternal Therapeutics Inc / Cambium Networks Corp / DermTech Inc / BioNTech SE / DraftKings Inc / Inhibrx Inc / Chinook Therapeutics Inc / Corsair Gaming Inc / Rackspace Technology Inc / Ondas Holdings Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / Spain / United Kingdom / Israel / Netherlands / Sweden / Taiwan / United States / Guernsey</td><td class="leftalignment">Banks / Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Apr. 15, 2021 / 11:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRNA=US / TSHA=US / MRK=US / NVS=US / AZN=US / LOGC=US / SGMO=US / FOLD=US / RGNX=US / SRPT=US / QURE=US / AGTC=US / NVTA=US / VYGR=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / KRYS=US / SLDB=US / RCKT=US / FIXX=US / MGTX=US / PASG=US / SIGHT:FP=FR / SIOX=US</td><td class="leftalignment">Moderna Inc / Taysha Gene Therapies Inc / Merck & Co Inc / Novartis AG / AstraZeneca PLC / LogicBio Therapeutics Inc / Sangamo Therapeutics Inc / Amicus Therapeutics Inc / Regenxbio Inc / Sarepta Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Invitae Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Krystal Biotech Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / MeiraGTx Holdings PLC / Passage Bio Inc / Gensight Biologics SA / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">MRNA (Buy, $182): Vaccines Day outlines path to build on mRNA-1273 successes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA=US / MRK=US / AZN=US / LOGC=US / SGMO=US / FOLD=US / RGNX=US / QURE=US / AGTC=US / VYGR=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / KRYS=US / SLDB=US / MGTX=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / AstraZeneca PLC / LogicBio Therapeutics Inc / Sangamo Therapeutics Inc / Amicus Therapeutics Inc / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Krystal Biotech Inc / Solid Biosciences Inc / MeiraGTx Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MTEM=US / SPXC=US / AAPL=US / DELL=US / IBM=US / MRK=US / VECO=US / INTC=US / ADI=US / AMD=US / MSFT=US / C=US / AMZN=US / QCOM=US / ORCL=US / TXN=US / BAC=US / WFC=US / NVDA=US / GS=US / MPWR=US / JPM=US / STM=FR / SMTC=US / AZN=US / XLNX=US / KLAC=US / CSL=US / IEX=US / TTWO=US / LRCX=US / ATVI=US / ASML=US / LECO=US / DOV=US / APPS=US / AVGO=US / CRUS=US / DCI=US / EQIX=US / FLS=US / GGG=US / HEAR=US / ITT=US / IFX=US / NOW=US / MCHP=US / TEAM=US / PNR=US / SHOP=US / WTS=US / ACN=US / NET=US / GME=US / AOS=US / FB=US / SWKS=US / TWLO=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / MWA=US / AIMC=US / VMW=US / 700-HK=US / UBI-PAR=US / TCEHY=US / MXL=US / NXPI=US / 2454-TW=US / XYL=US / ZNGA=US / EA=US / RXN=US / GOOGL=US / PAYC=US / BABA=US / HUBS=US / QRVO=US / ON=US / AKTS=US / MDB=US / BILI=US / HUYA=US / ESTC=US / UBER=US / FSLY=US / CRSR=US / RXT=US / ABNB=US / PLTK=US / DOCN=US</td><td class="leftalignment">Molecular Templates Inc / SPX Corp / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Merck & Co Inc / Veeco Instruments Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Citigroup Inc / Amazon.com Inc / Qualcomm Inc / Oracle Corp / Texas Instruments Inc / Bank of America Corp / Wells Fargo & Co / NVIDIA Corp / Goldman Sachs Group Inc / Monolithic Power Systems Inc / JPMorgan Chase & Co / STMicroelectronics NV / Semtech Corp / AstraZeneca PLC / Xilinx Inc / KLA Corp / Carlisle Companies Inc / IDEX Corp / Take-Two Interactive Software Inc / Lam Research Corp / Activision Blizzard Inc / ASML Holding NV / Lincoln Electric Holdings Inc / Dover Corp / Digital Turbine Inc / Broadcom Inc / Cirrus Logic Inc / Donaldson Company Inc / Equinix Inc / Flowserve Corp / Graco Inc / Turtle Beach Corp / ITT Inc / Infineon Technologies AG / ServiceNow Inc / Microchip Technology Inc / Atlassian Corporation PLC / Pentair PLC / Shopify Inc / Watts Water Technologies Inc / Accenture PLC / Cloudflare Inc / GameStop Corp / A O Smith Corp / Meta Platforms Inc / Skyworks Solutions Inc / Twilio Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / Mueller Water Products Inc / Altra Industrial Motion Corp / VMware Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tencent Holdings Ltd / Maxlinear Inc / NXP Semiconductors NV / MediaTek Inc / Xylem Inc / Zynga Inc / Electronic Arts Inc / Zurn Water Solutions Corp / Alphabet Inc / Paycom Software Inc / Alibaba Group Holding Ltd / HubSpot Inc / Qorvo Inc / ON Semiconductor Corp / Akoustis Technologies Inc / MongoDB Inc / Bilibili Inc / HUYA Inc / Elastic NV / Uber Technologies Inc / Fastly Inc / Corsair Gaming Inc / Rackspace Technology Inc / Airbnb Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Financial Services / Info. Tech./Computers / Info. Tech./Software / Machinery / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">JNJ COVID Vax Remains Paused; Age & Gender Restrictions Seem Likely</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Danielle J. Antalffy / Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A / ALB / APD / ASH / ATO / BBY / BKR / BXP / CE / CNI / COST.O / CP / CPE / CUZ / DD / DOW / DRI / EAT / EMN / EQR / ETR / FMC / FOE / FTI / GS / HAL / HIW / HP / HPP / HUN / IFF / JNJ / KNX / KRC / LIN / NBR / NEX / NOV / NSC / OFC / OII / OLN / PPG / RES / RIG / RNR / RPM / SHW / SLB / SLG / SM / SOI / STT / TMO / UNP / WLK / WRE / IRM / JBHT.O / OIS / HUBG.O / SBAC.O / LBRT.N / DEI / NTAP.O / HXL.N / AXS / PTEN.O / CREE.O / CAKE.O / LYB / TXRH.O / DENN.O / BJRI.O / HST.N / XPO / IVZ / WRB.N / MRNA.O / NXPI.O / ESTE.K / BLMN.O / AMBA.O / ESRT.K / AXTA.K / TGNA.K / PGRE.K / CSX.O / NGVT.K / PUMP.K / NCSM.O / IQV / WTTR.K / NINE.N / CDLX.O / EVRG.K / LNT.O / DELL.K / AVNT.K / ALGM.O / CHX.O</td><td class="leftalignment">Agilent Technologies Inc / Albemarle Corp / Air Products and Chemicals Inc / Ashland Global Holdings Inc / Atmos Energy Corp / Best Buy Co Inc / Baker Hughes Co / Boston Properties Inc / Celanese Corp / Canadian National Railway Co / Costco Wholesale Corp / Canadian Pacific Railway Ltd / Callon Petroleum Co / Cousins Properties Inc / Dupont De Nemours Inc / Dow Inc / Darden Restaurants Inc / Brinker International Inc / Eastman Chemical Co / Equity Residential / Entergy Corp / FMC Corp / Ferro Corp / TechnipFMC PLC / Goldman Sachs Group Inc / Halliburton Co / Highwoods Properties Inc / Helmerich and Payne Inc / Hudson Pacific Properties Inc / Huntsman Corp / International Flavors & Fragrances Inc / Johnson & Johnson / Knight-Swift Transportation Holdings Inc / Kilroy Realty Corp / Linde PLC / Nabors Industries Ltd / Nextier Oilfield Solutions Inc / Nov Inc / Norfolk Southern Corp / Corporate Office Properties Trust / Oceaneering International Inc / Olin Corp / PPG Industries Inc / RPC Inc / Transocean Ltd / Renaissancere Holdings Ltd / RPM International Inc / Sherwin-Williams Co / Schlumberger NV / SL Green Realty Corp / SM Energy Co / Solaris Oilfield Infrastructure Inc / State Street Corp / Thermo Fisher Scientific Inc / Union Pacific Corp / Westlake Chemical Corp / Washington Real Estate Investment Trust / Iron Mountain Inc / J B Hunt Transport Services Inc / Oil States International Inc / Hub Group Inc / SBA Communications Corp / Liberty Oilfield Services Inc / Douglas Emmett Inc / NetApp Inc / Hexcel Corp / AXIS Capital Holdings Ltd / Patterson-UTI Energy Inc / Wolfspeed Inc / Cheesecake Factory Inc / LyondellBasell Industries NV / Texas Roadhouse Inc / Denny's Corp / BJ's Restaurants Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Invesco Ltd / W R Berkley Corp / Moderna Inc / NXP Semiconductors NV / Earthstone Energy Inc / Bloomin' Brands Inc / Ambarella Inc / Empire State Realty Trust Inc / Axalta Coating Systems Ltd / Tegna Inc / Paramount Group Inc / CSX Corp / Ingevity Corp / ProPetro Holding Corp / NCS Multistage Holdings Inc / IQVIA Holdings Inc / Select Energy Services Inc / Nine Energy Service Inc / Cardlytics Inc / Evergy Inc / Alliant Energy Corp / Dell Technologies Inc / Avient Corp / Allegro Microsystems Inc / ChampionX Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Bad News = COVID is Here to Stay! Good News = Moderna Vaccines; Target to $234</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : Is the Pandemic Over Yet? Takeaways from MRNA's 2021 Vaccines Day</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Second Vaccine Day: Platform Starting to Shine</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRNA=US / MRK=US / AZN=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Apr. 14, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Declines 3% Including COVID-19 Vaccine Volume Benefit</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">JNJ COVID Pause Likely to Become a Pass, Share Should Shift to mRNAs, NVAX</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / PFE=US / GSK=GB / AZN=US / GSK=US / JNJ=US / SNY=US / MRNA=US / BNTX=US</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Sanofi SA / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Danielle J. Antalffy / Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD / Dr. Andrew S. Berens, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">FDA & CDC Pause J&J Vaccine Due to Blood Clots; MRNA Vaccine Day Tomorrow</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: 6-mo MRNA C19 data; DRNA sells ALNY royalties</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRNA.OQ / ALNY.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Moderna Inc / Alnylam Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.9.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / FTNT=US / AAPL=US / IBM=US / CSII=US / ALL=US / BMY=US / COST=US / DIS=US / INTC=US / MO=US / AMD=US / MSFT=US / CL=US / GLW=US / K=US / AMZN=US / QCOM=US / T=US / ORCL=US / A=US / WMT=US / TXN=US / RUN=US / CG=US / CSR=US / D=US / ED=US / NTRS=US / AMT=US / DOX=US / GS=US / AKAM=US / MPWR=US / JPM=US / PLUG=US / CHTR=US / NICE=US / V=US / NVS=US / VZ=US / PBR=US / EL=US / SMTC=US / VRTS=US / CHKP=US / SAP=US / URI=US / CCI=US / UPS=US / ENR=US / GSK=US / CTAS=US / CSL=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / CMCSA=US / SRCL=US / CI=US / W=US / UNH=US / DISH=US / INTU=US / NUAN=US / AAII=US / ABMD=US / ALB=US / AMED=US / APPS=US / APLS=US / AVGO=US / BOX=US / B=US / BETA=US / HRB=US / CALM=US / CSV=US / KMX=US / CME=US / CRVL=US / CSGP=US / CYBR=US / DHI=US / EW=US / EGAN=US / EGHT=US / EQIX=US / EXAS=US / FIVE=US / ISRG=US / ITRI=US / LIFE=US / MS=US / MCO=US / TEAM=US / PZZA=US / QUIK=US / QDEL=US / ROK=US / ROP=US / SBAC=US / POOL=US / HSIC=US / SNAP=US / UTL=US / VG=US / WDFC=US / WSC=US / WIX=US / ALGN=US / OSUR=US / PDFS=US / RDWR=US / SNOW=US / PRVB=US / NET=US / CRNT=US / GME=US / ARE=US / FB=US / HR=US / MGRC=US / NEP=US / PRA=US / BIO=US / O=US / SWKS=US / NFLX=US / VRNT=US / ENSG=US / AMSF=US / TWLO=US / ERIC=US / NDAQ=US / PTON=US / RPD=US / BIIB=US / RNG=US / CRI=US / OPEN=US / CEVA=US / MRNA=US / DPZ=US / GOOG=US / DLR=US / OLED=US / VIAC=US / FRPT=US / MORN=US / DISCA=US / FIS=US / CCOI=US / ATNI=US / BIG=US / TEL=US / CSIQ=US / RSI=US / QSR=US / BX=US / LLNW=US / LULU=US / VMW=US / LUMN=US / SPGI=US / TBK=US / SWI=US / ADUS=US / GNRC=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / AMRC=US / HZNP=US / ZNGA=US / EA=US / SVB=US / CCXI=US / ENPH=US / SPLK=US / PANW=US / QLYS=US / WDAY=US / TMUS=US / FEYE=US / GTT=US / AVYA=US / TME=US / QURE=US / COUP=US / LOVE=US / QRVO=US / BILL=US / ETSY=US / WING=US / ZS=US / SQ=US / MIME=US / RETA=US / DZSI=US / TTD=US / CRSP=US / UAA=US / OKTA=US / CVNA=US / ATUS=US / IOVA=US / RDFN=US / ROKU=US / MDB=US / SAIL=US / PLXP=US / BILI=US / HUYA=US / FOCS=US / FTDR=US / ESTC=US / UBER=US / ZM=US / CYCN=US / TUFN=US / FSLY=US / CRWD=US / CMBM=US / FVRR=US / PING=US / NLOK=US / DKNG=US / KDNY=US / RXT=US / ONDS=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Fortinet Inc / Apple Inc / International Business Machines Corp / Cardiovascular Systems Inc / Allstate Corp / Bristol-Myers Squibb Co / Costco Wholesale Corp / Walt Disney Co / Intel Corp / Altria Group Inc / Advanced Micro Devices Inc / Microsoft Corp / Colgate-Palmolive Co / Corning Inc / Kellogg Co / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Agilent Technologies Inc / Walmart Inc / Texas Instruments Inc / Sunrun Inc / Carlyle Group Inc / Centerspace / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / American Tower Corp / Amdocs Ltd / Goldman Sachs Group Inc / Akamai Technologies Inc / Monolithic Power Systems Inc / JPMorgan Chase & Co / Plug Power Inc / Charter Communications Inc / Nice Ltd / Visa Inc / Novartis AG / Verizon Communications Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / Semtech Corp / Virtus Investment Partners Inc / Check Point Software Technologies Ltd / SAP SE / United Rentals Inc / Crown Castle International Corp / United Parcel Service Inc / Energizer Holdings Inc / GlaxoSmithKline PLC / Cintas Corp / Carlisle Companies Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Comcast Corp / Stericycle Inc / Cigna Corp / Wayfair Inc / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Alabama Aircraft Industries Inc / ABIOMED Inc / Albemarle Corp / Amedisys Inc / Digital Turbine Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Box Inc / Barnes Group Inc / Beta Drugs Ltd / H & R Block Inc / Cal-Maine Foods Inc / Carriage Services Inc / Carmax Inc / CME Group Inc / CorVel Corp / CoStar Group Inc / Cyberark Software Ltd / D R Horton Inc / Edwards Lifesciences Corp / eGain Corp / 8x8 Inc / Equinix Inc / Exact Sciences Corp / Five Below Inc / Intuitive Surgical Inc / Itron Inc / aTyr Pharma Inc / Morgan Stanley / Moody's Corp / Atlassian Corporation PLC / Papa John's International Inc / QuickLogic Corp / Quidel Corp / Rockwell Automation Inc / Roper Technologies Inc / SBA Communications Corp / Pool Corp / Henry Schein Inc / Snap Inc / Unitil Corp / Vonage Holdings Corp / WD-40 Co / Willscot Mobile Mini Holdings Corp / Wix.Com Ltd / Align Technology Inc / OraSure Technologies Inc / PDF Solutions Inc / Radware Ltd / Snowflake Inc. / Provention Bio Inc / Cloudflare Inc / Ceragon Networks Ltd / GameStop Corp / Alexandria Real Estate Equities Inc / Meta Platforms Inc / Healthcare Realty Trust Inc / McGrath RentCorp / Nextera Energy Partners LP / ProAssurance Corp / Bio Rad Laboratories Inc / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Verint Systems Inc / Ensign Group Inc / Amerisafe Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / Nasdaq Inc / Peloton Interactive Inc / Rapid7 Inc / Biogen Inc / RingCentral Inc / Carter's Inc / Opendoor Technologies Inc / CEVA Inc / Moderna Inc / Domino's Pizza Inc / Alphabet Inc / Digital Realty Trust Inc / Universal Display Corp / ViacomCBS Inc / Freshpet Inc / Morningstar Inc / Discovery Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / ATN International Inc / Big Lots Inc / TE Connectivity Ltd / Canadian Solar Inc / Rush Street Interactive Inc / Restaurant Brands International Inc / Blackstone Inc / Limelight Networks Inc / Lululemon Athletica Inc / VMware Inc / Lumen Technologies Inc / S&P Global Inc / Triumph Bancorp Inc / SolarWinds Corp / Addus Homecare Corp / Generac Holdings Inc / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Ameresco Inc / Horizon Therapeutics PLC / Zynga Inc / Electronic Arts Inc / SilverBridge Holdings Ltd / ChemoCentryx Inc / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Qualys Inc / Workday Inc / T-Mobile US Inc / Mandiant Inc / GTT Communications Inc / Avaya Holdings Corp / Tencent Music Entertainment Group / Uniqure NV / Coupa Software Inc / Lovesac Co / Qorvo Inc / Bill.com Holdings Inc / ETSY Inc / Wingstop Inc / Zscaler Inc / Block Inc / Mimecast Ltd / Reata Pharmaceuticals Inc / DZS Inc / Trade Desk Inc / CRISPR Therapeutics AG / Under Armour Inc / Okta Inc / Carvana Co / Altice USA Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / MongoDB Inc / SailPoint Technologies Holdings Inc / PLx Pharma Inc / Bilibili Inc / HUYA Inc / Focus Financial Partners Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / Zoom Video Communications Inc / Cyclerion Therapeutics Inc / Tufin Software Technologies Ltd / Fastly Inc / CrowdStrike Holdings Inc / Cambium Networks Corp / Fiverr International Ltd / Ping Identity Holding Corp / NortonLifeLock Inc / DraftKings Inc / Chinook Therapeutics Inc / Rackspace Technology Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Israel / Netherlands / Sweden / United States / South Africa / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AIG / AJG / ALL / AMAT.O / AON / BLK / CB / CCO / CHD / CL / CLX / DIS / EL / EOG / ETM / GBX / HIG / IPG / JNJ / KMB / KO / LNC / LTC / MET / MMC / OMC / PG / PGR / PPG / PRU / RE / RNR / SHW / SPB / STZ / TAP.N / TRV / CMCSA.O / PAYX.O / WWE / BRO / FIS / EPC / SBGI.O / SQ / GTN / SIRI.O / FISV.O / CHTR.O / GPN / AXS / MNST.O / CALA.O / ACGL.O / NFLX.O / NXST.O / VIAC.O / DISCA.O / INFI.O / WRB.N / MRNA.O / AMCX.O / UIHC.O / MEIP.O / BCEI.K / VOYA.K / FOXA.O / COTY.K / HMTV.O / CABO.N / TGNA.K / PYPL.O / WLTW.O / LGFb.N / JNCE.O / CLLS.O / ATUS.N / BHF.O / IOVA.O / BOMN.O / ROKU.O / PEP.O / EQH / SPOT.K / SSP.O / KDP.N / AUTL.O / NWL.O / IHRT.O / EXC.O / BRP.O / PGEN.O / ROOT.O / GRCL.O</td><td class="leftalignment">American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Applied Materials Inc / Aon PLC / BlackRock Inc / Chubb Ltd / Clear Channel Outdoor Holdings Inc / Church & Dwight Co Inc / Colgate-Palmolive Co / Clorox Co / Walt Disney Co / Estee Lauder Companies Inc / EOG Resources Inc / Audacy Inc / Greenbrier Companies Inc / Hartford Financial Services Group Inc / Interpublic Group of Companies Inc / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lincoln National Corp / LTC Properties Inc / MetLife Inc / Marsh & McLennan Companies Inc / Omnicom Group Inc / Procter & Gamble Co / Progressive Corp / PPG Industries Inc / Prudential Financial Inc / Everest Re Group Ltd / Renaissancere Holdings Ltd / Sherwin-Williams Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Molson Coors Beverage Co / Travelers Companies Inc / Comcast Corp / Paychex Inc / World Wrestling Entertainment Inc / Brown & Brown Inc / Fidelity National Information Services Inc / Edgewell Personal Care Co / Sinclair Broadcast Group Inc / Block Inc / Gray Television Inc / Sirius XM Holdings Inc / Fiserv Inc / Charter Communications Inc / Global Payments Inc / AXIS Capital Holdings Ltd / Monster Beverage Corp / Calithera Biosciences Inc / Arch Capital Group Ltd / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Discovery Inc / Infinity Pharmaceuticals Inc / W R Berkley Corp / Moderna Inc / AMC Networks Inc / United Insurance Holdings Corp / MEI Pharma Inc / Civitas Resources Inc / Voya Financial Inc / Fox Corp / Coty Inc / Hemisphere Media Group Inc / Cable One Inc / Tegna Inc / PayPal Holdings Inc / Willis Towers Watson PLC / Lions Gate Entertainment Corp / Jounce Therapeutics Inc / Cellectis SA / Altice USA Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Boston Omaha Corp / Roku Inc / PepsiCo Inc / Equitable Holdings Inc / Spotify Technology SA / E W Scripps Co / Keurig Dr Pepper Inc / Autolus Therapeutics PLC / Newell Brands Inc / iHeartMedia Inc / Exelon Corp / BRP Group Inc / Precigen Inc / Root Inc / Gracell Biotechnologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: March 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / AAL.L / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Anglo American PLC / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">AI-Powered ETF Works with IBM Watson to Analyze Market Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / WMT.N / GME.N / GILD.OQ / COST.OQ / MRNA.OQ / AMC.N / TDOC.N</td><td class="leftalignment">Johnson & Johnson / Walmart Inc / GameStop Corp / Gilead Sciences Inc / Costco Wholesale Corp / Moderna Inc / AMC Entertainment Holdings Inc / Teladoc Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) update for QURE in hemB; new tech for DRNA</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">UQ1.F / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Uniqure NV / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Notwithstanding JNJ, Outlook for COVID Control via Vax Increasingly Positive</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Moderna climbs 25% in past quarter, CEO Stephane Bancel sells</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna climbs 25% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippines - GT Capital: FY20 result review: In line with decent 4Q finish. Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GTCAP.PS / MBT.PS / AZN.L / MRNA.OQ</td><td class="leftalignment">GT Capital Holdings Inc / Metropolitan Bank and Trust Co / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Chesca Bugia-Tenorio</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Moderna Inc</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: 100 Million COVID-19 Vaccine Doses Delivered to US Government, 200 Million More by July</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">A / AAP / ABT / ACN / ALC / AMT / ATO / AZO / BAX / BBY / BDX / BIO / BKR / BSX / CCI / CMG / CNP / COO / CRL / DG / DGX / DHR / DLR / DRI / DY / EXR / FND / FTI / GBX / GPS / HAL / HD / HP / HTA / JNJ / LH / LOW / MCD / MDT / MTD / NBR / NEX / NKE / NOV / OII / PEN / PKI / RES / RH / RIG / RKT / RL / SLB / SOI / SPB / SYK / SYY / T / TAP.N / TFX / TMO / TPR / TRN / USM / VFC / W / WAB / WAT / WMT / WSM / AMZN.O / EW / IRM / OGS / OIS / ICLR.O / BBBY.O / SBAC.O / CONE.O / LBRT.N / SGMO.O / IART.O / VZ / SBUX.O / ROST.O / DLTR.O / ILMN.O / TECH.O / CTSH.O / ISRG.O / DXC / PTEN.O / CAKE.O / TSCO.O / HOLX.O / PROG.O / BLUE.O / MMSI.O / ORLY.O / EQIX.O / WOOF.O / BRKR.O / NUVA.O / DXCM.O / CNSL.O / CCOI.O / PODD.O / TNDM.OQ / MRNA.O / ZIOP.O / LUNG.O / ADSGn.DE / EPAM.K / FIVE.O / GMED.K / PFSI.K / MAR.O / FATE.O / NVRO.K / TCON.O / GKOS.K / WING.O / ZBH / CYAD.O / SPNE.O / OLLI.O / PFGC.K / NVCR.O / TMUS.O / ADAP.O / EDIT.O / NTLA.O / GATX.K / USFD.K / CRSP.O / UAA / JNCE.O / UNIT.O / CLLS.O / PUMP.K / NCSM.O / CVNA.K / IOVA.O / SWCH.K / IQV / EYE.O / WTTR.K / QGEN.K / NINE.N / INSP.K / AUTL.O / AXNX.O / CPRI.K / SWAV.O / TPTX.O / AVTR.K / PGEN.O / BEAM.O / VRM.O / NARI.O / LUMN.K / SFT.O / EAR.O / GHLD.K / CHX.O / GRCL.O / HMPT.O / 87975H100</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Abbott Laboratories / Accenture PLC / Alcon AG / American Tower Corp / Atmos Energy Corp / Autozone Inc / Baxter International Inc / Best Buy Co Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Baker Hughes Co / Boston Scientific Corp / Crown Castle International Corp / Chipotle Mexican Grill Inc / CenterPoint Energy Inc / Cooper Companies Inc / Charles River Laboratories International Inc / Dollar General Corp / Quest Diagnostics Inc / Danaher Corp / Digital Realty Trust Inc / Darden Restaurants Inc / Dycom Industries Inc / Extra Space Storage Inc / Floor & Decor Holdings Inc / TechnipFMC PLC / Greenbrier Companies Inc / Gap Inc / Halliburton Co / Home Depot Inc / Helmerich and Payne Inc / Healthcare Trust Of America Inc / Johnson & Johnson / Laboratory Corporation of America Holdings / Lowe's Companies Inc / McDonald's Corp / Medtronic PLC / Mettler-Toledo International Inc / Nabors Industries Ltd / Nextier Oilfield Solutions Inc / Nike Inc / Nov Inc / Oceaneering International Inc / Penumbra Inc / PerkinElmer Inc / RPC Inc / RH / Transocean Ltd / Rocket Companies Inc / Ralph Lauren Corp / Schlumberger NV / Solaris Oilfield Infrastructure Inc / Spectrum Brands Holdings Inc / Stryker Corp / Sysco Corp / AT&T Inc / Molson Coors Beverage Co / Teleflex Inc / Thermo Fisher Scientific Inc / Tapestry Inc / Trinity Industries Inc / United States Cellular Corp / VF Corp / Wayfair Inc / Westinghouse Air Brake Technologies Corp / Waters Corp / Walmart Inc / Williams-Sonoma Inc / Amazon.com Inc / Edwards Lifesciences Corp / Iron Mountain Inc / ONE Gas Inc / Oil States International Inc / ICON PLC / Bed Bath & Beyond Inc / SBA Communications Corp / CyrusOne Inc / Liberty Oilfield Services Inc / Sangamo Therapeutics Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Starbucks Corp / Ross Stores Inc / Dollar Tree Inc / Illumina Inc / Bio-Techne Corp / Cognizant Technology Solutions Corp / Intuitive Surgical Inc / DXC Technology Co / Patterson-UTI Energy Inc / Cheesecake Factory Inc / Tractor Supply Co / Hologic Inc / Progenity Inc / bluebird bio Inc / Merit Medical Systems Inc / O'Reilly Automotive Inc / Equinix Inc / Petco Health and Wellness Company Inc / Bruker Corp / NuVasive Inc / Dexcom Inc / Consolidated Communications Holdings Inc / Cogent Communications Holdings Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / ZIOPHARM Oncology Inc / Pulmonx Corp / Adidas AG / Epam Systems Inc / Five Below Inc / Globus Medical Inc / PennyMac Financial Services Inc / Marriott International Inc / Fate Therapeutics Inc / Nevro Corp / TRACON Pharmaceuticals Inc / Glaukos Corp / Wingstop Inc / Zimmer Biomet Holdings Inc / Celyad Oncology SA / SeaSpine Holdings Corp / Ollie's Bargain Outlet Holdings Inc / Performance Food Group Co / Novocure Ltd / T-Mobile US Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Intellia Therapeutics Inc / GATX Corp / US Foods Holding Corp / CRISPR Therapeutics AG / Under Armour Inc / Jounce Therapeutics Inc / Uniti Group Inc / Cellectis SA / ProPetro Holding Corp / NCS Multistage Holdings Inc / Carvana Co / Iovance Biotherapeutics Inc / Switch Inc / IQVIA Holdings Inc / National Vision Holdings Inc / Select Energy Services Inc / Qiagen NV / Nine Energy Service Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Axonics Inc / Capri Holdings Ltd / Shockwave Medical Inc / Turning Point Therapeutics Inc / Avantor Inc / Precigen Inc / Beam Therapeutics Inc / Vroom Inc / Inari Medical Inc / Lumen Technologies Inc / Shift Technologies Inc / Eargo Inc / Guild Holdings Co / ChampionX Corp / Gracell Biotechnologies Inc / Home Point Capital Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Cell and Gene Therapy Newsletter Companion</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP.O / AUTL.O / SGMO.O / BLUE.O / MRNA.O / ZIOP.O / FATE.O / CYAD.O / EDIT.O / NTLA.O / CRSP.O / CLLS.O / IOVA.O / TPTX.O / PGEN.O / BEAM.O / GRCL.O</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Autolus Therapeutics PLC / Sangamo Therapeutics Inc / bluebird bio Inc / Moderna Inc / ZIOPHARM Oncology Inc / Fate Therapeutics Inc / Celyad Oncology SA / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Cellectis SA / Iovance Biotherapeutics Inc / Turning Point Therapeutics Inc / Precigen Inc / Beam Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / France / United Kingdom / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Mr. Yanan Zhu / Joseph Poen / Chuck Whitesell</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: The Weekly Observer - AIC Special Edition</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">0303.HK / 0902.HK / 2330.TW / 7267.T / GM.N / HMB.ST / RIO.AX / RIO.L / RL.N / TOTF.PA / VOLVB.ST / 9984.T / ETN.N / BWA.N / DE.N / 4689.T / HON.N / XOM.N / 0175.HK / NKE.N / IFXGN.DE / 0857.HK / SRE.N / 2354.TW / TWTR.N / BTU.N / BLK.N / CVX.N / 600011.SS / INTC.OQ / AAPL.OQ / TEAM.OQ / SBUX.OQ / AMZN.OQ / NFLX.OQ / 6723.T / 005930.KS / 0700.HK / 000807.SZ / RDSA.AS / BIDU.OQ / NEXT.OQ / MA.N / CLNE.OQ / 601857.SS / VIC.HM / CWN.AX / MRNA.OQ / NEE.N / TSLA.OQ / COAL.NS / 1378.HK / REGI.OQ / GOOGL.OQ / AMTX.OQ / BABA.N / SHLX.N / RUN.OQ / HFGG.DE / FB.PS / HUYA.N / 1810.HK / COL.AX / 9988.HK / 2222.SE / ENR1N.DE</td><td class="leftalignment">Vtech Holdings Ltd / Huaneng Power International Inc / Taiwan Semiconductor Manufacturing Co Ltd / Honda Motor Co Ltd / General Motors Co / H & M Hennes & Mauritz AB / Rio Tinto Ltd / Rio Tinto PLC / Ralph Lauren Corp / TotalEnergies SE / Volvo AB / SoftBank Group Corp / Eaton Corporation PLC / Borgwarner Inc / Deere & Co / Z Holdings Corp / Honeywell International Inc / Exxon Mobil Corp / Geely Automobile Holdings Ltd / Nike Inc / Infineon Technologies AG / PetroChina Co Ltd / Sempra Energy / Foxconn Technology Co Ltd / Twitter Inc / Peabody Energy Corp / BlackRock Inc / Chevron Corp / Huaneng Power International Inc / Intel Corp / Apple Inc / Atlassian Corporation PLC / Starbucks Corp / Amazon.com Inc / Netflix Inc / Renesas Electronics Corp / Samsung Electronics Co Ltd / Tencent Holdings Ltd / Yunnan Aluminium Co Ltd / Royal Dutch Shell PLC / Baidu Inc / NextDecade Corp / Mastercard Inc / Clean Energy Fuels Corp / PetroChina Co Ltd / Vingroup JSC / Crown Resorts Ltd / Moderna Inc / Nextera Energy Inc / Tesla Inc / Coal India Ltd / China Hongqiao Group Ltd / Renewable Energy Group Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Shell Midstream Partners LP / Sunrun Inc / Hellofresh SE / San Miguel Food and Beverage Inc / HUYA Inc / Xiaomi Corp / Coles Group Ltd / Alibaba Group Holding Ltd / Saudi Arabian Oil Co / Siemens Energy AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / China / Cayman Islands / Germany / France / United Kingdom / India / Ireland / Japan / Korea, Republic of / Philippines / Saudi Arabia / Sweden / Taiwan / United States / Vietnam</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity / Environmental, Social, Governance</td><td class="leftalignment">Phineas Glover / Alfred Chang / Ms. Betty Jiang / Michael Ziffer / Eugene Klerk / Bahar Sezer Longworth</td></tr>
<tr class="even"><td class="leftalignment">03/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) results from PRQR & KRYS; ide-cel approved</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.26.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ITT=US / TWOU=US / AAPL=US / BSX=US / NKE=US / CSII=US / SBUX=US / ABT=US / BK=US / CAT=US / COST=US / INTC=US / KLIC=US / WM=US / BWA=US / MDT=US / C=US / TD=US / AMZN=US / CS=US / TXN=US / RUN=US / CG=US / BAC=US / NTRS=US / STT=US / USB=US / WFC=US / NVDA=US / GS=US / MPWR=US / JPM=US / FCEL=US / PLUG=US / BBI=US / CRM=US / EL=US / SMTC=US / TSM=US / CRY=US / SPOT=US / CSL=US / JCI=US / TTWO=US / PNC=US / DE=US / W=US / COF=US / UNH=US / RSG=US / ALB=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / AVGO=US / CMI=US / CHE=US / CREE=US / EW=US / ITRI=US / MS=US / TEAM=US / PZZA=US / ROK=US / SNAP=US / TRMB=US / VG=US / WIX=US / DB=US / NET=US / ACA=US / BCS=US / FB=US / MGRC=US / NEP=US / NFLX=US / BE=US / CLH=US / WCN=US / NDAQ=US / PTON=US / RNG=US / TFC=US / MRNA=US / SPSC=US / ENS=US / TWIN=US / ORA=US / OLED=US / DXCM=US / HSBC=US / LHCG=US / AMRS=US / SPWR=US / XPO=US / TEL=US / CSIQ=US / RSI=US / FSLR=US / PODD=US / LULU=US / TNDM=US / DAN=US / SPGI=US / WPRT=US / KKR=US / AGCO=US / 005930-KR=US / ADUS=US / TCEHY=US / TSLA=US / AMRC=US / ENPH=US / WDAY=US / HASI=US / CNHI=US / TME=US / COUP=US / EKTAY=US / QRVO=US / CRBP=US / ETSY=US / SEDG=US / LIVN=US / AQMS=US / CERC=US / VRAY=US / WKHS=US / TTD=US / CRSP=US / OKTA=US / YEXT=US / IOVA=US / ROKU=US / NCNA=US / MDB=US / APTV=US / VOW3-DE=US / FOCS=US / CWEN=US / FTDR=US / ESTC=US / UBER=US / XFOR=US / CRWD=US / BXRX=US / TARA=US / DKNG=US / VLDR=US / SHLS=US / CHPT=US / AEVA=US</td><td class="leftalignment">ITT Inc / 2U Inc / Apple Inc / Boston Scientific Corp / Nike Inc / Cardiovascular Systems Inc / Starbucks Corp / Abbott Laboratories / Bank of New York Mellon Corp / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Kulicke and Soffa Industries Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Citigroup Inc / Toronto-Dominion Bank / Amazon.com Inc / Credit Suisse Group AG / Texas Instruments Inc / Sunrun Inc / Carlyle Group Inc / Bank of America Corp / Northern Trust Corp / State Street Corp / US Bancorp / Wells Fargo & Co / NVIDIA Corp / Goldman Sachs Group Inc / Monolithic Power Systems Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Brickell Biotech Inc / Salesforce.Com Inc / Estee Lauder Companies Inc / Semtech Corp / Taiwan Semiconductor Manufacturing Co Ltd / CryoLife Inc / Spotify Technology SA / Carlisle Companies Inc / Johnson Controls International PLC / Take-Two Interactive Software Inc / PNC Financial Services Group Inc / Deere & Co / Wayfair Inc / Capital One Financial Corp / UnitedHealth Group Inc / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Broadcom Inc / Cummins Inc / Chemed Corp / Wolfspeed Inc / Edwards Lifesciences Corp / Itron Inc / Morgan Stanley / Atlassian Corporation PLC / Papa John's International Inc / Rockwell Automation Inc / Snap Inc / Trimble Inc / Vonage Holdings Corp / Wix.Com Ltd / Deutsche Bank AG / Cloudflare Inc / Arcosa Inc / Barclays PLC / Meta Platforms Inc / McGrath RentCorp / Nextera Energy Partners LP / Netflix Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / Peloton Interactive Inc / RingCentral Inc / Truist Financial Corp / Moderna Inc / SPS Commerce Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / Universal Display Corp / Dexcom Inc / HSBC Holdings PLC / LHC Group Inc / Amyris Inc / SunPower Corp / XPO Logistics Inc / TE Connectivity Ltd / Canadian Solar Inc / Rush Street Interactive Inc / First Solar Inc / Insulet Corp / Lululemon Athletica Inc / Tandem Diabetes Care Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / KKR & Co Inc / AGCO Corp / Farfetch Ltd / Addus Homecare Corp / Tencent Holdings Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Workday Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Tencent Music Entertainment Group / Coupa Software Inc / Elekta AB (publ) / Qorvo Inc / Corbus Pharmaceuticals Holdings Inc / ETSY Inc / Solaredge Technologies Inc / LivaNova PLC / Aqua Metals Inc / Avalo Therapeutics Inc / ViewRay Inc / Workhorse Group Inc / Trade Desk Inc / CRISPR Therapeutics AG / Okta Inc / Yext Inc / Iovance Biotherapeutics Inc / Roku Inc / NuCana PLC / MongoDB Inc / Aptiv PLC / Volkswagen AG / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / X4 Pharmaceuticals Inc / CrowdStrike Holdings Inc / Baudax Bio Inc / Protara Therapeutics Inc / DraftKings Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / Taiwan / United States / Jersey</td><td class="leftalignment">Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Machinery / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SLDB makes progress in DMD</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">SLDB.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Solid Biosciences Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">The Need-to-Know in the Second Year of a Bull</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AAPL=US / CSII=US / SBUX=US / COST=US / AMZN=US / TXN=US / RUN=US / CG=US / NVDA=US / MPWR=US / CRM=US / EL=US / SMTC=US / CSL=US / TTWO=US / W=US / UNH=US / ALB=US / AVGO=US / CHE=US / EW=US / ITRI=US / MS=US / TEAM=US / PZZA=US / SNAP=US / VG=US / WIX=US / NET=US / ACA=US / FB=US / MGRC=US / NFLX=US / NDAQ=US / PTON=US / RNG=US / MRNA=US / OLED=US / LHCG=US / XPO=US / TEL=US / CSIQ=US / LULU=US / TNDM=US / SPGI=US / KKR=US / ADUS=US / TCEHY=US / WDAY=US / TME=US / COUP=US / QRVO=US / ETSY=US / TTD=US / CRSP=US / OKTA=US / IOVA=US / ROKU=US / MDB=US / FOCS=US / FTDR=US / ESTC=US / UBER=US / CRWD=US / DKNG=US</td><td class="leftalignment">Apple Inc / Cardiovascular Systems Inc / Starbucks Corp / Costco Wholesale Corp / Amazon.com Inc / Texas Instruments Inc / Sunrun Inc / Carlyle Group Inc / NVIDIA Corp / Monolithic Power Systems Inc / Salesforce.Com Inc / Estee Lauder Companies Inc / Semtech Corp / Carlisle Companies Inc / Take-Two Interactive Software Inc / Wayfair Inc / UnitedHealth Group Inc / Albemarle Corp / Broadcom Inc / Chemed Corp / Edwards Lifesciences Corp / Itron Inc / Morgan Stanley / Atlassian Corporation PLC / Papa John's International Inc / Snap Inc / Vonage Holdings Corp / Wix.Com Ltd / Cloudflare Inc / Arcosa Inc / Meta Platforms Inc / McGrath RentCorp / Netflix Inc / Nasdaq Inc / Peloton Interactive Inc / RingCentral Inc / Moderna Inc / Universal Display Corp / LHC Group Inc / XPO Logistics Inc / TE Connectivity Ltd / Canadian Solar Inc / Lululemon Athletica Inc / Tandem Diabetes Care Inc / S&P Global Inc / KKR & Co Inc / Addus Homecare Corp / Tencent Holdings Ltd / Workday Inc / Tencent Music Entertainment Group / Coupa Software Inc / Qorvo Inc / ETSY Inc / Trade Desk Inc / CRISPR Therapeutics AG / Okta Inc / Iovance Biotherapeutics Inc / Roku Inc / MongoDB Inc / Focus Financial Partners Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / CrowdStrike Holdings Inc / DraftKings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BNGO=US / NBSE=US / MRK=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BAX=US / GSK=US / CRY=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / ATRC=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / EXEL=US / GEN=US / ICPT=US / LH=US / LIFE=US / NBIX=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / PRVB=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / ALPN=US / MIST=US / MD=US / SLF=US / ISR=US / SLP=US / MRNA=US / ACAD=US / MBRX=US / MNKD=US / GOOG=US / INO=US / LHCG=US / AGRX=US / CBAY=US / CHNG=US / INFI=US / TPTX=US / ORTX=US / PODD=US / EHC=US / NMTR=US / TNDM=US / SWAV=US / ASND=US / ADUS=US / ALPMY=US / ACHC=US / PRTA=US / ENTA=US / AGIO=US / FATE=US / AERI=US / TRVN=US / FLXN=US / MDWD=US / CTRE=US / ALDX=US / VBIV=US / XENT=US / AUPH=US / OTIC=US / VCEL=US / WBA=US / SNPHY=US / RLMD=US / EVH=US / GKOS=US / CFMS=US / CATB=US / IONS=US / VRAY=US / TCMD=US / AVDL=US / SRRA=US / SVRA=US / SLNO=US / URGN=US / VREX=US / IOVA=US / MTEM=US / VERU=US / KALA=US / MBIO=US / MDNA=US / MOTS=US / VCNX=US / CUE=US / MRKR=US / ORGO=US / PDSB=US / IDYA=US / BCYC=US / KRTX=US / XAIR=US / DMTK=US / ETNB=US / VERO=US / PNTG=US / AYLA=US / FMTX=US / NNOX=US / KDNY=US / VRDN=US / EVAX=US / SOBE=US</td><td class="leftalignment">Bionano Genomics Inc / NeuBase Therapeutics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Baxter International Inc / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Neurocrine Biosciences Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / Alpine Immune Sciences Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Sun Life Financial Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Moleculin Biotech Inc / MannKind Corp / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Insulet Corp / Encompass Health Corp / 9 Meters Biopharma Inc / Tandem Diabetes Care Inc / Shockwave Medical Inc / Ascendis Pharma A/S / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Pacira Biosciences Inc / Mediwound Ltd / CareTrust REIT Inc / Aldeyra Therapeutics Inc / VBI Vaccines Inc / Intersect Ent Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Vericel Corp / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Relmada Therapeutics Inc / Evolent Health Inc / Glaukos Corp / Conformis Inc / Astria Therapeutics Inc / Ionis Pharmaceuticals Inc / ViewRay Inc / Tactile Systems Technology Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Savara Inc / Soleno Therapeutics Inc / Urogen Pharma Ltd / Varex Imaging Corp / Iovance Biotherapeutics Inc / Molecular Templates Inc / Veru Inc / Kala Pharmaceuticals Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Motus GI Holdings Inc / Vaccinex Inc / Cue Biopharma Inc / Marker Therapeutics Inc / Organogenesis Holdings Inc / PDS Biotechnology Corp / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / Beyond Air Inc / DermTech Inc / 89Bio Inc / Venus Concept Inc / Pennant Group Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Viridian Therapeutics Inc / Evaxion Biotech A/S / AT&T Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Denmark / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / INCY.OQ / LLY.N / MRK.N / AZN.L / SASY.PA / AMGN.OQ / REGN.OQ / ALKS.OQ / STSA.OQ / GILD.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / TEVA.N / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / SAGE.OQ / ZBH.N / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Incyte Corp / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / SAGE Therapeutics Inc / Zimmer Biomet Holdings Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: New England Journal of Medicine Publication Confirms mRNA-1273 Fully Neutralizes SARS-CoV-2 Variants</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell / Joseph Poen</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">TBIO: mRNA Utility in Cystic Fibrosis Unclear. Lowering PT to $28.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Tony Butler, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4502.T: Takeda Pharmaceutical - Factor in FY3/21 OTC sales gain; R&D and results key checkpoints for Apr-May</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4502.T / JNJ.N / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4502.T: 武田薬品工業 - 21/3期OTC売却益などを織り込む、4-5月の重要通過点はR&Dと決算</td><td class="leftalignment">Japanese</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / JNJ.N / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">COUP=US / ROP=US / CSII=US / MSFT=US / AMZN=US / NVDA=US / PLUG=US / CRM=US / SCI=US / EL=US / CRY=US / W=US / ATRC=US / CMI=US / CHD=US / FIVE=US / HRL=US / UTHR=US / OPT=US / MIST=US / MRNA=US / FRPT=US / XPO=US / RSI=US / PRPL=US / LULU=US / ULTA=US / IAC=US / WPRT=US / UTZ=US / AMRC=US / TRVN=US / LOVE=US / ETSY=US / VRAY=US / TCMD=US / CVNA=US / FIXX=US / SMAR=US / CUE=US / GRWG=US / ALLO=US / PDSB=US / CRWD=US / DKNG=US / ORIC=US / FUBO=US / TSHA=US / VRDN=US / VIRX=US</td><td class="leftalignment">Coupa Software Inc / Roper Technologies Inc / Cardiovascular Systems Inc / Microsoft Corp / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Salesforce.Com Inc / Service Corporation International / Estee Lauder Companies Inc / CryoLife Inc / Wayfair Inc / AtriCure Inc / Cummins Inc / Church & Dwight Co Inc / Five Below Inc / Hormel Foods Corp / United Therapeutics Corp / Opthea Ltd / Milestone Pharmaceuticals Inc / Moderna Inc / Freshpet Inc / XPO Logistics Inc / Rush Street Interactive Inc / Purple Innovation Inc / Lululemon Athletica Inc / Ulta Beauty Inc / IAC/Interactivecorp / Westport Fuel Systems Inc / UTZ Brands Inc / Ameresco Inc / Trevena Inc / Lovesac Co / ETSY Inc / ViewRay Inc / Tactile Systems Technology Inc / Carvana Co / Homology Medicines Inc / Smartsheet Inc / Cue Biopharma Inc / GrowGeneration Corp / Allogene Therapeutics Inc / PDS Biotechnology Corp / CrowdStrike Holdings Inc / DraftKings Inc / Oric Pharmaceuticals Inc / Fubotv Inc / Taysha Gene Therapies Inc / Viridian Therapeutics Inc / Viracta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Info. Tech./Software / Retailing / Semiconductors</td><td class="leftalignment">North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, MRNA</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Mar. 16, 2021 / 12:50PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">OCGN: COVAXIN Gains EUA in India, Could U.S. Be Next?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OCGN.OQ / MRNA</td><td class="leftalignment">Ocugen Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SHLS=US / INTC=US / AMD=US / NVDA=US / AXP=US / TMX=US / TSM=US / AZO=US / MNRO=US / QUIK=US / AAP=US / MTCH=US / ICAD=US / MRNA=US / TCEHY=US / YY=US / TME=US / CRBP=US / HUYA=US / GRWG=US / YALA=US</td><td class="leftalignment">Shoals Technologies Group Inc / Intel Corp / Advanced Micro Devices Inc / NVIDIA Corp / American Express Co / Terminix Global Holdings Inc / Taiwan Semiconductor Manufacturing Co Ltd / Autozone Inc / Monro Inc / QuickLogic Corp / Advance Auto Parts Inc / Match Group Inc / ICAD Inc / Moderna Inc / Tencent Holdings Ltd / JOYY Inc / Tencent Music Entertainment Group / Corbus Pharmaceuticals Holdings Inc / HUYA Inc / GrowGeneration Corp / Yalla Group Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Info. Tech./Computers / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Clinical Trial Expansion of mRNA-1273 into Pediatric Subjects Aged 0.5 - 11 yr.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell / Joseph Poen</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">First Subject Vaccinated in MRNA-1283 Phase I Study; Vaccine Day on April 14th</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MCK: Catching up with MCK on COVID Testing & Vaccine Distribution</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MCK.N / JNJ.N / MRNA.OQ</td><td class="leftalignment">Mckesson Corp / Johnson & Johnson / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INTERNAL REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BNTX/PFE efficacy in C19; (+) LentiGlobin news</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE.N / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Pfizer Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">OPT=US / VBIV=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / BMY=US / MDT=US / AMZN=US / WMT=US / INSP=US / CMS=US / GILD=US / DGX=US / BBI=US / RMD=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ISRG=US / LH=US / PHAR=US / REGN=US / USPH=US / UHS=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MRNS=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / EHC=US / NMTR=US / TMDI=US / SPRO=US / ASND=US / ADUS=US / ACHC=US / PRTA=US / OM=US / FLXN=US / CTRE=US / ALDX=US / XENT=US / WBA=US / EVH=US / ZBH=US / CATB=US / LIVN=US / CERC=US / AVDL=US / SRRA=US / SLNO=US / SYNH=US / FIXX=US / MRKR=US / GMDA=US / PDSB=US / TMDX=US / BCYC=US / KRTX=US / BNTX=US / PNTG=US</td><td class="leftalignment">Opthea Ltd / VBI Vaccines Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Amazon.com Inc / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Brickell Biotech Inc / Resmed Inc / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / Pharming Group NV / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Titan Medical Inc / Spero Therapeutics Inc / Ascendis Pharma A/S / Addus Homecare Corp / Acadia Healthcare Company Inc / Prothena Corporation PLC / Outset Medical Inc / Pacira Biosciences Inc / CareTrust REIT Inc / Aldeyra Therapeutics Inc / Intersect Ent Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Zimmer Biomet Holdings Inc / Astria Therapeutics Inc / LivaNova PLC / Avalo Therapeutics Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Soleno Therapeutics Inc / Syneos Health Inc / Homology Medicines Inc / Marker Therapeutics Inc / Gamida Cell Ltd / PDS Biotechnology Corp / Transmedics Group Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / BioNTech SE / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.12.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / ALDX=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">FIXX=US / MGTX=US / BMRN=US / LOGC=US / RARE=US / MRNA=US / ORTX=US / RGNX=US / QURE=US / AGTC=US / ABEO=US / VYGR=US / ADVM=US / ALSEN=FR / SYBX=US / KRYS=US / SLDB=US / RCKT=US / XCUR=US / RUBY=US / KOD=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US</td><td class="leftalignment">Homology Medicines Inc / MeiraGTx Holdings PLC / Biomarin Pharmaceutical Inc / LogicBio Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Moderna Inc / Orchard Therapeutics PLC / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / Abeona Therapeutics Inc / Voyager Therapeutics Inc / Adverum Biotechnologies Inc / Sensorion SA / Synlogic Inc / Krystal Biotech Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Exicure Inc / Rubius Therapeutics Inc / Kodiak Sciences Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">FIXX (Buy, $32): On track for PII PKU data & 2 more clinical programs in 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FIXX=US / BMRN=US / LOGC=US / RARE=US / MRNA=US / ORTX=US / RGNX=US / QURE=US / AGTC=US / ADVM=US / SYBX=US / SLDB=US / MGTX=US / RUBY=US</td><td class="leftalignment">Homology Medicines Inc / Biomarin Pharmaceutical Inc / LogicBio Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Moderna Inc / Orchard Therapeutics PLC / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / Adverum Biotechnologies Inc / Synlogic Inc / Solid Biosciences Inc / MeiraGTx Holdings PLC / Rubius Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / JNJ.N / LLY.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Johnson & Johnson / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Mar. 11, 2021 / 10:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Refreshing Our Model for 4Q20 Earnings and Recent Vaccine News Flow</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRNA=US</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FDS=US / WISH=US / MRK=US / VECO=US / ALL=US / BK=US / AMD=US / MSFT=US / C=US / CG=US / GL=US / BAC=US / NTRS=US / STT=US / USB=US / WFC=US / GILD=US / GS=US / FRC=US / AXP=US / JPM=US / HBAN=US / MMC=US / MET=US / BRK=US / AIG=US / BEN=US / TROW=US / GSK=US / LNC=US / BLK=US / JNJ=US / PBCT=US / PNC=US / CB=US / AFL=US / UNM=US / PGR=US / HIG=US / CI=US / COF=US / AIZ=US / CME=US / DFS=US / DG=US / AJG=US / MS=US / MCO=US / TRV=US / PFG=US / APO=US / PRU=US / L=US / RE=US / CINF=US / ZION=US / RJF=US / SIVB=US / RF=US / AON=US / NDAQ=US / TFC=US / MRNA=US / ACAD=US / GOOG=US / MKTX=US / OLED=US / INO=US / PERI=US / AMP=US / ICE=US / IVZ=US / WRB=US / SPGI=US / KKR=US / 005930-KR=US / CBOE=US / CFG=US / MSCI=US / SYF=US / WBA=US / CERC=US / WLTW=US / SLNO=US / MWK=US / KRTX=US / FUBO=US / ONDS=US</td><td class="leftalignment">Factset Research Systems Inc / ContextLogic Inc / Merck & Co Inc / Veeco Instruments Inc / Allstate Corp / Bank of New York Mellon Corp / Advanced Micro Devices Inc / Microsoft Corp / Citigroup Inc / Carlyle Group Inc / Globe Life Inc / Bank of America Corp / Northern Trust Corp / State Street Corp / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / Goldman Sachs Group Inc / First Republic Bank / American Express Co / JPMorgan Chase & Co / Huntington Bancshares Inc / Marsh & McLennan Companies Inc / MetLife Inc / Brooks Macdonald Group PLC / American International Group Inc / Franklin Resources Inc / T Rowe Price Group Inc / GlaxoSmithKline PLC / Lincoln National Corp / BlackRock Inc / Johnson & Johnson / People's United Financial Inc / PNC Financial Services Group Inc / Chubb Ltd / Aflac Inc / Unum Group / Progressive Corp / Hartford Financial Services Group Inc / Cigna Corp / Capital One Financial Corp / Assurant Inc / CME Group Inc / Discover Financial Services / Dollar General Corp / Arthur J Gallagher & Co / Morgan Stanley / Moody's Corp / Travelers Companies Inc / Principal Financial Group Inc / Apollo Global Management Inc / Prudential Financial Inc / Loews Corp / Everest Re Group Ltd / Cincinnati Financial Corp / Zions Bancorporation NA / Raymond James Financial Inc / SVB Financial Group / Regions Financial Corp / Aon PLC / Nasdaq Inc / Truist Financial Corp / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Marketaxess Holdings Inc / Universal Display Corp / Inovio Pharmaceuticals Inc / Perion Network Ltd / Ameriprise Financial Inc / Intercontinental Exchange Inc / Invesco Ltd / W R Berkley Corp / S&P Global Inc / KKR & Co Inc / Farfetch Ltd / Cboe Global Markets Inc / Citizens Financial Group Inc / MSCI Inc / Synchrony Financial / Walgreens Boots Alliance Inc / Avalo Therapeutics Inc / Willis Towers Watson PLC / Soleno Therapeutics Inc / Aterian Inc / Karuna Therapeutics Inc / Fubotv Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Singapore Market Strategy: Earnings upgrades supporting the recovery</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">SATS.SI / SE.N / CTDM.SI / DAIR.SI / DBSM.SI / GENS.SI / HKLD.SI / JARD.SI / KEPL.SI / KPLM.SI / OCBC.SI / RAFG.SI / SCIL.SI / SIAL.SI / STEG.SI / UOBH.SI / UTOS.SI / VENM.SI / SGXL.SI / CMLT.SI / AEMN.SI / CMDG.SI / STEL.SI / SPOS.SI / JCYC.SI / STAR.SI / SUNT.SI / MAPL.SI / KASA.SI / TBEV.SI / WLIL.SI / FCRT.SI / CDLT.SI / YAZG.SI / MRNA.OQ / MAPI.SI / MACT.SI / SHEN.SI / SPHR.SI / KEPE.SI / MANU.SI / KPEL.SI / FRPL.SI / PRIE.SI</td><td class="leftalignment">SATS Ltd / Sea Ltd / City Developments Ltd / Dairy Farm International Holdings Ltd / DBS Group Holdings Ltd / Genting Singapore Ltd / Hongkong Land Holdings Ltd / Jardine Matheson Holdings Ltd / Keppel Infrastructure Trust / Keppel Corporation Ltd / Oversea-Chinese Banking Corporation Ltd / Raffles Medical Group Ltd / Sembcorp Industries Ltd / Singapore Airlines Ltd / Singapore Technologies Engineering Ltd / United Overseas Bank Ltd / UOL Group Ltd / Venture Corporation Ltd / Singapore Exchange Ltd / CapitaLand Integrated Commercial Trust / Ascendas Real Estate Investment Trust / Comfortdelgro Corporation Ltd / Singapore Telecommunications Ltd / Singapore Post Ltd / Jardine Cycle & Carriage Ltd / StarHub Ltd / Suntec Real Estate Investment Trust / Mapletree Logistics Trust / Keppel REIT / Thai Beverage PCL / Wilmar International Ltd / Frasers Centrepoint Trust / CDL Hospitality Trusts / Yangzijiang Shipbuilding Holdings Ltd / Moderna Inc / Mapletree Industrial Trust / Mapletree Commercial Trust / Sheng Siong Group Ltd / SPH REIT / Keppel DC REIT / Manulife US Real Estate Investment Trust / Keppel Pacific Oak US REIT / Frasers Property Ltd / Prime US REIT</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Singapore / Thailand / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr Nicholas Teh</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Indonesia Healthcare Sector - New report: Bi-weekly vaccination tracker (Feb)-Daily first/second dose rates accelerate 177%/7% WoW</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / 1177.HK / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Indonesia / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Khun Steven Ho</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Indonesia Healthcare Sector: Bi-weekly vaccination tracker (Feb): Daily first/second dose rates accelerate 177%/7% WoW</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / AZN.L / NVAX.OQ / MRNA.OQ / 1099.HK</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Novavax Inc / Moderna Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / Indonesia / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Khun Steven Ho</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Call Takeaways: HIV Therapeutic Landscape</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / GILD=US / GSK=US / JNJ=US / MRNA=US / INO=US</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Moderna Inc / Inovio Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IVA=FR / PASG=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / PRVL=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / LYS=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Inventiva SA / Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Porvair PLC / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Lysogene SA / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Industrial End Market Analyser: Debating degrees of recovery and net price. Positioning for rotation to later-cycle</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">BOY.L / NELES.HE / 2308.TW / 4507.T / 6501.T / ALSO.PA / ARCLK.IS / ASSAB.ST / ATCOA.ST / DAST.PA / ECM.L / ELUXB.ST / FLS.N / GE.N / GRI.L / HEXAB.ST / HLMA.L / IMI.L / IR.N / JNJ.N / MRK.N / PFE.N / PHG.AS / ROR.L / RSW.L / SAND.ST / SCHN.PA / SKFB.ST / SMIN.L / SPX.L / SWK.N / VOLVB.ST / VWS.CO / WEIR.L / ROK.N / AZN.L / TKR.N / TKAG.DE / ETN.N / WCC.N / MSM.N / ABBN.S / GEBN.S / SIEGN.DE / HON.N / MMM.N / EMR.N / WHR.N / LONN.S / PALF.VI / JCI.N / RXL.PA / RAAG.DE / GSK.L / SXS.L / NEXS.PA / NKT.CO / ANDR.VI / HUBB.N / ALFA.ST / FLS.CO / FAST.OQ / TT.N / CMCO.OQ / NVAX.OQ / AMZN.OQ / AYI.N / SUN.S / SCHP.S / FAG.ST / KNEBV.HE / CGCBV.HE / G1AG.DE / LEGD.PA / ZUMV.VI / PRY.MI / WEGE3.SA / 0656.HK / FLUI.MC / INO.OQ / WRT1V.HE / MRNA.OQ / KU2G.DE / SHLG.DE / XYL.N / MRON.L / VSVS.L / FLOW.N / PTCT.OQ / KGX.DE / 000333.SZ / ALLE.N / FCT.MI / DOKA.S / SHA_P.DE / LIGHT.AS / FTV.N / ATKR.N / AZRE.N / KCRA.HE / AVT.OQ / EPIRA.ST / KBX.DE / OTIS.N / MOCORP.HE / CVAC.OQ / ENR1N.DE</td><td class="leftalignment">Bodycote PLC / Neles Oyj / Delta Electronics Inc / Shionogi & Co Ltd / Hitachi Ltd / Alstom SA / Arcelik AS / Assa Abloy AB / Atlas Copco AB / Dassault Systemes SE / Electrocomponents PLC / Electrolux AB / Flowserve Corp / General Electric Co / Grainger PLC / Hexagon AB / Halma PLC / IMI PLC / Ingersoll Rand Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Koninklijke Philips NV / Rotork PLC / Renishaw PLC / Sandvik AB / Schneider Electric SE / AB Skf / Smiths Group PLC / Spirax-Sarco Engineering PLC / Stanley Black & Decker Inc / Volvo AB / Vestas Wind Systems A/S / Weir Group PLC / Rockwell Automation Inc / AstraZeneca PLC / Timken Co / thyssenkrupp AG / Eaton Corporation PLC / Wesco International Inc / MSC Industrial Direct Co Inc / Abb Ltd / Geberit AG / Siemens AG / Honeywell International Inc / 3M Co / Emerson Electric Co / Whirlpool Corp / Lonza Group AG / Palfinger AG / Johnson Controls International PLC / Rexel SA / Rational AG / GlaxoSmithKline PLC / Spectris PLC / Nexans SA / Nkt A/S / Andritz AG / Hubbell Inc / Alfa Laval AB / FLSmidth & Co A/S / Fastenal Co / Trane Technologies PLC / Columbus McKinnon Corp / Novavax Inc / Amazon.com Inc / Acuity Brands Inc / Sulzer AG / Schindler Holding AG / Fagerhult AB / Kone Oyj / Cargotec Corp / GEA Group AG / Legrand SA / Zumtobel Group AG / Prysmian SpA / WEG SA / Fosun International Ltd / Fluidra SA / Inovio Pharmaceuticals Inc / Wartsila Oyj Abp / Moderna Inc / Kuka AG / Siemens Healthineers AG / Xylem Inc / Melrose Industries PLC / Vesuvius PLC / SPX FLOW Inc / PTC Therapeutics Inc / Kion Group AG / Midea Group Co Ltd / Allegion PLC / Fincantieri SpA / Dormakaba Holding AG / Schaeffler AG / Signify NV / Fortive Corp / Atkore Inc / Azure Power Global Ltd / Konecranes Abp / Avnet Inc / Epiroc AB / Knorr Bremse AG / Otis Worldwide Corp / Metso Outotec Corp / CureVac NV / Siemens Energy AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Brazil / Switzerland / China / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Ireland / Italy / Japan / Mauritius / Netherlands / Sweden / Turkey / Taiwan / United States</td><td class="leftalignment">Manufacturing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Andre Kukhnin, CFA / Mr Max R. Yates / Ms. Iris Zheng / Mr. Artem Tokarenko</td></tr>
<tr class="odd"><td class="leftalignment">03/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 booster developments; 4Q20 & FY20 earnings</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.5.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">EVAX=US / SNSE=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INSP=US / CMS=US / DGX=US / CRIS=US / AZN=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / BCRX=US / BMRN=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / GRTS=US / GEN=US / ICPT=US / PHG=US / LH=US / NBIX=US / PHAR=US / HOOK=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CMPI=US / SLF=US / ONCR=US / BIIB=US / MRNA=US / ACAD=US / GOOG=US / INO=US / LHCG=US / SNSS=US / AGRX=US / CHNG=US / TPTX=US / ORTX=US / EHC=US / CLDX=US / CVAC=US / ADUS=US / ACHC=US / SRPT=US / PRTA=US / MRTX=US / GNCA=US / CTRE=US / EKTAY=US / CLRB=US / WBA=US / NVTA=US / EVH=US / MCRB=US / CFMS=US / LIVN=US / CERC=US / IONS=US / SSKN=US / VRAY=US / SYRS=US / MDGL=US / FLGT=US / IRTC=US / AVDL=US / SLNO=US / VREX=US / ATNX=US / NCNA=US / RCKT=US / FIXX=US / ARVN=US / MRKR=US / XFOR=US / TMDX=US / BCYC=US / NEXI=US / KRTX=US / DMTK=US / BNTX=US / RCEL=US / PNTG=US / NNOX=US / TSHA=US / VIRX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Sensei Biotherapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Curis Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Gritstone bio Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / HOOKIPA Pharma Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Checkmate Pharmaceuticals Inc / Sun Life Financial Inc / Oncorus Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Viracta Therapeutics Inc / Agile Therapeutics Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Encompass Health Corp / Celldex Therapeutics Inc / CureVac NV / Addus Homecare Corp / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Genocea Biosciences Inc / CareTrust REIT Inc / Elekta AB (publ) / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Seres Therapeutics Inc / Conformis Inc / LivaNova PLC / Avalo Therapeutics Inc / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Avadel Pharmaceuticals PLC / Soleno Therapeutics Inc / Varex Imaging Corp / Athenex Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Arvinas Inc / Marker Therapeutics Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Neximmune Inc / Karuna Therapeutics Inc / DermTech Inc / BioNTech SE / AVITA Medical Inc / Pennant Group Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Viracta Therapeutics Inc / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">OCGN: COVAXIN Phase 3 Interim Efficacy Appears Competitive - Raising PT to $10.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OCGN.OQ / MRNA</td><td class="leftalignment">Ocugen Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Moderna strengthens 2.7% in past quarter; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Moderna, Inc - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Debates Reveal Where COVID Vaccines Are Going</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">EVAX=US / SRCL=US / AAPL=US / MRK=US / BSX=US / PFE=US / AMGN=US / BMY=US / AMD=US / TSM=US / AZN=US / GSK=US / ETN=US / ANGN=US / ACI=US / AZO=US / BCRX=US / KMX=US / GRTS=US / ICPT=US / PHG=US / ORLY=US / PHAR=US / WSC=US / RHHBY=US / BIIB=US / MRNA=US / INO=US / AGRX=US / TPTX=US / PRPL=US / CVAC=US / AMRC=US / 2454-TW=US / PRTA=US / GNCA=US / IONS=US / MDGL=US / IRTC=US / UAA=US / AVDL=US / CVNA=US / CSPR=US / ATNX=US / ZM=US / TMDX=US / BNTX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Stericycle Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Advanced Micro Devices Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / GlaxoSmithKline PLC / Eaton Corporation PLC / Angion Biomedica Corp / Albertsons Companies Inc / Autozone Inc / BioCryst Pharmaceuticals Inc / Carmax Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / O'Reilly Automotive Inc / Pharming Group NV / Willscot Mobile Mini Holdings Corp / Roche Holding AG / Biogen Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Agile Therapeutics Inc / Turning Point Therapeutics Inc / Purple Innovation Inc / CureVac NV / Ameresco Inc / MediaTek Inc / Prothena Corporation PLC / Genocea Biosciences Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Carvana Co / Casper Sleep Inc / Athenex Inc / Zoom Video Communications Inc / Transmedics Group Inc / BioNTech SE / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Ireland / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Pharmaceuticals / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">AI-driven Oncology Story with Near-Term Catalysts: Initiate with Outperform, PT $18</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">EVAX=US / MRK=US / PFE=US / GSK=US / GRTS=US / MRNA=US / CVAC=US / GNCA=US / BNTX=US</td><td class="leftalignment">Evaxion Biotech A/S / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Gritstone bio Inc / Moderna Inc / CureVac NV / Genocea Biosciences Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: February 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / AAL.OQ / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AWK / C / CNI / CP / DVN / EOG / JNJ / MGY / NSC / OLN / PVH / PXD / RKT / UNP / WLK / ASND.O / GILD.O / AMGN.O / SGMO.O / ARNA.O / ISRG.O / REGN.O / TSCO.O / CALA.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ZIOP.O / ARCT.O / RGLS.O / FANG.O / MEIP.O / RNA.O / FATE.O / QURE.O / AGTC.O / AFMD.O / BLCM.O / TCON.O / ZBH / CYAD.O / GBT.O / VYGR.O / CSX.O / IONS.O / ADAP.O / EDIT.O / AGLE.O / NTLA.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / IOVA.O / CDLX.O / AVRO.O / AUTL.O / KZR.O / STRO.O / CPRI.K / TPTX.O / RTLR.O / MORF.O / BCSF.K / IMV.O / PGEN.O / GHLD.K / GRCL.O / 87975H100</td><td class="leftalignment">American Water Works Company Inc / Citigroup Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Devon Energy Corp / EOG Resources Inc / Johnson & Johnson / Magnolia Oil & Gas Corp / Norfolk Southern Corp / Olin Corp / PVH Corp / Pioneer Natural Resources Co / Rocket Companies Inc / Union Pacific Corp / Westlake Chemical Corp / Ascendis Pharma A/S / Gilead Sciences Inc / Amgen Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / Calithera Biosciences Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Diamondback Energy Inc / MEI Pharma Inc / Avidity Biosciences Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Affimed NV / Bellicum Pharmaceuticals Inc / TRACON Pharmaceuticals Inc / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / CSX Corp / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Cardlytics Inc / AVROBIO Inc / Autolus Therapeutics PLC / Kezar Life Sciences Inc / Sutro Biopharma Inc / Capri Holdings Ltd / Turning Point Therapeutics Inc / Rattler Midstream LP / Morphic Holding Inc / Bain Capital Specialty Finance Inc / IMV Inc / Precigen Inc / Guild Holdings Co / Gracell Biotechnologies Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Ramping up Manufacturing Infrastructure to Support Aggressive COVID19 Vaccine Supply</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell / Joseph Poen</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA=US / EDIT=US / ADAP=US / MRK=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / DRRX=US / ISEE=US / GRTS=US / ICPT=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NK=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / VKTX=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / CWBR=US / NGM=US / KOD=US / AXLA=US / STOK=US / AKRO=US / NBSE=US / ETNB=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Moderna Inc / Editas Medicine Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / DURECT Corp / Iveric Bio Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Immunitybio Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Kodiak Sciences Inc / Axcella Health Inc / Stoke Therapeutics Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Assuming Coverage: Biotechnology</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AFMD.O / ADAP.O / CALA.O / INFI.O / HALO.O / MRNA.O / ZIOP.O / ARCT.O / MEIP.O / FATE.O / TCON.O / CYAD.O / JNCE.O / CLLS.O / ZYME.K / IOVA.O / AUTL.O / STRO.O / TPTX.O / PGEN.O / GRCL.O</td><td class="leftalignment">Affimed NV / Adaptimmune Therapeutics PLC / Calithera Biosciences Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / MEI Pharma Inc / Fate Therapeutics Inc / TRACON Pharmaceuticals Inc / Celyad Oncology SA / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Autolus Therapeutics PLC / Sutro Biopharma Inc / Turning Point Therapeutics Inc / Precigen Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / China / Cayman Islands / France / United Kingdom / Croatia / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Nick M. Abbott / Chuck Whitesell / Joseph Poen</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (from 1 Mar): Investors still on sidelines, but reassurance from stocks on lower multiples</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（3月1日～）: 様子見気分が続くが低バリューション株に安心感ある</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">MRNA (Buy): PT to $182 as new Covid-19 trials set to drive 2021 data flow</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRNA=US / MRK=US / AZN=US / LOGC=US / SGMO=US / FOLD=US / RGNX=US / QURE=US / AGTC=US / VYGR=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / KRYS=US / SLDB=US / MGTX=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / AstraZeneca PLC / LogicBio Therapeutics Inc / Sangamo Therapeutics Inc / Amicus Therapeutics Inc / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Krystal Biotech Inc / Solid Biosciences Inc / MeiraGTx Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">FORECASTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine boosters; BEAM acquires GuideTx</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.26.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the SVB Leerink Global Healthcare Conference - 2.25.21</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ADAP=US / BSX=US / CSII=US / INSP=US / GILD=US / SAN=FR / BAX=US / HOLX=US / IMGN=US / BLUE=US / CNMD=US / EXAS=US / ILMN=US / ICPT=US / TFX=US / SAGE=US / PRVB=US / IMTX=US / MREO=US / CPSI=US / BRKR=US / AMTI=US / ACRS=US / APTX=US / MRNA=US / ALNY=US / MNKD=US / CBAY=US / EQ=US / ITRM=US / FULC=US / ASND=US / CTSO=US / FGEN=US / FATE=US / RDUS=US / VCEL=US / MDGL=US / TRHC=US / RCM=US / KALV=US / SYBX=US / RCKT=US / RUBY=US / IMUX=US / ETNB=US / RVMD=US / NARI=US / MOLN=DE / ABCL=US / LNSR=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Boston Scientific Corp / Cardiovascular Systems Inc / Inspire Medical Systems Inc / Gilead Sciences Inc / Sanofi SA / Baxter International Inc / Hologic Inc / ImmunoGen Inc / bluebird bio Inc / Conmed Corp / Exact Sciences Corp / Illumina Inc / Intercept Pharmaceuticals Inc / Teleflex Inc / SAGE Therapeutics Inc / Provention Bio Inc / Immatics NV / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Bruker Corp / Applied Molecular Transport Inc. / Aclaris Therapeutics Inc / Aptinyx Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cymabay Therapeutics Inc / Equillium Inc / Iterum Therapeutics PLC / Fulcrum Therapeutics Inc / Ascendis Pharma A/S / Cytosorbents Corp / FibroGen Inc / Fate Therapeutics Inc / Radius Health Inc / Vericel Corp / Madrigal Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Kalvista Pharmaceuticals Inc / Synlogic Inc / Rocket Pharmaceuticals Inc / Rubius Therapeutics Inc / Immunic Inc / 89Bio Inc / Revolution Medicines Inc / Inari Medical Inc / Molecular Partners AG / Abcellera Biologics Inc / LENSAR Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">CRM=US / ICAD=US / AAPL=US / IBM=US / MRK=US / LSI=US / DIS=US / INTC=US / TWTR=US / ADI=US / GBT=US / MSFT=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / TXN=US / RUN=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / STM=FR / VZ=US / SMTC=US / CCI=US / UPS=US / XLNX=US / SYMC=US / ASML=US / CMCSA=US / DISH=US / INTU=US / NUAN=US / AMED=US / APPS=US / AZO=US / AVGO=US / BDX=US / BYND=US / HRB=US / BLUE=US / CTL=US / CME=US / DCI=US / EGAN=US / EGHT=US / EQIX=US / FLS=US / ICPT=US / TREE=US / MCHP=US / NBIX=US / ORLY=US / PZZA=US / QUIK=US / SBAC=US / SHOP=US / SUNS=US / SNAP=US / UTHR=US / VGR=US / VG=US / WSC=US / RDWR=US / SNOW=US / CGEN=US / AAP=US / NET=US / CRNT=US / FB=US / SWKS=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / RNG=US / FTCH=US / CEVA=US / MRNA=US / SFM=US / DPZ=US / MNKD=US / GOOG=US / DLR=US / ORA=US / VIAC=US / LHCG=US / DISCA=US / CHNG=US / CCOI=US / FSLR=US / ANET=US / LLNW=US / VMW=US / LUMN=US / 005930-KR=US / ADUS=US / SLRC=US / TSLA=US / NXPI=US / MRAAY=US / NMFC=US / ANGI=US / TCPC=US / WDAY=US / ABBV=US / TMUS=US / AGIO=US / AERI=US / CHGG=US / GTT=US / AVYA=US / GOOGL=US / FIVN=US / BABA=US / EKTAY=US / VBLT=US / QRVO=US / OUT=US / SHAK=US / ETSY=US / AQMS=US / NVCR=US / HPE=US / VYGR=US / EDIT=US / NTLA=US / SRTS=US / DZSI=US / IRTC=US / TEUM=US / ATUS=US / IOVA=US / KALA=US / CARG=US / RCKT=US / ALLO=US / ZM=US / FSLY=US / PSNL=US / CMBM=US / FVRR=US / FMTX=US / VLDR=US / CZMWY=US / RXT=US / ABNB=US / DASH=US / ONDS=US / VPAHF=US</td><td class="leftalignment">Salesforce.Com Inc / ICAD Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Life Storage Inc / Walt Disney Co / Intel Corp / Twitter Inc / Analog Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Texas Instruments Inc / Sunrun Inc / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / STMicroelectronics NV / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / Xilinx Inc / NortonLifeLock Inc / ASML Holding NV / Comcast Corp / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Amedisys Inc / Digital Turbine Inc / Autozone Inc / Broadcom Inc / Becton Dickinson and Co / Beyond Meat Inc / H & R Block Inc / bluebird bio Inc / Lumen Technologies Inc / CME Group Inc / Donaldson Company Inc / eGain Corp / 8x8 Inc / Equinix Inc / Flowserve Corp / Intercept Pharmaceuticals Inc / Lendingtree Inc / Microchip Technology Inc / Neurocrine Biosciences Inc / O'Reilly Automotive Inc / Papa John's International Inc / QuickLogic Corp / SBA Communications Corp / Shopify Inc / SLR Senior Investment Corp / Snap Inc / United Therapeutics Corp / Vector Group Ltd / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Compugen Ltd / Advance Auto Parts Inc / Cloudflare Inc / Ceragon Networks Ltd / Meta Platforms Inc / Skyworks Solutions Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / RingCentral Inc / Farfetch Ltd / CEVA Inc / Moderna Inc / Sprouts Farmers Market Inc / Domino's Pizza Inc / MannKind Corp / Alphabet Inc / Digital Realty Trust Inc / Ormat Technologies Inc / ViacomCBS Inc / LHC Group Inc / Discovery Inc / Change Healthcare Inc / Cogent Communications Holdings Inc / First Solar Inc / Arista Networks Inc / Limelight Networks Inc / VMware Inc / Lumen Technologies Inc / Farfetch Ltd / Addus Homecare Corp / SLR Investment Corp / Tesla Inc / NXP Semiconductors NV / Murata Manufacturing Co Ltd / New Mountain Finance Corp / Angi Inc / BlackRock TCP Capital Corp / Workday Inc / Abbvie Inc / T-Mobile US Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Chegg Inc / GTT Communications Inc / Avaya Holdings Corp / Alphabet Inc / Five9 Inc / Alibaba Group Holding Ltd / Elekta AB (publ) / Vascular Biogenics Ltd / Qorvo Inc / OUTFRONT Media Inc / Shake Shack Inc / ETSY Inc / Aqua Metals Inc / Novocure Ltd / Hewlett Packard Enterprise Co / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / DZS Inc / iRhythm Technologies Inc / Pareteum Corp / Altice USA Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / CarGurus Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Zoom Video Communications Inc / Fastly Inc / Personalis Inc / Cambium Networks Corp / Fiverr International Ltd / Forma Therapeutics Holdings Inc / Velodyne Lidar Inc / Carl Zeiss Meditec AG / Rackspace Technology Inc / Airbnb Inc / DoorDash Inc / Ondas Holdings Inc / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Israel / Japan / Netherlands / New Zealand / Sweden / United States / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRNA - Key Takeaways from the SVB Leerink Global Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA=US</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Moderna : 4Q Snapshot - A Lucrative Year Ahead</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q20 Review: Commercial Work Paving the Future</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA=US / MRK=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways from the 4Q20 Earnings Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA=US</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Feb. 25, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">mRNA-1273 Driving Transition into Profitable Global Commercial Biotech Company</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, Feb. 25, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Feb. 25, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4502.T / JNJ.N / PFE.N / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Variant mRNA-1273.351 Vaccine Shipped to NIH; 1.4 Billion Vaccines in 2022</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Variants, but Little Escape- JNJ Data Reduce Likelihood of Durable Boost Market</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRNA=US / BNTX=US</td><td class="leftalignment">Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">OCGN: EMA ODD for OCU400 Is Validating for Its Gene Therapy - Raising PT to $9.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OCGN.OQ / MRNA</td><td class="leftalignment">Ocugen Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Post-COVID Vax Opportunities for mRNA - Key Takeaways from our GHC Panel</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna sinks 13.5% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CTP2021-ALSEN, MGTX, SIGHT; LentiGlobin BLUEs</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MGTX.OQ / SIGHT.PA / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">MeiraGTx Holdings PLC / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 2.21.21</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ADAP=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / TMO=US / MDT=US / A=US / INCY=US / INSP=US / TEVA=US / GILD=US / MOR=DE / SAN=FR / GSK=GB / SYK=US / BAX=US / AZN=US / WAT=US / JNJ=US / MDRX=US / IMGN=US / NUAN=US / ABMD=US / ALKS=US / ALC=US / AMRN=US / ARNA=US / ATRC=US / BDX=US / BMRN=US / BLUE=US / CSTL=US / CALA=US / CERN=US / CNMD=US / EW=US / ENDP=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / INGN=US / ISRG=US / MYGN=US / NBIX=US / PRGO=US / PRTK=US / RARE=US / HOOK=US / REGN=US / RGEN=US / SENS=US / SIEN=US / SILK=US / TECH=US / TFX=US / VRTX=US / ALGN=US / SGEN=US / SAGE=US / OPT=US / PRVB=US / CGEN=US / ALVR=US / JAZZ=US / PHR=US / STSA=US / RNA=US / IMTX=US / MREO=US / NTRA=US / CPSI=US / NKTR=US / MRNS=US / AMTI=US / BIIB=US / ACRS=US / ARWR=US / APTX=US / NUVA=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / COGT=US / DXCM=US / CYRX=US / CBAY=US / GRAY=US / EQ=US / QTRX=US / AVRO=US / TPTX=US / AMRX=US / FOLD=US / PODD=US / TNDM=US / IFRX=US / ITRM=US / NXGN=US / FULC=US / LUN=US / ASND=US / AVEO=US / NEO=US / RCUS=US / MOLN / CTSO=US / ZGNX=US / PCRX=US / RGNX=US / CLVS=US / PBYI=US / AXGN=US / VCRA=US / CCXI=US / FGEN=US / SRPT=US / GMED=US / ABBV=US / EPZM=US / MRTX=US / AGIO=US / PINC=US / FATE=US / MGNX=US / VEEV=US / VCYT=US / KPTI=US / OM=US / ITCI=US / XNCR=US / HRTX=US / QURE=US / GNCA=US / TBPH=US / ARDX=US / RDUS=US / MASS=US / XENT=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / AFMD=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVRO=US / NVTA=US / RLMD=US / VKTX=US / BPMC=US / HTGM=US / ZBH=US / ABEO=US / TDOC=US / KURA=US / WVE=US / AXSM=US / IONS=US / BGNE=US / NTLA=US / ADVM=US / RETA=US / MDGL=US / PTGX=US / ACIU=US / TRHC=US / MYOV=US / ZYME=US / AVDL=US / OBSV=US / RCM=US / BHVN=US / MRSN=US / KALV=US / ATNX=US / SYBX=US / ZLAB=US / DCPH=US / SCPH=US / SLDB=US / GH=US / RCKT=US / EOLS=US / XERS=US / REPL=US / RUBY=US / CRNX=US / ALLK=US / SBTX=US / TWST=US / AXNX=US / MLND=US / OSMT=US / ORGO=US / HARP=US / GOSS=US / TCRR=US / IMUX=US / AXLA=US / BBIO=US / HCAT=US / BNTX=US / GMAB=US / IPHA=US / ETNB=US / PGNY=US / CNTG=US / IMVT=US / ONEM=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / GDRX=US / SPRB=US / SIOX=US / VTRS=US / ABCM=US / GLTO=US / TVTX=US / ABCL=US / KNTE=US / ELDN=US / PRTC=US / CGEM=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Incyte Corp / Inspire Medical Systems Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / MorphoSys AG / Sanofi SA / GlaxoSmithKline PLC / Stryker Corp / Baxter International Inc / AstraZeneca PLC / Waters Corp / Johnson & Johnson / Allscripts Healthcare Solutions Inc / ImmunoGen Inc / Nuance Communications Inc / ABIOMED Inc / Alkermes Plc / Alcon AG / Amarin Corporation PLC / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / Biomarin Pharmaceutical Inc / bluebird bio Inc / Castle Biosciences Inc / Calithera Biosciences Inc / Cerner Corp / Conmed Corp / Edwards Lifesciences Corp / Endo International PLC / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Inogen Inc / Intuitive Surgical Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Perrigo Company PLC / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Senseonics Holdings Inc / Sientra Inc / Silk Road Medical Inc / Bio-Techne Corp / Teleflex Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Allovir Inc / Jazz Pharmaceuticals PLC / Phreesia Inc / Satsuma Pharmaceuticals Inc / Avidity Biosciences Inc / Immatics NV / Mereo Biopharma Group PLC / Natera Inc / Computer Programs and Systems Inc / Nektar Therapeutics / Marinus Pharmaceuticals Inc / Applied Molecular Transport Inc. / Biogen Inc / Aclaris Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Aptinyx Inc / NuVasive Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cogent Biosciences Inc / Dexcom Inc / Cryoport Inc / Cymabay Therapeutics Inc / Graybug Vision Inc / Equillium Inc / Quanterix Corp / AVROBIO Inc / Turning Point Therapeutics Inc / Amneal Pharmaceuticals Inc / Amicus Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Iterum Therapeutics PLC / NextGen Healthcare Inc / Fulcrum Therapeutics Inc / H Lundbeck A/S / Ascendis Pharma A/S / Aveo Pharmaceuticals Inc / Neogenomics Inc / Arcus Biosciences Inc / Molecular Partners AG / Cytosorbents Corp / Zogenix Inc / Pacira Biosciences Inc / Regenxbio Inc / Clovis Oncology Inc / Puma Biotechnology Inc / AxoGen Inc / Vocera Communications Inc / ChemoCentryx Inc / FibroGen Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Abbvie Inc / Epizyme Inc / Mirati Therapeutics Inc / Agios Pharmaceuticals Inc / Premier Inc / Fate Therapeutics Inc / MacroGenics Inc / Veeva Systems Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Intra-Cellular Therapies Inc / Xencor Inc / Heron Therapeutics Inc / Uniqure NV / Genocea Biosciences Inc / Theravance Biopharma Inc / Ardelyx Inc / Radius Health Inc / 908 Devices Inc. / Intersect Ent Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Affimed NV / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Nevro Corp / Invitae Corp / Relmada Therapeutics Inc / Viking Therapeutics Inc / Blueprint Medicines Corp / HTG Molecular Diagnostics Inc / Zimmer Biomet Holdings Inc / Abeona Therapeutics Inc / Teladoc Health Inc / Kura Oncology Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Reata Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Protagonist Therapeutics Inc / AC Immune SA / Tabula Rasa HealthCare Inc / Myovant Sciences Ltd / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / R1 RCM Inc / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / Kalvista Pharmaceuticals Inc / Athenex Inc / Synlogic Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Guardant Health Inc / Rocket Pharmaceuticals Inc / Evolus Inc / Xeris Biopharma Holdings Inc / Replimune Group Inc / Rubius Therapeutics Inc / Crinetics Pharmaceuticals Inc / Allakos Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Axonics Inc / Tempest Therapeutics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / Gossamer Bio Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / BridgeBio Pharma Inc / Health Catalyst Inc / BioNTech SE / Genmab A/S / Innate Pharma SA / 89Bio Inc / Progyny Inc / Centogene NV / Immunovant Inc / 1Life Healthcare Inc / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Viatris Inc / Abcam PLC / Galecto Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc / PureTech Health PLC / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Moderna surges 88% in past quarter; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.19.21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">ALSN=US / CYH=US / AAPL=US / PFE=US / AMGN=US / INTC=US / ADI=US / AMD=US / MSFT=US / AMZN=US / QCOM=US / TXN=US / NVDA=US / GS=US / MX=US / MPWR=US / SMTC=US / TSM=US / XLNX=US / MGM=US / PENN=US / AMED=US / AVGO=US / CAKE=US / CHE=US / CRUS=US / DRI=US / ECL=US / IFX=US / ICPT=US / NOW=US / MCHP=US / QUIK=US / SHOP=US / UTHR=US / WIX=US / JEF=US / SWKS=US / TWLO=US / WCN=US / PTON=US / TCOM=US / CZR=US / MRNA=US / LHCG=US / BIDU=US / SPWR=US / RSI=US / IAC=US / JACK=US / SWAV=US / 005930-KR=US / ADUS=US / MXL=US / NXPI=US / 2454-TW=US / SRPT=US / WDAY=US / YY=US / NVTA=US / CLLS=US / GDDY=US / ETSY=US / VKTX=US / WING=US / SQ=US / MDGL=US / MDNA=US / IQ=US / TLRY=US / FSLY=US / DKNG=US / FUBO=US / AYLA=US / XPEV=US</td><td class="leftalignment">Allison Transmission Holdings Inc / Community Health Systems Inc / Apple Inc / Pfizer Inc / Amgen Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Texas Instruments Inc / NVIDIA Corp / Goldman Sachs Group Inc / MagnaChip Semiconductor Corp / Monolithic Power Systems Inc / Semtech Corp / Taiwan Semiconductor Manufacturing Co Ltd / Xilinx Inc / MGM Resorts International / Penn National Gaming Inc / Amedisys Inc / Broadcom Inc / Cheesecake Factory Inc / Chemed Corp / Cirrus Logic Inc / Darden Restaurants Inc / Ecolab Inc / Infineon Technologies AG / Intercept Pharmaceuticals Inc / ServiceNow Inc / Microchip Technology Inc / QuickLogic Corp / Shopify Inc / United Therapeutics Corp / Wix.Com Ltd / Jefferies Financial Group Inc / Skyworks Solutions Inc / Twilio Inc / Waste Connections Inc / Peloton Interactive Inc / Trip.com Group Ltd / Caesars Entertainment Inc / Moderna Inc / LHC Group Inc / Baidu Inc / SunPower Corp / Rush Street Interactive Inc / IAC/Interactivecorp / Jack in the Box Inc / Shockwave Medical Inc / Farfetch Ltd / Addus Homecare Corp / Maxlinear Inc / NXP Semiconductors NV / MediaTek Inc / Sarepta Therapeutics Inc / Workday Inc / JOYY Inc / Invitae Corp / Cellectis SA / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / Wingstop Inc / Block Inc / Madrigal Pharmaceuticals Inc / Medicenna Therapeutics Corp / iQIYI Inc / Tilray Brands Inc / Fastly Inc / DraftKings Inc / Fubotv Inc / Ayala Pharmaceuticals Inc / Xpeng Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / France / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Europe Purchases Another 150 Million mRNA-1273 Doses; Target to $208</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALSEN=FR / MGTX=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / REPL=US / KOD=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Sensorion SA / MeiraGTx Holdings PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / Replimune Group Inc / Kodiak Sciences Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AIMC=US / MCO=US / AAPL=US / BSX=US / CSII=US / LLY=US / PFE=US / SBUX=US / ABT=US / CAT=US / COST=US / INTC=US / AMD=US / WM=US / BWA=US / MSFT=US / MDT=US / JNPR=US / AMZN=US / QCOM=US / WMT=US / TXN=US / TEVA=US / RUN=US / NVDA=US / MPWR=US / FCEL=US / PLUG=US / CRM=US / SCI=US / EL=US / SMTC=US / BJ=US / DAL=US / TSM=US / HELE=US / CTAS=US / JCI=US / JNJ=US / TTWO=US / LSTR=US / DE=US / HUM=US / LECO=US / UNH=US / INTU=US / RSG=US / ALB=US / AMSC=US / ARRY=US / AVNT=US / AVGO=US / CMI=US / CHE=US / CREE=US / DHI=US / DG=US / EW=US / EGAN=US / EXEL=US / ITRI=US / PHG=US / MS=US / TEAM=US / PZZA=US / REGN=US / ROK=US / SNAP=US / TRMB=US / TYL=US / UTHR=US / VG=US / WIX=US / RDWR=US / NET=US / ACA=US / FB=US / NEP=US / JBLU=US / NFLX=US / VRNT=US / BE=US / CLH=US / WCN=US / NDAQ=US / RNG=US / MRNA=US / MNKD=US / ENS=US / GOOG=US / TWIN=US / ORA=US / OLED=US / FRPT=US / LHCG=US / AMRS=US / SPWR=US / AXON=US / XPO=US / ELF=US / TEL=US / CSIQ=US / FSLR=US / LULU=US / MASI=US / ULTA=US / TNDM=US / DAN=US / SPGI=US / WPRT=US / KKR=US / AGCO=US / ADUS=US / TCEHY=US / TSLA=US / AMRC=US / ENPH=US / WDAY=US / HASI=US / CNHI=US / COUP=US / OTIC=US / VBLT=US / QRVO=US / NVTA=US / ETSY=US / SEDG=US / AQMS=US / WKHS=US / TTD=US / EVBG=US / IRTC=US / CRSP=US / OKTA=US / IOVA=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / FOCS=US / CWEN=US / FTDR=US / ESTC=US / UBER=US / CRWD=US / DKNG=US / VLDR=US</td><td class="leftalignment">Altra Industrial Motion Corp / Moody's Corp / Apple Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Starbucks Corp / Abbott Laboratories / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Medtronic PLC / Juniper Networks Inc / Amazon.com Inc / Qualcomm Inc / Walmart Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Sunrun Inc / NVIDIA Corp / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / Salesforce.Com Inc / Service Corporation International / Estee Lauder Companies Inc / Semtech Corp / BJ's Wholesale Club Holdings Inc / Delta Air Lines Inc / Taiwan Semiconductor Manufacturing Co Ltd / Helen of Troy Ltd / Cintas Corp / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Landstar System Inc / Deere & Co / Humana Inc / Lincoln Electric Holdings Inc / UnitedHealth Group Inc / Intuit Inc / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / Avient Corp / Broadcom Inc / Cummins Inc / Chemed Corp / Wolfspeed Inc / D R Horton Inc / Dollar General Corp / Edwards Lifesciences Corp / eGain Corp / Exelixis Inc / Itron Inc / Koninklijke Philips NV / Morgan Stanley / Atlassian Corporation PLC / Papa John's International Inc / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / Snap Inc / Trimble Inc / Tyler Technologies Inc / United Therapeutics Corp / Vonage Holdings Corp / Wix.Com Ltd / Radware Ltd / Cloudflare Inc / Arcosa Inc / Meta Platforms Inc / Nextera Energy Partners LP / JetBlue Airways Corp / Netflix Inc / Verint Systems Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / RingCentral Inc / Moderna Inc / MannKind Corp / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Universal Display Corp / Freshpet Inc / LHC Group Inc / Amyris Inc / SunPower Corp / Axon Enterprise Inc / XPO Logistics Inc / elf Beauty Inc / TE Connectivity Ltd / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Masimo Corp / Ulta Beauty Inc / Tandem Diabetes Care Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / KKR & Co Inc / AGCO Corp / Addus Homecare Corp / Tencent Holdings Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Workday Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Coupa Software Inc / Otonomy Inc / Vascular Biogenics Ltd / Qorvo Inc / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Aqua Metals Inc / Workhorse Group Inc / Trade Desk Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Okta Inc / Iovance Biotherapeutics Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / CrowdStrike Holdings Inc / DraftKings Inc / Velodyne Lidar Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Pharmaceuticals / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Ex vivo GT sees positive readouts</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Cyclical Runway for Dow Transports</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AAPL=US / CSII=US / SBUX=US / COST=US / AMZN=US / WMT=US / TXN=US / RUN=US / NVDA=US / MPWR=US / CRM=US / EL=US / SMTC=US / DAL=US / HELE=US / TTWO=US / LSTR=US / HUM=US / UNH=US / ALB=US / AVGO=US / CHE=US / DHI=US / DG=US / EW=US / ITRI=US / MS=US / TEAM=US / PZZA=US / ROK=US / SNAP=US / VG=US / WIX=US / NET=US / ACA=US / FB=US / JBLU=US / NFLX=US / NDAQ=US / RNG=US / MRNA=US / OLED=US / LHCG=US / XPO=US / TEL=US / LULU=US / TNDM=US / SPGI=US / KKR=US / ADUS=US / TCEHY=US / WDAY=US / COUP=US / QRVO=US / NVTA=US / ETSY=US / TTD=US / CRSP=US / OKTA=US / IOVA=US / ROKU=US / MDB=US / FOCS=US / FTDR=US / ESTC=US / UBER=US / CRWD=US / DKNG=US</td><td class="leftalignment">Apple Inc / Cardiovascular Systems Inc / Starbucks Corp / Costco Wholesale Corp / Amazon.com Inc / Walmart Inc / Texas Instruments Inc / Sunrun Inc / NVIDIA Corp / Monolithic Power Systems Inc / Salesforce.Com Inc / Estee Lauder Companies Inc / Semtech Corp / Delta Air Lines Inc / Helen of Troy Ltd / Take-Two Interactive Software Inc / Landstar System Inc / Humana Inc / UnitedHealth Group Inc / Albemarle Corp / Broadcom Inc / Chemed Corp / D R Horton Inc / Dollar General Corp / Edwards Lifesciences Corp / Itron Inc / Morgan Stanley / Atlassian Corporation PLC / Papa John's International Inc / Rockwell Automation Inc / Snap Inc / Vonage Holdings Corp / Wix.Com Ltd / Cloudflare Inc / Arcosa Inc / Meta Platforms Inc / JetBlue Airways Corp / Netflix Inc / Nasdaq Inc / RingCentral Inc / Moderna Inc / Universal Display Corp / LHC Group Inc / XPO Logistics Inc / TE Connectivity Ltd / Lululemon Athletica Inc / Tandem Diabetes Care Inc / S&P Global Inc / KKR & Co Inc / Addus Homecare Corp / Tencent Holdings Ltd / Workday Inc / Coupa Software Inc / Qorvo Inc / Invitae Corp / ETSY Inc / Trade Desk Inc / CRISPR Therapeutics AG / Okta Inc / Iovance Biotherapeutics Inc / Roku Inc / MongoDB Inc / Focus Financial Partners Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / CrowdStrike Holdings Inc / DraftKings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.12.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BNGO=US / INO=US / AAPL=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / BMY=US / MDT=US / WMT=US / INCY=US / EPIX=US / CMS=US / DGX=US / NVS=US / AZN=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXEL=US / GEN=US / LH=US / NVAX=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / VRTX=US / SGEN=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / SNY=US / MD=US / SLF=US / BIIB=US / ISR=US / MRNA=US / ALNY=US / GOOG=US / DXCM=US / LHCG=US / CHNG=US / INFI=US / ORTX=US / EHC=US / BAYRY=US / SPRO=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / ARCT=US / ABBV=US / PRTA=US / ENTA=US / CTRE=US / WBA=US / NVTA=US / EVH=US / ZBH=US / IONS=US / EDIT=US / AVDL=US / MTEM=US / VERU=US / GMDA=US / NBSE=US / FREQ=US / RCEL=US / PNTG=US / TSHA=US / SIOX=US</td><td class="leftalignment">Bionano Genomics Inc / Inovio Pharmaceuticals Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / Novavax Inc / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / Sanofi SA / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / IsoRay Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Orchard Therapeutics PLC / Encompass Health Corp / Bayer AG / Spero Therapeutics Inc / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Arcturus Therapeutics Holdings Inc / Abbvie Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Zimmer Biomet Holdings Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Avadel Pharmaceuticals PLC / Molecular Templates Inc / Veru Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Frequency Therapeutics Inc / AVITA Medical Inc / Pennant Group Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">INO=US / TWOU=US / AAPL=US / MRK=US / WSM=US / NKE=US / PFE=US / BMY=US / HD=US / INTC=US / ADI=US / AMD=US / BWA=US / MSFT=US / AMZN=US / QCOM=US / BBY=US / TXN=US / EPIX=US / MPWR=US / NVS=US / SMTC=US / LOW=US / TSM=US / AZN=US / CRY=US / XLNX=US / EXPE=US / JNJ=US / UNH=US / ARCC=US / AVGO=US / BL=US / CRUS=US / IFX=US / FROG=US / MCHP=US / NVAX=US / REGN=US / TSCO=US / UTHR=US / VCTR=US / WTS=US / SGEN=US / RHHBY=US / PYPL=US / SWKS=US / ARES=US / DKS=US / BIIB=US / MRNA=US / ALNY=US / ENS=US / GOOG=US / BJRI=US / PBH=US / DXCM=US / XPO=US / LULU=US / GNRC=US / MXL=US / NXPI=US / ARCT=US / PRTA=US / VRNS=US / GDDY=US / UAA=US / CARG=US / DDOG=US / RCEL=US / SIOX=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / 2U Inc / Apple Inc / Merck & Co Inc / Williams-Sonoma Inc / Nike Inc / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Borgwarner Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Best Buy Co Inc / Texas Instruments Inc / ESSA Pharma Inc / Monolithic Power Systems Inc / Novartis AG / Semtech Corp / Lowe's Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / CryoLife Inc / Xilinx Inc / Expedia Group Inc / Johnson & Johnson / UnitedHealth Group Inc / Ares Capital Corp / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Infineon Technologies AG / Jfrog Ltd / Microchip Technology Inc / Novavax Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / United Therapeutics Corp / Victory Capital Holdings Inc / Watts Water Technologies Inc / Seagen Inc / Roche Holding AG / PayPal Holdings Inc / Skyworks Solutions Inc / Ares Management Corp / DICK'S Sporting Goods Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / EnerSys / Alphabet Inc / BJ's Restaurants Inc / Prestige Consumer Healthcare Inc / Dexcom Inc / XPO Logistics Inc / Lululemon Athletica Inc / Generac Holdings Inc / Maxlinear Inc / NXP Semiconductors NV / Arcturus Therapeutics Holdings Inc / Prothena Corporation PLC / Varonis Systems Inc / GoDaddy Inc / Under Armour Inc / CarGurus Inc / Datadog Inc / AVITA Medical Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">U.S. Government Purchases Additional 100 Million for Total of 300 Million Doses</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A DNA Medicines Disruptor Gaining Steam; Initiate at Outperform with $35 PT</td><td class="leftalignment">English</td><td class="rightalignment">93</td><td class="leftalignment">INO=US / MRK=US / PFE=US / AZN=US / JNJ=US / NVAX=US / REGN=US / UTHR=US / MRNA=US / ALNY=US / ARCT=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Moderna Inc / Alnylam Pharmaceuticals Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">JACK=US / NUAN=US / MCD=US / WEN=US / AMZN=US / WMT=US / YUM=US / TTWO=US / W=US / INTU=US / FIVE=US / GPN=US / PTON=US / BIIB=US / MRNA=US / ALNY=US / INFI=US / QSR=US / PRPL=US / LULU=US / FICO=US / TSLA=US / EA=US / ABBV=US / ENTA=US / VRNS=US / PAYC=US / CDK=US / LOVE=US / ETSY=US / EDIT=US / CVNA=US / VERU=US / GRWG=US / MWK=US / NBSE=US</td><td class="leftalignment">Jack in the Box Inc / Nuance Communications Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / Walmart Inc / Yum! Brands Inc / Take-Two Interactive Software Inc / Wayfair Inc / Intuit Inc / Five Below Inc / Global Payments Inc / Peloton Interactive Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / Fair Isaac Corp / Tesla Inc / Electronic Arts Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Varonis Systems Inc / Paycom Software Inc / CDK Global Inc / Lovesac Co / ETSY Inc / Editas Medicine Inc / Carvana Co / Veru Inc / GrowGeneration Corp / Aterian Inc / NeuBase Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Semiconductors</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Road to Reopening: The Evolution of COVID-19 Event Recap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">375558103 / 75886F107 / 452327109 / 74838J101 / 359664109 / 64049K104 / 60770K107 / 729139105 / 02155H200 / 01626L105</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Illumina Inc / Quidel Corp / Fulgent Genetics Inc / Neoleukin Therapeutics Inc / Moderna Inc / Pliant Therapeutics Inc / Altimmune Inc / Aligos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Yasmeen Rahimi, Ph.D. / Steven Mah, Ph.D. / Mr. Tyler M. Van Buren, M.SC / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback from Meeting with Management</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NBSE=US / MRNA=US / ALNY=US</td><td class="leftalignment">NeuBase Therapeutics Inc / Moderna Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR deal termination; big pharma engages GRTS</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GRTS.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - New report: China's vaccination roadmap-deep-dive into clinical data and market potential</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / 2196.HK / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Shanghai Fosun Pharmaceutical Group Co Ltd / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China's vaccination roadmap: Deep-dive into clinical data and market potential</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">2196.HK / 600196.SS / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / LONN.S / GSK.L / NVAX.OQ / MRNA.OQ / SVA.OQ / 300122.SZ / 300142.SZ / CVAC.OQ</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Moderna Inc / Sinovac Biotech Ltd / Chongqing Zhifei Biological Products Co Ltd / Walvax Biotechnology Co Ltd / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Switzerland / China / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.5.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippine Market Strategy - Philippine Vaccination: A govt-private sector alliance - key takeaways</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Hazel Tanedo / Mr. Justin J. Cimafranca</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary of 141 page Covid-19 Multilateralism Agility and Innovation TLSD Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">22UAy.DE / GSK.L / 4507.T / JNJ / LLY / PFE / AZN.L / BAVA.CO / REGN.O / 4563.T / IMM.L / CADI.NS / NVAX.O / SYNG.L / MRNA.O / 1099.HK / SVA.O / 4142.TW / ARCT.O / VBIV.O / ALT.O / VXRT.O / POLX.L / BNTX.O / VIR.O / 688185.SS</td><td class="leftalignment">BioNTech SE / GlaxoSmithKline PLC / Shionogi & Co Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Bavarian Nordic A/S / Regeneron Pharmaceuticals Inc / AnGes Inc / ImmuPharma PLC / Cadila Healthcare Ltd / Novavax Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Adimmune Corp / Arcturus Therapeutics Holdings Inc / VBI Vaccines Inc / Altimmune Inc / Vaxart Inc / Polarean Imaging PLC / BioNTech SE / Vir Biotechnology Inc / CanSino Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Canada / China / Germany / Denmark / United Kingdom / India / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / CORPORATE SUMMARY / STRATEGY / STRATEGIC ANALYSIS / EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">OCGN: COVAXIN Agreement with Bharat Is Very Favorable - Raising PT to $8</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OCGN.OQ / MRNA</td><td class="leftalignment">Ocugen Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">More Good News for mRNA-1273</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Table Mania for COVID-19 Vaccines: Navigating Key Data Readouts in 1Q21</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">45773H201 / 60770K107 / 02155H200 / 03969T109</td><td class="leftalignment">Inovio Pharmaceuticals Inc / Moderna Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Yasmeen Rahimi, Ph.D. / Edward A. Tenthoff / Mr. Christopher J. Raymond / Kristin Ko, Ph.D. / Nicole Gabreski, PhD / Mr. Allison M. Bratzel, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CNX / CPB / DANO.PA / EMN / EOG / GIS / GPS / HSY / K / PNC / RKT / SJM / SM / SYY / THS / TPR / UPS / WAT / BYND.O / PEB.N / ARNA.O / TECH.O / HAIN.O / MRNA.O / NXPI.O / RLJ.N / ARCT.O / MDLZ.O / FANG.O / SMPL.O / POST.K / PFSI.K / XHR.N / KHC.O / UAA / NOMD.K / CPRI.K / BRBR.K / GHLD.K / GRCL.O</td><td class="leftalignment">CNX Resources Corp / Campbell Soup Co / Danone SA / Eastman Chemical Co / EOG Resources Inc / General Mills Inc / Gap Inc / Hershey Co / Kellogg Co / PNC Financial Services Group Inc / Rocket Companies Inc / J M Smucker Co / SM Energy Co / Sysco Corp / TreeHouse Foods Inc / Tapestry Inc / United Parcel Service Inc / Waters Corp / Beyond Meat Inc / Pebblebrook Hotel Trust / Arena Pharmaceuticals Inc / Bio-Techne Corp / Hain Celestial Group Inc / Moderna Inc / NXP Semiconductors NV / RLJ Lodging Trust / Arcturus Therapeutics Holdings Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / Post Holdings Inc / PennyMac Financial Services Inc / Xenia Hotels & Resorts Inc / Kraft Heinz Co / Under Armour Inc / Nomad Foods Ltd / Capri Holdings Ltd / Bellring Brands Inc / Guild Holdings Co / Gracell Biotechnologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA/ARCT: Initial Thoughts in Sputnik V Adenoviral COVID19 Vaccine</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA.O / ARCT.O</td><td class="leftalignment">Moderna Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRNA Takeaways from PFE Earnings</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRNA=US</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MCK: Q&A Our Way: Shots in Arms & a Strong FY3Q Drive FY21 Outlook Higher</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MCK.N / CAH.N / PFE.N / ABC.N / MRNA.OQ / WBA.OQ</td><td class="leftalignment">Mckesson Corp / Cardinal Health Inc / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc / Walgreens Boots Alliance Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: January 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / ALB.N / AXP.N / BA.N / BAC.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CRM.N / CVS.N / DAL.N / DD.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / GM.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MDT.N / MO.N / MRK.N / OXY.N / SLB.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / CMA.N / PG.N / W.N / RIG.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / MGM.N / RCL.N / SYY.N / HON.N / VLO.N / HD.N / LOW.N / MRO.N / SYK.N / JWN.N / XOM.N / NKE.N / LIN.N / TGT.N / VZ.N / SNV.N / KSS.N / ORCL.N / VFC.N / HP.N / MAC.N / KMI.N / KMX.N / PWR.N / EQT.N / V.N / OKE.N / HWM.N / ACN.N / WSM.N / AIV.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / COHR.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / PII.N / REGN.OQ / ROL.N / SIVB.OQ / THO.N / QDEL.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / CREE.OQ / GILD.OQ / COST.OQ / CPRT.OQ / TRU.N / ACGL.OQ / SSNC.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / MRCY.OQ / EBAY.OQ / NVDA.OQ / MFA.N / CHTR.OQ / NUAN.OQ / ISRG.OQ / ILMN.OQ / ALGN.OQ / GPN.N / PTEN.OQ / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / SBNY.OQ / OSH.N / MOS.N / LVS.N / VIAC.OQ / DISCA.OQ / KOS.N / CDNS.OQ / MS.N / FIS.N / MA.N / SIX.N / SPR.N / CNK.N / IVZ.N / M.N / BGCP.OQ / PBF.N / MRNA.OQ / MSCI.N / CHNG.OQ / AVGO.OQ / FICO.N / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / NEE.N / TSLA.OQ / ADSGN.F / HHC.N / TWO.N / SABR.OQ / MPC.N / HFC.N / HZNP.OQ / AMD.OQ / ENPH.OQ / PSX.N / NOW.N / SRPT.OQ / BERY.N / FANG.OQ / ABBV.N / BFAM.N / COTY.N / FEYE.OQ / MAR.OQ / AAL.OQ / NCLH.N / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / WBA.OQ / SEDG.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / RETA.OQ / TWLO.N / SPG.NZ / TTD.OQ / CDEV.OQ / UAA.N / FTI.PA / CVNA.N / AXON.OQ / ROKU.OQ / PEP.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / FB.PS / CDAY.N / UAL.OQ / STNE.OQ / ETRN.N / NWL.OQ / CPRI.N / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / CRWD.OQ / PTON.OQ / SVC.OQ / SPCE.N / RTX.N / CARR.N / LMND.N / CHK.N^F20 / AMWL.N / LUMN.N / CHX.OQ</td><td class="leftalignment">Abbott Laboratories / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Merck & Co Inc / Occidental Petroleum Corp / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Comerica Inc / Procter & Gamble Co / Wayfair Inc / Transocean Ltd / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Royal Caribbean Cruises Ltd / Sysco Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Stryker Corp / Nordstrom Inc / Exxon Mobil Corp / Nike Inc / Linde PLC / Target Corp / Verizon Communications Inc / Synovus Financial Corp / Kohls Corp / Oracle Corp / VF Corp / Helmerich and Payne Inc / Macerich Co / Kinder Morgan Inc / Carmax Inc / Quanta Services Inc / EQT Corp / Visa Inc / ONEOK Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Coherent Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Thor Industries Inc / Quidel Corp / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Wolfspeed Inc / Gilead Sciences Inc / Costco Wholesale Corp / Copart Inc / TransUnion / Arch Capital Group Ltd / SS&C Technologies Holdings Inc / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Mercury Systems Inc / eBay Inc / NVIDIA Corp / MFA Financial Inc / Charter Communications Inc / Nuance Communications Inc / Intuitive Surgical Inc / Illumina Inc / Align Technology Inc / Global Payments Inc / Patterson-UTI Energy Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Signature Bank / Oak Street Health Inc / Mosaic Co / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Kosmos Energy Ltd / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Six Flags Entertainment Corp / Spirit AeroSystems Holdings Inc / Cinemark Holdings Inc / Invesco Ltd / Macy's Inc / BGC Partners Inc / PBF Energy Inc / Moderna Inc / MSCI Inc / Change Healthcare Inc / Broadcom Inc / Fair Isaac Corp / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Nextera Energy Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / Two Harbors Investment Corp / Sabre Corp / Marathon Petroleum Corp / HollyFrontier Corp / Horizon Therapeutics PLC / Advanced Micro Devices Inc / Enphase Energy Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Diamondback Energy Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Coty Inc / Mandiant Inc / Marriott International Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Reata Pharmaceuticals Inc / Twilio Inc / Stride Property Ltd / Trade Desk Inc / Centennial Resource Development Inc / Under Armour Inc / TechnipFMC PLC / Carvana Co / Axon Enterprise Inc / Roku Inc / PepsiCo Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Ceridian HCM Holding Inc / United Airlines Holdings Inc / StoneCo Ltd / Equitrans Midstream Corp / Newell Brands Inc / Capri Holdings Ltd / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Service Properties Trust / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / Chesapeake Energy Corp / American Well Corp / Lumen Technologies Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Liberia / New Zealand / Panama / Philippines / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">LONN.S: Lonza - FY20 Results: Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">LONN.S / A.N / RECI.MI / TMO.N / AZN.L / LUN.CO / MRCG.DE / SATG.DE / UCB.BR / SFZN.S / YPSN.S / IPN.PA / GXIG.DE / ALM.MC / MRNA.OQ / 068270.KS / CTLT.N / 207940.KS / GMAB.CO</td><td class="leftalignment">Lonza Group AG / Agilent Technologies Inc / Recordati Industria Chimica e Farmaceutica SpA / Thermo Fisher Scientific Inc / AstraZeneca PLC / H Lundbeck A/S / Merck KGaA / Sartorius AG / Ucb SA / Siegfried Holding AG / Ypsomed Holding AG / Ipsen SA / Gerresheimer AG / Almirall SA / Moderna Inc / Celltrion Inc / Catalent Inc / Samsung Biologics Co Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Italy / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary Covid-19 Multilateralism Agility and Innovation The Life Sciences Division Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / NVAX.OQ / JNJ.N / LLY.N / PFE.N / GSK.L / IMM.L / REGN.OQ / SYNG.L / MRNA.OQ / 1099.HK / SVA.OQ / ARCT.OQ / POLX.L / 6185.HK / VIR.OQ</td><td class="leftalignment">AstraZeneca PLC / Novavax Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / GlaxoSmithKline PLC / ImmuPharma PLC / Regeneron Pharmaceuticals Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Arcturus Therapeutics Holdings Inc / Polarean Imaging PLC / CanSino Biologics Inc / Vir Biotechnology Inc</td><td class="leftalignment">RESEARCH OVERVIEW - INVESTMENT STRATEGY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / CORPORATE SUMMARY / COMPANY REPORT</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">State of MRNA Debate After an Eventful Week</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRNA=US / PFE=US / JNJ=US / BNTX=US</td><td class="leftalignment">Moderna Inc / Pfizer Inc / Johnson & Johnson / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AOS=US / PNR=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / AMGN=US / CAT=US / INTC=US / CHRW=US / WM=US / BWA=US / MDT=US / GLW=US / QCOM=US / RUN=US / MPWR=US / FCEL=US / PLUG=US / AXL=US / SBH=US / CRM=US / SMTC=US / UMC=US / VRTS=US / URI=US / TSM=US / UPS=US / ENR=US / CHRS=US / JCI=US / JNJ=US / LSTR=US / DE=US / DOV=US / FLO=US / RSG=US / ALB=US / AMED=US / ECOL=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / CMI=US / CALM=US / CENX=US / CREE=US / CYBR=US / DAKT=US / EW=US / EXAS=US / FIVE=US / HTLD=US / ITRI=US / LGND=US / MTRX=US / MMS=US / NVAX=US / ODFL=US / PZZA=US / RBC=US / ROK=US / ROP=US / POOL=US / TRMB=US / TYL=US / VG=US / WDFC=US / SGEN=US / CCRN=US / ACA=US / HR=US / NEP=US / UFCS=US / BIO=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / PETS=US / WCN=US / TCOM=US / RNG=US / CRI=US / NUVA=US / MRNA=US / DPZ=US / BDC=US / PBF=US / ENS=US / GOOG=US / TWIN=US / MKTX=US / ORA=US / FRPT=US / PBH=US / MORN=US / BIDU=US / AMRS=US / SPWR=US / ATNI=US / TPTX=US / TEL=US / CSIQ=US / EBS=US / FSLR=US / TRIT=US / MASI=US / DAN=US / WPRT=US / TBK=US / AGCO=US / 005930-KR=US / GNRC=US / RRTS=US / TSLA=US / AMRC=US / ENPH=US / YY=US / HASI=US / CNHI=US / QURE=US / DNOW=US / COUP=US / SYF=US / VCEL=US / NVTA=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / WKHS=US / TRHC=US / FLGT=US / IRTC=US / HLNE=US / RDFN=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / IQ=US / VNE=US / FOCS=US / CWEN=US / ZM=US / VLDR=US / 120376391</td><td class="leftalignment">A O Smith Corp / Pentair PLC / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Intel Corp / CH Robinson Worldwide Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Corning Inc / Qualcomm Inc / Sunrun Inc / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Sally Beauty Holdings Inc / Salesforce.Com Inc / Semtech Corp / United Microelectronics Corp / Virtus Investment Partners Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Johnson Controls International PLC / Johnson & Johnson / Landstar System Inc / Deere & Co / Dover Corp / Flowers Foods Inc / Republic Services Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Cummins Inc / Cal-Maine Foods Inc / Century Aluminum Co / Wolfspeed Inc / Cyberark Software Ltd / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Five Below Inc / Heartland Express Inc / Itron Inc / Ligand Pharmaceuticals Inc / Matrix Service Co / Maximus Inc / Novavax Inc / Old Dominion Freight Line Inc / Papa John's International Inc / Regal Rexnord Corp / Rockwell Automation Inc / Roper Technologies Inc / Pool Corp / Trimble Inc / Tyler Technologies Inc / Vonage Holdings Corp / WD-40 Co / Seagen Inc / Cross Country Healthcare Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / United Fire Group Inc / Bio Rad Laboratories Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Petmed Express Inc / Waste Connections Inc / Trip.com Group Ltd / RingCentral Inc / Carter's Inc / NuVasive Inc / Moderna Inc / Domino's Pizza Inc / Belden Inc / PBF Energy Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Marketaxess Holdings Inc / Ormat Technologies Inc / Freshpet Inc / Prestige Consumer Healthcare Inc / Morningstar Inc / Baidu Inc / Amyris Inc / SunPower Corp / ATN International Inc / Turning Point Therapeutics Inc / TE Connectivity Ltd / Canadian Solar Inc / Emergent BioSolutions Inc / First Solar Inc / Triterras Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Triumph Bancorp Inc / AGCO Corp / Farfetch Ltd / Generac Holdings Inc / Roadrunner Transportation Systems Inc / Tesla Inc / Ameresco Inc / Enphase Energy Inc / JOYY Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Uniqure NV / NOW Inc / Coupa Software Inc / Synchrony Financial / Vericel Corp / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Workhorse Group Inc / Tabula Rasa HealthCare Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Hamilton Lane Inc / Redfin Corp / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / iQIYI Inc / Veoneer Inc / Focus Financial Partners Inc / Clearway Energy Inc / Zoom Video Communications Inc / Velodyne Lidar Inc / Proterra Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ABT / ACI / ADS / AEE / AEP / AGR / ALC / ALE / ATO / AWK / AWR / AZO / BAX / BDX / BEP / BIG / BIP / BKH / BSX / CCK / CE / CHD / CL / CLR / CLX / CMG / CMS / CNP / COO / CPB / CPE / CPK / CVX / CWT / D / DANO.PA / DCP / DFS / DK / DRI / DTE / DUK / DVN / ED / EIX / EL / EPD / ES / ETR / FE / FND / GIS / GPS / HD / HE / HFC / HSY / IDA / JNJ / K / KDP / KMB / KO / KR / LOW / MDT / MPC / MRO / MSFT.O / NEP / NI / NJR / NKE / OGE / OI / OKE / OLN / PCG / PEG / PEN / PG / PNM / PNW / POR / PPL / PSX / PVH / PXD / RH / RL / ROP / SF / SJI / SJM / SJW / SO / SPB / SR / SRE / ST / STZ / SWX / SYK / SYY / T / TAP.N / TFX / THS / TPR / TRV / UPS / VLO / WEC / WES / WLK / WLL / YUM / AMZN.O / BYND.O / ET / AMGN.O / EW / IRM / OGS / KMI / EPC / NWE / PEB.N / PBF / SIRI.O / IART.O / VZ / NWN / SBUX.O / CHRW.O / BJ.N / ROST.O / EXPE.O / DLTR.O / FTS.TO / ISRG.O / EMA.TO / CAKE.O / NEE / TSCO.O / MNST.O / UMBF.O / MMSI.O / ORLY.O / HAIN.O / SBNY.O / NUVA.O / DXCM.O / H.TO / IBKR.O / PODD.O / TNDM.OQ / MRNA.O / FICO.K / AQN / SCHW.K / LUNG.O / ADSGn.DE / LNG.N / ANGI.O / MTDR.K / ARCT.O / FB.O / TRGP.K / PDCE.O / FIVE.O / GMED.K / MDLZ.O / FANG.O / MPLX.K / SMPL.O / POST.K / COTY.K / SFM.O / MAR.O / GOOGL.O / NVRO.K / GKOS.K / WING.O / ZBH / KHC.O / SPNE.O / OLLI.O / PFGC.K / NVCR.O / OMF / 100088979 / IAC.O / TTD.O / USFD.K / UAA / GOOS.TO / SNAP.K / CDEV.O / CVNA.K / HESM.K / IQV / PEP.O / XEL.O / INSP.K / EVRG.K / NOMD.K / RAMP.K / AXNX.O / NWL.O / LNT.O / CPRI.K / UNFI.K / SWAV.O / LYFT.O / TPTX.O / UBER.K / PINS.K / FTCH.K / CHWY.K / EXC.O / BRBR.K / OAS.O / OMP.O / WTRG.K / BIPC.K / VRM.O / NARI.O / BEPC.K / SFT.O / EAR.O / DASH.N</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / Alliance Data Systems Corp / Ameren Corp / American Electric Power Company Inc / Avangrid Inc / Alcon AG / ALLETE Inc / Atmos Energy Corp / American Water Works Company Inc / American States Water Co / Autozone Inc / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Big Lots Inc / Brookfield Infrastructure Partners LP / Black Hills Corp / Boston Scientific Corp / Crown Holdings Inc / Celanese Corp / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / Chipotle Mexican Grill Inc / CMS Energy Corp / CenterPoint Energy Inc / Cooper Companies Inc / Campbell Soup Co / Callon Petroleum Co / Chesapeake Utilities Corp / Chevron Corp / California Water Service Group / Dominion Energy Inc / Danone SA / DCP Midstream LP / Discover Financial Services / Delek US Holdings Inc / Darden Restaurants Inc / DTE Energy Co / Duke Energy Corp / Devon Energy Corp / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / Enterprise Products Partners LP / Eversource Energy / Entergy Corp / FirstEnergy Corp / Floor & Decor Holdings Inc / General Mills Inc / Gap Inc / Home Depot Inc / Hawaiian Electric Industries Inc / HollyFrontier Corp / Hershey Co / Idacorp Inc / Johnson & Johnson / Kellogg Co / Keurig Dr Pepper Inc / Kimberly-Clark Corp / Coca-Cola Co / Kroger Co / Lowe's Companies Inc / Medtronic PLC / Marathon Petroleum Corp / Marathon Oil Corp / Microsoft Corp / Nextera Energy Partners LP / NiSource Inc / New Jersey Resources Corp / Nike Inc / OGE Energy Corp / O-I Glass Inc / ONEOK Inc / Olin Corp / PG&E Corp / Public Service Enterprise Group Inc / Penumbra Inc / Procter & Gamble Co / PNM Resources Inc / Pinnacle West Capital Corp / Portland General Electric Co / PPL Corp / Phillips 66 / PVH Corp / Pioneer Natural Resources Co / RH / Ralph Lauren Corp / Roper Technologies Inc / Stifel Financial Corp / South Jersey Industries Inc / J M Smucker Co / SJW Group / Southern Co / Spectrum Brands Holdings Inc / Spire Inc / Sempra Energy / Sensata Technologies Holding PLC / Constellation Brands Inc / Southwest Gas Holdings Inc / Stryker Corp / Sysco Corp / AT&T Inc / Molson Coors Beverage Co / Teleflex Inc / TreeHouse Foods Inc / Tapestry Inc / Travelers Companies Inc / United Parcel Service Inc / Valero Energy Corp / WEC Energy Group Inc / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Yum! Brands Inc / Amazon.com Inc / Beyond Meat Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / ONE Gas Inc / Kinder Morgan Inc / Edgewell Personal Care Co / NorthWestern Corp / Pebblebrook Hotel Trust / PBF Energy Inc / Sirius XM Holdings Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Northwest Natural Holding Co / Starbucks Corp / CH Robinson Worldwide Inc / BJ's Wholesale Club Holdings Inc / Ross Stores Inc / Expedia Group Inc / Dollar Tree Inc / Fortis Inc / Intuitive Surgical Inc / Emera Inc / Cheesecake Factory Inc / Nextera Energy Inc / Tractor Supply Co / Monster Beverage Corp / UMB Financial Corp / Merit Medical Systems Inc / O'Reilly Automotive Inc / Hain Celestial Group Inc / Signature Bank / NuVasive Inc / Dexcom Inc / Hydro One Ltd / Interactive Brokers Group Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / Fair Isaac Corp / Algonquin Power & Utilities Corp / Charles Schwab Corp / Pulmonx Corp / Adidas AG / Cheniere Energy Inc / Angi Inc / Matador Resources Co / Arcturus Therapeutics Holdings Inc / Meta Platforms Inc / Targa Resources Corp / PDC Energy Inc / Five Below Inc / Globus Medical Inc / Mondelez International Inc / Diamondback Energy Inc / MPLX LP / Simply Good Foods Co / Post Holdings Inc / Coty Inc / Sprouts Farmers Market Inc / Marriott International Inc / Alphabet Inc / Nevro Corp / Glaukos Corp / Wingstop Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / SeaSpine Holdings Corp / Ollie's Bargain Outlet Holdings Inc / Performance Food Group Co / Novocure Ltd / OneMain Holdings Inc / Huntington Bancshares Inc / IAC/Interactivecorp / Trade Desk Inc / US Foods Holding Corp / Under Armour Inc / Canada Goose Holdings Inc / Snap Inc / Centennial Resource Development Inc / Carvana Co / Hess Midstream LP / IQVIA Holdings Inc / PepsiCo Inc / Xcel Energy Inc / Inspire Medical Systems Inc / Evergy Inc / Nomad Foods Ltd / Liveramp Holdings Inc / Axonics Inc / Newell Brands Inc / Alliant Energy Corp / Capri Holdings Ltd / United Natural Foods Inc / Shockwave Medical Inc / Lyft Inc / Turning Point Therapeutics Inc / Uber Technologies Inc / Pinterest Inc / Farfetch Ltd / Chewy Inc / Exelon Corp / Bellring Brands Inc / Oasis Petroleum Inc / Oasis Midstream Partners LP / Essential Utilities Inc / Brookfield Infrastructure Corp / Vroom Inc / Inari Medical Inc / Brookfield Renewable Corp / Shift Technologies Inc / Eargo Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Distribution: Quick Thoughts Heading Into the Week of Distributors' Earnings</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CAH.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 4Q20 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Still the Premium Player Among COVID-19 Vaccines; PT to $206</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA=US / MRK=US / PFE=US / JNJ=US / NVAX=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / Pfizer Inc / Johnson & Johnson / Novavax Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccines vs variants; IND cleared for PASG</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PASG.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 1.29.21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Jan. 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CHE=US / HUM=US / BSX=US / CSII=US / LLY=US / ABT=US / AMGN=US / GBT=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / SYK=US / RMD=US / RAD=US / HCA=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CYH=US / EW=US / GEN=US / LH=US / LIFE=US / PHAR=US / PRVL=US / SILK=US / USPH=US / UTHR=US / UHS=US / SGEN=US / SAGE=US / OPT=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CASI=US / SLF=US / BIIB=US / MRNA=US / MNKD=US / GOOG=US / LHCG=US / SNSS=US / CHNG=US / EHC=US / NMTR=US / SWAV=US / ADUS=US / IRWD=US / ACHC=US / AGIO=US / CTRE=US / AUPH=US / VBLT=US / NVRO=US / WBA=US / CLLS=US / EVH=US / CATB=US / PEN=US / BGNE=US / IRTC=US / ZEAL=US / ZLAB=US / FIXX=US / BHC=US / NBSE=US / PNTG=US</td><td class="leftalignment">Chemed Corp / Humana Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Resmed Inc / Rite Aid Corp / HCA Healthcare Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Pharming Group NV / Porvair PLC / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / CASI Pharmaceuticals Inc / Sun Life Financial Inc / Biogen Inc / Moderna Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Shockwave Medical Inc / Addus Homecare Corp / Ironwood Pharmaceuticals Inc / Acadia Healthcare Company Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Walgreens Boots Alliance Inc / Cellectis SA / Evolent Health Inc / Astria Therapeutics Inc / Penumbra Inc / Beigene Ltd / iRhythm Technologies Inc / Zealand Pharma A/S / Zai Lab Ltd / Homology Medicines Inc / Bausch Health Companies Inc / NeuBase Therapeutics Inc / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">mRNA-1273 Stacks Up Well Versus the Emerging SARS-CoV-2 Vaccine Competition</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">NVAX Trial Results - There's Some Good News and Then Some Very Bad News</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">NVAX.OQ / PFE=US / SAN=FR / GSK=GB / AZN=US / JNJ=US / NVAX=US / MRNA=US / BNTX=US</td><td class="leftalignment">Novavax Inc / Pfizer Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MPWR=US / NDAQ=US / AAPL=US / IBM=US / BSX=US / LLY=US / ABT=US / INTC=US / ADI=US / MSFT=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / TXN=US / VZ=US / SYK=US / SMTC=US / SAP=US / URI=US / TSM=US / CCI=US / HELE=US / LSTR=US / SEIC=US / CMCSA=US / DISH=US / AVGO=US / CRUS=US / CREE=US / EW=US / LIFE=US / NOW=US / MNRO=US / MSI=US / PHAR=US / TYL=US / UTHR=US / WDC=US / SAGE=US / OPT=US / FB=US / SWKS=US / BIIB=US / MRNA=US / OLED=US / FRPT=US / SNSS=US / AXON=US / TEL=US / BX=US / OSS=US / MXL=US / TSLA=US / NXPI=US / TMUS=US / QRVO=US / CLLS=US / CATB=US / AKTS=US / FIXX=US / REZI=US / NBSE=US / HXGBY=US</td><td class="leftalignment">Monolithic Power Systems Inc / Nasdaq Inc / Apple Inc / International Business Machines Corp / Boston Scientific Corp / Eli Lilly and Co / Abbott Laboratories / Intel Corp / Analog Devices Inc / Microsoft Corp / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Texas Instruments Inc / Verizon Communications Inc / Stryker Corp / Semtech Corp / SAP SE / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / Helen of Troy Ltd / Landstar System Inc / SEI Investments Co / Comcast Corp / DISH Network Corp / Broadcom Inc / Cirrus Logic Inc / Wolfspeed Inc / Edwards Lifesciences Corp / aTyr Pharma Inc / ServiceNow Inc / Monro Inc / Motorola Solutions Inc / Pharming Group NV / Tyler Technologies Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / Opthea Ltd / Meta Platforms Inc / Skyworks Solutions Inc / Biogen Inc / Moderna Inc / Universal Display Corp / Freshpet Inc / Viracta Therapeutics Inc / Axon Enterprise Inc / TE Connectivity Ltd / Blackstone Inc / One Stop Systems Inc / Maxlinear Inc / Tesla Inc / NXP Semiconductors NV / T-Mobile US Inc / Qorvo Inc / Cellectis SA / Astria Therapeutics Inc / Akoustis Technologies Inc / Homology Medicines Inc / Resideo Technologies Inc / NeuBase Therapeutics Inc / Hexagon AB</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Germany / France / Ireland / Netherlands / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Pulse Call: 10 Insights from REGN Infectious Diseases Guru About COVID Variants</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN=US / PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Highlights: mRNA Vaccines Maintain Safety Profile, Adeno Efficacy Up Next</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">More Data on Potential Impact of SARS-COV-2 Variants on BNT162b2 Protection</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BNTX=US / PFE=US / MRNA=US</td><td class="leftalignment">BioNTech SE / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">SMID-Cap Names for 1H21; High Conviction Ideas</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LIFE=US / PHAR=US / UTHR=US / OPT=US / MRNA=US / SNSS=US / CLLS=US / CATB=US / NBSE=US</td><td class="leftalignment">aTyr Pharma Inc / Pharming Group NV / United Therapeutics Corp / Opthea Ltd / Moderna Inc / Viracta Therapeutics Inc / Cellectis SA / Astria Therapeutics Inc / NeuBase Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / France / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOLs' Views of Emerging SARS-CoV-2 Strains: Regulatory & Clinical Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccinations from end-February, seniors from late March</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナウイルス：ワクチン接種は2月末からスタート、高齢者は3月下旬から</td><td class="leftalignment">Japanese</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: MRNA - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRNA</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">SP Angel</td><td class="leftalignment">SP Angel Healthcare Conditions- 26-01-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRNA.OQ / FARN.L / GB00BLF79J41</td><td class="leftalignment">Moderna Inc / Faron Pharmaceuticals Oy / Abingdon Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Finland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Global</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Vadim Alexandre / Liam Gascoigne-Cohen</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: COVID19 Vaccine Supply Targets Intact</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD / Chuck Whitesell / Mr. Nick M. Abbott / Mr. Yanan Zhu / Joseph Poen</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AIMC=US / RXT=US / IBM=US / FDX=US / AMGN=US / MSFT=US / AMZN=US / INCY=US / SBH=US / CONE=US / SAP=US / TSM=US / UPS=US / NCR=US / DRRX=US / EQIX=US / GGG=US / ACN=US / STX=US / MRNA=US / GOOG=US / DLR=US / 005930-KR=US / DXC=US / 115525734</td><td class="leftalignment">Altra Industrial Motion Corp / Rackspace Technology Inc / International Business Machines Corp / FedEx Corp / Amgen Inc / Microsoft Corp / Amazon.com Inc / Incyte Corp / Sally Beauty Holdings Inc / CyrusOne Inc / SAP SE / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / NCR Corp / DURECT Corp / Equinix Inc / Graco Inc / Accenture PLC / Seagate Technology Holdings PLC / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / Farfetch Ltd / DXC Technology Co / indie Semiconductor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / Taiwan / United States</td><td class="leftalignment">Biotechnology / Financial Services / Household Products / Machinery / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">"Fahrenheit 351" - COVID Vaccine Alarm Bells Go Off Again</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Emerging Viral Strains Reopen Debates on Vaccine Efficacy & Endpoints</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA=US / PFE=US / BNTX=US</td><td class="leftalignment">Moderna Inc / Pfizer Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CCK / CCO / CLR / CNI / COO / CP / CPE / DIS / DUK / DVN / EOG / ETM / GBX / IPG / MGY / MPC / MRO / NSC / OI / OMC / PXD / SM / SYY / TRN / UNP / WAB / WLL / WWE / SBGI.O / GTN / SIRI.O / CONE.O / LPI / NFLX.O / NXST.O / VIAC.O / DISCA.O / MRNA.O / AMCX.O / MTDR.K / PDCE.O / FANG.O / FOXA.O / HMTV.O / TGNA.K / PFGC.K / ALLY.K / CSX.O / GATX.K / USFD.K / LGFb.N / CDEV.O / CVNA.K / BOMN.O / ROKU.O / SPOT.K / SSP.O / IHRT.O / OAS.O / VRM.O / SFT.O</td><td class="leftalignment">Crown Holdings Inc / Clear Channel Outdoor Holdings Inc / Continental Resources Inc / Canadian National Railway Co / Cooper Companies Inc / Canadian Pacific Railway Ltd / Callon Petroleum Co / Walt Disney Co / Duke Energy Corp / Devon Energy Corp / EOG Resources Inc / Audacy Inc / Greenbrier Companies Inc / Interpublic Group of Companies Inc / Magnolia Oil & Gas Corp / Marathon Petroleum Corp / Marathon Oil Corp / Norfolk Southern Corp / O-I Glass Inc / Omnicom Group Inc / Pioneer Natural Resources Co / SM Energy Co / Sysco Corp / Trinity Industries Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Whiting Petroleum Corp / World Wrestling Entertainment Inc / Sinclair Broadcast Group Inc / Gray Television Inc / Sirius XM Holdings Inc / CyrusOne Inc / Laredo Petroleum Inc / Netflix Inc / Nexstar Media Group Inc / ViacomCBS Inc / Discovery Inc / Moderna Inc / AMC Networks Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Fox Corp / Hemisphere Media Group Inc / Tegna Inc / Performance Food Group Co / Ally Financial Inc / CSX Corp / GATX Corp / US Foods Holding Corp / Lions Gate Entertainment Corp / Centennial Resource Development Inc / Carvana Co / Boston Omaha Corp / Roku Inc / Spotify Technology SA / E W Scripps Co / iHeartMedia Inc / Oasis Petroleum Inc / Vroom Inc / Shift Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Brief of Moderna Inc conference call, Jan. 25, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">MRNA.OQ - Event Transcript of Moderna Inc conference call, Jan. 25, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRNA.OQ</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">MRNA: Evidence of Activity Against SARS-CoV-2 Variants, But Headwinds Remain</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD / Chuck Whitesell / Mr. Nick M. Abbott / Mr. Yanan Zhu / Joseph Poen</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">mRNA-1273 Retains Activity Against Emergent SARS-CoV-2 Strains; Merck Out</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Edward A. Tenthoff / Kristin Ko, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LJPC=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">La Jolla Pharmaceutical Co / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Moderna, Inc.(MRNA) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">60770K107</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine from GRTS; TSHA designations</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GRTS.OQ / TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">A / AEE / AIG / AJG / ALL / AM / AON / BAC / BAX / BKR / CB / CCO / CLX / COF / CPB / DANO.PA / DG / DVN / EOG / ETM / FDX / GIS / HD / HIG / HSY / IPG / K / KMB / LNC / LOW / MCHP.O / MET / MGY / MMC / NGL / NOV / OMC / PE / PGR / PKI / PRU / PXD / RE / RMBS.O / RNR / SHW / SJM / SON / THS / TRV / TT / UNP / BYND.O / ASB / BRO / AAPL.O / ENB.TO / INTU.O / MXL / SBUX.O / BJ.N / CHH.N / SNPS.O / EXPE.O / DLTR.O / SLGN.O / AXS / GEF / HOLX.O / TRP.N / ACGL.O / UMPQ.O / HAIN.O / NFLX.O / SWKS.O / AINV.O / DENN.O / CDNS.O / PPL.TO / ULTA.O / MRNA.O / SCHW.K / NXPI.O / KEY.TO / GEI.TO / ARCT.O / FIVE.O / MDLZ.O / FANG.O / SMPL.O / UIHC.O / POST.K / VOYA.K / SFM.O / BANC.K / QRVO.O / KHC.O / OLLI.O / CSX.O / WLTW.O / IAC.O / FHB.O / USFD.K / BHF.O / EYE.O / SFIX.O / EQH / AVT.O / NOMD.K / CPRI.K / RPAY.OQ / IHRT.O / FTCH.K / BRP.O / BRBR.K / ROOT.O / ALGM.O</td><td class="leftalignment">Agilent Technologies Inc / Ameren Corp / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Aon PLC / Bank of America Corp / Baxter International Inc / Baker Hughes Co / Chubb Ltd / Clear Channel Outdoor Holdings Inc / Clorox Co / Capital One Financial Corp / Campbell Soup Co / Danone SA / Dollar General Corp / Devon Energy Corp / EOG Resources Inc / Audacy Inc / FedEx Corp / General Mills Inc / Home Depot Inc / Hartford Financial Services Group Inc / Hershey Co / Interpublic Group of Companies Inc / Kellogg Co / Kimberly-Clark Corp / Lincoln National Corp / Lowe's Companies Inc / Microchip Technology Inc / MetLife Inc / Magnolia Oil & Gas Corp / Marsh & McLennan Companies Inc / NGL Energy Partners LP / Nov Inc / Omnicom Group Inc / Premier Enterprise PCL / Progressive Corp / PerkinElmer Inc / Prudential Financial Inc / Pioneer Natural Resources Co / Everest Re Group Ltd / Rambus Inc / Renaissancere Holdings Ltd / Sherwin-Williams Co / J M Smucker Co / Sonoco Products Co / TreeHouse Foods Inc / Travelers Companies Inc / Trane Technologies PLC / Union Pacific Corp / Beyond Meat Inc / Associated Banc-Corp / Brown & Brown Inc / Apple Inc / Enbridge Inc / Intuit Inc / Maxlinear Inc / Starbucks Corp / BJ's Wholesale Club Holdings Inc / Choice Hotels International Inc / Synopsys Inc / Expedia Group Inc / Dollar Tree Inc / Silgan Holdings Inc / AXIS Capital Holdings Ltd / Greif Inc / Hologic Inc / TC Energy Corp / Arch Capital Group Ltd / Umpqua Holdings Corp / Hain Celestial Group Inc / Netflix Inc / Skyworks Solutions Inc / Apollo Investment Corp / Denny's Corp / Cadence Design Systems Inc / Pembina Pipeline Corp / Ulta Beauty Inc / Moderna Inc / Charles Schwab Corp / NXP Semiconductors NV / Keyera Corp / Gibson Energy Inc / Arcturus Therapeutics Holdings Inc / Five Below Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / United Insurance Holdings Corp / Post Holdings Inc / Voya Financial Inc / Sprouts Farmers Market Inc / Banc of California Inc / Qorvo Inc / Kraft Heinz Co / Ollie's Bargain Outlet Holdings Inc / CSX Corp / Willis Towers Watson PLC / IAC/Interactivecorp / First Hawaiian Inc / US Foods Holding Corp / Brighthouse Financial Inc / National Vision Holdings Inc / Stitch Fix Inc / Equitable Holdings Inc / Avnet Inc / Nomad Foods Ltd / Capri Holdings Ltd / Repay Holdings Corp / iHeartMedia Inc / Farfetch Ltd / BRP Group Inc / Bellring Brands Inc / Root Inc / Allegro Microsystems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / Ireland / Netherlands / Thailand / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMTK=US / VERU=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / GBT=US / MDT=US / DYN=US / WMT=US / CMS=US / GILD=US / DGX=US / NVS=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CSTL=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / PHG=US / LH=US / REGN=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / CCRN=US / CNC=US / ACA=US / STSA=US / NTRA=US / ENSG=US / MIST=US / MD=US / NKTR=US / SLF=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / TPTX=US / IVA=US / EHC=US / NEO=US / ADUS=US / BEAM=US / ACHC=US / SRPT=US / AGIO=US / FATE=US / VCYT=US / CTRE=US / WBA=US / NVTA=US / VKTX=US / EVH=US / VRAY=US / MDGL=US / IRTC=US / NCNA=US / GH=US / ARVN=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / APLT=US / IDYA=US / BCYC=US / BCEL=US / KRTX=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PNTG=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">DermTech Inc / Veru Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Dyne Therapeutics Inc / Walmart Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Castle Biosciences Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Satsuma Pharmaceuticals Inc / Natera Inc / Ensign Group Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Inventiva SA / Encompass Health Corp / Neogenomics Inc / Addus Homecare Corp / Beam Therapeutics Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Veracyte Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Viking Therapeutics Inc / Evolent Health Inc / ViewRay Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / NuCana PLC / Guardant Health Inc / Arvinas Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Atreca Inc / Karuna Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Pennant Group Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Coronavirus/Covid-19 Monitor - January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AM / BAC / BAX / CLX / COF / ETM / FDX / HD / KMB / LOW / MCHP.O / PKI / SHW / SON / SBUX.O / BJ.N / CHH.N / EXPE.O / SLGN.O / GEF / HOLX.O / AINV.O / DENN.O / ULTA.O / MRNA.O / SCHW.K / ARCT.O / OLLI.O / FHB.O / USFD.K / EYE.O / SFIX.O / CPRI.K / IHRT.O / FTCH.K</td><td class="leftalignment">Antero Midstream Corp / Bank of America Corp / Baxter International Inc / Clorox Co / Capital One Financial Corp / Audacy Inc / FedEx Corp / Home Depot Inc / Kimberly-Clark Corp / Lowe's Companies Inc / Microchip Technology Inc / PerkinElmer Inc / Sherwin-Williams Co / Sonoco Products Co / Starbucks Corp / BJ's Wholesale Club Holdings Inc / Choice Hotels International Inc / Expedia Group Inc / Silgan Holdings Inc / Greif Inc / Hologic Inc / Apollo Investment Corp / Denny's Corp / Ulta Beauty Inc / Moderna Inc / Charles Schwab Corp / Arcturus Therapeutics Holdings Inc / Ollie's Bargain Outlet Holdings Inc / First Hawaiian Inc / US Foods Holding Corp / National Vision Holdings Inc / Stitch Fix Inc / Capri Holdings Ltd / iHeartMedia Inc / Farfetch Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Adam Muro / Alexandra Green / Anne Bode</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Genetic Medicine 4Q20 Earnings Preview and Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">ABEO=US / ADVM=US / BLUE=US / ALVR=US / ARWR=US / MRNA=US / ALNY=US / AVRO=US / RGNX=US / WVE=US / IONS=US / NTLA=US / RCKT=US / BBIO=US / SIOX=US</td><td class="leftalignment">Abeona Therapeutics Inc / Adverum Biotechnologies Inc / bluebird bio Inc / Allovir Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / AVROBIO Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Ionis Pharmaceuticals Inc / Intellia Therapeutics Inc / Rocket Pharmaceuticals Inc / BridgeBio Pharma Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Singapore / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: 2020 Short-Side Winners\Losers</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">TSLA.OQ / BA.N / BAC.N / DAL.N / JPM.N / MCK.N / OMC.N / OXY.N / SE.N / T.N / WFC.N / SPG.N / W.N / ENB.TO / TRP.TO / XOM.N / MAC.N / ET.N / CVX.N / NIO.N / AAPL.OQ / MSFT.OQ / ZION.OQ / AMZN.OQ / ICPT.OQ / NVDA.OQ / PLUG.OQ / AMRN.OQ / NFLX.OQ / MRNA.OQ / AMD.OQ / ENPH.OQ / FB.OQ / WDIG.F / SHOP.TO / ZG.OQ / SQ.N / TWLO.N / TTD.OQ / SNAP.N / CVNA.N / MDB.OQ / PDD.OQ / UAL.OQ / ZM.OQ / RTX.N / NKLA.OQ / 9618.HK / LC0Ay.MU</td><td class="leftalignment">Tesla Inc / Boeing Co / Bank of America Corp / Delta Air Lines Inc / JPMorgan Chase & Co / Mckesson Corp / Omnicom Group Inc / Occidental Petroleum Corp / Sea Ltd / AT&T Inc / Wells Fargo & Co / Simon Property Group Inc / Wayfair Inc / Enbridge Inc / TC Energy Corp / Exxon Mobil Corp / Macerich Co / Energy Transfer LP / Chevron Corp / NIO Inc / Apple Inc / Microsoft Corp / Zions Bancorporation NA / Amazon.com Inc / Intercept Pharmaceuticals Inc / NVIDIA Corp / Plug Power Inc / Amarin Corporation PLC / Netflix Inc / Moderna Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Meta Platforms Inc / Wirecard AG / Shopify Inc / Zillow Group Inc / Block Inc / Twilio Inc / Trade Desk Inc / Snap Inc / Carvana Co / MongoDB Inc / Pinduoduo Inc / United Airlines Holdings Inc / Zoom Video Communications Inc / Raytheon Technologies Corp / Nikola Corp / JD.Com Inc / Luckin Coffee Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">PTON=US / VERU=US / INTC=US / AMD=US / AMZN=US / T=US / DYN=US / BAC=US / GILD=US / NVDA=US / GS=US / NICE=US / CHKP=US / TSM=US / SPOT=US / CYBR=US / MS=US / REGN=US / UTHR=US / VRTX=US / WIX=US / RDWR=US / OPT=US / NET=US / MTCH=US / STSA=US / NFLX=US / VRNT=US / MIST=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / VIAC=US / TPTX=US / IVA=US / SWI=US / FTNT=US / TSLA=US / BEAM=US / XYL=US / PANW=US / SRPT=US / FEYE=US / FATE=US / VRNS=US / GDDY=US / OKTA=US / SAIL=US / IQ=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / TUFN=US / APLT=US / IDYA=US / BCYC=US / CRWD=US / BCEL=US / KRTX=US / PING=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">Peloton Interactive Inc / Veru Inc / Intel Corp / Advanced Micro Devices Inc / Amazon.com Inc / AT&T Inc / Dyne Therapeutics Inc / Bank of America Corp / Gilead Sciences Inc / NVIDIA Corp / Goldman Sachs Group Inc / Nice Ltd / Check Point Software Technologies Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Spotify Technology SA / Cyberark Software Ltd / Morgan Stanley / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Radware Ltd / Opthea Ltd / Cloudflare Inc / Match Group Inc / Satsuma Pharmaceuticals Inc / Netflix Inc / Verint Systems Inc / Milestone Pharmaceuticals Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Inventiva SA / SolarWinds Corp / Fortinet Inc / Tesla Inc / Beam Therapeutics Inc / Xylem Inc / Palo Alto Networks Inc / Sarepta Therapeutics Inc / Mandiant Inc / Fate Therapeutics Inc / Varonis Systems Inc / GoDaddy Inc / Okta Inc / SailPoint Technologies Holdings Inc / iQIYI Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Tufin Software Technologies Ltd / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / CrowdStrike Holdings Inc / Atreca Inc / Karuna Therapeutics Inc / Ping Identity Holding Corp / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Info. Tech./Software / Machinery / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback from Early 2021 Large/Mid-Cap Biotech Presentations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US / REGN=US / UTHR=US / VRTX=US / MRNA=US / SRPT=US</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAC / CCO / CMA / CNI / CP / CPB / DANO.PA / EOG / ETM / FMC / GIS / HSY / IPG / K / MRO / NSC / OMC / SHW / SJM / SM / TFX / THS / UNP / BYND.O / GILD.O / AMGN.O / AAPL.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / AXS / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / HAIN.O / BIIB.O / INFI.O / HALO.O / NOG.A / MRNA.O / ARCT.O / MDLZ.O / FANG.O / SMPL.O / POST.K / FATE.O / AFMD.O / BLCM.O / KHC.O / CYAD.O / OMF / CSX.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / NOMD.K / KZR.O / STRO.O / IHRT.O / IMV.O / BRBR.K / RAPT.O</td><td class="leftalignment">Bank of America Corp / Clear Channel Outdoor Holdings Inc / Comerica Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Campbell Soup Co / Danone SA / EOG Resources Inc / Audacy Inc / FMC Corp / General Mills Inc / Hershey Co / Interpublic Group of Companies Inc / Kellogg Co / Marathon Oil Corp / Norfolk Southern Corp / Omnicom Group Inc / Sherwin-Williams Co / J M Smucker Co / SM Energy Co / Teleflex Inc / TreeHouse Foods Inc / Union Pacific Corp / Beyond Meat Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / AXIS Capital Holdings Ltd / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Hain Celestial Group Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Northern Oil and Gas Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / Post Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Kraft Heinz Co / Celyad Oncology SA / OneMain Holdings Inc / CSX Corp / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Nomad Foods Ltd / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Bellring Brands Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / France / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Moderna climbs 10.9% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRNA.O</td><td class="leftalignment">Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CCO / ETM / IPG / OMC / SHW / TFX / GILD.O / AMGN.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ARCT.O / FATE.O / AFMD.O / BLCM.O / CYAD.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / KZR.O / STRO.O / IHRT.O / IMV.O / RAPT.O</td><td class="leftalignment">Clear Channel Outdoor Holdings Inc / Audacy Inc / Interpublic Group of Companies Inc / Omnicom Group Inc / Sherwin-Williams Co / Teleflex Inc / Gilead Sciences Inc / Amgen Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Celyad Oncology SA / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Anne Bode</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KRYS=US / ADAP=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / LOGC=US / MGEN=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US</td><td class="leftalignment">Krystal Biotech Inc / Adaptimmune Therapeutics PLC / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / LogicBio Therapeutics Inc / Viridian Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Could Upcoming CF Readout Validate mRNA for Chronic Disease?</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRNA=US / BNTX=US</td><td class="leftalignment">Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : Putting a Wrap on The 2021 Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CVS.N / JNJ.N / MCK.N / PFE.N / GILD.O / AMGN.O / INCY.O / ALKS.O / BMRN.O / REGN.O / VRTX.O / RARE.O / BLUE.O / NVAX.O / SGEN.O / BIIB.O / ACAD.O / MRNA.O / CLVS.O / SAGE.O / GBT.O / NVCR.O / EDIT.O / PBYI.O / JNCE.O / ALLO.O / BNTX.O / LEGN.O / BCAB.O</td><td class="leftalignment">CVS Health Corp / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Alkermes Plc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Novavax Inc / Seagen Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / Editas Medicine Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc / BioNTech SE / Legend Biotech Corp / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe</td></tr>
</tbody></table>
</body>
</html>